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Testis development and function involve multiple cell types and require complex cellular 
interactions and signaling cascades; hence, the study of these processes necessitates improvement 
of ex situ models of testicular cells or tissue. Accordingly, objectives of the first and second studies 
in this thesis were to improve in vitro culture of testis cells by testing the effects of various culture 
components on proliferation, colony-formation, and potency of germline stem cells. The examined 
components included different media, serum types, and several key growth factors, tested in 
sequential experiments using a factorial design. The third study focused on assessment of 
pluripotency of cultured neonatal porcine gonocytes and their potential to trans-differentiae into 
somatic cells of different cell lineages. The goal of our fourth study was to investigate the 
feasibility of applying ultrasound biomicroscopy (UBM) for the assessment of testis tissue grafts 
and cell implants by initially validating its use in a short-term study. In the fifth study, we examined 
repeated application of UBM in a longitudinal manner to test its reliability and accuracy in 
representing the developmental changes in grafts and implants. As a result, we showed increased 
proliferation of porcine gonocytes with a given culture condition combination (DMEM+15% 
FBS), followed by attainment of pluripotency markers by cultured gonocytes and their colonies, 
indicative of their spontaneous transformation into a pluripotent state. Supplementation of certain 
growth factors at a given concentration to the base media also led to further increases in gonocyte 
numbers and colony diameters, while maintaining their expression of pluripotency and germ cell 
markers. We also observed successful derivation of somatic cells of different lineages from germ 
cell originated-pluripotent stem cells. Furthermore, application of UBM for non-invasive in vivo 
developmental study of testicular grafts and implants was shown to be accurate and reliable, 
thereby reducing the number of animals needed in future similar experiments. Taken together, the 
studies describe improved germ cell culture conditions, transformation of gonocytes into a 
pluripotent state, as well as validating and using UBM as an accurate and reliable tool for in vivo 
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Male germline stem cells (MGSCs) are a unique germ cell population owing to their dual potential 
for self-renewal and differentiation into specialized germ cells (Culty 2009). Primordial germ cells 
(PGCs) are the primitive MGSC population that migrate to the undifferentiated gonads and 
undergo spermatogenic pathway in the male embryo (Saitou and Yamaji 2012). Following 
colonization, PGCs give rise to a new germ cell population, known as gonocytes, which correspond 
to the fetal and neonatal germ cells between PGCs and spermatogonial stem cells (SSCs). Despite 
their importance in the continuity of species and a wide range of potential applications, our 
knowledge of factors affecting the proliferation or differentiation of MGSCs is far from complete. 
This is mainly due to the complexity of their microenvironment and inaccessibility to MGSCs in 
situ. Therefore, reliable new or improved in vivo and in vitro models are required to overcome the 
limitations associated with the study and manipulation of MGSCs.  
Once gonocytes develop from PGCs, their lifespan extends into early postnatal period. In rodents, 
being the frequently-used animal models for the studies on germ cells, gonocytes can be identified 
up to 2 weeks after birth, while in primates this period is extended up to several months (Markert 
1979). These cells are progenitors of spermatogonial stem cells (SSCs), known as the life-long 
reservoir of germline stem cells (Culty 2013). Gonocytes in the neonatal testis are the preferred 
source for use in the study and manipulation of MGSCs because of their greater proportion to other 
germ cells, unique morphological features, and specific markers, making them easily identifiable 
(Jiang and Short 1998; Jiang 2001; Goel et al. 2007; Culty 2009; Honaramooz and Yang 2011; 
Awang-Junaidi and Honaramooz 2018; Sahare et al. 2018). However, in rodents and pigs 
gonocytes still make up only ~2% and ~7% of the testis cell populations, respectively 
(Honaramooz et al. 2005; Lee et al. 2013) and as such, utilization of highly efficient methods for 
their isolation and enrichment is necessary prior to their application. As such, thus far, a diverse 
range of methods have been developed for enrichment of germ cells including culturing, 
differential plating, magnetic activated cell soring (MACS), and fluorescence activated cell sorting 
(FACS), combined with utilizing cell-specific markers (Nagano et al. 1998; Goel et al. 2007; 
Hamra et al. 2008; Kim et al. 2010; Younan et al. 2010). A testis cell isolation method has also 





gonocytes and 60% somatic cells. Isolated testis cells can even undergo further enrichment to yield 
to a cell population consisting of ~90% gonocytes using density gradient centrifugation and 
differential plating (Yang et al. 2010; Honaramooz and Yang 2011).  
In vitro culture is one of the feasible approaches to increase the gonocyte numbers prior to their 
application. It also provides a means to study the underlying factors involved in gonocyte 
proliferation and differentiation (Park et al. 2017; Sakib et al. 2019). Being the primitive/early 
germ cells, both gonocytes and spermatogonia have been the focus of many in vitro studies in 
rodents. In piglets, however, gonocytes are the main germ cells in the neonatal testes (Goel et al. 
2007), while little is known about the exact timing of their transformation into spermatogonia 
(Kanatsu-Shinohara et al. 2014; Almunia et al. 2018). Furthermore, due to similarities between 
human and porcine testicular structure and pathophysiology, pigs have been used as suitable 
models for in vitro studies targeting germ cells (Piquet-Pellorce et al. 2000; Kubota et al. 2004, 
2011; Goel et al. 2007; Kim and Belmonte 2011; Sato et al. 2011; Kanatsu-Shinohara and 
Shinohara 2013; Sahare et al. 2016, 2018). However, there are still challenges associated with in 
vitro propagation of porcine gonocytes. These cells are largely affected by their milieu and thereby, 
their successful culture depends on establishment of a supportive microenvironment in which they 
ideally maintain their germ- and stem cell potential (Nagano et al. 2001; Hamra et al. 2002; 
Kanatsu-Shinohara, Toyokuni et al. 2004a; Goel et al. 2007).  
Two main components of most culture conditions are media and serum which can directly affect 
the survival and proliferation of germ cells. Therefore, to find the best media composition which 
can optimally support gonocyte survival and propagation and to improve our previously-
established culture conditions, in Chapter 3 of the present thesis we tested the effects of 6 different 
media combined with two sources of serum supplements, fetal bovine serum (FBS) and/or knock-
out serum replacement (KSR) (Awang-Junaidi and Honaramooz 2018). We then used our 
optimized conditions as a base to further enhance gonocyte proliferation and colony-formation by 
testing the effects of 24 groups of growth factor supplementation (Chapter 4). 
When cultured, gonocytes form clusters and large 3-D colonies, which resemble embryonic stem 
(ES) cell colonies (Kuijk et al. 2009; Mirzapour et al. 2012; Awang‐Junaidi et al. 2020). Some 
reports have also shown expression of pluripotency-determining factors by cultured germ cells of 





spontaneous reprogramming of cultured MGSCs into a pluripotent state (Kanatsu-Shinohara, 
Inoue et al. 2004; Goel et al. 2007; Ko et al. 2009; Kim and Belmonte 2011). As such, cultured 
germ cells can potentially be used as alternatives for existing pluripotent stem cells for in vitro 
differentiation into various cell types (Kim and Belmonte 2011; Wang et al. 2015). This is 
especially important due to ethical issues and general concerns regarding the use of ES cells or 
induced pluripotent stem (iPS) cells as a source for cell-based therapy and regenerative medicine. 
We also showed expression of pluripotency-determining factors by cultured gonocytes in our 
refined culture conditions in Chapter 3 and 4 and concluded that these cells undergo spontaneous 
reprogramming into more primitive developmental stages in vitro. As such, we designed and 
carried out additional experiments in Chapter 5 to confirm the pluripotency of cultured gonocytes 
using an in vivo implantation assay and directed their trans-differentiation towards cell derivatives 
from all three germinal layers (i.e., endoderm, mesoderm, and ectoderm). 
Beside in vitro culture systems, several in vivo models have been developed and improved over 
time to gain a deeper understating of testis development and function (Dufour et al. 2002; 
Honaramooz et al. 2002; Honaramooz et al. 2007; Awang-Junaidi et al. 2020). Among different 
models, testis tissue xenografting (TTX) and testis cell aggregate implantation (TCAI) have 
offered alternative in vivo strategies for the study of male gonadal development, spermatogenesis, 
steroidogenesis, and cell-cell interactions within an ex situ testis model from a wide range of 
animals species (Honaramooz et al. 2002; Dobrinski 2007; Ibtisham and Honaramooz 2020). 
In TTX, small pieces of testis tissue from immature donor species, grafted into immunodeficient 
recipient mice developed into functional tissue and produced fertilization competent sperm 
(Honaramooz et al. 2002). Porcine testis tissue was used in the first attempts of TTX (Honaramooz 
et al. 2002), and thereafter, a range of species were used as donors showing that this regeneration 
potential is retained among donor species (Honaramooz 2014). As such, TTX provided an 
invaluable approach for fundamental study of testis development and function in diverse 
mammalian species and opened new windows of opportunity for conservation of endangered 
species as well as preservation of fertility potential of testis cancer patients whose survival depends 
upon gonadotoxic treatments (Ibtisham and Honaramooz 2020; Ibtisham et al. 2020). TCAI has 
been another invaluable approach to study testicular development and potential factors affecting 





donor piglets into the subcutaneous tissue of recipient mice. The cell aggregates were prepared by 
enzymatic digestion of testis parenchyma, underwent extensive rearrangements following 
implantation and developed into a functional testis tissue (Honaramooz et al. 2007). Formation of 
testis tissue has been also observed using immature donor mouse, rat, pig, sheep, cattle, peccary, 
and marmoset testis cells (Gassei et al. 2006; Honaramooz et al. 2007; Kita et al. 2007; Arregui et 
al. 2008; Aeckerle et al. 2013; Sharma et al. 2018). This model allowed manipulation of testis 
development and can be used to gain a better understanding of testis morphogenesis (Honaramooz 
et al. 2007). 
An important aspect of TTX and TCAI studies is evaluation of the grafts and implants, which has 
been dependent upon surgical retrieval of samples followed by (immuno)histological analysis. As 
such, in initial TTX and TCAI experiments, sample assessment was limited to the time of 
euthanasia of the recipients (Honaramooz, et al. 2002; Honaramooz et al. 2007). Later, recipients 
underwent multiple surgical sampling, allowing the same recipient to be used for obtaining several 
samples over time. Even though the latter approach provided a longitudinal assessment strategy, 
it was still invasive, required a large quantity of recipients, and could pose a high risk of infection 
(Abbasi and Honaramooz 2011a,b, 2012; Fayaz et al. 2020a,b). Additionally, obtained samples 
had to be processed for (immuno)histological evaluation, leading to inaccurate measurements. 
Another limitation of surgical sampling for evaluation purposes is limited number of grafts and 
implants per recipients (Honaramooz 2014). Therefore, we decided to establish a non-invasive 
approach to be able to visualize sample development without the need for surgical retrieval and 
histological evaluation by taking advantage from an ultrasound imaging system, known as 
ultrasound biomicroscopy (UBM), which offers high-definition images of the tissues at 
microscopic resolutions. 
Among different imaging modalities, UBM is a non-invasive approach for real-time assessment 
of organs and tissues at high magnifications (Greco et al. 2012). This imaging system has been 
widely used with great precision in various clinical and research fields, including reproductive 
biology (Baerwald et al. 2009; Jaiswal et al. 2009; Mircea et al. 2009; Pfeifer et al. 2012, 2014). 
In the present work, we designed the first UBM experiment aimed at its validation using a short-
term assessment of grafts and implants (Chapter 5). Given the accuracy of this method in providing 





utilized this monitoring approach for long-term evaluation of grafts and implants in a second UBM 
experiment (Chapter 6). In the latter longitudinal evaluation, we also compared de novo testis 
morphogenesis among craniocaudal implantation locations and compared graft vs. implant 
development mainly by using UBM.  
Rodents are traditional animal models in biomedicine which allow basic genetic manipulations 
with high reproducibility and are easily manageable in research facilities; however, they lack 
pathophysiological complexities of human body (Bassols et al. 2014). Pigs are considered as an 
alternative and well-suited animal model in translational research due to anatomical, physiological, 
genetic, and metabolic similarities to humans (Swindle et al. 2012). More specifically, similar 
physiology, protein distribution, structure and development of reproductive organs make them a 
suitable animal model for the study and manipulation of the testes (Swindle et al. 2012). Moreover, 
porcine gonocytes can be identified up to ~2 months after birth while in rodents these cells 
differentiate into spermatogonia in the first few days post-partum (dpp) (Russell 1980). 
Availability of gonocytes in the neonatal porcine testis for a longer period of time, their unique 
morphological features, and specific biomarkers for their identification make them a well-suited 
option among MGSCs to study physiology and manipulation of germline stem cells (de Rooij and 
Russell 2000; Meng et al. 2000a; Culty 2009; Awang-Junaidi and Honaramooz 2018). 
Overall, there are unravelled biological aspects in physiology of germ cells as well as numerous 
potential applications. However, complexities associated with in situ studies and manipulations of 
germ cells necessitate reliable development of refined alternative ex situ models. In the present 
thesis we set out to use novel optimized approaches to gain in-depth understanding of testis 
biology, morphogenesis, and cellular interplay. Thus, the overall objective of the present thesis 
was to gain a better understanding of the developmental potential of porcine testis cells and tissue 











LITERATURE REVIEW AND OBJECTIVES 
2.1. Physiology and Function of the Testis 
2.1.1. Prenatal Testis Development 
Sexual development in mammals is comprised of two separate processes known as sex 
determination and sexual differentiation. Sex determination is the process that establishes the 
sexual fate of an organism, which may be driven by a number of genetic and/or environmental 
cues, leading to structural changes and formation of either ovaries or testes from undifferentiated 
gonads (Luckenbach and Yamamoto 2018). Sexual differentiation is the period when gender-
specific structures such as gonads become established (Greenfield 2015; Capel 2017; Yang et al. 
2019). Among different species, the mouse is a well-studied animal model of mammalian gonadal 
development due to extensive work conducted on its embryos. Development of the gonads in other 
mammalian species is expected to follow the same pattern with small timing and anatomical 
differences (Wilhelm et al. 2007). Testis development is typically divided into two phases. The 
first phase culminates in formation of bipotential gonads, also known as the genital ridges and 
during the second phase, triggering of the testis-determining gene Sry leads to extensive cellular 
rearrangements and differentiation of the bipotential gonads into testes (Yang et al. 2019). During 
embryonic development, genital ridges arise from the intermediate mesoderm as a pair in the 
coelomic cavity and on either side of the dorsal mesentery at ~10.5 days post-coitum (dpc). These 
structures are formed by increased coelomic epithelial cell divisions on the ventromedial surface 
of the mesonephroi. Each mesonephros contains a mesonephric duct (Wolffian duct) which further 
develops into epididymis, vas deferens, and seminal vesicles in the male embryo. The female 
equivalent of mesonephric ducts known as the paramesonephric duct is also present in each 
mesonephros, and develops into oviduct, uterus, and vagina in the female embryo (Hannema and 
Hughes 2007; Shaw and Renfree 2014; Yang et al. 2019). Coelomic epithelial cell divisions on 
the ventromedial surface of the mesonephros create a dense, pseudostratified epithelial cell layer 
(Gropp and Ohno 1966; Pelliniemi 1974; Wartenberg et al. 1991). Gradually, the basement 
membrane of epithelial cells undergo fragmentation, allowing them to move dorsally towards the 





undergo epithelial to mesenchymal transition and later differentiate into somatic and stromal cells 
in the gonads (Karl and Capel 1998; Ito et al. 2006; Kusaka et al. 2010; Mork et al. 2012). 
Epithelial cells are present in early gonads and continue to delaminate from the coelomic 
epithelium up to ~11.5 dpc, forming the precursors of the supporting cells and steroid-secreting 
cells (Merchant-Larios et al. 1993; Karl and Capel 1998). 
In the developing gonads, PGCs can potentially produce both male and female germline (Yang et 
al. 2019). In response to chemoattractants released by somatic cells, this population of alkaline 
phosphatase-positive cells migrate from yolk sac to the base of allantois and colonize the gonads 
by ~7 dpc in mice or week 3-4 of gestation in humans (Lawson et al. 1999). About 45 PGCs initiate 
their migration to the gonads and establish the population of germline stem cells in the mouse 
(Lefebvre et al. 1997). During their migration, PGCs undergo extensive cell divisions and reach a 
population of ~3,000 cells by the time they arrive at the genital ridges. When located at the genital 
ridges, PGCs lose their motility while sustaining their self-renewal divisions. Colonization of 
PGCs in the indifferent gonads takes up to ~8.5-13.5 dpc in mice and week ~4.5 of gestation in 
humans (Wilhelm et al. 2007). PGCs express gene transcripts that are associated with the 
undifferentiated pluripotent state such as POU domain class 5 transcription factor 1 (POU5F1), 
also known as octamer-binding transcription factor 4 (OCT4) and alkaline-phosphatase (Wilhelm 
et al. 2007). These markers are also expressed in the inner cell mass (ICM) during initial stages of 
embryonic development. The cells of ICM are an established source of ES cells which can undergo 
infinite rounds of proliferation and are capable of differentiation into all tissues (Wilhelm et al. 
2007). Typically, once established from ES cells, primary germ layers lose their ability to express 
pluripotency-associated markers such as POU5F1 and alkaline-phosphatase (Lawson and Hage 
1994). However, expression of these markers is maintained in PGCs, thereby they can potentially 
be used for derivation of embryonic germ cell lines with similar properties to ES cells (McLaren 
et al. 1984; Wilhelm et al. 2007). Once in gonads, PGCs upregulate the genes required for 
gametogenesis and concurrently downregulate the expression of pluripotency-related gene 
transcripts. The regulation of gene expression in PGCs during their specialization is known as 
licensing (Stebler et al. 2004; Gill et al. 2011; Rolland et al. 2011; Seisenberger et al. 2012; 
Fayomi and Orwig 2018). Licensing of PGCs results in formation of a cell population known as 
gametogenesis-competent cells (GCCs) which can differentiate into male or female specialized 





During male embryonic development, sex-determining region Y (SRY) protein also known as 
testis determining factor (TDF), encoded by SRY gene, induces the production of regulatory 
proteins which direct the transformation of bipotential gonads towards testis formation, while 
absence of SRY results in formation of the female embryo (Gubbay et al. 1990; Sinclair et al. 
1990; Karl and Capel 1998). SRY triggers a cascade of gene expressions which ultimately lead to 
testis differentiation, first by encoding a transcription factor that can activate production of testis-
specific enhancer SRY-Box Transcription Factor 9 (SOX9) (Koopman et al. 1991; Vidal et al. 
2001; Wilhelm et al. 2007). Activation of SOX9 is essential for differentiation of somatic cell 
precursors to Sertoli cells (Koopman et al. 1990). Sertoli cells regulate differentiation of all other 
cell types in the gonad and organize gonadal structures during differentiation process (Karl and 
Capel 1998). Precursors of Sertoli cells originate from the pluripotent coelomic epithelial cells and 
are the first to differentiate in the gonad from bipotential precursor cells and as such, can be 
considered as early indicators of sexual differentiation during embryonic development (Wilhelm 
et al. 2007). In mice, SRY-positive cells first appear in the middle third or central regions of the 
indifferent gonads and gradually expand towards the poles (Albrecht and Eicher 2001; Bullejos 
and Koopman 2001; Wilhelm et al. 2007). SRY expression reaches a threshold at ~11 dpc, 
activates SOX9 expression, which in turn leads to pre-Sertoli cell differentiation and cord 
formation (Svingen and Koopman 2013). However, Sertoli cell differentiation does not happen 
synchronously in all parts of the developing gonad, which can explain ovotestis formation in 
abnormal conditions (Svingen and Koopman 2013). In the absence of SOX9, the precursor cells 
transform into specialized follicle cells, which normally happens during development of a female 
embryo (Albrecht and Eicher 2001). In response to SRY, high expression of SOX9 is maintained 
within Sertoli cells. Reaching a sufficient population of SOX9-positive cells triggers 
morphological changes of the indifferent gonad into testis (Warr and Greenfield 2012). These 
morphological changes include generation of interstitial cell lineages such as peritubular myoid 
cells (PMCs) and Leydig cells, mitotic arrest of germ cells, and formation of testis cords (Larney 
et al. 2014). SRY expression also results in formation of intercellular membrane connections and 
generation of gonadal cords around PGCs in the medulla (Patni et al. 2017). Peritubular myoid 
cells gradually appear on the outer side of the testis cords (Patni et al. 2017). SRY also activates 
FGF-9 expression, which is pivotal for increasing the SOX9-positive cell divisions. This in turn 





(Schmahl et al. 2000). FGF-9 is also crucial for development of testis cords as its absence interferes 
with in vitro testis cord formation (Hiramatsu et al. 2010). This is also shown by Fgf9-null mice 
displaying male to female sex reversal (Colvin et al. 2001; Kim et al. 2007; Bagheri-Fam et al. 
2008). FGF-9 suppresses the expression of pro-ovary genes such as Wnt family 4 (Wnt4) (Jameson 
et al. 2012). Formation of the gonadal ridges and differentiation of the bipotential gonads also 
involve extensive gene expression, including Wilms’ tumor suppressor 1 (WT1) (Kreidberg et al. 
1993; Hammes et al. 2001), LIM homeobox gene 9 (LHX9) (Birk et al. 2000), GATA-binding 
protein 4 (GATA4) (Hu et al. 2013), and empty spiracles homeobox gene 2 (EMX2) (Miyamoto et 
al. 1997). Homozygous null mutation of any of the above-mentioned genes show gonadal agenesis. 
Embryonic development of other organ systems is also dependent on these genes, thereby their 
mutation leads to a range of abnormal phenotypes beyond the reproductive system (Ingraham et 
al. 1994; Klamt et al. 1998; Hammes et al. 2001; Tevosian et al. 2015). 
SOX9 activation triggers both somatic cell specialization and their aggregation around clusters of 
germ cells, leading to de novo formation of testis cords (Svingen and Koopman 2013). At this 
time, somatic cells in close contact with the PGCs are called Sertoli cells. Once the population of 
PGCs arrive at the genital ridge and become surrounded by Sertoli cells they undergo 
morphological transformation and convert into a cell population known as M-prospermatogonia 
or more generally as gonocytes (Wilhelm et al. 2007). M-prospermatogonia retain their mitotic 
activity but before birth become mitotically inactive and are then called T1-prospermatogonia. The 
process of normal cord formation has been also shown to occur in gonads devoid of germ cells 
(Merchant 1975; Escalante-Alcalde and Merchant-Larios 1992; Merchant-Larios et al. 1993), 
indicating that cord formation depends on Sertoli cell interactions but not germ cell aggregation 
(Svingen and Koopman 2013). This process also requires changes to Sertoli cell surface molecules, 
enabling them to recognize each other, form aggregates and 3-D cordal tubes (Svingen and 
Koopman 2013). Formation of PGC-containing cords is a defining event in differentiation of the 
testis. These cords provide the basis for two important functions of the testis, namely 
spermatogenesis and steroidogenesis. Cords also prevent early exposure of gonocytes to retinoic 
acid (RA) which is present in the interstitium, and which otherwise can induce immature initiation 
of meiosis (McCoshen 1982, 1983; Escalante-Alcalde and Merchant-Larios 1992; Merchant-
Larios et al. 1993; Griswold and Behringer 2009). Sertoli cells play a pivotal role in survival and 





that influence the germline. For instance, Sertoli cells produce CYP26B1 which restricts entry of 
germ cells into early meiosis by catabolizing RA (Bowles et al. 2006; Koubova et al. 2006). 
Similarly, these cells release FGF-9 which also prevents the effects of RA on germ cells (Bowles 
and Koopman 2010) and triggers expression of Nodal coreceptor Cripto, which leads to 
maintenance of germ cell pluripotency and increases spermatogenic fate (Bowles and Koopman 
2010; Spiller et al. 2012). Activin A, transforming growth factor β (TGF-β), platelet-derived 
growth factor (PDGF), and estrogen are among other important supporting factors produced by 
Sertoli cells and are essential for pre- and post-natal survival as well as quiescence regulation of 
germ cell (Moreno et al. 2010; Mendis et al. 2011). 
About 13 cords are initially formed in the mouse gonads at ~12 dpc. These cords appear as a stack 
of circular cell organizations which later join to form 3-D tube-shaped structures (Svingen and 
Koopman 2013). Vascular endothelial cells which originate from the mesonephros are also crucial 
in formation of the gonadal cords since disruption of their migration interferes with normal cord 
formation (Coveney et al. 2008; Combes et al. 2009; Cool et al. 2011). Over time, Sertoli cells 
proliferate and establish stronger contacts with germ cells, which together, lead to cord elongation 
(Nel-Themaat et al. 2011). By ~13 dpc, cords are shaped into toroid structures. At this stage, the 
appearance of Sertoli cells changes from fibroblast-like to epithelial-like cells, PMCs form an outer 
layer on the cords, and the somatic cells develop an extracellular matrix (ECM) (Nel-Themaat et 
al. 2011). 
PMCs develop shortly after formation of testis cords and can be identified as early as ~13.5 dpc in 
mice and week ~12 of gestation in humans (Ostrer et al. 2007). PMCs were believed to originate 
from the migrating cells of the mesonephros, while more recent studies revealed that mesonephric 
cells can transform to endothelial cells but not PMCs in the differentiating gonads, and as such the 
origin of PMCs remains unknown (Buehr et al. 1993; Combes et al. 2009; Cool et al. 2011; Nurmio 
et al. 2012). Due to lack of cell-specific markers early identification of PMC remains a challenge. 
However, it is speculated that they arise from the intragonadal cells or coelomic epithelium 
(Campagnolo et al. 2001; Combes et al. 2009). PMCs form a single cell monolayer in smaller 
rodents, while in larger mammals they generate multiple cell layers separated by connective tissue 
(Maekawa et al. 1996). ECM and PMCs together form the lamina propria which acts as a 





the rete testis. In humans, this layer also contains myofibroblasts (Davidoff et al. 1990; Dym 1994; 
Holstein et al. 1996). 
The steroidogenic function of the testis depends on Leydig cells, making them crucial for the drive 
and maintenance of secondary sexual features. Due to their endocrine features, Leydig cells 
typically are seen in clusters close to the blood vessels of the testis interstitium (Bowles and 
Koopman 2010). Interestingly, Leydig cells which appear during the embryonic stage do not 
simply develop into those found in the post-pubertal testis. Rather, two separate populations of 
Leydig cells have been identified with distinct functions (Roosen-Runge and Anderson 1959; 
Lording and De Kretser 1972; Vergouwen et al. 1991; Chen et al. 2009; O’Shaughnessy and 
Fowler 2011). The fetal Leydig cells (FLCs) partially arise from the mesonephros at ~12.5 dpc 
and are responsible for androgen synthesis and development of male characteristics during this 
period. Differentiation of FLCs is regulated by anti-Müllerian hormone (AMH) and Sertoli cell 
signals. FLCs maintain a small cell population after birth (O’Shaughnessy and Fowler 2011).  
These cells release androgens required for secondary sexual development during embryonic stage, 
including maintenance of Wolffian ducts, external genitalia, and testicular descent (Svingen and 
Koopman 2013). Hence, masculinization process in the embryo happens independently, as a result 
of androgen production by FLCs, and prior to the establishment of the hypothalamus-pituitary-
gonadal axis (Huhtaniemi 1989; O’Shaughnessy and Fowler 2011). As such, unlike adult Leydig 
cells (ALCs) differentiation of FLCs is not luteinizing-hormone (LH) dependent (O’Shaughnessy 
et al. 2000; Shima 2019). Also, in contrast to ALCs, FLCs lack hydroxysteroid 17-beta 
dehydrogenase 3 (HSD17B3) which is an enzymatic component required for conversion of 
cholesterol to testosterone. Therefore, FLCs produce androstenedione which is subsequently 
converted to testosterone by fetal Sertoli cells (O’Shaughnessy and Fowler 2011; Shima et al. 
2013). Testosterone is also converted to dihydrotestosterone (DHT) by 5α-reductase, which is a 
more effective androgen. DHT induces formation of prostate and external genitalia and transforms 
the cranial and caudal portions of the mesonephric duct to epididymis and ductus deferens, 
respectively (Mäkelä et al. 2019). Production of fetal androgens by FLCs not only results in 
differentiation of male gonads and genitalia, but also drives subtle differences in the brain 
patterning which is normally followed by development of male-specific behaviors (Barker 1990; 
Vilain and McCabe 1998; Robinson 2006). FLCs also produce insulin-like peptide 3 (INSL3), 





transabdominal descent of the testes and regulates their migration towards scrotum, and as such 
absence of INSL3 leads to failure of testicular descent and results in cryptorchidism (Nef and 
Parada 1999; Zimmermann et al. 1999; Adham et al. 2000; Emmen et al. 2000; Bogatcheva et al. 
2003; Tomiyama et al. 2003; Hutson and Hasthorpe 2005). ALCs differentiate shortly after birth 
from mesenchymal precursor cells located in the interstitium (Bowles and Koopman 2010). The 
main trigger for differentiation of these cells is not clear but desert hedgehog (DHH) or PDGF are 
suggested to be involved in this process (Clark et al. 2000; Gnessi et al. 2000). DHH is released 
by Sertoli cells, which attaches to the receptor patched (Ptc1), expressed on the Leydig cell 
precursors (Yao et al. 2002). In Leydig cells, steroidogenic factor-1 (Sf1) regulates the enzymes 
required for testosterone production. These enzymes include steroid acute regulatory protein 
(StAR), cytochrome P450 family 11 subfamily A member 1 (CYP11A1), cytochrome P450 
hydroxylase (CYP17), and 3β-hydroxysteroid dehydrogenase (3βHSD) (Yao et al. 2002). 
Produced androgens exert their effects through androgen receptors (AR) on Sertoli cells, Leydig 
cells, and PMCs (Ketelslegers et al. 1978; Corbier et al. 1992; Bremner et al. 1994; Sharpe 1994). 
Further structural development of the testis includes formation of septa between the convoluted 
seminiferous cords by mesenchymal cells, giving lobulated appearance to the testis parenchyma. 
The mesenchyme also produces a connective tissue between the testis cords and tunica albuginea 
(Patni et al. 2017). Furthermore, while in the male embryo AMH produced by Sertoli cells results 
in regression of the Müllerian ducts, the absence of AMH in female embryos leads to regression 
of Wolffian ducts and differentiation of Müllerian ducts into female reproductive tract (Shima et 
al. 2015).  
During the final stages of prenatal development, testes migrate from their embryonic 
intraabdominal position into the scrotum. This process can be divided into two phases of 
transabdominal and inguinoscrotal (Gier and Marion 1969; Puri 1986). Transabdominal phase 
occurs between week 10-15 of gestation in humans, 14.5-16.5 dpc in mice, and ~55 dpc in pigs 
(Klonisch et al. 2004). During the transabdominal phase, testes descend from their pararenal 
location into a lower abdominal location. This phase is androgen independent and controlled by 
INSL3. The inguinoscrotal phase, however, is androgen dependent and is characterized by the 





birth in humans, within the first 2 weeks of neonatal development in mice and ~90 dpc in pigs 
(Hadziselimovic and Herzog 1993; Klonisch et al. 2004; Hutson et al. 2010). 
2.1.2. Postnatal Testis Development 
Gonocytes and more specifically T1-prospermatogonia in the neonatal testis are located in the 
center of seminiferous cords and are in mitotic arrest (Hutson et al. 2013). During the postnatal 
testis development, these cells form cytoplasmic processes enabling them to migrate between 
Sertoli cells and towards the basement membrane of the cords. T1-prospermatogonia become T2-
prosperamognia when they are released from mitotic arrest and start their migration (Phillips et al. 
2010). The migratory phase of gonocytes happens between 3-9 months of age in humans and 2-6 
days after birth in mice (Huff et al. 2001; Drumond et al. 2011). Once they arrive at the cordal 
basement membrane, gonocytes establish the pool of spermatogonia. Gonocytes which fail to 
travel from the center to periphery of the cords undergo degeneration (Kluin and de Rooij 1981), 
indicating the important role of basement membrane environment for progression of germ cell 
development (Vergouwen et al. 1991; Nagano et al. 2000). Gonocytes continue proliferating even 
after they complete their migration. The exact trigger and regulatory mechanism for this migration 
are not fully understood but PDGF B and D and PDGF receptor-β (PDGFR-β) are suggested to be 
involved in this process (Basciani et al. 2008, 2010). Also, expression of c-KIT has been shown 
to be critical in formation of the pseudopodia by gonocytes and activation of their migratory 
behavior (Orth et al. 1997). Since gonocytes are in immediate contact with Sertoli cells, their 
migration is also dependent upon the physical support and paracrine secretions from neighboring 
Sertoli cells (Orth et al. 1997).  
Following their migration, gonocytes give rise to a pool of undifferentiated spermatogonia 
(Vergouwen et al. 1991; Drumond et al. 2011). Establishment of the SSC pool is essential to 
sustain continuous supply of undifferentiated spermatogonia throughout life (Culty 2009). A 
fraction of gonocytes also produces differentiating type A spermatogonia which has the potential 
of differentiation towards spermatozoa (de Rooij 1998; Phillips et al. 2010). Type A 
spermatogonia are early germ cells and are subdivided into A single (As), A paired (Apr), and A 
aligned (Aal), depending on their differentiation stage and incomplete cytokinesis. Type A 
spermatogonia express a range of markers such as integrin β-1 and integrin α-6 (Kanatsu‐





family receptor (GFRα-1), and receptor tyrosine kinase (RET) (de Rooij and Russell 2000). 
Differentiating spermatogonia are also immunopositive for SOHLH1, SOHLH2, neurogenin 3 
(NGN3), and c-KIT which is a receptor for stem cell factor (SCF) (Besmer et al. 1993; Ballow et 
al. 2006; Yoshida et al. 2006; Filipponi et al. 2007; Hao et al. 2008). Close to puberty, A 
spermatogonia give rise to intermediate and B spermatogonia. B spermatogonia are more 
specialized germ cells which can differentiate into spermatocytes and progress into meiosis 
(Phillips et al. 2010). The number of germ cells slightly decreases during the first 3 years of life 
in humans, possibly because of apoptosis, but then it increases by 7 years of age at which time it 
reaches a plateau. This increase in germ cell numbers is mainly due to the proliferation of type A 
spermatogonia and their differentiating version, type B spermatogonia. After the prepubertal 
period and during puberty, spermatogonial population increases exponentially along with the testis 
volume (Mäkelä et al.). Although fetal germ- and pluripotent stem cells have the potential to 
differentiate to any cell types, postnatal germ cells retain the differentiation potential after birth 
but only into more specialized germ cells (Hofmann et al. 2005). SSCs undergo self-renewal 
divisions throughout life and their mitotic activity is dependent on the extrinsic factors of their 
niche similar to other adult stem cells in the body. These extrinsic factors mainly originate from 
their surrounding Sertoli cells which dictate the intracellular signalling pathways, gene expression, 
and regulation of cell cycles (Yang and Oatley 2014).  
Between birth and puberty, Sertoli cells play key roles in regulation of testis development. These 
cells increase in numbers by about four-fold during the first five months after birth in humans 
along with increased length of the testis cords, leading to an overall increase in the size of the testes 
(Rey et al. 1993; Marshall and Plant 1996; Berensztein et al. 2002). Between 2-4 months of age 
in humans, secretion of gonadotropin-releasing hormone (GnRH) increases testosterone 
production in prepubertal testes. Thereafter, testosterone levels decrease and become negligible 
until the onset of puberty. The sudden increase in GnRH during prepubertal period is called “mini-
puberty”. While androgen levels fall in the prepubertal period, AMH secretion by Sertoli cells 
increases and remains high until puberty (Job et al. 1988; Hadziselimovic and Zivkovic 2007; 
Hutson et al. 2013). Between the mini-puberty and puberty, the hypothalamic-pituitary-gonadal 
(HPG) axis remains inactive, resulting in limited testosterone production, and the HPG axis 
increases its pulsatile activity only closer to puberty (Mäkelä et al.). Between birth and onset of 





features including limited cytoplasm and small nucleoli (Rey 1999). Immature Sertoli cells 
gradually become elongated and develop tight junctions. The proliferative activity of these cells 
diminishes and finally stops at puberty, which happens at 15 and 20 days of age in mice (Orth 
1982) and rats (Vergouwen et al. 1991), respectively. Since testicular function during adulthood 
is largely dependent upon the number of Sertoli cells, factors affecting Sertoli cell proliferation 
during prepubertal period indirectly affects the spermatogenic activity later in life (Sharpe et al. 
2003; Meroni et al. 2019). Among these factors are hormones such as follicle stimulating hormone 
(FSH) and androgens which stimulate Sertoli cell proliferation during both fetal and early postnatal 
life. Similarly, insulin family of growth factors such as insulin-like growth factor 1 and 2 (IGF-1 
and IGF-2), and relaxin have proliferative effects on immature Sertoli cells (Borland et al. 1984; 
Saez et al. 1988; Khan et al. 2002; Meroni et al. 2019). Also, activin and inhibin belong to the 
transforming growth factor-β (TGF-β) family with significant effects on proliferation of immature 
Sertoli cells prior to puberty. Activin A which is mainly produced by PMCs, induces Sertoli cell 
division, and its levels drop at puberty which marks the Sertoli cell maturation. Inhibin is 
synthetized by Sertoli cells, and its increasing levels counteract activin effects at puberty (Meroni 
et al. 2019). 
Reactivation of the HPG axis, release of LH and FSH, and their effects on gonads mark the 
initiation of puberty. FSH upregulates AR expression on Sertoli cells, PMCs, and Leydig cells and 
boosts germ cell proliferation, leading to increased testicular volume (Rey 2014; Koskenniemi et 
al. 2017). Knock-out mice lacking FSH receptor have shown reduced Sertoli cell proliferation and 
declined testicular growth, which indicates the crucial role of this hormone in testicular 
development during puberty (Koskenniemi et al. 2017). LH-release induces maturation of Leydig 
cells which in turn, initiates secretion of androgens (Rey 2014). Sertoli cells undergo maturation 
process when exposed to increased levels of intratesticular androgens at about 3 months and 7 
years of age in pigs and humans, respectively. Sertoli cell maturation entails formation of blood-
testis barrier, loss of Sertoli cell mitotic activity, and downregulation of AMH synthesis (Rey et 
al. 2009). At this stage, morphology of Sertoli cells also changes to provide sufficient room for 
embracing germ cells. Also, AR expression by Sertoli cells and testosterone levels increase, while 
AMH levels decrease (Koskenniemi et al. 2017). FSH during prepubertal and pubertal periods 





spermatogenesis and their release marks the culmination of testicular growth (Koskenniemi et al. 
2017). 
After birth, germ- and Sertoli cells continuously proliferate in the seminiferous cords but at 
different growth rates. Proliferative activity of Sertoli cells during this period is twice as much as 
that of germ cells and as such, prepubertal increase in the size of the cords is mainly owing to the 
Sertoli cell expansion (Van Straaten and Wensing 1977). At puberty, however, Sertoli cells reduce 
their proliferative activity and thereby germ cell expansion becomes the main factor responsible 
for enlargement of tubules both in diameter and length (Hilscher et al. 1974; Iczkowski et al. 1991; 
Des Jardins 1993; França et al. 2000). Attachment of androgens to AR at puberty results in Sertoli 
cell secretion of paracrine factors and development of cell surface receptors required for initiation 
of germ cell differentiation (Emmen et al. 2000; Hutson et al. 2010; Mäkelä et al. 2019). Tight 
junctions between Sertoli cells are further developed to form the blood-testis barrier. This barrier 
defines a border where undifferentiated germ cells such as germline stem cells reside near the 
basement membrane. Conversely, germ cells undergoing differentiation and haploid cells develop 
above this barrier (O’Donnell et al. 2015). Also, LH release at puberty triggers differentiation of 
ALCs and production of testosterone (Shima 2019). PMC and Sertoli cell secretions are also 
essential for Leydig cell maturation and production of steroids. Release of androgens from Leydig 
cells in turn triggers initiation of spermatogenesis and SSC differentiation into spermatocytes and 
more specialized germ cells (Koskenniemi et al. 2017). Spermatogenesis starts at about 9 years of 
age in humans, takes up to 64 days, leading to first produced sperm at ~14 years of age (O’Donnell 
et al. 2015). This process requires precise spatial organization in testis structure (Sharpe 1994; 
O’Donnell et al. 2015). 
2.1.3. Testis Structure 
Testes have dual functions of spermatogenesis and steroidogenesis which necessitates a complex 
structural foundation and are located within the scrotum. Two testes are separated by scrotal 
septum, and covered by visceral and parietal vaginal tunics (Tiwana and Leslie 2017). During 
testicular descent, gubernaculum testis steers the testes into the scrotum. This ligamentous 
structure originates from undifferentiated mesenchymal cells attached to the genital swelling and 
testes. Testicular enlargement during regression of the mesonephros as well as the swelling 





divisions and production of extracellular matrix in gubernaculum increase, leading to its 
enlargement while its proximal portion remains short. The enlargement of gubernaculum in its 
distal portion will pull the testes along with the peritoneal layers covering the abdominal cavity 
into the scrotum (Hutson et al. 2013). Thereafter, the testes will be attached to the body via the 
spermatic cord from one side and to the scrotum by scrotal ligament which is the remnant of the 
gubernaculum testis (Burgos and Fawcett 1955). The cremaster muscle covering the spermatic 
cord is involved in thermoregulation of the testes by controlling their movement towards or against 
the body (Kayalioglu et al. 2008). Following the testicular descent, tunica vaginalis forms a double 
layer around the testes which is essentially the extensions of visceral and parietal peritoneum. 
Between the two layers of tunica vaginalis resides a fluid-filled space (i.e., tunica vaginalis cavity), 
which facilitates the free movement of the testes within the scrotum (Schumacher 2012; Hutson et 
al. 2013). Layers of tunica vaginalis surround the deepest attached testicular layer, tunica 
albuginea. Tunica albuginea is a fibrous tissue which directly covers the testes and branches 
inward, forms septa within the testes, and divides the parenchyma into lobes and lobules. Each 
lobule contains two main compartments known as interstitial tissue and seminiferous tubules 
(Sprengel et al. 1990).  
The seminiferous tubule compartment contains Sertoli cells and developing germ cells. During the 
prepubertal period, these tubules initially lack the lumen and are hence known as seminiferous 
cords (Lara et al. 2018; de Lima e Martins Lara et al. 2019). The tubules are U-shaped continuous 
channels lined with Sertoli cells, embracing germ cells. At the onset of spermatogenesis, the cords 
undergo enlargement as they become hollow and filled with fluid (Hess and Hermo 2018). The 
cords/tubules open into a chamber of anastomosing channels known as the rete testis. The seminal 
fluid is then transported into the efferent ductules, which emerge from the rete. The efferent 
ductules connect the rete to the epididymis, a convoluted tubular structure (Robaire et al. 2006; 
Robaire and Hinton 2015). Within the seminiferous tubules, Sertoli cells envelop the germ cells 
and provide them with physical and functional support (Russell and de França 1995). The 
interstitial (intertubular) compartment of the testis is a highly vascularized structure containing 
fibroblasts, mast cells, vasculature, macrophages, and Leydig cells which especially surround the 
vessels. This compartment is mainly colonized by Leydig cells which possess large smooth 
endoplasmic reticulum and mitochondria, enabling them to produce testosterone in response to LH 





within the interstitium and seminiferous tubules (Jones and Fuller 2009; Schumacher 2012). PMCs 
are a type of smooth muscle cells which surround the seminiferous tubules and are in the 
peritubular region. These cells possess abundant actin filaments in their cytoplasm as well as other 
cytoskeletal proteins including myosin, desmin/vimentin, and alpha-actin. Being contractile in 
nature, PMCs play a key role in transport of spermatozoa and testicular fluid in the tubules 
(Maekawa et al. 1996; Zhou et al. 2019). 
Products of the seminiferous tubules, known as seminal fluid, are transferred into the epididymis 
via the rete testis and efferent ductules. Epididymis is a small, highly convoluted, and tube-like 
structure. This highly compressed canal consists of three parts including the head, body, and tail 
(Hutson et al. 2013; Tiwana and Leslie 2017). The head of the epididymis receives the seminal 
fluid from efferent ductules and allows the passage of sperm to more distal parts. Convoluted 
structure of the epididymis provides the space required for storage and maturation of sperm 
(Robaire et al. 2006; Tiwana and Leslie 2017). 
2.1.4. Spermatogenesis, Steroidogenesis, and their Regulation 
Spermatogenesis is a chronological process of sperm production from immature germ cells which 
takes ~35 days in mice, ~54 days in rats, and ~72 days in humans (Sikka and Gurbuz 2006). This 
highly organized process can be divided into three phases of proliferation of spermatogonia, 
meiosis, and spermiogenesis (O’Donnell 2014). During the proliferation phase, spermatogonia 
undergo multiple mitotic divisions to form a large population of germ cells for further 
development. As such, this phase of spermatogenesis is also known as spermatocytogenesis. 
Among the population of spermatogonia, As spermatogonia are relatively quiescent and are unique 
in that they possess the ability of self-renewal divisions and differentiation into more specialized 
spermatogonia (de Rooij and Russell 2000). Division of As spermatogonia leads to formation of 
either two new As spermatogonia or two attached spermatogonia with incomplete cytokinesis, 
namely paired. Apr spermatogonia can further divide to generate attached spermatogonia known as 
aligned Aal comprised of chains of 4-16 cells. All three types of spermatogonia are considered 
undifferentiated; however, attached cells are more committed to undergo transition into A1 
differentiating spermatogonia without cell divisions. A1 spermatogonia will produce more 
differentiating (A2, A3, A4) and differentiated (intermediate, B type) spermatogonia. The 





differentiation in germ cells which is involved with major changes in their morphological features 
(Hess and Moore 1993; Russell and de França 1995; Phillips et al. 2010). 
In the second phase of spermatogenesis, B spermatogonia must migrate through the blood-testis 
barrier, enter the adluminal compartment, and give rise to primary spermatocytes by undergoing 
another mitotic division. The primary spermatocytes go through two stages of meiotic divisions 
and produce haploid round spermatids (Sharpe 1994; de Rooij and Russell 2000). Round 
spermatids produced from meiosis do not have proliferative activity and will undergo a complex 
series of cytodifferentiation to form spermatozoa over a period of 2-3 weeks in mice and rats 
(Oakberg 1956; Clouthier et al. 1996; Sikka and Gurbuz 2006). The process by which round 
spermatids transform into elongated spermatids and spermatozoa is known as spermiogenesis. 
During spermatid maturation these cells undergo nuclear elongation and chromatin condensation, 
which involves replacement of histones by arginine and cysteine-rich protamine (O’Donnell 2014; 
Zirkin and Goldberg 2018). The chromatin becomes tightly packed and transcriptionally inactive 
once it undergoes condensation. Also, during maturation, the Golgi apparatus produces acrosomal 
granules containing hydrolytic enzymes required later for penetration of sperm during fertilization. 
Following production of acrosomal granules, acrosome and nucleus polarize to one side of the 
head, signalling initiation of elongation phase. At this stage, spermatids establish junctions with 
Sertoli cells (Wong et al. 2008). Another major event during maturation of spermatids is formation 
and development of flagellum. Following completion of meiosis, the central component of the 
flagellum is assembled from microtubules. During elongation of spermatids, additional structures 
involved in normal function of flagellum, such as dense fibers, fibrous sheath, and mitochondrial 
sheath are assembled on top of the central axoneme (Escalier 2006; Hermo et al. 2010). Following 
elongation, spermatids are translocated to the luminal edge by Sertoli cells. The spermatid head 
and flagella are gradually extended into the lumen while the cytoplasm remains anchored to the 
Sertoli cells (McLean et al. 2003; O’Donnell 2014; Zirkin and Goldberg 2018).  
The last step of spermiogenesis is spermiation, which is a critical determinant of the sperm number 
in epididymis and as such, it defines sperm content in ejaculate (O’Donnell et al. 2011). During 
spermiation, elongated spermatids undergo multi-step remodelling and are released from the 
seminiferous epithelium. This step happens over several days (~82 hours in rats) at the apical 





the luminal edge of the seminiferous tubules (O’Donnell et al. 2011). The process encompasses 
removal of intercellular adhesion junctions and remodeling of the cytoplasm. During spermiation, 
tubulobulbar complexes (TBCs), a form of endocytic machinery, are formed between spermatids 
and Sertoli cells. These complexes contain a tubular region surrounded by actin filaments, and a 
bulbous portion. Clathrin is suggested to be involved in organizing actin filaments for TBC 
formation. TBC formation is initiated when a small portion of spermatid cytoplasm protrudes into 
the Sertoli cell membrane (Russell and Clermont 1976; Russell 1979). Internalization and 
degradation of spermatid-Sertoli cell cytoplasmic membrane depends on TBCs (Young et al. 2009; 
O’Donnell 2014). The cytoplasm of the spermatid undergoes repositioning until it is separated 
from the spermatid and remains as a residual body on Sertoli cells (Russell and Griswold 1993). 
Failure in normal formation of TBCs has been associated with spermiation failure, indicative of 
their important role in release of mature spermatozoa into the seminiferous tubules (D’Souza et al. 
2009). Overall, during spermiation, TBCs are involved in reduction of spermatid cytoplasmic 
volume, endocytosis of junctional molecules, modeling of the spermatid acrosome and finally 
detachment of spermatozoa from the luminal edge. Once spermatozoa are released into the tubule, 
spermiation is completed (Saito et al. 2000; O’Donnell et al. 2011).  
Spermatogenesis is largely affected by hormonal fluctuations in the testis environment and is 
highly dependent on hormonal regulation (Miller and Auchus 2011). Notably, testosterone, which 
is an anabolic steroid, plays a key role in initiation and progression of spermatogenesis (Toor and 
Sikka 2017). In general, steroid hormones regulate a variety of processes during fetal life and 
adulthood. These hormones are derived from cholesterol and have relatively similar structural 
basis. In humans, cholesterol is supplied from two sources; de novo synthesis from acetate and 
circulating low-density lipoproteins (LDL) derived from diet. In rodents, however, cholesterol is 
mainly produced by adrenal gland and from high-density lipoproteins through the activity of 
scavenger receptor B1. Cholesterol is then transferred to mitochondria, the known hub for steroid 
production. Within the mitochondria, StAR facilitates movement of cholesterol from the outer to 
the inner mitochondrial membrane (Brown et al. 1979; Horton et al. 2002; Flück and Pandey 
2017). 
Production of high frequency GnRH signals the initiation of spermatogenesis and leads to 





GnRH neurons of the hypothalamus. During pubertal period, upon release, GnRH travels to the 
pituitary gland and stimulates production of FSH and LH (Millar 2005; Flanagan and Manilall 
2017). In the testis, LH binds to its receptor on Leydig cells and enhances biosynthesis of 
testosterone, which happens shortly after birth in mice and about 5-8 months of age in pigs 
(Almeida et al. 2006; Bowles and Koopman 2010; Montoto et al. 2012). Similar to other 
androgens, testosterone is produced from cholesterol in mitochondria. The main source of 
circulating testosterone in the body is the testes; however, a small amount is also secreted by the 
adrenal cortex and peripheral organs by converting precursor steroids (Shima et al. 2013; Flück 
and Pandey 2017). ALCs are specialized cells for production of testosterone since they can express 
all required factors common to testosterone producing cells (Hansson et al. 1976). StAR activity 
is upregulated following attachment of LH to its receptor on the surface of ALCs, resulting in 
increased cholesterol uptake and transport into the inner mitochondrial membrane (Sharpe 1994; 
Clark et al. 1995). Within the mitochondria, cholesterol is converted into pregnenolone by activity 
of CYP11A1, ferredoxin (FDX1), and ferredoxin-reductase (FDXR) (Miller and Auchus 2011). 
Pregnenolone is then converted into 17α-hydroxy pregnenolone (17OHPreg) and 
dehydroepiandrosterone (DHEA) by delta 5 pathway, which is supported by CYP17A1 (Flück et 
al. 2003). DHEA is turned into testosterone by the activity of groups of enzymes that belong to 
the hydroxysteroid dehydrogenase family. Germ cells lack functional receptor for androgens, 
thereby the released testosterone diffuses into the Sertoli cells, attaches to AR, and induces 
functional responses essential for regulation of spermatogenesis. Testosterone is locally and 
mainly produced by Leydig cells, thereby its concentration is typically 25-125 folds higher within 
the testis compared to the serum (Smith and Walker 2014). Although testosterone plays a key role 
in maintaining the population of spermatogonia, its main function has been associated with 
development of post-meiotic germ cells (O’shaughnessy et al. 2012). As is the case for FSH, 
effects of testosterone on germ cells are indirectly mediated through somatic cells since germ cells 
lack AR (Abel et al. 2008).  
FSH increases the production of androgen binding protein (ABP) by Sertoli cells and triggers the 
establishment of the blood-testis barrier. ABP binds to testosterone, transports it to the epididymis, 
and once released from ABP, testosterone is converted into DHT by epithelial 5α-reductase in 
genital skin and prostate (Creasy and Chapin 2013). DHT has about 10 times more affinity for 





stimulates production of inhibin, a dimeric glycoprotein, by Sertoli cells. Inhibin reduces FSH 
release from the pituitary gland through a negative feedback loop (Meachem et al. 2001; Toor and 
Sikka 2017). Mice lacking FSH or its receptor have been shown to develop reduced number of 
germ cells (McLachlan et al. 1995; Matthiesson et al. 2005). Also, administration of FSH to rats 
lacking functional GnRH has been associated with increased germ cell numbers, both indicative 
of FSH roles in survival of germ cells (McLachlan et al. 1995). In contrast, small amounts of 
androstenedione and testosterone are transformed into estradiol and estrone via the activity of 
CYP19A1. Produced steroid hormones not only affect the reproductive function but also regulate 
general homeostasis in the body (Flück and Pandey 2017; Miller et al. 2021). 
2.2. Origin, Development, and Specialization of Male Germline Stem Cells 
2.2.1. Primordial Germ Cells 
PGCs are precursors of sperm and oocytes, derived from a population of pluripotent cells in the 
proximal epiblast and next to extraembryonic ectoderm. Therefore, these cells originate far from 
their site of function during gastrulation (de Rooij and van Dissel-Emiliani 1997; Achermann and 
Hughes 2011). PGCs are alkaline-phosphate positive cells which migrate through the hindgut to 
reach and colonize the genital ridges. During their migration, PGCs divide to form a large 
population (de Rooij and van Dissel-Emiliani 1997; De Felici et al. 2004; Chuma et al. 2005). By 
day ~13 of development in mice, PGCs are mostly confined to the genital ridges. Colonization of 
the genital ridges by PGCs is regulated by influences from molecules, receptors, and matrix 
proteins including KIT, KIT ligand (KITLG), integrin β-1, E-cadherin, interferon-induced 
transmembrane protein 1 (IFITM1), IFITM3, CXCL12, and its receptor (Achermann and Hughes 
2011). The undifferentiated state of PGCs is maintained by factors such as POU5F1. However, 
these cells are committed to differentiation as a result of specific signaling molecules. Once arrived 
at the genital ridges, PGCs enter mitotic arrest (Kispert and Gossler 2004). 
Different transcription factors have been suggested to determine PGC identity prior to colonization 
of the genital ridges. For instance, derivation of PGCs from epiblast has been shown to largely 
depend upon bone morphogenetic protein (BMP) signaling. Bmp4 and Bmp8b are expressed in the 
extraembryonic ectoderm and their knock-out results in loss of PGCs (Ying et al. 2000; Ying and 
Zhao 2001). Bmp heterozygous mice also show reduced functional PGCs (Ying and Zhao 2001). 





and intracellular BMP-transducer Smad5 and Smad1 all demonstrate reduced number of PGCs. As 
such, BMP production by extraembryonic ectoderm is essential for PGC induction (Leitch et al. 
2013). In addition to BMP, PR-domain-containing protein 1 (PRDM1) also known as B-
lymphocyte-induced maturation protein 1 (BLIMP1) is involved in derivation of PGCs from 
epiblast. BMP triggers expression of BLIMP1 by activating specific genes such as Stella and 
Fragilis and reducing the activity of somatic genes (e.g., Hox). As such, PGCs develop from the 
epiblast cells and obtain cytoplasmic extensions enabling them to migrate towards the genital 
ridges where they transform into gonocytes (Leitch et al. 2013). 
At ~7 dpc, PGCs develop pseudopodia and start their migration towards the gonadal ridges 
(Grimaldi and Raz 2020). The migratory behavior of PGCs through hindgut appears to be highly 
conserved among mammalian species (Tanaka et al. 2005; Lange et al. 2008; Sasaki et al. 2016). 
When PGCs enter the embryonal endodermal layers, they attach to the basolateral region of 
endodermal epithelial cells. Next, PGCs become incorporated into the ventral hindgut, which is 
facilitated through the process of gastrulation. These cells actively move towards the genital ridges 
in a random manner. The migratory potential of PGCs is retained in vitro, which further confirms 
the active process of their translocation during embryonic development (Donovan et al. 1986; 
Kanamori et al. 2019). Attachment of PGCs to the basement membrane has been shown to be 
essential for initiation of their active movement. Particularly, the dorsal mesentery forms a 
complex matrix composed of laminin, fibronectin, type IV collagen, perlecan, and heparin sulphate 
to provide a scaffold upon which PGC movement is facilitated in the coelomic epithelium 
(Kanamori et al. 2019). PGCs then become distributed from the ventral side to the entire 
circumference of the endodermal tube. Overall, successful migration of PGCs seems to be the 
result of their passive translocation from epiblast to the hindgut followed by active and random 
movements towards the left and right gonads. During their migration and divisions, these cells 
maintain the expression of STELLA and other gene transcripts associated with pluripotency such 
as OCT4, NANOG, SOX2, and stage-specific embryonic antigen-1 (SSEA-1) (Tilgner et al. 2008; 
Wolf et al. 2011; Saitou and Yamaji 2012).  
While undergoing multiple mitotic divisions along their movement, PGCs navigate through the 
hindgut via chemotaxis mechanisms (Molyneaux et al. 2001). Stromal-derived factor-1 (SDF-1) 





of PGCs. Knock-out studies have shown that SDF-1 or its G-protein coupled receptor chemokine 
(CXCR4) leads to failure in normal colonization of the genital ridges by PGCs. This indicates that 
CXCL12 and CXCR4 are both essential for directing PGCs towards their destination and are 
important chemokine-receptor complexes for PGC migration (Ara et al. 2003; Molyneaux, 
Zinszner et al. 2003). Other important factors for migration of PGCs are c-KIT and its ligand Steel 
factor (Runyan et al. 2006; Gu et al. 2009), WNT5A (Chawengsaksophak et al. 2012), and E-
cadherin (Bendel-Stenzel et al. 2000). Once they arrive at the genital ridges, PGCs lose their 
cytoplasmic extensions and become immobile possibly as a result of CXCR4 downregulation. 
PGCs which fail to migrate and relocate completely to the genital ridges remain in the midline and 
undergo apoptosis (Kanamori et al. 2019; Grimaldi and Raz 2020). While migrating, PGCs retain 
their genomic properties associated with pluripotency by expressing core pluripotency genes 
(Tilgner et al. 2008; Wolf et al. 2011; Saitou and Yamaji 2012). At this stage, these cells are even 
able to produce teratoma when injected into the mouse testes (Chuma et al. 2005). When arrived 
at the genital ridges, PGCs start expressing a set of gene transcripts essential for sexual 
differentiation and gametogenesis, and turn off the expression of pluripotency program (Gill et al. 
2011). PGCs are then referred to as GCCs, can undergo male or female differentiation, and initiate 
meiosis (Gill et al. 2011; Hu et al. 2015). GCCs receive signals from their surrounding somatic 
cells to enter either spermatogenesis or oogenesis pathways once the indifferent gonads undergo 
transition into testis or ovary at ~12.5 dpc in mice. Entrance of GCCs into one of these pathways, 
known as licensing, is a major step in faith determination of germ cells (McLaren and Southee 
1997). Transition of PGCs into GCCs and their subsequent specialization is suggested to be 
dependent upon their localization into the genital ridges since it has been shown that loss of somatic 
transcription factor Gata4 leads to failure in development of genital ridges, subsequent PGC to 
GCC transition, and lack of GCC competence to enter spermatogenic pathway (Hu et al. 2015). 
PGCs do not autonomously choose to undergo spermatogenesis or oogenesis pathways and sexual 
differentiation. Instead, this process depends on the somatic gonad. Sustained specialization of 
ectopic germ cells in male adrenal glands towards oocyte production further support the role of 
neighboring somatic cells of the genital ridge in fate determination of PGCs (Upadhyay and 
Zamboni 1982). Since genital ridges and adrenal glands both originate from adrenogonadal 





azoospermia-like (DAZL) and DEAD-box helicase 4 (DDX4), essential for licensing process and 
induction of differentiation in PGCs (Hatano et al. 1996; Gill et al. 2011; Laufer et al. 2012). 
2.2.2. Gonocytes 
Gonocytes, also known as prospermatogonia, are a finite population of germ cells derived from 
PGCs (Culty 2009). PGCs become resident in the gonads and once surrounded by gonadal somatic 
cells, they start expressing germ cell nuclear antigen (GCNA1). This is the time that PGCs are 
usually referred to as gonocytes (Enders and May; Richards et al. 1999; Culty 2009). At around 
birth, gonocytes appear as round in shape, are located at the center of the seminiferous cords while 
being embraced by the Sertoli cell cytoplasm. These cells are considered as functional SSC 
precursors that ensure the life-long generation of spermatozoa (Culty 2009, 2013; McGuinness 
and Orth 1992). Developmental phases of gonocytes can be classified into quiescence, 
proliferation, migration, and differentiation (Manku and Culty 2015). In mice, however, the 
developmental stages of gonocytes are not completely synchronized, leading to coexistence of two 
different categories of quiescent and proliferative gonocytes during the neonatal period (Culty 
2013). After birth, gonocytes are released from their fetal-early neonatal quiescence state, re-
initiate their proliferative phase, and move towards the basement membrane (Huff et al. 2001; 
Culty 2009, 2013; Drumond et al. 2011), leading to their translocation and differentiation into 
SSCs (Manku and Culty 2015). Generally, gonocytes are comprised of a heterogenous cell 
population including successive stages of mitotic (M) and transitional (T) prospermatogonia, 
which itself is subdivided into T1 and T2-prospermatogonia (Hilscher et al. 1974; Fukuda et al. 
1975; Hilscher 1991; Vergouwen et al. 1991). Gonocytes at each developmental stage express 
different subsets of gene transcript combinations in varying levels including melanoma antigen-
A4 (MAGE-A4) (Aubry et al. 2001) and guanylate cyclase-activating protein (GCAP) (Pauls et 
al. 2006; Culty 2009). The presence of these germ cells is not necessarily synchronized within the 
seminiferous cords/tubules, generating an overlap of different cell populations. For instance, 
quiescent, mitotic, and differentiating prospermatogonia which are at different developmental 
stages can be simultaneously present (Culty 2009). M-prospermatogonia appear during the 
prenatal period, are mitotically active, located far from the basement membrane, and can be found 
in the center of the cords (McLaren 2003). This type of prospermatogonia has the same 





suggested that the first identifiable distinction between male and female germ cells can be observed 
at the T1-prospermatogonia stage, where germ cells enter mitotic arrest (McCarrey 2013). M-
prospermatogonia become T1-prospermatogonia and enter G0 of the cell cycle at ~16.5 dpc in 
mice (Yoshida et al. 2007; Culty 2009, 2013). These cells remain mitotically inactive until a few 
days after birth when they transform into T2-prospermatogonia and re-start their cell division while 
migrating towards the basement membrane (Yoshida et al. 2007; Culty 2009). Following their 
migration and once located in the basement membrane niche, these cells give rise to type A 
spermatogonia which later establish the life-long process of spermatogenesis. Transformation of 
prospermatogonia into SSCs starts at birth and takes up to ~6 days in rodents (Wu et al. 2009).  
The proliferation vs. quiescent state of prospermatogonia during the fetal and neonatal periods is 
regulated through paracrine and endocrine release of hormones and cytokines (Busada and Geyer 
2016). Several studies support the role of RA in determining the prospermatogonia fate. During 
the fetal period, these cells are normally protected from RA exposure which otherwise would 
induce their premature differentiation and activate their apoptosis program. Protection of these 
cells against RA is partly achieved through the action of cytochrome P450 enzyme CYP16B1 
(MacLean et al. 2007; Li et al. 2009). Another study showed that RA increases the proliferative 
activity of prospermatogonia but induces apoptosis at greater rates, which overall points at the loss 
of fetal germ cells following exposure to RA (Livera et al. 2000). Also, activin A and androgens 
are suggested to negatively regulate fetal germ cell proliferation (Li et al. 2009; Mendis et al. 
2011). In addition, aberrations of normal temporal sequences in cytokine release can lead to 
abnormal behavior of germ cells such as premature initiation of their proliferation or differentiation 
(Manku and Culty 2015). For instance, improper initiation of germ cell differentiation can result 
in development of carcinoma in situ, known as a cause of testicular germ cell tumor (TGCT), 
which has been especially prevalent in young adults in the past few decades. The underlying 
triggers for TGCT are yet to be fully understood but abnormal exposure to endocrine-disrupting 
compounds is often held responsible (Skakkebaek et al. 1987; Sonne et al. 2009). 
Depending on the species, translocation of the prospermatogonia happens before or shortly after 
birth (de Rooji 1998; Nel-Themaat et al. 2011). These cells develop pseudopodia and pass through 
the cytoplasm of the Sertoli cells by ameboid movements (Nagano et al. 2000). Failure in proper 





of germ cells with the basement membrane results in continuation of their development into 
spermatogonia and establishment of SSC pool (Orwig et al. 2002). The migratory behavior of 
gonocytes also depends upon expression of molecular cues from germ and somatic cells as well as 
germ-somatic cell interactions (Orth et al. 1997). KIT is one of the transcription factors expressed 
by germ cells undergoing translocation towards the basal compartment. Blocking this factor can 
result in reduced numbers of gonocytes in vitro and failure of their migration in vivo (Besmer et 
al. 1993; Lamb 1993; Orth et al. 1997). PDGF is another factor produced by Sertoli cells which 
promotes germ cell migration to the periphery of the cords (Marziali et al. 1993; Basciani et al. 
2008). Also, deletion of Aip1 in Sertoli cells was shown to impair the migration of germ cells, 
suggestive of involvement of actin interacting protein 1 (AIP1) in translocation of germ cells from 
the center to the cordal periphery (Xu et al. 2015). In addition, several members of A-Disintegrin 
and A-Metalloproteinase domain (ADAM), a surface receptor, are expressed in the fetal, neonatal, 
and prepubertal testis and have been proposed to be involved in migration of gonocytes (Rosselot 
et al. 2003). Once located on the basement membrane, gonocytes become engulfed in a 
microenvironment composed of vasculature, somatic cells, growth factor milieu, and physical 
architecture which all contribute to their fate determination. This unique microenvironment is 
referred to as the germ cell ‘niche’. 
2.2.3. Spermatogonial Stem Cells 
SSCs are adult stem cells in the testis which arise from T2-prospermatogonia. T2-prospermatgonia 
continue their mitotic divisions even after sitting on the basement membrane. A subset of these 
cells give rise to A spermatogonia (Kubota and Brinster 2018). SSCs first appear at ~5 days after 
birth in rodents, 1-2 months after birth in pigs, and ~3 months of age in humans (Goel et al. 2007; 
Jan et al. 2012; Hutson et al. 2013). These cells constitute a very rare population of germ cells in 
the testis and ensure the life-long maintenance of spermatogenesis (Tagelenbosch and de Rooij 
1993). SSCs are also unique germ cells owing to their ability to both undergo mitotic divisions to 
repopulate and produce daughter cells committed to generate terminally differentiated haploid 
cells (Aponte 2015; Kubota and Brinster 2018). As discussed earlier, different types of A 
spermatogonia include As, Apr, and Aal (Nagano and Yeh 2013; Kubota and Brinster 2018). While 
As spermatogonia are only ~0.03% of total adult testis cells in rodents, they are the only source of 





Honaramooz 2020). Aal to A1 transition marks the initiation of differentiation and major 
morphological changes in germ cells. Clones of Aal spermatogonia differentiate to A1 to A4, 
intermediate and B spermatogonia. (de Rooij and Russell 2000; Griswold 2016; Kubota and 
Brinster 2018). 
In primates, A spermatogonia are further classified as Adark and Apale, depending on the intensity 
of their nuclear staining. Although both spermatogonia types reside on the basement membrane 
Adark spermatogonia possess smaller and round shape, darker nucleus, are considered as reserve 
stem cells, and have relatively limited mitotic activity. In contrast, Apale spermatogonia are larger 
and oval shape, and show lighter nuclear staining (Clermont 1969). Apale and Adark spermatogonia 
in primates correspond to the undifferentiated spermatogonia composed of As, Apr, and Aal, 
whereas primate type B spermatogonia are counterparts of rodent differentiating spermatogonia 
(Boitani et al. 2016). Self-renewal and differentiation of the spermatogonia relies on paracrine 
factors and cytokines released in the niche. Notably, GDNF released by Sertoli cells promotes self-
renewal divisions through attachment to the GDNF receptors, RET and GFRα1 on the surface of 
clustered spermatogonia. This has been supported by knock-out studies showing depletion of 
seminiferous tubules in GDNF+/– mice (de Rooij 2001; Kanamori et al. 2019). However, 
progression of spermatogonia differentiation depends on RA and PDGF signaling (Wang and 
Culty 2007; Manku et al. 2015). 
2.3. In Vivo Models to Study Testis Development and Function  
2.3.1. Germ Cell Transplantation 
Germ cell transplantation (GCT), also known as SSC transplantation, is a process where isolated 
germ cells from a donor male are transplanted into the testis of a recipient, leading to their 
colonization, and even donor-derived spermatogenesis (Honaramooz and Yang 2011). GCT was 
first introduced by Brinster and colleagues in 1994 by isolating testis cells from ZFlacZ mice, 
expressing the Escherichia coli β-galactosidase, and transferring them to the tubules of busulfan-
treated recipient mice which lacked endogenous germ cells. Following transplantation, donor germ 
cells colonized the recipient seminiferous tubules visualized by exposure to X-Gal and produced 
donor-derived spermatozoa (Brinster and Avarbock 1994). In this method, donor germ cells that 
are initially localized in the center of the seminiferous tubules, gradually pass between Sertoli cells 





generate a new spermatogenic colony. These colonies further develop and can potentially initiate 
spermatogenesis (Nagano et al. 1999; Ohta et al. 2000). Although this technique was first 
introduced in mice (Brinster and Zimmermann 1994), it was also successfully applied in rats (Jiang 
and Short 1995). GCT from different laboratory animals such as mouse, hamster, and rat into mice 
can successfully lead to establishment of spermatogenesis. However, spermatogenesis cannot be 
achieved when donors and recipients are phylogenetically more distant; for instance, when germ 
cells from rabbit or farm animals are microinjected into recipient mice, donor cells only colonize 
the testes and do not undergo complete spermatogenesis (Dobrinski et al. 1999, 2000; Kim et al. 
2006). This is believed to be the result of limited support from recipient Sertoli cells (Honaramooz 
and Yang 2011). Nevertheless, this technique remains as the only reliable bioassay to detect the 
stemness potential of donor germ cells from any donor species (Hermann et al. 2012).  
GCT has important potential applications in fertility restoration of cancer patients for instance by 
auto-transplantation of the cryopreserved germ cells back into their testes following cytotoxic 
cancer treatments. Other potential applications include preservation of genetic potential of 
endangered species/prized animals, correction of spermatogenic defects, elucidation of the 
mechanisms regulating MGSCs and their niche, and production of transgenic animals (Dobrinski 
2005; Hamra et al. 2017; Uchida and Dobrinski 2018). Notably, this method represents a unique 
functional bioassay to test the functionality of ‘true’ SSCs (Honaramooz and Yang 2011). 
Production of transgenic animals by GCT involves transplantation of genetically modified germ 
cells from a donor to the recipients, leading to production of spermatozoa carrying a transgene. 
Transgenesis through MGSCs has great potential especially in large domestic species such as goats 
and pigs where available methods for transgene transmission are inefficient, expensive, and 
complex (Dobrinski 2008; Kim et al. 2008; Zeng et al. 2013). Especially, transduction of the 
transgene through germline stem cells circumvents the complexities associated with traditional 
methods such as pronucleus microinjection or somatic cell nuclear transfer where manipulation of 
embryos and can cause subsequent developmental abnormalities (Honaramooz and Yang 2011; 
Zeng et al. 2013). In addition, utilization of recently developed molecular tools for manipulation 
of the genome such as clustered regularly interspaced short palindromic repeat/CRISPR-associated 
protein 9 (CRISPR/Cas9) combined with GCT may provide tremendous advantages over the 





MGSCs can act as vehicles for the transgene, colonize the recipient seminiferous tubules, and 
produce transgenic sperm over the life of the recipient (Honaramooz et al. 2003; Zeng et al. 2013). 
GCT in laboratory animals usually requires inherently immunodeficient recipients or cytoablative 
treatments to prevent from rejection of the transplanted cells and facilitate their migration and 
colonization. In contrast, large animal recipients do not typically reject germ cells from genetically 
unrelated donors of the same species (Dobrinski et al. 2000; Nagano et al. 2001; Dobrinski 2005; 
Honaramooz and Yang 2011). Also, the success rate of GCT increases when endogenous germ 
cells are reduced. In laboratory animals, different approaches have been utilized to remove or 
reduce the recipient germ cells prior to GCT. These include utilization of mouse recipients with 
white-spotting (W) mutations, resulting in defective c-kit proto-oncogene or Steel (Sl) mutant 
mice, which lack functional KITLG (Kitl), application of hyperthermal or cytoablative treatments, 
cold ischemia, or irradiation to deplete germ cells (Brinster and Zimmermann 1994; Kim et al. 
2006; Honaramooz and Yang 2011). In large animals, unlike laboratory animal models, recipients 
with genetically impaired spermatogenesis are not available and as such, different approaches have 
been developed for preparation of the testes prior to GCT. These include busulfan treatment in 
pregnant sows to remove the germ cells in their progeny, and irradiation of the testes in recipient 
goats (Honaramooz et al. 2003; Honaramooz et al. 2005). Also, using immature recipients has 
been shown to facilitate the migration process of donor germ cells from lumen to the periphery of 
the tubules since immature animals lack multiple cellular layers in the seminiferous tubules. 
Nevertheless, the efficiency of GCT in farm animals is still low with ~7% donor-derived progeny 
in goats, which has been only improved by ~1-3% following preparation by irradiation 
(Honaramooz et al. 2002; Honaramooz et al. 2003; Honaramooz and Yang 2011).  
The efficiency of GCT is also dependent on preparation or choice of donors. SSCs form only ~0.02 
to 0.2% of testis cells in rodents at post-pubertal stage while only ~7-20% of the transplanted SSCs 
colonize the tubules following transplantation (Huckins 1971; Tagelenbosch and de Rooij 1993; 
Kanatsu-Shinohara 2005). Expectedly, transplantation of increased numbers of SSCs will enhance 
their colonization and establishment of spermatogenesis. Different strategies have been used to 
increase germ cell proportion among transplanted cells such as using cryptorchid, vitamin-A 
deficient or Steel mutant mice, which possess greater number of undifferentiated spermatogonia 





the practicality of these methods is low due to added complication to the procedure and instead, 
immature animals can serve as donors, which naturally offer greater proportion of undifferentiated 
SSCs (Honaramooz and Yang 2011). Another approach to increase germ cell numbers is 
application of efficient isolation and enrichment techniques which enhance the removal of somatic 
cells while increasing isolated germ cells (Yang et al. 2010). Frequently-used enrichment methods 
for increasing germ cell populations include density gradient centrifugation such as Nycodenz 
density centrifugation, leading to a testis cell population with ~80% gonocytes (Yang et al. 2010), 
differential plating, magnetic activated cell sorting (MACS) (Buageaw et al. 2005), and 
fluorescent-activated cell soring (FACS) (Shinohara et al. 2000). Combination of Nycodenz 
density gradient and differential plating has been shown to offer enriched testis cell populations 
containing ~90% gonocytes (Honaramooz and Yang 2011). 
To evaluate the success rate of GCT and track the transplanted cells, several approaches has been 
used. For instance, donor cells are tagged with a dye such as trypan blue or a fluorochrome (e.g., 
carboxyfluorescein diacetate succinyl diester-CFDA-SE or PKH26) prior to transplantation 
(Honaramooz et al. 2002; Hill et al. 2005; Rodriguez-Sosa et al. 2006, 2009; Zhang et al. 2008). 
Alternatively, a particular transcript can be integrated into the germ cell genome by viral 
transduction (e.g., adeno-associated virus; rAAV) which leads to production of a fluorescent signal 
(e.g., green fluorescent protein-GFP) or expression of the transcript leads to production of an 
enzyme which can generate a visible color following incubation with a substrate (e.g., lacZ) 
(Brinster and Avarbock 1994; Brinster et al. 2003). Using rAAV vectors, transgenic goats have 
been produced with long-term expression of GFP and presence of transgenic sperm in ~35% of 
the ejaculates (Honaramooz et al. 2008). 
2.3.2. Testis Tissue Xenografting 
Grafting of testis tissue was first experimented in 18th century to understand the role of testis in 
development of the secondary sexual characteristics, mechanism of androgen production, and 
spermatogenesis. The initial experiments of testis grafting were limited to allografting, where 
donor and recipient of the tissue were different individuals of the same species, or even more 
scarce reports of autografting, where obtained tissues of an individual were grafted back into the 
body (reviewed in Setchell 1990; Honaramooz 2014). Allografting and xenografting studies were 





overcome later by introduction of different strains of immunodeficient mice which are unable to 
initiate immune response towards the grafted tissue (Honaramooz 2014). The first grafting of testis 
into immunodeficient mice with the aim of tissue preservation was performed in the 20th century, 
where fetal human testis tissue was embedded into subcutis of nude mice. Xenografted tissue was 
accepted by the recipient mice and its histological architecture was preserved (Povlsen et al. 1974; 
Skakkebaek et al. 1974). The same group also reported formation of pachytene spermatocytes in 
the grafts following xenotransplantation of rat testis tissue into nude mice (Setchell 1990; Arregui 
and Dobrinski 2014).  
In 2002, testis tissue from newborn mice, pigs and goats were shown to develop up to full 
spermatogenesis following xenografting into nude mice (Honaramooz et al. 2002; Dobrinski 
2005). In the later study, fragments of ~1 mm3 in size were obtained from donor testis and grafted 
under the back skin of castrated immunocompromised nude mice. Dorsal subcutaneous skin 
normally provides appropriate temperature, corresponding to that of in situ requirements for 
spermatogenesis (~36.5° C) in most domestic animals and is an accessible and observable location 
for grafting, harvesting, and visualization of the tissues (Honaramooz 2014). The grafts from all 
donor species increased in size and underwent complete structural and functional development to 
complete spermatogenesis. This report was the first to show initiation of spermatogenesis in testis 
tissue xenografts and production of haploid sperm. Surprisingly, the sequence and kinetics of tissue 
development, testicular cell differentiation, and spermatogenic efficiency were comparable to 
those of intact testis tissue. However, spermatogenesis happened slightly faster in the porcine 
xenografts compared to in situ tissue. Interestingly, retrieved spermatozoa from xenografts were 
fertilization-competent, shown by intracytoplasmic sperm injections (ICSI) (Honaramooz et al. 
2002). Following the initial reports of TTX using murine, caprine, and porcine species, multiple 
research groups utilized the same approach to test the feasibility of sperm production in xenografts 
of different species such as hamsters (Schlatt et al. 2002), monkeys (Honaramooz et al. 2004), 
rabbits (Shinohara 2002), bulls (Oatley et al. 2004; Rathi et al. 2005), dogs (Abrishami et al. 2010), 
and cats (Rathi et al. 2006). To date, a wide range of species have been used as donors in TTX 
studies contributing to its establishment as an applicable and reliable model especially for 





TTX can be considered as an in vivo tissue culture system where the host provides structural, 
nutritional, and hormonal support for the grafted tissue. Xenografts are typically placed under the 
back skin of immunocompromised mice, triggering a functional circulatory connection between 
the host subcutaneous tissue and the grafted testis fragment (Schlatt et al. 2010a). Using rat testis 
xenografts, outgrowth of endogenous endothelial cells within the grafts and simultaneous 
development of blood vessels from the host was shown to establish an interconnecting vasculature, 
ensuring an active blood supply to the xenograft (Schlatt et al. 2010b). Followed by establishment 
of blood circulation within the grafts, endogenous functional feedback loop from pituitary 
hormones of the host mouse stimulates the expansion and development of the grafted tissue to 
fulfill spermatogenesis and steroidogenesis. Although harvested spermatozoa at this time lack 
epididymal maturation, they can successfully be used for ICSI (Honaramooz 2014). Sperm from 
xenografts have also been used for production of rabbit and pig embryos via ICSI, with normal 
development after being transferred into the uterus of recipient females (Shinohara 2002; Nakai et 
al. 2010; Kaneko et al. 2012). 
TTX have a variety of applications in several research and experimental settings. Grafted tissues 
can be used to study testis development and function where no in vitro or in vivo alternative models 
are available or in situ studies are inherently complicated (e.g., humans or endangered/rare species) 
(Honaramooz 2014). Importantly, TTX is an advantageous approach for the study of gonadal 
development in that it provides greater accessibility and ease of manipulation of the xenografts 
and their milieu in the host species compared to in situ tissues (Arregui and Dobrinski 2014; 
Honaramooz 2014). In addition, since preserved testis tissue has shown similar developmental 
potential as fresh samples, it is feasible to save testis fragments by hypothermic treatments or 
cryopreservation in situations where immediate grafting is not possible or desired (Abrishami et 
al. 2010; Honaramooz 2014). Moreover, given that xenografts develop up to complete 
spermatogenesis and produce fertilization competent sperm, TTX offers the opportunity to even 
produce embryos to be cryopreserved when combined with ICSI and other assisted reproductive 
technologies. Combination of testis tissue preservation, TTX, and ICSI opens up new windows of 
opportunity to possibly rescue the genetic potential of endangered species or prized farm animals, 
or even preserve the fertility potential of immature boys undergoing cytotoxic cancer therapies 





2.3.3. Testis Cell Aggregate Implantation  
TCAI is the next model developed following the introduction of GCT and TTX. In TCAI, testis 
cells are first dissociated using enzymatic digestion, leading to formation of a tightly packed 
single-cell aggregate. This aggregate is then transferred into the subcutaneous tissue of 
immunodeficient recipient mice, which act as a bioincubator to ensure proper supply of blood, 
nutrients, and temperature to the implant (Dufour et al. 2002; Gassei et al. 2006; Honaramooz et 
al. 2007; Kita et al. 2007; Arregui et al. 2008; Zhang et al. 2008). Following implantation, testis 
cells undergo spontaneous reorganization and de novo formation of testis cords. TCAI has been 
experimented using diverse donor species with subcutaneous tissue of immunodeficient recipient 
mice being the frequently-used site for the implantation procedure (Gassei et al. 2006; 
Honaramooz et al. 2007; Kita et al. 2007; Arregui et al. 2008; Dores et al. 2012; Campos-Junior 
et al. 2014). 
When using neonatal piglets as donors of implants, testis cells start to align themselves at ~4 days 
post-implantation, form cord-like structures after ~7 days post-implantation, and by the end of the 
second week, immature cords are transformed into structures resembling complete seminiferous 
cords of the neonatal pig testis (Honaramooz et al. 2007). Cellular arrangements following TCAI 
include polarisation of Sertoli cells to the basal compartment, translocation of gonocytes to the 
center of the newly-formed cords, and re-formation of the interstitial compartment consisting of 
Leydig cells and supporting cells of the connective tissue. Over time, regenerated testis cords 
develop into seminiferous tubules with complete maturation of germ cells and sequential rounds 
of spermatogenesis, resulting in fertilization-competent sperm (Honaramooz et al. 2007; Awang-
Junaidi et al. 2020). Judging from the vesicular gland weight in castrated recipients, regenerated 
testis tissue developed from ectopic testis cells were also capable of producing androgens to the 
same level as in situ testis tissue (Honaramooz et al. 2007). 
TCAI has been experimented using a diverse range of donors including the pig (Honaramooz et 
al. 2007; Awang-Junaidi et al. 2020), mouse (Kita et al. 2007), sheep (Arregui et al. 2008), cattle 
(Zhang et al. 2008), horse (Zeng et al. 2017) and monkey (Aeckerle et al. 2013; Shetty et al. 2018) 
(Fig. 2.1). Although there are numerous potential applications for TCAI, studies on this model 
have been rather limited. Spontaneous de novo morphogenesis of testis tissue from dissociated 





reorganize themselves to form a tissue that is structurally and functionally identical to that in situ 
(Kita et al. 2007; Arregui et al. 2008; Zhang et al. 2008). Therefore, TCAI provides a unique 
opportunity to study male gonadal development in an ex situ environment, which is especially 
important where in situ studies are inherently difficult, for instance in endangered or rare species, 
or impossible in case of humans (Dores and Dobrinski 2014). TCAI can also provide a means to 
preserve the fertility potential of immature boys whose life relies on cytotoxic cancer therapies, by 
isolating unaffected testicular cells from samples obtained through biopsies, preserving them, 
followed by implanting them to regenerate testis tissue at later time points. Notably, TCAI is a 
suitable model to study the effects of environmental factors or novel pharmaceutical compounds 
such as experimental drugs, potential toxicants, and various growth factors on testis development 
(Honaramooz et al. 2007; Dores and Dobrinski 2014; Awang-Junaidi et al. 2020).  
Dissociated testis cells from different donor species retain their re-organization potential once 
implanted into the recipient mice (Dufour et al. 2002; Gassei et al. 2006; Kawasaki et al. 2006, 
2010; Honaramooz et al. 2007; Kita et al. 2007; Arregui et al. 2008; Zhang et al. 2008; Aeckerle 
et al. 2013; Campos-Junior et al. 2014). However, establishment of complete spermatogenic 
rounds has been reported in mouse- (Kita et al. 2007) and haploid germ cells in pig- and sheep 
implants (Honaramooz et al. 2007; Arregui et al. 2008; Campos-Junior et al. 2014). Cattle were 
used as donors only in one report with successful regeneration of cords containing Sertoli cells, 
while no spermatogenesis was observed since the implants were only maintained for 3 months 
(Zhang et al. 2008). 
Timing in development of the grafts and implants in TTX and TCAI also appears to be different. 
While developmental sequence is delayed in testis cell implants, time required for full 
development of the grafts to achieve spermatogenesis is relatively closer to that in intact testis 
tissue (Berger et al. 1980; Honaramooz et al. 2002; Honaramooz et al. 2007). Testis tissue 
xenografts from neonatal porcine donors grafted into nude mice showed complete tubular 
formation containing spermatozoa at ~28 weeks post grafting (Honaramooz et al. 2002). In a 
comparable TCAI study, dissociated porcine testis cells formed seminiferous tubules at ~14 days 
post implantation and formed elongated spermatids at ~30 weeks (Honaramooz et al. 2007). Since 
sexual maturity and initiation of spermatogenesis in intact boars happen at ~6-7 months of age, it 





accurate representatives of in situ testis tissue (Berger et al. 1980; Honaramooz et al. 2002). Using 
sheep as a donor, complete spermatogenic cycle was first observed at ~12 weeks following grafting 
which was comparable with intact tissue, while spermatogenesis in sheep cell implants happened 
at ~40 weeks post implantation (Arregui et al. 2008). Similarly, in TTX and TCAI studies of 
collard peccary, spermatogenesis was reported to occur at 6 and 8 months, respectively (Campos-
Junior et al. 2014).  
Although implanted testis cells form a testis tissue with comparable architecture to the intact tissue, 
some studies reported scarcity or total absence of germ cells within seminiferous tubules (Gassei 
et al. 2006; Honaramooz et al. 2007; Kita et al. 2007; Arregui et al. 2008). This phenomenon may 
be due to a low germ cell proportion among the donor cells and/or a loss of germ cells following 
isolation and implantation processes; in either case, this results in a reduced number of spermatids 
and spermatozoa produced by implants (Rathi et al. 2006; Arregui et al. 2008; Campos-Junior et 
al. 2014). Interestingly, regeneration of testicular cords can occur even in the absence of germ cells 
and when implanted cell aggregates were only comprised of somatic cells. This observation points 
to the important role of somatic cells in reorganization of testis architecture and its maintenance 
even in intact testis tissue (Dufour et al. 2002). Also, among all TCAI studies, there has been a 
notable lack of a consistent approach for isolation and delivery of testis cells to the implantation 
site. Each report used a different number of testis cells containing various germ cell proportions 
for implantation (Gassei et al. 2006; Honaramooz et al. 2007; Arregui et al. 2008; Watanabe et al. 
2009). These factors can in turn affect the reliability of the TCAI outcomes. A recent study has 
optimised the method for delivery of the cell aggregates by systematically comparing different 
extracellular matrices as carriers of the aggregates, as well as injection vs. conventional surgical 
delivery method. In the latter study it was concluded that injection of the aggregates leads to 
reduced cell loss compared to conventional surgical embedding the aggerates into the 
subcutaneous fascia (Awang-Junaidi et al. 2020). In addition, TTX and TCAI studies mostly rely 
on surgical removal of the samples in anesthetized or euthanized animals for evaluation of the 
grafted or implanted tissues. Repeated retrieval of implant samples from immunodeficient mice 
can pose a risk of infection and other complications. Also, post-retrieval processing of the samples 
prior to their (immuno)histological examination expectedly leads to tissue distortion or shrinkage 
and biased post-retrieval assessment. As an alternative, establishment of a non-invasive 





prospective TTX and TCAI studies as it will reduce the number of required recipients and allows 
longitudinal examination of the subcutaneous samples.  
Overall, TCAI has provided an unprecedented approach to study the unexplored aspects of male 
gonadal development, and to elucidate potential factors involved in the regulation of testis 
morphogenesis (Fig. 2.1). TCAI has also offered a unique in vivo culture system to gain a deeper 
understanding of spermatogenesis, steroidogenesis, and factors affecting them via manipulation of 

















Fig. 2.1. Overview of procedures in testis tissue xenografting (TTX) and testis cell aggregate 
implantation (TCAI). Experimentations with TTX and TCAI have utilized a wide range of donor 
species. In TTX, small fragments of testis parenchyma (usually 1 mm3 in size) are isolated 
following castration or surgical biopsy of a mature/immature donor. Testis fragments are then 
embedded under the back skin of immunodeficient recipient mice through aseptic surgical 
procedure. Subcutaneous tissue acts as a bioincubator leading to complete development of the 
testis tissue with production of fertilization-competent sperm (after ~28 wk of incubation in case 
of neonatal donor piglets). In TCAI, testis parenchyma is isolated and digested using a step-wise 
enzymatic protocol, which is a combination of physical dissociation and enzymatic digestion, 
leading to a highly concentrated cell aggregate. The aggregate is then embedded/injected into the 
subcutaneous tissue of an immunodeficient recipient mouse (usually 0.1 mL per injection site). 
Testis cells in the implants reorganize to form small cords (at ~2 wk after implantation in case of 
neonatal donor piglets), and completely regenerate functional seminiferous tubules with 










2.3.4. Factors Affecting the Development of Grafts and Implants  
Following the initial experiments, TTX and TCAI were extensively applied to different donor 
species with varying outcomes. Expectedly, the time required for maturation of the tissue in TTX, 
complete development of the implants to fulfill spermatogenesis in TCAI, and rate of 
spermatogenesis in both sample types rely on factors from the donors and the recipients. Therefore, 
the main sources of variation in results of TTX and TCAI are usually classified into the factors 
associated with the donors and recipient animals (Abbasi and Honaramooz 2010; Abrishami et al. 
2010; Dores et al. 2012; Arregui and Dobrinski 2014). 
Thus far, a wide range of species have been used as donors in TTX and TCAI studies. Grafts and 
implants in nearly all studies developed into a mature tissue and contained advanced germ cells 
(Paris and Schlatt 2007; Honaramooz 2014). While in the majority of TTX studies the maturation 
timing of the ectopically grafted tissue corresponded to that of in situ testis, cells in implants 
initially required some time to reorient themselves and undergo reorganization to form cord-like 
structures (Honaramooz et al. 2002; Honaramooz et al. 2007; Paris and Schlatt 2007; Arregui and 
Dobrinski 2014). As such, development of cords and more advanced germ cells appear to be 
delayed in cell implants compared to the age-matched tissues. Grafts from the lamb, beef calf, deer 
fawn, and bison turn into fully mature tissues after ~3, ~7, ~12, and more than ~16 months, 
respectively, which is approximately the same amount of time required for in situ maturation of 
testis tissue (Rodriguez-Sosa and Dobrinski 2009; Abrishami et al. 2010; Abbasi and Honaramooz 
2011c, 2012). However, this is not the case in human grafts/implants, where their development is 
limited regardless of their developmental stage at the time of grafting/implantation (Schlatt et al. 
2006; Yu et al. 2006; Geens et al. 2008). Similarly, grafts from banteng calves showed a long 
pause in meiotic development (Honaramooz et al. 2004). Grafts from pig, rhesus monkey, and 
collared peccary start to produce spermatozoa in shorter periods of time compared to in situ tissue 
(Honaramooz et al. 2004; Sato et al. 2010; Campos-Junior et al. 2014), while initiation of 
spermatogenesis takes longer in cat xenografts (Kim et al. 2007). Also, it is speculated that 
exposure of immature testis tissue to post-pubertal hormonal environment in the host mouse can 
lead to accelerated maturation of the xenografts from rhesus monkeys, although this has not been 





In addition to timing of spermatogenesis, donor species also determines the efficiency of 
spermatogenesis, usually reported as the percentage of seminiferous tubules with sperm or 
elongated spermatids. In grafts from sheep or goat, spermatogenic efficiency appeared to be high 
compared with that of dairy or beef cattle, buffalo, bison, and deer (Honaramooz et al. 2002; Oatley 
et al. 2004; Rathi et al. 2005b, 2006; Zeng et al. 2006). This can be due to greater compatibility 
of the grafts with the host HPG axis. The overall structure of gonadotropins shows a conserved 
sequence of homology among species (Bousfield et al. 2006); however, slight differences in amino 
acid sequences results in diversity in gonadotropin binding affinity to their receptors of various 
species (Arregui and Dobrinski 2014). Another hormonal regulator for development of the ectopic 
graft is testosterone. Although testosterone is also structurally conserved among vertebrates, some 
grafts, especially from bovine species, inherently produce large amounts of androgens, which in 
turn affects spermatogenic efficiency of the xenografts through the established feedback loop 
(Rathi et al. 2005; Rodriguez-Sosa et al. 2012). Taken together, both timing and efficiency of 
spermatogenesis varies between xenografts from different species (Arregui and Dobrinski 2014).  
Age of donors is also an important determinant in success of spermatogenesis following grafting 
or implantation. Overall, grafts from immature donors seem to have a considerably greater 
developmental potential compared to those from mature donors (Honaramooz et al. 2002; 
Shinohara 2002; Schlatt et al. 2002; Kim et al. 2007; Arregui and Dobrinski 2014). Degeneration 
of the testis tissue is frequently reported following grafting from mature donors. Grafts which 
contain high percentage of complete spermatogenic cycles at the time of grafting demonstrated 
faster degeneration compared to grafts from young and immature donors (Schlatt et al. 2006; 
Arregui et al. 2008; Turner et al. 2010). Also, the extent of degeneration has been greater in grafts 
from donors with naturally greater spermatogenic efficiency (e.g., pigs and goats) or with more 
advanced stages of spermatogenesis at the time of grafting (Arregui et al. 2008). Post-grafting 
degeneration may be the result of susceptibility of differentiated germ cells to hypoxia, limited 
blood supply, limited angiogenic potential of the mature tissues, inhospitable microenvironment 
immediately after ectopic grafting/implantation, and/or loss of proliferative potential of mature 
Sertoli cells, which in turn limits the overall regeneration of grafts following TTX (Schlatt et al. 
2002; Rathi et al. 2006; Kim et al. 2007; Arregui et al. 2008; Abrishami et al. 2010). Treatment 
of the grafts with vascular endothelial growth factor (VEGF) was shown to promote angiogenesis 





application of VEGF was suggested to enhance survival of grafts or implants and offset the 
negative effects of initial hypoxia by triggering neovascularization (Schmidt et al. 2006). Also, 
xenografts from immature donors present greater responsiveness towards the recipient’s 
gonadotropins (Rathi et al. 2008). Donor age also plays a role in germ cell loss following TTX 
(Sato et al. 2010; Campos-Junior et al. 2014). Germ cells typically undergo apoptosis immediately 
after grafting and this loss is not limited to mature donor tissue but also appears to be as great in 
fetal tissues since spermatogonia comprise a smaller population in the testis during prenatal period 
compared to that of neonates (Arregui et al. 2014). In addition, different patterns of gene 
expression between mature and immature testicular cells affect cell survival, somatic cell function, 
and proliferation vs. differentiation fate of germ cells (Honaramooz 2014). However, in some 
species, spermatogenic efficiency is greater when grafts are in more advanced developmental 
stages at the time of grafting. For instance, in some species such as bovine or feline, relatively 
enhanced spermatogenic efficiency has been reported in grafts from young donors compared to 
neonatal. This observation has been attributed to increased number of SSCs in grafts because of 
their proliferation prior to grafting (Oatley 2005; Kim et al. 2007). 
Grafting or implantation are not always applicable immediately following collection of testis 
samples, for instance when the tissue is to be transferred to the laboratory where procedures for 
TTX or TCAI are feasible. As such, several studies have been conducted on viability and 
regeneration potential of grafted tissues or implanted cells after experiencing a period of cold 
treatment or cryopreservation (Abrishami et al. 2010; Honaramooz 2012). In fact, a period of cold 
storage or cryopreservation of tissues has been shown to reduce hypoxic damage by lowering 
tissue/cell metabolism and increase cell adaptability with new ectopic environment. This has been 
shown by advanced development of cold-treated or cryopreserved tissues grafted into recipients 
(Honaramooz et al. 2002; Shinohara 2002; Jahnukainen et al. 2007; Zeng et al. 2009; Abrishami 
et al. 2010; Campos-Junior et al. 2014). 
Generally, mice are the species of choice when it comes to grafting studies, since they have been 
genetically manipulated and offer variety of options such as hairless and immunodeficient 
phenotypes (Geens et al. 2006; Hirenallur-Shanthappa et al. 2017). Ease of manipulation, 
accessibly to large areas of loose skin for grafting/implantation purposes, and cost-effective 





to develop immune response against the grafted tissues or implanted cells, they have been used 
frequently in TTX and TCAI studies. The two frequently used strains of mice in TTX and TCAI 
are SCID and nude (Honaramooz et al. 2002; Honaramooz et al. 2007; Abbasi and Honaramooz 
2010; Arregui and Dobrinski 2014; Dores and Dobrinski 2014; Hirenallur-Shanthappa et al. 2017). 
Systematic studies point at superior support of SCID strain for graft development and its 
spermatogenic efficiency when compared to nude mice (Abbasi and Honaramooz 2010; 
Honaramooz 2014; Awang-Junaidi et al. 2020). Also, reduced degeneration of human testis grafts, 
greater spermatogenic output in porcine grafts, and greater morphogenesis potential in implants 
have been reported in SCID recipients (Schlatt et al. 2006; Abbasi and Honaramooz 2010). 
Gonadal status of the recipients also determines the outcome of TTX/TCAI. Expectedly, castration 
of recipients reduces androgens, obliterates the endogenous feedback loop, and as such increases 
release of gonadotropins from the pituitary gland. This, in turn will initially lead to stimulation of 
the grafts and implants by the recipients’ pituitary gonadotropins and enhances steroidogenesis in 
grafts/implants (Schlatt et al. 2002). Castration of recipients also leads to elimination of 
stimulatory effects of testosterone on vesicular glands, making the size of this gland a reliable 
indicator of androgenic competence of grafts/implants. Nevertheless, the overall effects of gonadal 
status on TTX/TCAI are also donor-dependent since intact male recipients sufficiently supported 
the development of grafts from pigs, rabbits, hamsters, cattle, and buffalo (Shinohara 2002; Huang 
et al. 2008; Abbasi and Honaramooz 2010; Schlatt et al. 2010a; Honaramooz 2014) but grafts from 
immature testis of horse and rhesus monkey experienced degeneration (Honaramooz et al. 2004; 
Rathi et al. 2006). Sex of the recipients also seems to have some effect on the outcome of TTX 
(Abbasi and Honaramooz 2010). Although even female recipient mice with intact ovaries could 
support neonatal porcine testis grafts to full spermatogenesis, similar grafts in male recipients were 
slightly larger in size and showed greater recovery with more developed seminiferous tubules 
(Abbasi and Honaramooz 2010). Age of recipients also appears to be an important factor for graft 
development, since Sertoli cell-only tubules were increased in hamster testis tissue grafts 
developed in young mouse recipients compared to those developed in more mature recipients 
(Ehmcke et al. 2008; Honaramooz 2014). Also, greater number of grafts per recipients (i.e., 16 
grafts per mouse) led to greater overall weight, spermatogenic efficiency, and androgen release 
compared to lower number of grafts in recipience (i.e., 2 grafts per mouse). Effects of recipient 





cannot necessarily be extrapolated when using different donor species. For instance, no significant 
effect of castration was observed on the status of grafts when dairy calves were used as donors 
(Huang et al. 2008). Conversely, in case of water buffalo donors, application of non-castrated 
recipients seemed to be crucial for development of the ectopic tissue grafts (Reddy et al. 2011).  
Social interactions between male mice correlates with production of androgens in the body, which 
in turn can potentially affect the development of grafted tissues. However, the results of a study 
on group vs. individual housing of male nude mice showed that graft recovery rate, spermatogenic 
efficiency, as well as graft and vesicular gland weight were not affected when housing mice 
individually or together (Arregui et al. 2008). Finally, the life span of immunodeficient mice is 
~1.5 years, which is shorter than the onset of spermatogenesis in many species such as rhesus 
monkeys. As such, TTX or TCAI are not always applicable to represent in situ testis development 
(Honaramooz et al. 2004; Sato et al. 2010).  However, in some cases, the onset of sperm production 
in grafts can be possibly shortened by application of exogenous hormones, which warrants further 
investigation (Honaramooz et al. 2004; Rathi et al. 2008). 
Majority of studies have been focused on the effects of multiple factors from donors or recipients 
on tissue graft survival and development, which cannot necessarily represent the same outcomes 
for the cell implants (Dores et al. 2012; Arregui and Dobrinski 2014; Honaramooz 2014). 
Therefore, establishment of a systematic study on both donors and recipients of implants or 
exogenous supplementation of growth factors or hormones to implants would greatly benefit 
prospective TCAI studies and their downstream applications. 
2.4. In Vitro Models for the Study and Manipulation of Testis Cells 
2.4.1. Identification, Isolation, and Enrichment of Gonocytes 
Gonocytes are the dominant germ cells in the neonatal testis (Culty 2013). Depending on the 
species, these cells exist up to several days, months, or even years in the seminiferous tubules 
(Goel et al. 2007; Culty 2009, 2013). In neonatal rodents, gonocytes along with undifferentiated 
spermatogonia are present in the testis, while in neonatal pigs, gonocytes are the primary germ 
cells which transform into spermatogonia at ~2 months of age (Goel et al. 2007; Drumond et al. 
2011). However, the exact time point for the transition from gonocytes to spermatogonia is not yet 





rats, and between 3 to 12 months after birth in humans (Roosen‐Runge and Leik 1968; Bellve et 
al. 1977; Zogbi et al. 2012; Su et al. 2014). This variability in duration of gonocyte-to-
spermatogonia transition is predominantly the result of differences in the the quiescent stage 
(Tiptanavattana et al. 2015). Gonocytes have unique characteristics such as unique morphology 
which makes them easily identifiable. In addition, these cells are the progenitors of SSCs which 
establish the foundation of spermatogenesis. The unique features of gonocytes make them an 
attractive tool with multiple downstream applications (Culty 2009). However, the scarcity of 
gonocytes in the testis (~2% and 7% of testis cells in neonatal rats and pigs, respectively) limits 
their applications (Orwig et al. 2002; Honaramooz et al. 2005). Thus, different methods have been 
developed and carried out for enrichment of gonocytes. 
Gonocytes possess a unique morphology with a large nucleus and a ring-like cytosol. These cells 
appear as large round cells in the center of the seminiferous cords with prominent nucleoli and low 
complexity of cytoplasmic organelles (Orwig et al. 2002). After birth, these cells develop 
cytoplasmic extensions which help them migrate through the Sertoli cell cytoplasmic membrane 
towards the basal compartment (Culty 2009, 2013). Development of pseudopodia by gonocytes 
has also been shown when they are propagated in vitro (Awang‐Junaidi et al. 2020). Gonocyte is 
a general term which encompasses M-, T1-, and T2-prospermatogonia depending on their 
developmental stage. These stages, however, are morphologically indistinguishable using light 
microscopy (Culty 2009; Tiptanavattana et al. 2015). This has been especially shown in rats where 
general morphological appearance of gonocytes from 16 dpc to 3 dpp were similar (Culty 2009). 
Once sitting on the basement membrane, gonocytes initiate their transformation into a new germ 
cell population with distinct morphology, known as spermatogonia. Unlike different subtypes of 
gonocytes, spermatogonia possess different morphologies depending on their developmental 
stage, including As, Apr, Aal, A1-A4, intermediate, and B spermatogonia (Culty 2009; Phillips et 
al. 2010). In humans, on the other hand, only three stages of spermatogonia have been identified 
including Apale, Adark, and B spermatogonia based on the heterochromatic contents of the cells 
(Phillips et al. 2010). There are limited studies about different categories of gonocytes and their 






Neonatal gonocytes in mice are divided into three categories, namely I, II, and III based on slight 
morphological differences. All types show the same nuclear size and one to three nucleoli. From 
subtype I to III there is a gradual transition in shape from round to oval. Subtype I cells are usually 
located in the center of the cords, and show regular cytoplasmic membrane with no extensions, 
while the nucleoli of subtype II are less condensed with more reticulated morphology and irregular 
shape. Subtype II gonocytes are also located closer to the center of the cords but usually possess 
cytoplasmic extensions, indicative of their migratory ability. This subtype shows a peculiar 
structure resembling acrosomal vesicles proximal to the nuclear envelope. Nucleoli of type III are 
the least condensed and reticulated. The later subtype lacks the cytoplasmic extensions and are 
usually found on the basement membrane. Subtype III ultimately gives rise to type A 
spermatogonia, which in contrast to gonocytes have smaller nuclear diameter, are more oval, and 
possess more condensed nucleoli. More advanced stages of spermatogonia, on the other hand, 
demonstrate larger diameters, lighter staining, and increasing heterochromatin (Clermont and 
Perey 1957; Chiarini-Garcia and Russell 2001; Drumond et al. 2011). In mice, the number of 
gonocytes is reported to stay constant in the first 24 hours due to an established balance between 
their proliferation and apoptosis (Drumond et al. 2011). After that, gonocyte numbers sharply 
decreases by ~3 dpp in mice since a fraction of these cells undergo mitosis, while a considerable 
number go through degeneration (Roosen‐Runge and Leik 1968; Kluin and de Rooij 1981). As 
gonocyte numbers decrease in seminiferous cords, the population of A spermatogonia increases 
up to 37 days after birth (Drumond et al. 2011). 
Based on in vitro studies, rat gonocytes capable of developing pseudopodia are destined to migrate 
and differentiate while gonocytes which lack cytoplasmic extensions and are unable to migrate 
undergo apoptosis (Manku and Culty 2015). Development of pseudopodia has been also reported 
in a fraction of transplanted gonocytes and is believed to be crucial in their translocation towards 
the basal compartment, survival, and establishment of donor-derived spermatogenesis (Orwig et 
al. 2002). As such, gonocytes can alternatively be classified based on their ability to develop 
cytoplasmic extensions. Another classification method for gonocytes has been suggested based on 
their size, where they can be distinguished as very large cells (~12 µm or larger in diameter) and 
medium cells (10-12 µm in diameter), both being larger than somatic cells (Culty 2009; Manku 
and Culty 2015). Relative size of gonocytes compared to somatic cells is even more evident 





identifiable morphological features, which provide valuable means to distinguish them; however, 
availability of cell-specific molecular markers which are exclusively expressed by gonocytes is 
still crucial for their efficient identification and isolation. 
Since there has been no established marker that is exclusively expressed in gonocytes, these cells 
are usually identified using generic early germ cell markers (e.g., VASA, DAZL) (Goel et al. 2007; 
Culty 2009). Gonocytes also express a number of makers which are associated with pluripotency 
such as NANOG and OCT4 (Ohbo et al. 2003; Goel et al. 2007; Culty 2009). Since these cells 
arise between the two intermediary stages of ES cells and adult MGSCs, they are expected to 
express stem cell-specific markers (Culty 2009). OCT4 is present in cells of the ICM and is known 
as a biomarker for ES cells. Using GFP under Oct4 promoter, mouse germ cells were also positive 
for OCT4 and as such, it has been accepted as a marker for PGCs, gonocytes, and spermatogonia 
(Zhao and Garbers 2002; Ohbo et al. 2003; Ohmura et al. 2004). Another possible marker for 
gonocytes is c-KIT. The proto-oncogene c-kit was first introduced as a hematopoietic stem cell 
marker (Ashman et al. 1991). c-KIT was later shown to be present on the surface of PGCs, which 
acts as a regulator of PGC migration towards the genital ridges (Koshimizu et al. 1992). Co-
expression of c-KIT and OCT4 was observed in PGCs during 11.5-13.5 dpc, while PGCs at 16.5 
dpp were c-KIT– and OCT4+ (Ohbo et al. 2003). Expression of c-kit becomes positive for 
differentiating spermatogonia, while it is absent in more primitive SSCs and is present in a limited 
number of gonocytes (Culty 2009, 2013). OCT4 expression correlates with stemness features of 
gonocytes since the majority of OCT4+ gonocytes show high levels of proliferative and 
repopulation activity (Ohmura et al. 2004). At ~7 dpp in mice, almost half of the gonocyte 
population also express GDNF receptors, indicative of different gonocyte sub-populations 
(Ohmura et al. 2008; Culty 2009). Thy-1 is another marker for identification of germline stem 
cells. This marker was initially found on hematopoietic, mesenchymal, and embryonic stem cells 
(Ling and Neben 1997; Izadpanah et al. 2006). Thy-1 is present on neonatal gonocytes, as well as 
a mixed population of spermatogonia (Culty 2009, 2013). Another stem cell pluripotency marker 
associated with identification of germline stem cells is NANOG. This marker is a homeodomain 
transcription factor originally explored while investigating the stem cell self-renewal (Chambers 
et al. 2003). NANOG is expressed by cells of pre-implantation embryos and post-implantation ES 
cells and regulates self-renewal while restricting transition into a differentiating stage (Chambers 





with OCT4 (Yoshida et al. 1994). NANOG expression diminishes after birth, with only 1% of 
gonocytes being positive at ~16.5 dpc and almost no positive cells in adult mouse testis (Kerr et 
al. 2008). In humans, NANOG expression is present until 20 weeks of gestation, is retained only 
in a small group of gonocytes until 3 months after birth and is absent in childhood and adult testes 
(Hoei-Hansen et al. 2005; Rajpert-De Meyts 2006; Culty 2009). Another set of markers for 
gonocyte identification includes ZBTB16 (PLZF) and SALL4 (Culty 2009; Ibtisham and 
Honaramooz 2020). PLZF is involved in the proliferation of gonocytes and its knock-out leads to 
failure in establishing the SSC pool (Costoya et al. 2004). Also, members of Sall gene family, such 
as Sall4 are highly conserved among species and play key roles both in formation of germ cell 
pool and axis development in the embryo. SALL4 directly interacts with PLZF in regulating 
mitotic divisions of germ cells (Gassei and Orwig 2013). Gonocytes also show alkaline 
phosphatase activity, express surface molecules such as CD9 and ubiquitin carboxyl-terminal 
hydrolase-L1 (UCH-L1; also known as PGP9.5) (Kubota et al. 2003; Kanatsu-Shinohara et al. 
2004b; Luo et al. 2006; Goel et al. 2007; Kim et al. 2013; Zheng et al. 2014). Although not a 
transcription factor, Dolichos biflorus agglutinin (DBA) is an alternative surface marker for 
gonocytes which has a high affinity for N-acetyl galactosamine of the cytoplasmic membrane, and 
as such can be used with high specificity to identify gonocytes (Goel et al. 2007; Yang et al. 2010). 
Overall, expression of surface markers in gonocytes is highly dependent on their developmental 
stage and displays different patterns with varying combinations at each stage (Goel et al. 2007; 
Culty 2009, 2013). 
Dissociation of testis cells from parenchyma is the first step to obtain a mixed cell population, 
including germ cells, for downstream applications including in vitro propagation, GCT, or even 
TCAI (Khaira et al. 2005; Dobrinski and Travis 2007; de Rooij and Mizrak 2008; Oatley and 
Brinster 2008). Since the population of gonocytes diminishes over time from prepubertal to 
pubertal period, testis from neonatal donors is expectedly a superior source to obtain greater 
gonocyte proportion. As mentioned above, duration of gonocyte-to-spermatogonia transition is 
species-specific, which in rodents takes about a few days, leaving a small window during which 
these cells can be efficiently isolated after birth. Different strategies have been developed so far to 
obtain a single cell suspension from testis, yielding various proportions of germ cells (Goel et al. 
2007; Culty 2009; Yang et al. 2010). Predictably, one of the major drawbacks in cell isolation is 





multiple steps of cell extraction from the parenchyma. The initial strategies for isolation of MGSCs 
from testis were consisted of two-step enzymatic digestions, where the parenchyma was first 
physically dissociated and the resultant fragments were exposed to an enzymatic solution, usually 
consisting of trypsin combined with other enzymes (e.g., DNase). However, conventional 
approaches of cell isolation were inefficient, yielding very limited percentages of gonocytes (~5-
10%) (van Dissel-Emiliani et al. 1989; Orth and Bohem 1990; Li et al. 1997a; Honaramooz et al. 
2002; Orwig et al. 2002; Honaramooz et al. 2003). To overcome this limitation, a three-step 
enzymatic digestion method was developed, resulting in noticeably improved cell recovery and 
gonocyte yield (~40% gonocytes). The later method was composed of a brief physical dissociation 
step by mincing and vortexing the parenchyma, followed by enzymatic treatment of the resultant 
suspension with a cocktail of digestive enzymes composed of hyaluronidase, DNases, and 
collagenase with final exposure of the cell isolates to an erythrolysis solution. Although intact 
porcine testis tissue prior to digestion contains ~7% gonocytes, this percentage reached ~40% with 
>90% viability following application of the latter method for germ cell isolation (Honaramooz et 
al. 2005; Yang et al. 2010). 
Since gonocytes are a rare germ cell population in the neonatal testis, additional enrichment 
strategies have been developed to increase their numbers prior to their downstream applications. 
This is mainly because such applications (e.g., GCT, in vitro propagation, or transgenesis) will 
expectedly improve when the cell isolates contain a high proportion of germ cells (Goel et al. 
2007; Yang et al. 2010; Honaramooz and Yang 2011). One of the main techniques for enrichment 
of germ cells is based on utilization of fluorophore-labelled antibodies. Fluorescent activated cell 
sorting (FACS) (Moudgal et al. 1997; Shinohara et al. 2000; Lo et al. 2005; Herrid et al. 2009), 
magnetic activated cell sorting, (MACS) (Kubota et al. 2004a; Buageaw et al. 2005; Herrid et al. 
2009), density gradient centrifugation (Izadyar et al. 2002; Luo et al. 2006; Herrid et al. 2009), or 
differential plating (Izadyar et al. 2002; Luo et al. 2006; Herrid et al. 2009; Honaramooz and Yang 
2011) can lead to enrichment of SSCs up to ~75% in testis cell isolates of farm animals. For 
gonocyte enrichment, a number of strategies have been applied in rodents and pigs, leading to 
improved gonocyte percentage up to ~70-90% in rats (van Dissel-Emiliani et al. 1989; van Den 
Ham et al. 1997; Moore et al. 2002) and 70% in pigs (Goel et al. 2007). A study in our lab showed 





or differential poly-D-lysine coated plating and even up to ~90% if the two methods are combined 
(Yang et al. 2010; Honaramooz and Yang 2011). 
2.4.2. Maintenance and Propagation of Germline Stem Cells in Culture Systems 
The first few reports of successful development of a culture system for germ cells in rodents 
attracted many researchers to explore germ cell biology and underlying factors involved in their 
proliferation and differentiation (Sahare et al. 2018). Culture of MGSCs can be used to increase 
their numbers from limited sources including biopsies to achieve larger cell populations for 
downstream applications. These applications can include GCT aimed at preserving fertility, 
understanding the biology of MGSCs, or producing transgenic animals with enhanced productivity 
traits through genetic manipulation of germ cells prior to GCT. Germ cell culture is also a valuable 
tool in investigating the factors involved in their proliferation and differentiation, especially given 
that in situ study of MGSCs is difficult or not feasible. Cultured MGSCs may also serve as 
pluripotent stem cells given that limited available studies have demonstrated MGSCs ability to 
spontaneously transform into pluripotent/multipotent stem cells in vitro (Jiang and Short 1998a; 
Jiang 2001; Bai et al. 2018). Therefore, in vitro propagated MGSCs offer a promising alternative 
source of stem cells for regenerative therapy since the application of induced pluripotent stem 
(iPS) cells and ES cells usually entails safety or ethical concerns (Seandel et al. 2007; Zheng et al. 
2013). 
Elucidating the essential factors in maintenance and proliferation of germ cells in the testis is key 
in their successful expansion in vitro. For instance, GDNF was one of the initial cytokines shown 
to be crucial for self-renewal as well as differentiation of mouse MGSCs (Meng et al. 2000b). 
GDNF exerts its effects through a multicomponent receptor complex composed of GFRα-1 and 
RET tyrosine kinases in many cell types (Jing et al. 1996). These two components of the receptor 
complex have been recognized as markers for MGSCs (Widenfalk et al. 2000). Given the 
important role of GDNF in proliferation of germ cells, short-term culture systems were developed 
with GDNF supplementation to improve germ cell survival, while retaining their ability to colonize 
the recipients’ seminiferous tubules following GCT (Nagano et al. 2003; Kanatsu-Shinohara 2005; 
Naughton et al. 2006). However, a similar response cannot be expected from germ cells of different 
sources following growth factor supplementation since it has been shown that growth factor 





can be possibly applied to germ cells of different species (Kubota et al. 2004a). This in turn may 
suggest that MGSCs in the testis of different species require a species- or strain-specific growth 
factor combinations with different concentrations. To date, species-specific growth factor 
requirements for in vitro propagation of germ cells have been studied in rats (Ryu et al. 2005; 
Hamra et al. 2005), hamsters (Kanatsu-Shinohara et al. 2008), and rabbits (Kubota et al. 2011). 
Several growth factors have been suggested to play important roles in self-renewal regulation of 
germ cells. These include PDGF, leukemia inhibitory factor (LIF), SCF, basic fibroblast growth 
factor (bFGF) (also known as FGF-2), FGF-9, and RA (Tu et al.; Jaillard et al. 1987; Wang and 
Culty 2007; Mirzapour et al. 2012; Sahare et al. 2016, 2018). 
Unlike many other cell types, MGSCs in culture are normally non-adherent, requiring a supportive 
feeder layer for survival. Therefore, MGSCs have been co-cultured with endogenous somatic cells 
of the testis, which gradually form an attached flat monolayer at the bottom of the culture dish 
(Orth and Rosemarie 1990; McGuinness and Orth 1992; van Dissel-Emiliani et al. 1993; Awang-
Junaidi and Honaramooz 2018; Awang‐Junaidi et al. 2020). Survival of gonocytes depends on 
their ability to establish connections with the monolayer while floating gonocytes undergo 
apoptosis and are removed with media (van Dissel-Emiliani et al. 1993). The somatic cell 
monolayer is also involved in regulation of germ cell metabolism and self-renewal vs. 
differentiation by producing cytokines and molecular signals. It is speculated that these molecular 
cues from Sertoli cells especially direct cultured germ cells towards differentiation pathways 
(Griswold et al. 1989). Other types of feeder layers used for culture of MGSCs include mitotically-
inactivated cells including SIM mouse embryo-derived thioguanine and ouabain resistant 
fibroblast cell lines (STO) as well as mouse embryonic fibroblast cell lines (MEF) (van Dissel-
Emiliani et al. 1993; Nagano et al. 1998; Hasthorpe et al. 1999; Kubota et al. 2004a; Han et al. 
2009; Wu et al. 2009; Nasiri et al. 2012). Notably, STO has been the most supportive feeder layer 
for the culture of spermatogonia of various species such as rodents, livestock, and humans. 
Although required, application of a feeder layer is usually associated with reduced proliferative 
activity of germ cells and may introduce a confounding factor due to variation in its source, 
batches, and treatments applied during its development. Cellular biproducts in the feeder layer also 
potentially exert negative effects on germ cells. Therefore, co-culture of germ cells with 
endogenous Sertoli cells can be advantageous as they provide a relatively similar 





MGSC culture has also been experimented using livestock donors, including pigs, leading to 
mainly successful establishment of short-term cultures (Goel et al. 2007; Sahare et al. 2018; 
Ibtisham and Honaramooz 2020; Ibtisham et al. 2020). In such studies, a range of media (e.g., 
DMEM, DMEM/F12, MEM, and StemPro) has been used with DMEM being the most prevalent 
medium (van Dissel-Emiliani et al. 1993; Goel et al. 2007; Awang-Junaidi and Honaramooz 
2018). Typically, culture media is supplemented with serum substitutes containing a pool of 
growth factors, cytokines, and hormones. Unknown serum contents might not necessarily benefit 
germ cell survival (Kubota et al. 2004b; Zheng et al. 2013; Sahare et al. 2016, 2018; Suyatno et 
al. 2018). For instance, fetal bovine serum (FBS) supplemented at 5% has been shown to maintain 
porcine gonocytes up to 9 days (Marret and Durand 2000), while its deleterious effects were 
observed when supplemented at 2-8% (van Dissel-Emiliani et al. 1993). Also, increased FBS 
concentrations led to reduced colony formation of porcine gonocytes (Zheng et al. 2013). Synthetic 
serum replacements, such as KSR, have been developed as alternatives to FBS and are used 
extensively in cell culture research (Kanatsu-Shinohara et al. 2011, 2014; Sadri-Ardekani et al. 
2011; Sahare et al. 2018). Serum replacements have more consistent components and defined 
formulation, and were developed primarily to culture undifferentiated stem cells such as ES cells 
(Hua et al. 2009). SSCs from rats and mice have also been cultured using media supplemented 
with serum replacement (Kubota et al. 2004a; Ryu et al. 2005). However, there is no established 
protocol or culture media formulation for long-term maintenance and propagation of MGSCs from 
large animal species including pigs, which can provide a practical and suitable model for human 
germ cells (Kim et al. 2014; Sahare et al. 2016). Particularly, a systematic study on long-term 
culture requirements for porcine MGSCs is of great importance since, as shown in rodents, 
cultured MGSCs can potentially offer an alternative source for undifferentiated pluripotent stem 
cells for numerous downstream applications and will provide a stronger proof-of-concept for 
similar potential in human MGSCs. 
2.4.3. In Vitro Generation of Pluripotent Cells from Male Germline Stem Cells 
Pluripotent stem cells can undergo self-renewal and differentiation into specialized cell types from 
three germinal layers (i.e., ectoderm, mesoderm, and endoderm) (Wobus and Boheler 2005). 
Mainly, there are two types of pluripotent stem cells: ES cells and iPS cells. ES cells are derived 





their pluripotent state in vitro (Evans and Kaufman 1981; Thomson et al. 1998). Pluripotent stem 
cells can be also generated by inducing dedifferentiation of adult somatic cells through insertion 
of pluripotency transcription factors into the somatic cell genome which directs them through 
‘reprogramming’ pathways into more primitive developmental stages (Takahashi and Yamanaka 
2006; Takahashi et al. 2007). Similar to ES cells, iPS cells can self-renew indefinitely and have 
the potential to give rise to derivatives of three germinal layers (Romito and Cobellis 2016). These 
cells are produced by suppression of somatic cell gene program and increased expression of 
pluripotency-associated transcription factors. Given that pluripotent stem cells, including ES and 
iPS cells, can differentiate into all specialized cell types, they are considered as promising sources 
for cell-based therapies (Romito and Cobellis 2016). So far, preclinical cell therapy experiments 
in animal models have shown beneficial effects of pluripotent stem cells, such as restoration of 
locomotion following spinal cord injuries (Kriks et al. 2011), improved vision in blindness models 
using ES cell derived retinal pigment epithelium (Lund et al. 2006), and treatment of cardiac 
ischemia in a porcine model using iPS cell-derived cardiomyocytes (Kawamura et al. 2012). 
However, application of iPS cells and ES cells usually entails ethical issues regarding manipulation 
of embryos to obtain ES cells, biosafety risks associated with gene delivery into the somatic cells, 
and/or tumorigenicity. As such, more extensive research is required to find alternative sources for 
pluripotent stem cells, which can be utilized safely and efficiently (Golestaneh et al. 2009; Chen 
et al. 2020).  
So far, several reports have shown derivation of ES-like cells from cultured germline stem cells 
(Kim and Belmonte 2011). Mouse MGSCs were first documented to obtain characteristics of ES 
cells in vitro. MGSCs of mice showed very similar morphological features and gene expression 
pattern as mouse ES cells, developed into all three germinal layers in vitro, formed teratoma upon 
implantation into nude mice, and contributed to formation of chimera. Interestingly, 
dedifferentiation process of MGSCs was carried out without addition of reprogramming factors, 
or introduction of pluripotency transcription factor to the germline stem cells (Kanatsu-Shinohara 
et al. 2004). Pluripotent germline stem cells were also produced from adult mice with various 
genetic backgrounds (Guan et al. 2006; Seandel et al. 2007). Further work resulted in introduction 
of multipotent human germline stem cells by utilizing ES cell culture conditions (Sadri-Ardekani 
2009). Later, it was shown that acquisition of pluripotency by MGSCs is age-dependent meaning 





(Guan et al. 2006; Seandel et al. 2007; Azizi et al. 2016). The overall mechanism of germ cell 
conversion into more primitive stages in vitro is not yet clearly understood, but it is proposed that 
testis microenvironment restricts the MGSC potential to both express pluripotency gene transcripts 
(e.g., Oct4, Nanog, and c-Myc), and produce somatic cell derivatives. Conversely, in vitro 
environment lacks the in situ factors and as such, induces pluripotency by modulating the MGSC 
gene expression, and triggers the fate conversion under in vitro conditions (Kanatsu-Shinohara et 
al. 2004; Seandel et al. 2007). In addition to rodents, germline-derived ES-like cells were produced 
using human, porcine, bovine, and caprine MGSCs in vitro (Goel et al. 2007; Fagoonee et al. 2011; 
Awang‐Junaidi et al. 2020; Kumar et al. 2021). Taken together, this conversion potential in 
MGSCs is especially important for production of multipotent germline stem cells from autologous 
sources with possible applications in fertility restoration and tissue regeneration, without 
associated risks of immunorejection and tumorigenicity as well as biosafety concerns (Struijk et 
al. 2013; Sahare et al. 2018). 
2.4.4. In Vitro Trans-Differentiation of Male Germline Stem Cells 
Several studies have been conducted so far to optimize the conversion of MGSCs to ES-like cells 
following the initial reports using a mouse model (Kanatsu-Shinohara et al. 2004; Chen et al. 
2020). Studies on dedifferentiation of MGSCs were all suggestive of their unique potential in 
different species to spontaneously transform into a pluripotent state in culture conditions without 
addition of exogenous transcription factors or enforcing genetic manipulation (Golestaneh et al. 
2009; Azizi et al. 2016, 2019; Sahare et al. 2018; Chen et al. 2020). Given that MGSCs display 
the morphological and biomolecular features of ES cells in culture conditions, they were 
subsequently directed to differentiate into different somatic cell lineages (Kanatsu-Shinohara et al. 
2004; Azizi et al. 2016, 2017; Conrad et al. 2016). So far, pluripotent MGSCs have been 
differentiated into somatic cells of neuronal origin, cardiomyocytes, gastrointestinal cells, 
adipocytes, hepatocytes, and striated myofibroblasts in different species (Guan et al. 2006; Glaser 
et al. 2008; Streckfuss-Bömeke et al. 2009; Li et al. 2010; Cheng et al. 2012; Zhang et al. 2013; 
Luan et al. 2014; Wang et al. 2015; Kim et al. 2015; Chen et al. 2016; Javanmardy et al. 2016; 
Liu et al. 2016; Yang et al. 2017). The unique differentiation features of MGSCs are attributed to 
their intrinsic and extrinsic factors which collectively have made them an attractive potential 





proliferation and higher adaptability to the extrinsic environment (Kubota et al. 2004b, 2011; Yang 
et al. 2015).  
Since MGSCs have more similarity to ES cells than stem cells of other somatic tissues, recently, 
it was suggested that they can directly trans-differentiate when recombined with fetal or neonatal 
mesenchyme from various organs. This idea was experimented using an in vivo grafting approach 
in a mouse model where the mesenchyme acted as an instructive inducer, leading to direct 
differentiation of murine germ cells into tissues of all germ layers including prostatic, uterine, and 
skin epithelium (Simon et al. 2009, 2010). Similarly, a recent study showed trans-differentiation 
of human germline stem cells into hepatocytes by extracting liver mesenchymal cells, recombining 
them with germ cells, and grafting them under the renal capsule of nude mice (Chen et al. 2017). 
However, this approach has its own challenges, including isolation of tissue-specific mesenchymal 
cells, recombining them with germ cells, and in vivo grafting. Expectedly, even slight changes at 
genetic or epigenetic levels to the resultant stem cells following multiple steps of this approach as 
well as exposure of MGSCs to exogenous mesenchyme, and in vivo culture conditions can limit 
their applications. 
Although MGSCs can potentially serve as a stem cell source, generation of germ cell-derived 
pluripotent stem cells in vitro is still challenging and complicated since based on established 
protocols, it requires multiple passaging, addition of multiple proteins, growth factors/cytokines, 
and/or co-culturing with exogenous feeder layers. These can introduce unwanted changes in their 
gene regulation or generate unknown epigenetic changes and as such limit their downstream 
applications (Golestaneh et al. 2009; Chen et al. 2020). Therefore, developing alternative simple 
strategies for derivation of pluripotent germline stem cells and straight-forward trans-
differentiation approaches, which eliminate any possible exogenous confounding factors or 
concerns regarding their use will be of great value. Overall, compared to other stem cell types, the 
potential application of MGSCs in clinical settings can bypass immunorejection, safety and ethical 
concerns and as such, they are a promising source of stem cells for regenerative medicine and cell-
based therapy. 
2.4.5. In Vitro Spermatogenesis 
In vitro spermatogenesis (IVS) is the process of producing haploid germ cells from spermatogonia 





understand the complex biological interactions between testicular cells, cellular interactions, 
epigenetic processes, gene regulation, genetic disorders, or pathological conditions in the testis, as 
well as the effects of exogenous factors on spermatogenesis. These models can include culturing 
testis organ/tissue or cells either using two dimensional (2-D) or three dimensional (3-D) systems 
(Izadyar et al. 2003; Ibtisham and Honaramooz 2020). Using germ cells from infertile donors in 
this system can for instance help the investigations on the causes of infertility and as such, paves 
the way for experimentations that are not otherwise feasible to be conducted in vivo including 
genetic manipulation of germ cells to resolve potential causes of infertility. In addition to 
advantages of in vitro spermatogenesis models in clinical fields, their use is also consistent with 
ethical principles since multiple replications can be prepared and studied at a time from a limited 
testis sample and/or testicular samples from animals can potentially represent human models 
(Stukenborg et al. 2009). 
The first successful in vitro differentiation of male germ cells was reported in 1920 (Champy 1920; 
Song and Wilkinson 2012). Over time, progress has been made to develop a more consistent and 
efficient microenvironment with close resemblance to that of in situ testis conditions. Major 
components of the in vitro environment, which predictably affect the fate of germ cells and their 
survival, proliferation, and differentiation include culture media composition and serum additives. 
FBS has been one of the widely used media supplements which stimulates germ cells to enter 
differentiation. Serum alternatives such as KSR have been associated with more inconsistencies in 
the results and controversial outcomes; this includes improvement of germ cell differentiation in 
some studies (Sato et al. 2011; Riboldi et al. 2012), while preventing germ cells from undergoing 
specialization in others (Hogg and Western 2015). Direct application of hormones and growth 
factors has also been experimented with the aim of improving the efficiency of IVS. For instance, 
supplementation of the culture media with testosterone and FSH together or individually enhanced 
differentiation of germ cells. Similarly, RA has been shown to trigger differentiation of murine 
germ cells and induce initial steps of spermatogenesis (Wang et al. 2016). 
Given the importance of the testicular architecture in germ cell survival and progression of germ 
cell proliferation and differentiation, organ/tissue culture is deemed as a feasible approach to 
achieve IVS. The 3-D architecture is retained in testis tissue fragments, offering an endogenous 





environment (Roulet et al. 2006; Edmonds and Woodruff 2020; Ibtisham and Honaramooz 2020). 
One of the major challenges in organ/tissue culture is the limited diffusion of media through the 
cultured tissues, leading to reduced tissue viability compared to other culture methods. 
Organ/tissue culture was established by introduction of a gas-liquid interface system, where testis 
tissue fragments were in contact with the culture media at a constant temperature and CO2 
concentration (Trowell 1959). Over time, this system was improved by adjusting the temperature 
and pH as well as addition of different supplements including vitamins, hormones, sera, and tissue 
extracts (Trowell 1959). A study in 2011 showed that utilization of agarose gel in minimum 
essential medium (α-MEM) supplemented with KSR for culture of mouse testis fragments can lead 
to successful production of fertilization-competent sperm (Sato et al. 2011). Subsequent 
modifications to this system such as application of microfluidic technology allowed consistent 
supply of nutrients and removal of metabolites which resulted in increased length of tissue viability 
up to ~6 months (Komeya et al. 2016). 
Another approach used for in vitro differentiation of spermatogonia into haploid germ cells is 2-D 
culture systems, in which a cell suspension of enzymatically-dissociated testis cells is prepared 
from testis parenchyma and propagated in culture wells. This approach is especially advantageous 
when the aim is to expand germ cells for applications in auto-transplantation following 
cytoablative cancer treatments as well as in investigation of cell-specific roles or underlying 
genetic factors in proliferation or differentiation of germ cells (Zhang et al. 2017; Dissanayake 
2018; Kapałczyńska et al. 2018). However, since this system does not provide the 3-D structural 
architecture, it does not replicate the in situ spatial properties of the seminiferous tubules. A 2-D 
culture system also makes morphological identification of cell types cumbersome, where 
identification of various cell types would only be feasible via application of molecular markers or 
cell sorting techniques (Jiang and Short 1998a; Jiang 2001; Bai et al. 2018; Kapałczyńska et al. 
2018). This system has also been improved over time to provide a platform for IVS. The first 
offspring resulting from mouse haploid germ cells developed in 2-D spermatogonia culture 
systems were produced in 2003 (Marh et al. 2003). Overall, this system can also provide the basis 
for IVS, where the continuous interactions between germ cells and somatic cells in 2-D culture 
systems appear to play a substantial role in survival and progression of spermatogenesis (van 





3-D culture of testis cell aggregates is another approach for in vitro study of testicular cell 
interactions and testis organogenesis. Artificially constructed 3-D testis cell aggregates were first 
cultured in 2006 using 18-day old rat testis cells (Lee et al. 2006). Testis cell aggregates were 
placed on collagen gel matrices to represent the basement membrane. This 3-D culture system 
supported survival of the germ cells and even resulted in their differentiation. This system was 
further improved by application of a soft agar, which consisted of a gel phase containing 
spermatogonia and a solid phase comprised of somatic cells. Using this system differentiated germ 
cells from rhesus monkeys have been produced (Stukenborg et al. 2008; Huleihel et al. 2015). 
Later, a 3-D model was described using a three-layer gradient system which allowed 
reorganization of testicular cells obtained from 20-day old rats. Cells in organoids were consisted 
of germ- and somatic cells along with the first report of establishment of blood-testis barrier 
(Alves-Lopes et al. 2017; Sakib et al. 2019). 
2.5. Growth Factors and Testis Development  
2.5.1. Basic Fibroblast Growth Factor 
Normal development of the testis results from complex processes of coordinated cell divisions, 
migrations, and spatial cellular arrangements. It is well established that these processes mainly rely 
on secretion of gonadotropins (i.e., LH and FSH) and androgens (i.e., testosterone) (Gnessi et al. 
1997; Mackay and Smith 2007). Together with endocrine regulators, an intercellular network of 
transcription factors or highly regionalized paracrine secretions are involved in testis development 
and initiation and/or maintenance of steroidogenesis and spermatogenesis. Both endocrine and 
paracrine pathways mediate the testis physiology through growth factors, cytokines, and cell-cell 
contacts (Basciani et al. 2010). Numerous paracrine factors are likely to regulate cellular 
interactions and spermatogenesis within the testis. Among intrinsic paracrine regulators, GDNF, 
LIF, and FGF family have been shown to play key roles in the function and development of the 
testes (Tu et al.; Jaillard et al. 1987; Wang and Culty 2007; Mirzapour et al. 2012; Sahare et al. 
2016, 2018) (Fig. 2.2). 
The FGF family is known for their important function in tissue patterning and organogenesis 
(Angelin et al. 2012). Members of this growth factor family trigger proliferation of mesenchymal 
cells, migration of mesonephric cells into the testis, and formation of the interstitial compartment 





member of the FGF family with multiple roles such as tissue development and repair, exerted by 
binding to FGF receptor 1, 2, or 3 (Ornitz and Itoh 2015). This growth factor was first isolated and 
characterized in bovine testes, and thereafter its expression was reported in the testes of different 
species (Ueno et al. 1987; El Ramy et al. 2005). FGF-2 is produced by many cell types in the testis 
including Sertoli cells, Leydig cells, and germ cells (Mullaney and Skinner 1992; Han et al. 1993). 
Expression of FGF-2 becomes downregulated in an age-dependent manner by Sertoli cells; 
however, it is deemed as a bona-fide self-renewal factor for spermatogonia (Shubhada et al. 1993; 
van Dissel-emiliani et al. 1996; Skinner 2005; Masaki et al. 2018) and has been shown to be 
expressed especially by A spermatogonia, pachytene spermatocytes, and spermatids (Abo‐
Elmaksoud and Sinowatz 2005; Jiang et al. 2013). Rat fetal and neonatal gonocytes co-cultured 
with Sertoli cells significantly increased in numbers following addition of FGF-2, while 
supplementation of FGF-2 neutralizing antibodies in the culture significantly decreased their 
numbers, indicating that FGF-2 is both a survival and mitogenic factor for gonocytes (van Dissel-
emiliani et al. 1996). Addition of GDNF together with FGF-2 to the culture media has been shown 
to induce spermatogonia to increase exponentially for 2 years (Kanatsu-Shinohara 2005). 
Spermatogonia proliferate and survive in cultures with FGF-2 but under GDNF-free conditions 
and can restore fertility following GCT (Takashima et al. 2015; Masaki et al. 2018). Cultured germ 
cell populations exposed to FGF-2 show characteristics of more differentiated cells by expressing 
KIT and low SSC activity, indicative of bFGF roles in regulation of undifferentiated 
spermatogonia (Masaki et al. 2018).  
The main production site of FGF-2 in the testis has remained controversial. Some reports indicated 
its expression by Sertoli cells (Smith et al. 1989; Tadokoro et al. 2002), whereas others showed 
FGF-2 release by germ cells (Han et al. 1993; Zhang et al. 2012). However, more recent work has 
shown that Sertoli cells may not be the only source of FGF-2 in the testis (Garcia et al. 2014; 
Masaki et al. 2018). Depletion of endogenous germ cells by busulfan has been associated with fgf-
2 attenuation which raised the concept that germ cells, the niche under regulation of germ cells, 
and/or the niche independent from the germ cells produce FGF-2 (Masaki et al. 2018). FGF-2 
triggers germ cell divisions in the seminiferous tubules and permits RA-mediated differentiation 
through enhancing the expression of RA receptor (RAR) on germ cells. FGF-2 also acts on the 
niche to facilitate the actions of RA (Masaki et al. 2018). It is speculated that the niche undergoes 





promote germ cell self-renewal, GDNF overexpression, which likely happens during GDNF-
dominant state inhibits germ cell differentiation, while FGF-2-release allows generation of 
spermatogonia population with greater tendency towards differentiation (Nagano et al. 1999; 
Nagai et al. 2012). 
The effects of FGF-2 on somatic cells of the testis have also been investigated in a number of 
studies (Jiang et al. 2013). FGF-2 significantly increased the number of Sertoli cells isolated from 
the fetal and newborn rats in vitro (van Dissel-emiliani et al. 1996). Fetal and mature Leydig cells 
have also been shown to appear positive for FGF-2 expression (Gonzalez et al. 1990; Han et al. 
1993) (Fig. 2.2). This growth factor also increased the steroidogenic function of cultured Leydig 
cells following induction by human chorionic gonadotropin (hCG) (Sordoillet et al. 1992). FGF-2 
has also been reported as a morphogen for formation of testis cords since it promoted cord-like 
structures in cultures of rat embryonic testis cells (El Ramy et al. 2005). 
2.5.2. Glial Cell-derived Neurotrophic Factor 
GDNF is a member of the transforming growth factor-beta (TGF-β) superfamily and was first 
extracted from rat glioma cell-line cultures (Kakiuchi et al. 2018). This growth factor promotes 
the survival of dopaminergic neurons and has been shown to influence other neuronal 
subpopulations (Airaksinen and Saarma 2002). Although GDNF expression is mainly reported in 
the central nervous system, it is also widely produced in various non-neuronal tissues such as 
kidney, gastrointestinal tract, and testis (Golden et al. 1999). GDNF plays an important role in the 
survival of spermatogonia since heterozygous GDNF-deficient mice show reduced germ cell 
proliferation, impaired spermatogenesis, and eventually Sertoli cell-only phenotype. In contrast, 
overexpression of GDNF has been associated with abnormal accumulation of spermatogonia, 
which is attributed to a block in germ cell differentiation (Meng et al. 2000a) as well as promotion 
of seminomatous tumors (Meng et al. 2001). Production of GDNF by Sertoli cells is regulated by 
FSH. This growth factor is necessary for self-renewal and inhibition of apoptosis in germ cells in 
a dose-dependent manner (Meng et al. 2000a; Bojnordi et al. 2014). GDNF exerts its proliferative 
stimulatory effects on germ cells following attachment to GFRα-1 through phosphoinositide-3 
kinase (PI3K)/AKT pathway (Lee et al. 2007). GFRα-1 is the ligand-binding domain of GDNF 
and has been detected on spermatogonia (Kakiuchi et al. 2018) (Fig. 2.2). Crucial effects of GDNF 





serum-free culture conditions, while maintaining their potential to colonize the seminiferous 
tubules, and establish donor-derived spermatogenesis (Kubota et al. 2004b). Further work has also 
shown colonization potential of rabbit germ cells cultured in serum-free conditions supplemented 
with GDNF and as such, confirmed the critical role of GDNF in unlimited proliferation of 
undifferentiated spermatogonia (Kubota et al. 2011). Disruption of GDNF signaling by ETS 
variant gene 5 (Etv5)-knock out resulted in germ cell loss, confirming the critical role of GDNF in 
survival of SSCs (Simon et al. 2010). Similar to many species, GDNF expression in mice is cyclic 
since it increases during SSC proliferation and decreases during the stages where spermatogonia 
are quiescent and undergo differentiation (Meng et al. 2000a; Johnston et al. 2011; Sato et al. 
2011; Grasso et al. 2012; Sharma and Braun 2018). GDNF also stimulates germ cell expansion in 
vitro and mouse spermatogonia survive in a long-term culture on MEF when supplemented with 
GDNF, EGF, LIF, and FGF-2 (Kanatsu-Shinohara et al. 2003). As a result, GDNF has been used 
as one of the major culture components for SSC culture (Kanatsu-Shinohara et al. 2004; Kubota 
et al. 2004a; Ogawa et al. 2004; Ryu et al. 2005). 
GDNF also triggers migration of MGSCs. Formation of GDNF-receptor complex has been shown 
to induce the assembly of cytoskeleton in germ cells and stimulates germ cell migration in vitro 
(Dovere et al. 2013). Additionally, GDNF is not involved in proliferation of seminoma cell lines, 
but predominantly acts as an important regulator for induction of directional cell migration and 
promotes the invasive cell translocation in vitro (Ferranti et al. 2012; Dovere et al. 2013). 
Activation of ETV5 via GDNF also upregulates the expression of CXCR4 which in turn is required 
for migration of PGCs to the developing gonads as well as translocation of germ cells from the 
center to the basolateral compartment of the seminiferous cords in neonatal testes (Niu et al. 2016). 
GDNF also has stimulatory effects on Sertoli cell proliferation during testis development (Wu et 
al. 2005). Overall, GDNF is an essential transcription factors for normal development of 
spermatogonia as well as continuation of germ cell proliferation and establishment of 
spermatogenesis (Ara et al. 2003; Kanatsu-Shinohara et al. 2012; Kanatsu-Shinohara and 
Shinohara 2013). 
2.5.3. Leukemia Inhibitory Factor 
LIF is a multifunctional member of interleukin-6 (IL-6) family of cytokines which, once released, 





2015). LIF has been shown to be structurally and functionally related to IL-6, oncostatin M, and 
ciliary neurotrophic factor, which can all bind to specific cell surface receptors in different cell 
types and trigger tyrosine phosphorylation of gp130, Janus kinase 1 (JAK1), JAK2, and TYK2 
kinases. This will in turn activate signal transducers and activators of transcription (STAT)-
3/STAT-1 pathway, thereby induces transcriptional regulation of different genes (Nakajima and 
Wall 1991; Yuan et al. 1994). Expression of LIF and its receptor (LIFR) has been reported in both 
fetal and adult rodent testes with PMCs being the principal origin for LIF production (Piquet-
Pellorce et al. 2000; Molyneaux et al. 2003; Dorval-Coiffec et al. 2005). As such, LIF is deemed 
as an essential paracrine factor for testis development and function. Since PMCs are located 
between the seminiferous and interstitial compartments, production of LIF by PMCs is speculated 
to affect both spermatogenesis and steroidogenesis. PMCs, Sertoli, Leydig, and germ cells all 
express LIFR (Piquet-Pellorce et al. 2000).  
LIF is one of the paracrine cytokines with significant effects on propagation of germ and somatic 
cells (Fig. 2.2). Although LIFR is also expressed by somatic cells, germ cells are the main target 
for LIF paracrine signaling (Dorval-Coiffec et al. 2005). The widespread LIF and LIFR expression 
by testis somatic and germ cells implies the importance of this paracrine cytokine in testicular 
functions. This was also shown by in vitro studies where LIF supplementation to the culture 
medium increased survival of germ and somatic cells, and stimulated proliferation of 
spermatogonia in testis tissue cultures (de Miguel et al. 1996; Dorval-Coiffec et al. 2005). Also, 
germ cell colonies increased in the presence of LIF and transformed into more differentiated 
spermatogonia (Kanatsu-Shinohara et al. 2007; Aponte et al. 2008). Another study on murine 
PGCs showed increased proliferative activity in the presence of LIF in the media, while blocking 
LIFR by antibodies led to germ cell apoptosis (Pesce et al. 1993; Cheng et al. 1994). However, 
derivation of normal offspring from germline stem cell cultures in the absence of LIF may indicate 
that LIF alone is not involved in proliferation of germ cells. Further, it has been suggested that LIF 
may be required for initiation of germline stem cell cultures, and together with other factors is 
involved in transition of gonocytes into spermatogonia (Kanatsu-Shinohara et al. 2007). 
Conversely, LIF overexpression has detrimental effects on germ cells and leads to germ cell loss 
(Hilton and Gough 1991; Shen et al. 1994; Yano et al. 1998). The stimulatory effects of LIF on 
germ cell proliferation and its anti-apoptotic effects are likely mediated through Sertoli cells, since 





1998; Curley et al. 2018). Spermatids are normally produced in LIF-deficient seminiferous 
tubules, pointing at sufficient support of Sertoli cells for germ cell proliferation/differentiation; 
however, LIFR-deficiency leads to sloughing of the epithelium, resulting in an abnormal 
spermatogenic cycles. As such, it is speculated that LIF is required for ensuring maturation of 
differentiated germ cells prior to their release into the luminal compartment and development of 















Fig. 2.2. Overview of testis structure and its potential paracrine signaling map. Gonocytes arriving 
at the basement membrane transform into a new germ cell identity known as spermatogonia. In 
an adult testis, spermatogonia undergo self-renewal divisions to sustain their population and 
differentiate to produce more advanced germ cells such as spermatocytes, spermatids, and 
ultimately, spermatozoa. Spermatogenesis and steroidogenesis are highly regulated by paracrine 
signalling. Among paracrine factors basic fibroblast growth factor (bFGF or FGF-2), glial-cell 
derived neurotrophic factor (GDNF), and leukemia inhibitory factor (LIF) play vital roles in cell-
cell interactions. FGF-2 is released by PMCs, Leydig, Sertoli, and germ cells and increases self-
renewal divisions of spermatogonia and somatic cells. Sertoli cells and PMCs produce GDNF, 
which is also an important factor for mitotic divisions of spermatogonia through interactions with 
GFRα-1. LIF is primarily synthesized by PMCs and interacts with its receptor on both germ and 
somatic cells. LIF promotes divisions of spermatogonia and somatic cells of the testis and is 








2.6. Applications of Ultrasound Biomicroscopy in Reproductive Sciences 
Ultrasound biomicroscopy (UBM) is a high-frequency ultrasound technique which allows real-
time imaging of tissue structural details at near light microscopic resolution (He et al. 2012). UBM 
was first developed in 1989 by Pavlin’s group initially to provide a means for more accurate and 
non-invasive examination of ocular tissues (Pavlin et al. 1990; Greco et al. 2012). Since then, 
applications of UBM have expanded into different clinical and research fields (Greco et al. 2012). 
Compared to conventional ultrasound machines which use low frequency ultrasound waves (i.e., 
~2-20 MHz), higher-frequency transducers (20-100 MHz) are utilized in UBM to record high-
definition cross sectional images of the tissues (Pavlin and Foster 2012). As such, UBM 
transducers can provide high-definition images with up to 25 µm axial and 50 µm lateral resolution 
(Turnbull et al. 1995). UBM along with other non-invasive monitoring technologies such as 
computed tomography (CT), has had tremendous impact on in situ evaluation of organs and 
tissues, notably in a longitudinal approach. However, compared to other imaging techniques, UBM 
is superior since it is less costly and provides detailed real-time information from tissue structure 
and composition (Greco et al. 2012). 
UBM has been widely used for examination of the eye and visualization of ocular structures 
(Pavlin et al. 1992; He et al. 2007; Pavlin and Foster 2012). Applications of UBM is not limited 
to imaging of ocular pathophysiology. For instance, this non-invasive monitoring method has been 
used to characterize the neovessel formation in mice (Hibino et al. 2011), visualize longitudinal 
follicular dynamics in mice and rats (Jaiswal et al. 2009), measure ovarian follicles and corpora 
lutea in mice (Mircea et al. 2009), cattle (Pfeifer et al. 2012), humans (Baerwald et al. 2009), and 
rabbits (Cervantes et al. 2013). Other applications include the study of cardiac development 
(Spurney et al. 2006), as well as cardiac structure and function following aortic constriction, or 
cardiomyopathy following induced heart failure in mice (Buckley and Stokes 2011; Jaffré et al. 
2012). UBM has also been utilized to image small superficial peripheral nerves in humans (Stokvis 
et al. 2009) and embryonic brain development in mice (Turnbull et al. 1995). Previous applications 
of UBM in cancer research include analysis of melanoma xenografts and their treatment in mice 
(Cheung et al. 2005; Nuccitelli et al. 2006) as well as quantification of pancreatic tumor growth 
in mice (Snyder et al. 2009). Mouse pre- and post-natal development has also been investigated 





UBM has been also applied for the study of testis pathophysiology. In a recent study, testis cell 
implants were monitored for a short-term period using UBM. In that study, dimensions and 
structure of the implanted testis cells were efficiently and accurately recorded and the structural 
changes of the implants were clearly visualized through UBM. The results were suggestive of 
UBM potential to be used as a possible alternative tool for examination of a wide range of 
superficial masses in a non-invasive manner and more accurate approach (Awang-Junaidi et al. 
2020). Another example of UBM application in the study of male gonads is testicular UBM for 
evaluation of spermatogenic function in busulfan-treated mice. The latter study showed that pixel 
intensity returned to normal 126 days after busulfan treatment, when the spermatogenesis could 
be observed in the tubules, and it was concluded that UBM is an accurate tool for evaluation of 
spermatogenic function (Huang et al. 2021). 
2.7. Applications of Male Germline Stem Cells in Research and Clinical Settings 
As discussed above, MGSCs represent a robust population of stem cells which hold great promise 
for downstream applications not only in reproductive sciences but also in regenerative medicine 
and stem cell therapy. MGSCs can be isolated at different time points in life and cultured using 
different 2-D or 3-D approaches, and as such can be maintained over extended periods or 
differentiated to produce more advanced germ cells. Alternatively, these cells can be used for in 
vivo culture systems (e.g., TTX and TCAI) to study, manipulate, improve male gonadal 
development, or even produce mature spermatozoa. Establishment of donor-derived 
spermatogenesis via GCT is another important application of MGSCs, which has opened new 
avenues of research into transgenesis and genetic manipulation of germ cells prior to 
transplantation to produce genetically-modified animals. Transgenic animals, in turn, can offer 
enhanced productivity traits, provide organs or tissues for transplantation to humans, or serve as 
models for biomedical research. Additionally, combination of above-mentioned applications with 
current reproductive technologies such as in vitro fertilization (IVF) has opened more windows of 
opportunity for genetic conservation and fertility restoration.  
One of the important applications of MGSCs is preservation of fertility in cancer patients following 
cytotoxic treatments such as chemo- or radiotherapy. This can be achieved by cryopreservation of 
small testicular samples or isolated testis cells obtained prior to gonadotoxic treatments while 





as fresh testis tissues can be used for in vitro tissue culture, TTX, or even isolation of testis cells. 
Alternatively, cryopreserved isolated testis cells can be applied in GCT, in vitro culture, or TCAI 
aimed at ectopic regeneration of testicular architecture. Cryopreservation does not hinder the 
spermatogenic efficiency and differentiation potential of spermatogonia as has been shown in in 
vitro studies (Suzuki and Sato 2003). Interestingly, cryopreserved testis cells possess a slightly 
higher fertilization rate compared to that of intact in situ testis cells (Sato et al. 2011; Yokonishi 
et al. 2014). Even live progeny has been produced following round spermatid-injection (ROSI) or 
ICSI using round spermatid or spermatozoa produced in the cultures of previously-cryopreserved 
testis tissues (Sato et al. 2015). The cryopreserved testis tissues and cells have been shown to retain 
cellular viability and differentiation potential after being grafted or implanted into 
immunodeficient recipient mice in TTX or TCAI studies and display similar recovery rate as fresh 
control tissue or cell samples (Honaramooz et al. 2002; Shinohara 2002; Zeng et al. 2009; 
Abrishami et al. 2010; Arregui and Dobrinski 2014). Particularly, combined applications of 
foregoing technologies such as cryopreservation, culture, and IVF provide a unique chance to 
prepubertal cancer patients to sire their own progeny since they are not yet able to produce 
spermatozoa to be preserved (Blash et al. 2000; Struijk et al. 2013; Arregui and Dobrinski 2014; 
Honaramooz 2014). Cryopreservation also offers the opportunity to save the testis cells or tissues 
from immature rare/endangered species for future applications such as in vitro culture, GCT, TTX, 
or TCAI to recover spermatozoa (Honaramooz et al. 2002; Zeng et al. 2006; Honaramooz et al. 
2007; Watanabe et al. 2009; Arregui and Dobrinski 2014; Arregui et al. 2014; Honaramooz 2014). 
Using a range of domestic animals (e.g., sheep, goat, cattle, horse, pig, alpaca, cat, and dog) 
representative of endangered counterparts (e.g., ungulate, equine, swine, camelid, feline, and 
canine species) tissue grafts have been demonstrated to retain their regeneration potential by TTX 
even after cryopreservation (Snedaker et al. 2004; Oatley et al. 2005; Zeng et al. 2006; Abrishami 
et al. 2010; Abrishami et al. 2010; Elzawam 2013).  
Additionally, cryopreserved or fresh MGSCs can undergo genetic manipulations to develop a germ 
cell population carrying a specific gene transcript (Honaramooz et al. 2003; Honaramooz et al. 
2003; Brinster et al. 2003; Honaramooz and Yang 2011; Zeng et al. 2012). Given the unique ability 
of MGSCs to undergo both proliferation and differentiation, they can be initially expanded in vitro 
to increase the number of transgenic germ cells, and colonize the recipient seminiferous tubules 





2008; Zeng et al. 2013; Kalds et al. 2019). This is especially important in large domestic species 
such as goats and pigs where available methods for transgene transmission are not efficient or cost-
effective. Transplantation of germ cells carrying a transgene can potentially establish production 
of an infinite number of transgenic spermatozoa throughout the life of the recipient (Dobrinski 
2008; Kim et al. 2008; Honaramooz and Yang 2011). Also, application of MGSCs in transgenesis 
will provide an approach to produce animals as donors of tissues and organs for 
xenotransplantation to humans. Transgenic animals can also serve as models for biomedical 
research or bioreactors for production of biopharmaceutical products for instance in milk-
producing animals (Niemann and Kues 2003; Honaramooz and Yang 2011). Plus, GCT using 
transgenic MGSCs is potentially an alternative to artificial insemination for dissemination of 
superior farm animal genetic materials especially where limited manipulation for semen collection 
is allowed (Hill and Dobrinski 2005). 
As discussed earlier, MGSCs have the potential to transform into more primitive developmental 
stages in vitro. These cells, known as germline-derived pluripotent stem cells, can serve as an 
alternative stem cell type parallel to ES cells and iPS cells to investigate the mechanisms by which 
cells acquire pluripotency and maintain it (Golestaneh et al. 2009; Ko et al. 2009; Chen et al. 
2020). Also, these cells can be potentially used as a stem cell source in patients suffering from 
pathological conditions (e.g., cardiomyopathy, neurodegenerative diseases, diabetes). Once 
pluripotent MGSCs are produced, they can be expanded in vitro and directed to differentiate into 
desired cell types (e.g., contractile cardiomyocytes, endothelial cells, neural cells, pancreatic cells) 
prior to transplantation to patients (Kanatsu-Shinohara et al. 2004; Guan et al. 2006; Seandel et al. 
2007; Izadyar et al. 2008; Kossack et al. 2009). Germline-derived pluripotent stem cells are 
advantageous in that they are not associated with ethical concerns raised form derivation of human 
ES cells, where destruction of embryos is needed, and lack the risk of immunological rejection, 
associated with iPS cells. Prospective applications and investigated potential of MGSCs described 
here have been partly investigated in animals and to a lesser extent in humans. Expectedly, 
feasibility of these potential approaches in clinical settings is not yet tested mainly due to ethical 






Testis is a unique organ owing to its dual function of spermatogenesis and steroidogenesis, which 
necessitates complexities in its structure and cellular interactions. These cell interactions are 
established during prenatal and postnatal development among seminiferous tubular and interstitial 
cells comprised of somatic cells (e.g., Sertoli cells, Leydig cells, myofibroblasts, and 
macrophages) and MGSCs. Both testis development and function are regulated by highly 
coordinated and complex cellular interactions and signaling cascades. Not to mention, scarcity of 
testicular samples from humans or endangered/rare species makes the study of testis development 
and function even more challenging in these species. 
Extensive studies conducted thus far on MGSCs from different species all point at their great 
potential to be used not only in reproductive sciences but also in stem cell therapy and regenerative 
medicine. Testicular cells can be cultured indefinitely, transplanted into recipient seminiferous 
tubules where they establish donor-derives spermatogenesis, and through TCAI/TTX regenerate 
fully-formed testicular tissue, induced to revert into more primitive developmental stages or 
differentiate into a different somatic cell lineage, or even be subjected to genetic manipulation to 
carry a transgene to the next generation following GCT. To this end, understanding complex 
processes of testis development/function, harnessing the full potential of MGSCs, and their 
applicability in clinical settings are not feasible without availability of accurate models which can 














2.9. Objectives and Hypotheses 
The overreaching goal of this thesis was to develop tools and protocols to enable in vivo and in 
vitro study of the testicular cell and tissue development in a porcine animal model. General 
objectives of this thesis were to establish new strategies for in vivo developmental study of testis 
cells and tissues and in vitro harnessing the developmental potential of isolated testis cells. Our 
specific objectives and hypotheses were as follows: 
STUDY 1: 
Objectives: To test the effects of supplementation of six different culture media (DMEM, 
DMEM/F12, GMEM, α-MEM, RPMI and StemPro SFM) with three different concentrations of 
FBS or its replacement (5%, 10% and 15%) on (1) in vitro proliferation and colony-formation of 
porcine gonocytes; and on (2) their ultrastructure and expression of gonocyte and pluripotency 
markers.  
Hypotheses: (1) No media, sera, or serum replacement would affect the gonocyte number or their 
colony number/size; and (2) culturing in the selected condition would not affect the expression of 
germ cell or pluripotency markers (e.g., NANOG, E-cadherin, SSEA-1, and POU5F1) of 
gonocytes and their colonies. 
STUDY 2: 
Objectives: To investigate the effects of different growth factors alone or in combination, on (1) 
in vitro proliferation and colony-formation of porcine gonocytes; and on (2) expression of 
gonocyte and pluripotency markers. 
Hypotheses: Culturing with selected growth factors would not affect (1) the gonocyte number or 
their colony number/size; or (2) the expression of pluripotency markers (e.g., NANOG, E-
cadherin, SSEA-1, and POU5F1) of gonocytes and their colonies. 
STUDY 3: 
Objective: To investigate trans-differentiation potential of porcine gonocytes and their colonies, 
developed in the optimized culture condition from study 2 into cells with origins from the three 





Hypothesis: Once cultured under appropriate conditions, porcine gonocytes would differentiate 
into derivatives of all three primary germinal layers and express the lineage-specific markers 
detectable by RT-PCR or immunocytochemistry. 
STUDY 4: 
Objectives: (1) To validate the use of UBM as a feasible and reliable technique for non-invasive 
monitoring of the testis tissue grafts and cell implants; and (2) to correlate the UBM data with 
physical attributes of the retrieved samples (e.g., graft or implant dimension and volume). 
Hypotheses: (1) The use of UBM would be feasible and reliable for monitoring the grafted testis 
tissues/implanted cells; and (2) the UBM data would be positively correlated with the physical 
attributes of retrieved testis tissue grafts/cell implants. 
STUDY 5: 
Objectives: (1) To perform longitudinal evaluation of the grafts and implants using UBM and 
histology; and (2) to compare pre- and post-retrieval UBM and microscopic measurements of the 
grafts and implants over a 6-month period (e.g., composition and pixel intensity, detectability of 
blood vessels and descriptive comparison). 
Hypotheses: (1) UBM would be able to demonstrate long-term 3-D growth and compositional 
changes of the samples; and (2) UBM findings would be positively correlated with the histological 













EFFECTS OF DIFFERENT CULTURE CONDITIONS ON PROLIFERATION, 
COLONY-FORMATION, AND PLURIPOTENCY STATE OF PORCINE MALE GERM 
CELLS 1, 2 
3.1. Abstract 
Gonocytes are progenitor germ cells in the neonatal testis with important potential applications in 
fertility restoration and transgenesis. Using stepwise experiments, we examined the effects of 
different media combined with fetal bovine serum (FBS) and/or knockout serum replacement 
(KSR) on the in vitro proliferation, colony-formation, ultrastructure, and expression of 
pluripotency markers of porcine gonocytes. Testis cells from 1-wk-old piglets were cultured for 
28 days in 6 different culture media (DMEM, DMEM/F12, GMEM, MEM, StemPro, and RPMI), 
each supplemented with 5%, 10%, or 15% FBS and/or KSR. The media and FBS/KSR 
combination leading to the maximum number of gonocytes, and their colonies was selected for 
further analyses. KSR supplementation resulted in a reduced somatic cell propagation and 
increased gonocyte colony formation (P < 0.001). Culturing in DMEM+15%FBS led to the 
greatest number of gonocytes (P < 0.001), while the largest diameter and greatest number of 
colonies were formed in DMEM+5%FBS+10%KSR cultures (P < 0.001). Gonocytes and their 
colonies in DMEM+15%FBS expressed all the examined gonocyte and pluripotency markers. 
KSR alone did not support gonocyte propagation, likely due to a reduced somatic cell proliferation; 
however, the combination of FBS and KSR increased gonocyte colony formation and their size.  
3.2. Introduction 
Male germline stem cells (MGSCs) include primordial germ cells (PGCs), gonocytes, and 
spermatogonial stem cells (SSCs). During fetal development, PGCs differentiate into a transitory 
population of germ cells known as gonocytes or prospermatogonia (De Felici 2016). Shortly after 
 
1 This manuscript has been submitted for publication in Theriogenology under joint co-authorship with Ali 
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2 As first author, MAF contributed to the experimental design, conducted the study, and wrote the first draft 






birth, gonocytes move from the center toward the basement membrane of the seminiferous cords 
and transform into SSCs (Brinster 2002). Being the foundational source of all subsequent germ 
cell types, SSCs can both proliferate to maintain their stem cell pool and differentiate into more 
specialized germ cells to transfer genetic information to the next generation (Jiang 2001; 
Chikhovskaya et al. 2014). SSCs are surrounded by the stem cell niche components including the 
extracellular matrix, Sertoli cells, peritubular myoid cells, Leydig cells, and blood vessels, all 
contributing to the structural and functional support of SSCs (Kuijk et al. 2009; Phillips et al. 
2010; Ibtisham and Honaramooz 2020; Ibtisham et al. 2020). Within this niche, Sertoli cells play 
a pivotal role in regulating the proliferation and differentiation of SSCs by providing essential 
nutrients as well as mediating the endocrine and paracrine signals (Phillips et al. 2010). 
Among different types of MGSCs, gonocytes are relatively accessible and easily identifiable due 
to being the only type of germ cells in the neonatal testis, their unique morphological features, and 
the availability of gonocyte-specific biomarkers. Hence, gonocytes provide a feasible model for 
the study and manipulation of MGSCs (de Rooij and Russell 2000; Meng et al. 2000a; Culty 2009; 
Awang-Junaidi and Honaramooz 2018). PGCs, on the other hand, are only accessible through 
collection of embryos and at limited numbers, (Jiang and Short 1998a; Ohta et al. 2004; Awang-
Junaidi and Honaramooz 2018) and SSCs are a rare population of germ cells in the testis, and in 
the absence of unequivocal cell-specific markers, true SSCs can only be verified using the germ 
cell transplantation assay (Ibtisham and Honaramooz 2020; Ibtisham et al. 2020). 
MGSCs have great potential in being used as a cell source for restoration of fertility, regenerative 
medicine, and transgenesis. Upon germ cell transplantation into a recipient animal’s seminiferous 
tubules, MGSCs obtain/display stemness due to their potential to colonize the recipient testis and 
establish donor-derived spermatogenesis (Jiang and Short 1998b; Jiang 2001; Yang and 
Honaramooz 2011; Sahare et al. 2018). MGSCs from immature and pubertal donors have also 
been shown to possess the ability to spontaneously transform into embryonic-like stem cells in 
vitro (Jiang and Short 1998a; Jiang 2001; Bai et al. 2018). Therefore, MGSCs can be potentially 
used as an alternative source for regenerative therapy, which is otherwise largely limited to 
embryonic stem (ES) cells or induced pluripotent stem (iPS) cells (Seandel et al. 2007; Zheng et 
al. 2013). The use of MGSCs would circumvent some of the ethical concerns surrounding the use 





carcinogenic transcription factors. Transplantation of MGSCs from a fertile donor can overcome 
certain types of infertility (Zheng et al. 2013), and auto-transplantation of MGSCs from 
cryopreserved biopsies may also be considered for the restoration of fertility following 
gonadotoxic cancer treatments (Hwang and Lamb 2010). Additionally, the transplantation of 
genetically modified MGSCs can be used as an alternative approach to the currently inefficient 
methods of generating transgenic farm animals (Ibtisham and Honaramooz 2020). 
Downstream applications of MGSCs in reproductive biology and technology require their scale up 
in vitro (Guan et al. 2006; Phillips et al. 2010). In vitro culture can be used to expand MGSCs 
from scarce resources such as small biopsies and to obtain high numbers of these cells by 
promoting their proliferation. In vitro culture is also a valuable tool to elucidate mechanisms by 
which proliferation and differentiation of MGSCs are regulated (Phillips et al. 2010; Bai et al. 
2018). For instance, successful and efficient colonization of germ cells in the recipient 
seminiferous tubules largely depends on the number of transferred MGSCs, necessitating 
enrichment of SSCs or gonocytes prior to transplantation (Dobrinski et al. 1999; Awang-Junaidi 
and Honaramooz 2018). In neonatal murine testes and porcine seminiferous cords, gonocytes only 
comprise ~2% (Huckins 1971; Tagelenbosch and De Rooij 1993; Li et al. 1997; Orwig et al. 2002) 
and ~7% (Honaramooz et al. 2005) of the cell population, respectively. Also, conventional 
methods of cell isolation lead to testis cell populations comprised of only up to ~10% gonocytes 
(van Dissel-Emiliani et al. 1989; Li et al. 1997; van Den Ham et al. 1997; Honaramooz et al. 2005; 
Goel et al. 2007). Nevertheless, cell-specific markers such as germ cell markers (e.g.  DAZL, 
VASA) (Castrillon et al. 2000; Reijo et al. 2000) and gonocyte markers (e.g. DBA, UCH-L1, 
THY-1) (Goel et al. 2007; Yang et al. 2010; Zheng et al. 2014) can be used for subsequent 
enrichment through magnetic activated cell sorting (MACS) or fluorescent activated cell sorting 
(FACS) (Kim et al. 2010). However, cell sorting methods have low efficiency in enrichment of 
large quantities of MGSCs in large domestic animals including pigs for subsequent applications 
(Kim et al. 2010). Efficient enrichment of gonocytes have also been shown using Nycodenz 
gradient centrifugation and differential plating (Yang and Honaramooz 2011), but are of limited 
use for SSCs. 
Expectedly, in culture conditions, medium and serum play crucial roles in cell survival and 





few studies have examined optimal conditions for in vitro culture of MGSCs from large animals 
(Awang-Junaidi and Honaramooz 2018; Bai et al. 2018; Sahare et al. 2018), and none have 
systematically examined the effects of media type or sera on long-term culture of porcine 
gonocytes. Porcine gonocytes were selected in the present study since they provide a more relevant 
model for the study of germ cells in prepubertal boys and a suitable model for the study of stem 
cell pluripotency (Dirami et al. 1999; Goel et al. 2007; Petersen et al. 2009; Awang-Junaidi and 
Honaramooz 2018; Sahare et al. 2018; Awang‐Junaidi et al. 2020). In two-dimensional (2-D) 
culture systems, Dulbecco’s modified Eagle's medium (DMEM), Dulbecco’s modified Eagles 
medium and Ham’s F12 (DMEM/F12; 50%/50% vol/vol), and minimum essential medium 
(MEM), supplemented with either serum or serum replacement, are the most prevalent 
medium/serum sources for in vitro culture of MGSCs (Kanatsu-Shinohara et al. 2011, 2014; Sadri-
Ardekani et al. 2011; Sahare et al. 2018). Given the indispensable effects of media and sera on 
survival of gonocytes, we designed the present study to optimize our previously established culture 
conditions (Awang-Junaidi and Honaramooz 2018) by investigating the effects of six different 
media supplemented with one of three concentrations of fetal bovine serum (FBS) and/or knock-
out serum replacement (KSR) on long-term porcine gonocyte proliferation, colony-formation, and 
expression of pluripotency-determining factors.  
3.3. Materials and Methods 
3.3.1. Study Design 
The present study consists of two stepwise experiments, as schematically shown in Figure 3.1. We 
first tested the effects of six different media combined with various individual concentrations of 
FBS or KSR on the number of gonocytes or their colonies and their expression of pluripotency-
determining factors, using our previously reported general culture conditions (Awang-Junaidi and 
Honaramooz 2018; Awang‐Junaidi et al. 2020). The culture medium which improved the 
proliferation of gonocytes and enhanced their colony-formation was selected to be combined with 
increasing concentrations of FBS along with decreasing concentrations of KSR. In Experiment 
3.2, the combination culture condition which enhanced gonocyte proliferation and colony-
formation the most was selected to examine the expression of pluripotency-determining factors of 
cultured gonocytes and their resultant colonies. Also, the culture condition leading to the greatest 





for subsequent cultures to examine the ultrastructure of EBLCs by transmission electron 
microscopy (TEM). 
3.3.2. Castration of Animals, Cell Isolation, and Culture 
Castration of 1-wk-old donor Yorkshire-cross piglets (n = 230; Camborough-22 line 65; PIC 
Canada, Winnipeg, MB, Canada) and isolation of testis cells were carried out as described in our 
previous studies (Yang et al. 2010; Awang-Junaidi and Honaramooz 2018; Awang‐Junaidi et al. 
2020). In total, 51 combinations of media and sera (i.e., treatment groups) were tested. For each 
treatment group, three replicates of isolated cell suspensions were prepared (each round of testis 
cell isolation was considered as a replicate), and for each replicate we used ~3 testes. Cell 
quantification and viability assessments were performed as described previously (Awang-Junaidi 
and Honaramooz 2018; Awang‐Junaidi et al. 2020). Relative number of gonocytes was calculated 
using a gonocyte-specific marker. 
In Experiment 3.1, testis cells were cultured using 6 different media listed in Table 3.1 in an 
optimized condition reported previously by our laboratory (Awang-Junaidi and Honaramooz 
2018). Each medium was supplemented with one of three concentrations (5%, 10%, or 15%) of 
either FBS (catalogue no. A15-701; PAA Laboratories, Etobicoke, ON, Canada) or KSR 
(catalogue no. 10828028, Gibco, Thermo Fisher Scientific, Waltham, MA, USA). StemPro-SFM 
medium is supplied as a basal medium along with a proprietary nutrient supplement to be mixed 
by users. Hence, in addition to using the basal StemPro-SFM medium when adding different 
concentration of FBS or KSR, we also tested it using its own nutrient supplement-only. Each of 
the three cell isolate replicates for each treatment was seeded in two separate wells of a single 6-
well plate, and the cells were maintained by changing the media every 7 days for 28 days. The 
cultured cells were briefly monitored daily under an inverted phase-contrast microscope (Nikon, 
Eclipse TS100).  
As a follow up to Experiment 3.1, using the medium which led to the overall highest numbers of 
gonocytes on Day 28, we also tested the effects of supplementation with even higher 
concentrations (20%) of FBS or KSR under otherwise similar culture conditions as above. To test 
the effects of combined FBS and KSR concentrations in Experiment 3.2, the same medium 





combination of increasing concentrations of FBS (0%, 5%, 10%, or 15%) and decreasing 
concentrations of KSR (15%, 10%, 5%, or 0%). 
3.3.4. Evaluation of Cultured Gonocytes and Gonocyte Colonies 
In each experiment, on Days 7, 14, 21, and 28, randomly selected wells from all three replicates 
of each treatment were used for morphometrical evaluations and visual quantification of 
gonocytes. Quantification of EBLCs was performed on Day 28 of culture. Selected wells were 
observed using an inverted phase-contrast microscope equipped with a camera for 
photomicrography (Sony α5000, Sony Corporation, Tokyo, Japan). Images were captured from 
randomly selected fields of view at 40× and 200× (n = 10 images per magnification). Using ImageJ 
software (ImageJ, U.S. National Institutes of Health, Bethesda, MD, USA), the number of 
individual gonocytes, and if present, EBLCs was quantified at 40× magnification. The average 
diameter of EBLCs along the X and Y axes was measured and calculated in all captured images at 
200× magnification. Given that gonocytes in culture appear as individual cells or colonies (Awang-
Junaidi and Honaramooz 2018), two or more gonocytes with identifiable interface were still 
considered as separate entities. 
3.3.5. Sampling and Immunocytochemistry 
Sampling and immunocytochemistry were performed on both cultured and smears of freshly-
isolated testis cells as described previously (Awang-Junaidi and Honaramooz 2018). Antibodies 
used in the present study are summarized in Table 3.2 and fluorescein isothiocyanate (FITC)-
labelled Dolichos biflorus agglutinin (DBA-FITC; catalogue no. FL1031; Vector Labs, 
Burlington, ON, Canada) was used as a gonocyte-specific marker (Goel et al. 2007). 
Photomicrographs of the stained samples were captured at 400× magnification by using specific 
filter sets to visualize 4′, 6-diamidino-2-phenylindole (DAPI), FITC, and Alexa Fluor 594 as 
described our previous work (Awang‐Junaidi et al. 2020).  
3.3.6. RNA Extraction and RT-PCR Analysis 
To confirm the expression of pluripotency markers, reverse-transcriptase polymerase chain 
reaction (RT-PCR) analysis was used. Total RNA was extracted from both freshly isolated testis 
cells and samples of cultured cells on Days 7, 14, 21, and 28. To obtain a single cell suspension 





above and the harvested cells were centrifuged. The supernatant was removed, and pelleted cells 
were resuspended in PBS, and centrifuged again. The supernatant was removed, and the resultant 
cells as well as testis cells obtained from fresh samples underwent RNA extraction using 
Invitrogen RNAqueous Micro Total Isolation Kit (catalogue no. AM1931; Thermo Fisher 
Scientific), according to the manufacturer’s instructions. Next, contaminating gDNA was 
eliminated and complimentary DNA (cDNA) was synthetized using the Primer Mix and iScript 
gDNA Clear cDNA Synthesis Kit (catalogue no. 172-5034; Bio-Rad, Mississauga, ON, Canada). 
Developed cDNA was amplified using Ssofast EvaGreen Supermix (catalogue no. 1725200; Bio-
Rad), according to the manufacturer’s instructions. The primers used for RT-PCR analyses are 
shown in Table 3.3. A 2% agarose gel was prepared and the PCR products, stained with ethidium 
bromide, were run and visualized under ultraviolet light.  
3.3.7. Transmission Electron Microscopy 
Preparation of culture wells for TEM was performed as described previously (Awang‐Junaidi et 
al. 2020). Briefly, cells and EBLCs in the optimal treatment condition (selected for increasing the 
number and size of EBLCs) were fixed on Day 28 with 2% glutaraldehyde in 0.1 M sodium 
cacodylate buffer (pH = 7.2) at 4° C. Fixed cells and EBLCs were then immersed in 0.1 M sodium 
cacodylate buffer, stored at 4° C overnight, immersed in 1% osmium tetroxide for 1 h, and washed 
with distilled water. Cells and EBLCs were dehydrated in ethanol, covered by two changes of 
absolute ethanol and LR White resin mix (1:1 and 1:2) for 1 h, and immersed in 100% resin for 2 
h. The samples were sealed, and polymerization was performed at 65° C overnight. Following 
polymerization, the samples were split, separated, and blocked. Sectioning was performed at 100 
nm using Leica Ultracut UCT and the prepared samples were examined under a transmission 
electron microscope (HT7700, Hitachi), using an accelerating voltage of 80 kV. 
3.3.8. Statistical Analyses 
Data are presented as mean ± standard error of mean (SEM) and P < 0.05 was considered as 
significant. All the data were analyzed using t-test, one- or two-way analysis of variance 
(ANOVA) and Tukey’s HSD was used as the post hoc test, unless stated otherwise. For all data 
analyses Statistical Package for Social Sciences was used (IBM SPSS Statistics for Macintosh, 






3.4.1. Morphometrical and Developmental Assessment 
3.4.1.1. Experiment 3.1: Effects of Individual Concentrations of FBS and KSR 
Rather unexpectedly, in groups treated with StemPro medium with or without FBS/KSR, the cell 
confluency was less than ~10% after 7 days in culture (Fig. 3.2A). As such, StemPro medium 
group was removed from statistical analyses. Similarly, in all KSR-supplemented media, the cell 
confluency did not advance beyond ~20%, while colonization of gonocytes was improved (Fig. 
3.2B). Hence, the groups supplemented with KSR were included in the analyses of EBLC 
numbers. In all remaining groups, the pattern of morphometrical cellular changes was similar. 
Heterogenous populations of round floating cells were observed immediately after culturing of 
isolated testis cells. In the following 24 h, floating cells started to settle and adhere to the bottom 
of the culture well, forming a monolayer. By Day 3, gonocytes appeared as large round cells and 
started to attach to the adherent monolayer. By Day 5, further attachment of somatic cells formed 
a wave-shaped monolayer, with round gonocytes sitting on the top (Fig. 3.2C). By Day 7, 
extension of somatic cells formed ~90% confluency in the groups treated with DMEM, 
DMEM/F12, α-MEM, GMEM, and RPMI, supplemented with different concentrations of FBS.  
On Day 7, gonocytes appeared individually or within clusters of 2 or more cells. Somatic cells 
appeared as fibroblast-like cells and by Day 7 they formed organized round patterns (Fig. 3.2D). 
These patterns, previously termed ‘circular arrangements’ (Awang‐Junaidi et al. 2020), consisted 
of aggregated somatic cells in specific locations, while embracing a few clustered gonocytes via 
their cytoplasmic extensions. By Day 14, clustered gonocytes within the circular arrangements 
formed 3-D colonies with indistinct cytoplasmic membrane between individual cells within the 
colony (Fig. 3.2E and 3.2F). These structures, previously termed EBLCs (Awang‐Junaidi et al. 
2020) were seen exclusively within circular arrangements. When FBS was used as a source of 
serum, EBLCs formed in all treatment groups except GMEM-, RPMI-, and StemPro-treated 
groups. By Day 28, the number of gonocytes and EBLCs increased in all above-mentioned 
treatment groups, while the DMEM cultures had the greatest number of gonocytes and EBLCs. 
Since FBS supported in vitro propagation of testis cells, a new treatment group comprised of all 





In FBS-supplemented cultures, an interaction was found between the medium type and FBS 
concentration on the number of gonocytes on Day 28 (P < 0.001; Fig. 3.3), where DMEM+15% 
FBS led to the greatest number of gonocytes. Among different medium types, the maximum 
number of gonocytes was found in cultures treated with DMEM (P < 0.001), and the maximum 
number of EBLCs was found in cultures with DMEM supplemented with 10-20% FBS. Also, in 
cultures provided with DMEM+15% FBS, the number of gonocytes and EBLCs increased by ~2 
and ~3 folds, from Day 7 to Day 28, respectively (P < 0.001 for both). 
In cultures where KSR was used, the morphology of post-seeding floating cells was not different 
from that of FBS-supplemented media. However, the cytoplasmic extensions of somatic cells did 
not develop compared with FBS-supplemented groups, the monolayer did not form the wave-
shaped appearance, and cell confluency did not increase beyond ~20%. However, compared with 
FBS-supplemented groups, gonocytes showed a greater tendency to aggregate and form small 
clusters with the same appearance as small EBLCs (Fig. 3.4). The number of small EBLCs was 
affected by the interaction between KSR concentration and medium type, where numerically, the 
greatest number of small EBLCs was found in groups provided with DMEM+5% KSR (P = 0.005). 
Compared with the cultures supplemented with FBS, KSR-supplemented cultures with DMEM 
developed greater numbers of EBLCs at each concentration (P = 0.001; Fig. 3.5A), but smaller 
EBLC diameters by 53% (P < 0.001; Fig. 3.5B). Increasing the FBS concentration increased EBLC 
formation, while increasing the KSR concertation, decreased EBLC formation in DMEM (serum 
type*serum percentage P = 0.001). 
Gonocytes comprised ~39% of the isolated cells based on the ratio of DBA-positive cells. The 
average cell viability in cultures of DMEM+15% FBS on Day 28 and fresh cell isolates was ~95%. 
In cultures of DMEM+15% FBS, the number of gonocytes and their resultant EBLCs increased 
by ~2 and ~3 times from Day 7 to Day 28, respectively.  
3.4.1.2. Experiment 3.2: Effects of Combined Concentrations of FBS and KSR 
Since DMEM optimally supported gonocyte proliferation and EBLC formation in Experiment 3.1, 
we tested this medium supplemented with increasing concentrations of FBS and decreasing 
concentrations of KSR in Experiment 3.2. Here, the morphology of gonocytes, somatic cell 





groups except for cultures supplemented with only KSR, where the cell confluency was less than 
~20% with large numbers of small gonocyte aggregates.  
On Day 28, the greatest gonocyte and EBLC numbers were developed in cultures of DMEM+15% 
FBS and DMEM+5% FBS+10% or 15% KSR, respectively (P < 0.001; Fig. 3.6A and 3.6B). 
Overall, largest EBLCs were found in combined concentrations of FBS and KSR (P < 0.001; Fig. 
3.6C). Thus, DMEM+15% FBS was selected as the optimal condition for increasing the gonocyte 
number and DMEM+5% FBS+10% KSR was selected as the optimal condition to improve EBLC 
development for subsequent study of their ultrastructure on Day 28. 
3.4.2. Immunocytochemistry  
Gonocytes appeared positive for DBA as a gonocyte-specific marker both on smears of freshly-
isolated cells and after 28 days in culture. EBLCs were also positive for DBA in optimal conditions 
developed for EBLC formation (Fig. 3.7). The DBA signal was identified on the surface of 
gonocytes and EBLCs but not in their nuclei (Fig. 3.7). Furthermore, gonocytes in fresh cell 
isolates appeared positive for SSEA-1, as a porcine germ-cell and pluripotency-determining 
marker. The expression of POU5F1, NANOG, and E-cadherin as pluripotency-determining 
markers was not observed in freshly-isolated testis cells, while cultured gonocytes and their 
developed EBLCs appeared positive for these markers both in the nuclei and cytoplasm (Fig. 3.7).  
3.4.3. Gene Expression Analyses 
Gene transcripts of pluripotency-determining factors, comprised of POU5F1, FUT4 (gene for 
SSEA-1), NANOG, and E-cadherin were confirmed in samples obtained from cultured gonocytes, 
while freshly-isolated testis cells were only positive for FUT4. Quantification of fold change in 
expression level of these transcript markers revealed that the expression levels of POU5F1, 
NANOG, and E-cadherin were maintained from Day 7 to Day 28 of culture. Similarly, FUT4 
expression levels did not change from cell isolation to Day 28 of culture (Fig. 3.8). 
3.4.4. Ultrastructural Assessment of Cultured Gonocytes and EBLCs in Selected Media 
TEM was used to elucidate the underlying cellular structures and organelles as well as physical 
contacts between the cells. The number of gonocytes was relatively lower in cultures with 
DMEM+5% FBS+10% KSR than in cultures with DMEM+15% FBS. However, the overall 





basic conditions composed of DMEM+15% FBS. Somatic cells adhered to the culture well, 
forming a flat and thin cellular layer (Fig. 3.9A). Gonocytes appeared as round single cells or in 
contact with each other while located on top of the monolayer. They possessed a large nucleolus 
with electron-dense heterochromatin associated with the nuclear envelope and randomly 
distributed euchromatin, giving the nucleolus a spongy-shape appearance (Fig. 3.9B). Gonocytes 
and EBLCs in the selected culture condition showed large numbers of electron-lucent vesicles in 
the cytoplasm (Fig. 3.9C and 3.9D). Gonocytes also possessed small cytoplasmic projections 
devoid of microtubules. EBLCs appeared as syncytia with multiple nuclei without a distinctive 
membrane separating them and contained the same cytoplasmic organelles as individual 
gonocytes. The gonocytes were in close contact with somatic cells while maintaining a physical 
gap in between (Fig. 3.9C). The main organelles observed within the cytoplasm of somatic cells 
included rough endoplasmic reticulum with stacks of paired membranes, sparse mitochondria, and 
lysosomes. Also, smooth endoplasmic reticulum mainly appeared as interconnecting tubules 


















Table 3.1. Name and specification of media used in treatment groups 
Name of the media Abbreviation Company Catalogue number 
Dulbecco’s modified Eagle’s medium DMEM Corning 12-604F 
Dulbecco’s modified Eagle’s medium and Ham’s F12 DMEM/F12 Corning 10092CV 
α-Minimum essential medium α-MEM Gibco 12561056 
Glasgow’s minimum essential medium GMEM Gibco 11710035 
Roswell Park Memorial Institute medium RPMI Gibco 11875093 
StemPro-34 serum free medium StemPro-SFM Gibco 10639011 
 
Table 3.2. Summary of primary and secondary antibodies used for immunofluorescence assay 
Antibody Company Catalogue number Dilution 
Rabbit anti-POU5F1 Abcam AB18976 1:200 
Mouse anti-SSEA-1 Santa Cruz Biotechnology sc-21702 1:200 
Mouse anti-NANOG Sigma-Aldrich N3038 1:200 
Rabbit anti-E-cadherin Abcam 15148 1:200 
Alexa Fluor 594 goat anti-rabbit Abcam AB150088 1:200 
Alexa Fluor 594 goat anti-mouse Abcam 150116 1:200 
FITC, fluorescein isothiocyanate; POU5F1 or OCT4, octamer-binding transcription factor 4; 














Table 3.3. Primers used for RT-PCR analysis 







































Fig. 3.1. Schematic overview of the experimental design. In Experiment 3.1, we tested the effects 
of six different media supplemented with three different concentrations of fetal bovine serum 
(FBS) or knock-out serum replacement (KSR) on gonocyte proliferation, colony-formation, and 
pluripotency. After culturing the cells for 28 days, DMEM+15% FBS was found as an optimal 
combination to increase the number of cultured gonocytes among different combinations. Hence, 
the cultured cells and colonies in this combination were also tested for the expression of 
pluripotency-determining transcription factors. In Experiment 3.2, we compared the effects adding 
to DMEM a combination of FBS and KSR at different concentrations. DMEM+5% FBS+10% 
KSR resulted in the largest and greatest number of embryoid body-like colonies (EBLCs) and as 
such, this treatment group was used to increase EBLCs for the study of their ultrastructure using 






Fig. 3.2. Representative images demonstrating varying developmental status of cultured testis cells 
in different media and serum/serum replacement combinations. (A) After 1 wk of culture, the 
somatic cells (arrows) in StemPro medium (containing its proprietary supplement) did not reach 
the optimal confluency. The same morphology of the cells was observed when StemPro medium 
was supplemented with serum or serum replacement. Consequently, gonocytes (black arrowheads) 
did not increase in numbers, likely because their survival largely depends on support of the somatic 
cells. (B) Confluency of somatic cells (arrows) did not improve beyond 20% in any media 
supplemented with KSR-only. Gonocytes (black arrowheads) showed a greater tendency to form 
clusters and small embryoid body-like colonies (EBLCs; white arrowheads) in the presence of 
KSR. (C-F) Maximum number of gonocytes (black arrowheads) was found in cultures with 
DMEM+15% FBS, where somatic cells (black arrows) formed a complete wave-shaped 
monolayer on the culture well surface by Day 7 (C). These cells formed circular arrangements 
(dotted circle) within the monolayer by Day 14 (D). Over time, gonocytes increased in numbers 
by Day 21 (E) and merged to form large embryoid body-like colonies (EBLCs; white arrowhead) 







Fig. 3.3. Effects of different media supplemented with various serum concentrations on gonocyte 
numbers after 28 days of in vitro culture. The gonocyte numbers (mean ± SEM) was affected by 
an interaction between the media type and serum concentrations, where DMEM+15% FBS was 
selected as the optimal combination as it resulted in the numerically greatest gonocyte numbers (P 
< 0.001). Since StemPro media did not support gonocyte propagation, it was removed from the 
analysis. The minimum number of gonocytes was found in GMEM and RPMI supplemented with 
any serum concentration. Media types with different letters in each serum concentration group 













Fig. 3.4. Representative images of testis cells cultured in DMEM+10% KSR. When supplemented 
with KSR-only, somatic cell confluency did not increase beyond 20% and as a result, the number 
of gonocytes was also smaller than that found in FBS-supplemented media. By Day 7, somatic 
cells formed spindle-shaped extensions on the culture dish (A), and their confluency gradually 
increased by Day 14 (B). In the presence of KSR, gonocytes showed a greater tendency to form 
small clusters, which gradually transformed into EBLCs by Day 21 (C). These EBLCs increased 
in size by fusion of adjacent individual gonocytes by Day 28 (D). The same morphology was 

















Fig. 3.5. Effects of DMEM combined with serum or serum replacement on EBLC numbers (mean 
± SEM) (A) and diameters (mean ± SEM) (B). Greater numbers of EBLCs developed by Day 28 
in groups supplemented with KSR (A). However, the diameters of EBLCs in KSR-supplemented 
groups were smaller than those formed in FBS-supplemented groups on Day 28 (P < 0.001) (B). 
Increased serum concentration led to an increase in EBLC formation, whereas less EBLCs were 
formed following increasing KSR concentrations (interaction P = 0.001). Asterisks denote 














Fig. 3.6. Average number of gonocytes (mean ± SEM) (A) and EBLCs (mean ± SEM) (B) as well 
as the diameter of EBLCs (mean ± SEM) (C) in DMEM supplemented with combined 
concentrations of FBS and KSR on Day 28 of culture. Since DMEM supported the proliferation 
of testis cells and formation of the somatic cell monolayer, it was supplemented with combined 
concentrations of FBS and KSR to find the optimal conditions for gonocyte proliferation and 
EBLC formation. Among different treatments, the maximum number of gonocytes was observed 
in DMEM+15% FBS (P < 0.001) (A), while the maximum number of EBLCs developed in cultures 
with DMEM+5% FBS+10% or 15% KSR (P < 0.001) (B). Combined concentrations of FBS and 
KSR also led to formation of larger EBLCs compared with cultures where FBS- or KSR-only were 























Fig. 3.7. Double immunocytochemistry of freshly-isolated and 28-day cultured porcine testis cells 
for gonocyte-specific and pluripotency-determining markers. Fluorescein isothiocyanate (FITC)-
labeled Dolichos biflorus agglutinin (DBA-FITC) was used as a gonocyte-specific marker and 
pluripotency-determining markers including POU5F1, stage-specific embryonic antigen-1 (SSEA-
1), homeobox NANOG, and anti-epithelial-cadherin (E-cadherin) in both gonocytes and EBLCs. 
Co-localization of the signals was indicative of germ- and stem-cell potential of 28-day cultured 
gonocytes. Cultured gonocytes and their developed EBLCs appeared positive for all pluripotency 
and gonocyte markers while testis cells in freshly-isolated cell smears appeared negative for 
POU5F1, NANOG, E-cadherin as pluripotency markers but were positive for SSEA-1. This may 
point to the in vitro changes in gonocytes to a pluripotent state in our optimized culture conditions 
while maintaining their germ cell potential. DAPI was used to stain the nuclei. Insets show a higher 












Fig. 3.8. Expression of pluripotency-determining gene transcripts in samples of freshly-isolated 
testis cells from neonatal piglets and those cultured for 7, 14, 21, or 28 days. In all the sampling 
time points, cultured testis cells showed positive expression of POU5F1, FUT4, NANOG, and E-
cadherin. Freshly-isolated testis cells only appeared positive for FUT4 as a common germ- and 
stem cell marker, and were negative for pluripotency-determining factors including POU5F1, 
NANOG, and E-cadherin. N, no template control; M, 50-bp DNA ladder; Lines 1-5, cDNA 








Fig. 3.9. Transmission electron microscopy of cultured porcine testis cells in the selected media 
and serum combination (DMEM+5% FBS+10% KSR). A somatic cell monolayer (som) covered 
the culture wells by Day 7 (A). The somatic cells contained different organelles including extended 
membrane stacks of rough endoplasmic reticulum (green arrowheads) and lysosomes (L). 
Gonocytes (gon) and somatic cells maintained a gap (B and C), which along with cytoplasmic 
projections (cp), enabled gonocytes to migrate freely on top of the monolayer. Gonocytes also 
contained multiple organelles including a large nucleus (N) which contained nucleoli (white 
arrows) and heterochromatin clusters (white arrowheads), rough endoplasmic reticulum (green 
arrowheads), lysosomes (L), mitochondria (orange arrowheads), and electron-lucent vesicles (V). 
Gonocytes appeared as singles (B), or in close contact with each other (C). Gonocytes initially 
formed clusters and merged to form 3-D colonies (D). Morphologically, gonocytes and EBLCs 
developed in DMEM supplemented with both FBS and KSR contained a large number of electron-








To our knowledge, the present study is the first to systematically investigate the effects of different 
culture media and various levels of serum or serum replacement on in vitro propagation of neonatal 
porcine gonocytes, their colony-formation potential, and expression of pluripotency-determining 
factors. Here, we defined an optimal combination of medium and serum/serum replacement which 
maximized the proliferation of gonocytes, encouraged their colony-formation, and induced their 
spontaneous transformation into a pluripotent state without addition of growth promoting factors 
or other supplements. We also examined the ultrastructure of EBLCs developed in the optimized 
medium and serum combination and found that each EBLC is comprised of a large syncytium with 
multiple nuclei and similar cytoplasmic organelles as in their surrounding gonocytes.  
Development of a simple culture condition to maintain and propagate MGSCs remains a key 
challenge since the safety concerns in their downstream applications depend largely on their in 
vitro culture components. Medium and serum are the two main culture components, which 
expectedly affect the proliferation and colony-formation of MGSCs. We showed here that DMEM 
sufficiently supported in vitro propagation of gonocytes and somatic cells. DMEM is a standard 
media widely used for the culture of testis cells of different species (Wang et al. 2015; Niu et al. 
2016; Awang-Junaidi and Honaramooz 2018; Sahare et al. 2018; Awang‐Junaidi et al. 2020) and 
has twice the amino acid concentration and four times the amount of vitamins compared with 
DMEM/F12 and α-MEM. This composition might be an underlying mechanism for its great 
support for cell propagation and colony-formation in the present study (Schultheiss et al. 2013; 
Inoue et al. 2020). Although porcine gonocytes were previously cultured in DMEM/F12 (Goel et 
al. 2007), we showed moderate gonocyte proliferation in this medium, which might be the result 
of incomplete compatibility of porcine testis cells with components or concentrations of nutrients 
in this medium. 
Similarly, we found limited growth of testis cells in α-MEM. α-MEM has been widely used to 
maintain a range of cells in vitro including neurons (Kanoh et al. 1991; Roudebush et al. 1994), 
osteoblasts (Coelho et al. 2000; Mizuno et al. 2000), and mesenchymal stem cells (Meuleman et 
al. 2006; Kang et al. 2012). This medium has a simple composition containing almost a quarter as 
much vitamins, amino acids, and glucose as DMEM, which can explain limited gonocyte 





Sahare et al. 2016; Suyatno et al. 2018). Here, we also showed reduced proliferative activity of 
testis cells in GMEM and RPMI media. GMEM is a modification of Eagle’s medium with two 
times the levels of amino acids, vitamins, and tryptose phosphate broth. Although GMEM has been 
widely used to culture embryonic stem cells (Hamilton et al. 2019), its components may have 
contributed to the limited testis cell proliferation in the present study. We also found lowest testis 
cell proliferation in cultures containing RPMI medium. This medium is characterized by low levels 
of magnesium and calcium and high levels of phosphate (Yao and Asayama 2017), which may 
indicate that these two minerals play a key role in metabolism and proliferation of cultured testis 
cells and their absence can potentially limit germ cell proliferation. Overall, similar to our results, 
a previous study on mouse MGSCs showed that α-MEM, GMEM, and RPMI cannot support 
murine testis cell propagation in vitro (Kanatsu-Shinohara et al. 2014). 
In the present study, StemPro with or without serum/serum replacement also failed to support 
gonocyte and somatic cell survival, indicating that it either lacks supportive components for 
somatic cell proliferation or has components which hamper their expansion. Somatic cells are 
crucial for survival and proliferation of gonocytes, and as such underdeveloped monolayer leads 
to loss of non-adherent gonocytes in culture (van Dissel-Emiliani et al. 1993; Awang-Junaidi and 
Honaramooz 2018). StemPro has also been used for in vitro culture of mouse SSCs but with limited 
cell proliferation, which further supports our findings (Kanatsu-Shinohara et al. 2014). 
KSR is a serum-free formulation and a more defined substitute for FBS. Using KSR also provides 
more consistency since it eliminates batch to batch production variations in components (Hua et 
al. 2009). Compared with KSR, greater support of FBS for proliferation of testis cells can be 
attributed to the presence of various known and unknown compounds in the serum. In KSR-
supplemented media, limited cell confluency and reduced somatic cell growth might have in turn 
encouraged gonocyte aggregation and formation of smaller EBLCs. Similar to our findings, 
previously, KSR supplementation increased colonisation of cultured bovine SSCs (Youssefi et al. 
2016). Although in theory KSR is a more reliable and consistent alternative source for FBS, 
available literature on its application in culture of germ cells of different species shows an 
inconsistency in using a homogenous feeder layer to support the germ cell growth (Sato et al. 
2011; Aoshima et al. 2013; Zhang et al. 2017). Taken together, enhanced proliferative potential of 





the support of an exogenous feeder layer (Wang and Hna 2008). However, in contrast to previous 
reports, we used testicular somatic cells as the feeder layer to eliminate this potential confounding 
influence when examining the direct effects of media and serum/serum replacement. 
In studies on culture of MGSCs, the basal media is typically supplemented with either serum or 
serum replacement (Zhang et al. 2017; Awang-Junaidi and Honaramooz 2018; Sahare et al. 2018; 
Awang‐Junaidi et al. 2020). As such, in Experiment 3.2 we investigated the effects of combined 
concentrations of FBS and KSR with DMEM on in vitro culture of neonatal porcine gonocytes. 
We showed that 15% FBS alone best suits gonocyte proliferation, where gonocytes could increase 
by up to ~35% compared with 10% FBS in DMEM in long-term culture. However, lowered 
numbers of gonocytes in cultures with 20% FBS are possibly the result of somatic cell 
overpopulation, which in turn limited the gonocyte proliferation. As described in previous reports, 
somatic cells tend to overgrow in the culture of testis cells, which is likely triggered by a 
combination of unknown factors in FBS (Shikina and Yoshizaki 2010; Zheng et al. 2014). 
Additionally, increases in concentration of FBS led to increased numbers of EBLCs. Given the 
pivotal role of somatic cells in providing the necessary foundation for EBLC formation, increased 
FBS concentration may have led to increased somatic cell population, which in turn provided the 
basis for formation of gonocyte clusters and subsequently EBLC formation. Here, we also showed 
that gonocytes and somatic cells require a proportionally combined concentration of FBS and KSR 
for enhanced EBLC formation. Perhaps combined FBS and KSR concentrations imposed a dual 
effect on cultured testis cells, where FBS enhanced somatic cell proliferation, which in turn led to 
formation of circular arrangements. Exposure to KSR on the other hand, encouraged gonocyte 
cluster- and EBLC formations. Similar results were shown previously in bovine SSC cultures 
(Youssefi et al. 2016). In addition, here, EBLCs in the combined FBS and KSR-supplemented 
media had larger diameters compared with FBS- or KSR-only cultures. In vitro aggregation of 
porcine gonocytes and subsequent formation of colonies have also been reported in different 
culture conditions (Goel et al. 2007, 2009; Kuijk et al. 2009; Lee et al. 2013; Awang-Junaidi and 
Honaramooz 2018). Here, the three-dimensional appearance of EBLCs resembled that of 
pluripotent ES cell colonies in culture (Lee et al. 2013; Sahare et al. 2016). 
Introducing an alternative source for ES cells and iPSCs is of great interest since currently the 





and safety concerns. Here, we demonstrated that cultured gonocytes and EBLCs express a number 
of pluripotency-determining factors that are typically present in ES cells and their colonies (Goel 
et al. 2009; Chen et al. 2010; Shi and Jin 2010; Wolf et al. 2011; Yang et al. 2015; Devi et al. 
2017; Choi et al. 2019; Awang‐Junaidi et al. 2020). We showed that the expression of all examined 
markers started from the first wk in culture without fold changes in their expression level over 
time. This is indicative of spontaneous changes happening in gonocytes when grown in our 
selected cultures. Among these markers, POU5F1 plays a central role in self-renewal of pluripotent 
ES cells (Nichols et al. 1998). Here, we also observed SSEA-1 expression in freshly-isolated and 
cultured gonocytes. In line with our findings, this marker is present in ES cells, neonatal murine 
germ cells, porcine PGCs, and spermatogonia in prepubertal pig testis (Goel et al. 2007; Kim et 
al. 2013; González and Dobrinski 2015). Additionally, here, expression of NANOG and E-
cadherin was detected as early as 7 days in our selected cultures. Hence, this phenomenon also 
points at dedifferentiation of gonocytes to a more primitive stage in our selected cultures. 
Spontaneous dedifferentiation of human, porcine, and bovine germ cells in culture conditions has 
been also shown previously (Hoei-Hansen et al. 2005; Mirzapour et al. 2012; Kim et al. 2014). 
Collectively, this is an outstanding achievement since these cells can serve as an alternative source 
for ES cells and iPSCs. This in turn can eliminate the ethical concerns associated with the use of 
ES cells or limitations in development and use of iPSCs due to exogenous confounding factors.  
TEM findings further confirmed our light microscopy observations where gonocytes represented 
different populations of cells, ranging from single, paired, or clustered groups to EBLCs. EBLCs 
contained multiple nuclei and a large cytoplasm, which perhaps formed during the fusion of 
cytoplasmic membranes of adjacent gonocytes. Because these cells were obtained from a mixed 
population of testis cells of healthy 1-wk old piglets and cultured for 4 weeks, senescence or 
pathological conditions as the leading cause of EBLC formation is not likely (Miething 1993, 
1995; Gallagher et al. 2013; Hutson et al. 2013). Extensive migration ability of MGSCs has been 
shown following transplantation of germ cells from a donor male to the recipients, where the 
transplanted cells translocate from the luminal compartment of the seminiferous tubules to the 
basal compartment in order to colonize the recipient testis (Brinster and Zimmermann 1994; 
Brinster 2002; Honaramooz and Yang 2011). We speculate that a similar underlying trigger which 
initiates the migration of MGSC that find themselves ‘misplaced’ upon germ cell transplantation 





in our 2-D cultures seemed to be the monolayer circular arrangements. The nature of such a trigger 
is not clear but it likely includes transcription factors produced by misplaced gonocytes and/or 
somatic cells that activate signalling cascades within gonocytes that initiate further development 
of the F-actin filaments, cytoskeleton, and extension of gonocyte cytoplasmic projections. 
Additionally, a narrow gap between gonocytes and the monolayer indicates the non-adherent 
nature of gonocytes, consistent with their extensive mobility. Also, compared with our findings in 
a previous report, (Awang‐Junaidi et al. 2020) gonocytes and EBLCs in our selected media and 
serum combination (DMEM+5% FBS+10% KSR), possessed large numbers of electron-lucent 
vesicles in the cytoplasm; their presence can possibly point at greater secretory activity of 
gonocytes and EBLCs exposed to our selected culture conditions. 
In conclusion, among the commonly used media, DMEM shows a greater support for the culture 
of gonocytes. This medium supplemented with 15% FBS or with a combination of 5% FBS+10% 
KSR provides the optimal condition to maximize the number of gonocytes and their resultant 
EBLCs, respectively. Importantly, gonocytes cultured in DMEM+15% FBS, without addition of 
growth factors or other supplements, spontaneously dedifferentiate into primitive stages and 
express markers that are normally present in ES cells. Overall, our findings provide a means to 
easily obtain large numbers of MGSCs. Furthermore, our results are indicative of the great 
potential of neonatal germ cells to be used as a source of stem- and germ cells for downstream 















In Chapter 3, we tested the effects of different media and serum/serum replacement combinations 
on proliferation, colony-formation, and pluripotency of porcine gonocytes and reported the optimal 
conditions to increase these cells and their colonies in an in vitro environment. In order to further 
enhance gonocyte proliferation and colony-formation, in Chapter 4 we used our selected condition 
in Chapter 3 to test the effects of individual or combined concentrations of three main growth 
factors on proliferation of gonocytes and formation of their colonies. In Chapter 4, we also 





















CULTURE SUPPLEMENTATION OF BFGF, GDNF, AND LIF ALTERS IN VITRO 
PROLIFERATION, COLONY-FORMATION, AND PLURIPOTENCY OF NEONATAL 
PORCINE GERM CELLS 3, 4 
4.1. Abstract 
Gonocytes in the neonatal testis have male germline stem cell properties and as such have 
important potential applications in fertility preservation and regenerative medicine. Such 
applications require further studies aimed at increasing gonocyte numbers and evaluating their 
pluripotency in vitro. The objective of the present study was to test the effects of basic fibroblast 
growth factor (bFGF), glial cell-derived neurotrophic factor (GDNF), and leukemia inhibitory 
factor (LIF) on in vitro propagation, colony-formation, and expression of pluripotency markers of 
neonatal porcine gonocytes. Testis cells from 1-wk-old piglets were cultured in basic media 
(DMEM+15% FBS), supplemented with various concentrations of bFGF, GDNF, and LIF, either 
individually or in combinations, in a stepwise experimental design. Gonocytes and/or their 
colonies were evaluated every 7 days and the gonocyte- (DBA) and pluripotency-specific markers 
(POU5F1, SSEA-1, E-cadherin, and NANOG) assessed on Day 28. Supplementation of a basic 
medium consisting of DMEM+15% FBS with only 10 ng/mL bFGF can effectively maximize in 
vitro proliferation of porcine gonocytes. Furthermore, supplementation of LIF alone to the basic 
media can enhance porcine gonocyte colony-formation while the addition of 10 ng/mL bFGF+100 
ng/mL GDNF+1500 U/mL LIF significantly increases EBLC diameters. The resultant gonocytes 
and colonies expressed both germ cell- and pluripotency-specific markers. These results shed light 
on growth hormone requirements of porcine gonocytes for in vitro proliferation and colony-
formation. 
 
3 This manuscript has been submitted for publication in Cell & Tissue Research under joint co-authorship 
with Fahar Ibtisham, Tat-Chuan Cham, and Ali Honaramooz. 
4 MAF contributed to the experimental design, performed the study, and wrote the first draft of the 
manuscript. FI and TCC contributed to the collection of the samples and revised the manuscript. AH 






During embryonic development, primordial germ cells (PGCs) colonize the developing gonad and 
form a transient population of primitive germ cells known as gonocytes (i.e., prospermatogonia) 
that reside in the center of testicular cords (Culty 2009). After birth, these gonocytes gradually 
migrate towards the cordal basement membrane and transform into spermatogonial stem cells 
(SSCs). In the mature testis, SSCs maintain a reserve stem cell population within the seminiferous 
tubules by way of self-renewal while simultaneously producing generations of spermatogonia 
committed to successive divisions and differentiation. As such, SSCs establish and sustain a 
continuous process of spermatogenesis to produce a life-long supply of spermatozoa (Brinster 
2002; Culty 2009; Ibtisham et al. 2020; Kuijk et al. 2009).  
When SSCs, gonocytes, and even PGCs were transplanted into the testis of recipients, they were 
able to colonize the recipient seminiferous tubules and initiate donor-derived spermatogenesis 
(Brinster and Zimmermann 1994; Orwig et al. 2002; Chuma et al. 2005). Given this ability, SSCs, 
gonocytes, and PGCs are referred to as male germline stem cells (MGSCs) (Ibtisham and 
Honaramooz 2020). Importantly, the transfer of MGSCs from a fertile donor into the testes of an 
infertile mouse can restore the fertility potential of the recipient (Kanatsu-Shinohara et al. 2003; 
Kubota et al. 2004). SSCs in particular can be cultured long-term or cryopreserved for years, and 
still maintain their potential to initiate spermatogenesis when transferred into recipient testes 
(Kanatsu-Shinohara 2005; Wu et al. 2012). Furthermore, SSCs and gonocytes from diverse 
species, including pigs, can be genetically manipulated prior to the transplantation into wild-type 
recipient testes to generate transgenic-sperm producing recipients (Honaramooz et al. 2008; Zeng 
et al. 2013, 2012). Transplantation of germ cells (containing SSCs) is hence viewed as an 
alternative strategy to produce transgenic founders, especially in farm animals, where true 
embryonic stem cell lines are not yet available (reviewed in Honaramooz and Yang 2011; Ibtisham 
et al. 2020; Savvulidi et al. 2019). Interestingly, upon being cultured, mouse germ cells can form 
embryonic stem (ES)-like cells and colonies that express several pluripotency-determining 
markers and have the potential to contribute to development of chimeras (Guan et al. 2006; 
Kanatsu-Shinohara et al. 2004). Therefore, MGSCs hold great promise for various basic and 
clinical applications including potential use in genetic conservation, infertility treatment, and 





The potential use of MGSCs for downstream applications depends greatly on our expanding ability 
to isolate, identify, enrich, culture, and manipulate these cells in vitro. Among MGSCs, gonocytes 
tend to be most readily available, given that they are the only type of germ cell present in the 
neonatal testis. Relatively large numbers of gonocytes can be collected from the neonatal testes of 
livestock (e.g., after routine castration of piglets) and identified using their unique morphology or 
specific cell-surface markers (e.g., VASA, DAZL, DBA, and UCH-L1) (Awang-Junaidi and 
Honaramooz 2018; Culty 2009; Goel et al. 2007). Upon enzymatic digestion of neonatal rodent or 
porcine testis tissue using conventional protocols, ~2% or ~7% of the resultant testis cells are 
expected to be gonocytes (Lee et al. 2013; Honaramooz et al. 2005). There is a direct relationship 
between the number of donor germ cells transplanted and the degree of recipient testis colonization 
(Honaramooz and Yang, 2011). Therefore, different approaches have been taken to increase 
gonocyte numbers, including in vitro proliferation in culture, differential plating, magnetic 
activated cell sorting (MACS), fluorescence activated cell sorting (FACS), and the utilization of 
cell-specific markers (Kim et al. 2010). To obtain an enriched population of neonatal porcine 
gonocytes, we have developed an optimized three-step enzymatic digestion method which yields 
cell aggregates comprised of ~40% gonocytes (Yang and Honaramooz 2011; Yang et al. 2010). 
Further, a combination of the foregoing cell isolation method with Nycodenz centrifugation and 
differential plating can result in a highly enriched and homogenous cell population, comprised of 
~90% gonocytes (Yang and Honaramooz 2011).  
Each of these approaches for obtaining a sufficient proportion of MGSCs may be suitable for 
different applications. While isolation and enrichment of MGSCs from a fresh tissue may seem 
ideal, it is not always possible nor desirable to use fresh tissue as the primary source. For example, 
one of the envisioned clinical applications for MGSCs is their use in preserving the fertility 
potential of preadolescent boys undergoing cancer therapy; many prepubertal oncology patients 
face infertility in adulthood due to the gonadotoxic effects of chemotherapy and total body 
irradiation. In such cases, cryopreserved tissue acts as the primary source of MGSCs. Prior to the 
start of these treatments, small biopsies of the immature testis tissue can be obtained and 
cryopreserved long-term for potential future use if the individual indeed becomes infertile 
(reviewed in Honaramooz 2012; Ibtisham and Honaramooz 2020). While there seem to be no limit 
in the number of years cryopreserved MGSCs can maintain their developmental potential (Wu et 





MGSCs to repopulate the recipient testis without their further in vitro expansion (Wu et al. 2009). 
Further, the investigation into optimal culture conditions is also required for fundamental 
understanding and manipulation of male germ cells. Optimizing culture conditions for MGSCs is 
especially important for their in vitro development, proliferation, differentiation, and eventual 
production of haploid germ cells. Additionally, optimized culture systems would enable 
experimentations that are otherwise difficult to be performed in vivo, such as the pharmaceutical 
or toxicological study of new drugs or potential toxicants on development of neonatal human germ 
cells. Other applications include the study of mechanisms of testicular tumors, genetic causes of 
male infertility, or even correction of genetic disorders causing infertility (reviewed in Ibtisham 
and Honaramooz 2020). Cultured germ cells can also develop ES-like cells and colonies to be used 
as a source of pluripotent stem cells or undergo in vitro differentiation into any of the three 
germinal layer lineages for downstream applications in cell-based therapy (Kubota and Brinster 
2006; Mirzapour et al. 2012; Phillips et al. 2010). 
Within the in vivo environment of the seminiferous tubules, germ cell survival, proliferation, and 
differentiation depend on a variety of growth factors and cytokines released by the stem cell niche. 
Expectedly, these growth factors are equally important for the proliferation of germ cells in vitro. 
Among these growth factors are different types of fibroblast growth factors (FGF) which are 
necessary for fetal and neonatal testis development (Shubhada et al. 1993; Skinner 2005; van 
Dissel-Emiliani et al. 1996). For instance, basic fibroblast growth factor (bFGF), a member of the 
FGF family, is involved in the proliferation of testis somatic cells (e.g., Sertoli and Leydig cells) 
and has stimulating effects on gonocyte self-renewal. The expression of Etv5, a transcription factor 
essential for self-renewal of SSCs, is also upregulated by bFGF; indicative of direct and indirect 
effects of this growth factor on proliferation of spermatogonia (Phillips et al. 2010; Schlesser et 
al. 2008). Another major regulator of the seminiferous niche is the glial cell-derived neurotrophic 
factor (GDNF) secreted by Sertoli cells (Tadokoro et al. 2002; Takahashi 2001). Self-renewal of 
gonocytes also depends on the paracrine release of GDNF; in vivo overexpression of this factor is 
shown to block SSC differentiation. Furthermore, mouse germ cells developed in culture media 
supplemented with GDNF successfully colonized the recipient seminiferous tubules following 
transplantation (Nagano et al. 2003). Leukemia inhibitory factor (LIF) was also shown to be an 
essential component for the long-term culture of PGCs and embryonic germ cells, which acts by 





Piquet-Pellorce et al. 2000). However, the presence of growth factors can potentially lead to 
overgrowth of somatic cells, including fibroblasts, Sertoli cells, and endothelial cells, which in 
turn may hinder survival of germ cells (Guan et al. 2006). Importantly, there is limited information 
available on the effects of these growth factors on the stem cell function of porcine germ cells 
(Kuijk et al. 2009). 
In preliminary studies, we tested various culture conditions, comprised of different media and 
serum sources, and found a combination that resulted in ~35% increase in gonocyte proliferation. 
Combining the latter findings with supplementation of select growth factors can potentially have 
additive effects on in vitro proliferation and colony-formation of gonocytes. As such, the objective 
of the present study was to test the effects of bFGF, GDNF, and LIF, supplemented individually 
or in combination, using a stepwise manner, on proliferation, colony-formation, and expression of 
the pluripotency-determining markers of neonatal porcine gonocytes. 
4.3. Materials and Methods 
4.3.1. Study Design 
As outlined in Figure 4.1, to test the effects of individual and combined growth factors on neonatal 
porcine testis cells, the present study consisted of two main experiments conducted in a stepwise 
manner. For Experiment 4.1, using a total of 20 groups, we tested the effects of three different 
concentrations of three different growth factors (bFGF, GDNF, and LIF) alone by adding each to 
Dulbecco’s modified Eagle’s medium (DMEM), supplemented with either 15% fetal bovine serum 
(FBS) or 15% knockout serum replacement (KSR). After analyzing the effects on cultured cells, a 
single group with the optimal effects was selected for further investigations. In Experiment 4.2, 
we examined an additional 6 groups by starting with the selected group from Experiment 4.1 (a 
given concentration of a given growth factor), to test the effects of combining this mixture with 
three different concentrations of the next growth factor. This was followed by analysis and 
selection of an optimal group to test the effects of combining this new mixture with three different 
concentrations of the remaining growth factor using an additional 7 groups. A final culture 
condition (group with optimal concentrations of all three growth factors) was then selected to 





4.3.2. Collection of Testes and Isolation of Testis Cells 
The procedures used for the collection of piglet testes and isolation of testis cells have been 
described in greater detail (Awang-Junaidi and Honaramooz 2018). In summary, testes were 
obtained aseptically from ~1 wk-old Yorkshire-cross piglets (n = 180) during routine weekly 
castrations at a university affiliated swine facility (Prairie Swine Center, Saskatoon, SK, Canada). 
All experiments involving animals were reviewed and approved by the University of 
Saskatchewan’s Institutional Animal Care and Use Committee (Protocol # 20080042). The testes 
were cooled immediately, transferred to the laboratory within ~1 h, and the testis parenchyma was 
harvested. The tissue underwent our afore-established three-step enzymatic digestion method 
(Yang et al. 2010) which yields a mixed population of testis cells containing ~40% gonocytes. We 
have previously shown that the characteristics of testis cells from this source are consistent over 
time (Yang et al. 2010).  
For each treatment group, multiple replicates were prepared; each round of cell isolation was 
regarded as an individual replicate. To prepare each replicate of testis cells for culture, ~5 testes 
were used. Briefly, the parenchyma was completely minced for 5 min using fine scissors, the 
resultant suspension vortexed for 60 sec, and then digested at 37° C for 10 min using an enzymatic 
cocktail containing 0.2% w/v collagenase IV (catalogue no. C153; Sigma-Aldrich, St Louis, MO, 
USA), 0.1% w/v hyaluronidase (catalogue no. H3884; Sigma-Aldrich), and 0.01% w/v 
deoxyribonuclease (DNase; catalogue no. FN25; Sigma-Aldrich) in Dulbecco’s modified Eagles 
medium (DMEM; catalogue no. 12-604F; Corning, New York, NY, USA) with 1% w/v antibiotic. 
The digestion was stopped by addition of fetal bovine serum (FBS; catalogue no. A15-701; PAA 
Laboratories, Etobicoke, ON, Canada), followed by vortexing for 30 sec, filtration using 40-µm 
cell strainers, centrifugation at 500× g at 16° C for 5 min, elimination of the erythrocytes, and two 
rounds of rinsing and centrifugation (Awang-Junaidi and Honaramooz 2018). 
All the growth factors were reconstituted at 100 µg/mL in Dulbecco’s phosphate-buffered saline 
(DPBS; catalogue no. 20-031-CV; Mediatech, Manassas, VA, USA), containing 0.1% bovine 
serum albumin (BSA; catalogue no. 2452C055; Amresco, Solon, OH, USA), aliquoted, and stored 
at –80° C upon arrival. To prepare different dilutions from each growth factor, prepared aliquots 
were thawed at 37° C and mixed with DMEM based on the final required concentration. For 





FBS or DMEM+15% KSR with 1% w/v antibiotics, supplemented with one of three individual 
concentrations of bFGF (0.1, 1, or 10 ng/mL; catalogue no. 233-FB-025; R&D Systems, 
Minneapolis, MN, USA), GDNF (10, 50, or 100 ng/mL; catalogue no. 212-GD-010; R&D 
Systems), or LIF (1000, 1200, or 1500 U/mL equivalent to 10000, 12000, and 15000 pg/mL, 
respectively; catalogue no. 7734-LF-025; R&D Systems).  
For Experiment 4.2, the resultant cell pellets were mixed with DMEM+15% FBS+1% w/v 
antibiotics, supplemented with the optimal individual bFGF concentration and each concentration 
of GDNF (10, 50, and 100 ng/mL). However, due to the low cell confluency in KSR-treated wells 
after 21 days of culture, these were not included in further analyses. For the next step of 
Experiment 4.2, after the last round of centrifugation, cell pellets were mixed with DMEM+15% 
FBS+1% w/v antibiotics supplemented with the optimal concentrations of bFGF+GDNF in 
combination with each LIF concentration (1000, 1200, or 1500 U/mL). By gentle pipetting, the 
cell pellets were mixed with media and growth factor combinations, to prepare a single cell 
suspension for each treatment. For control groups in Experiment 4.1, cell pellets were resuspended 
in DMEM+15% FBS or DMEM+5% FBS+10% KSR without growth factor supplementation. For 
control groups in Experiment 4.2, pellets were mixed with DMEM+15% FBS or DMEM+5% 
FBS+10% KSR either without growth factor supplementation, with bFGF, or bFGF+GDNF 
supplementation (Fig. 4.1). 
4.3.3 Evaluation of Viability and Number of Isolated Cells 
Cell count and assessment of cell viability were performed immediately after isolation of testis 
cells and again after 28 days of culture for randomly selected culture wells (n = 3 per treatment) 
using the trypan blue exclusion technique. Briefly, to detach the cultured cells on Day 28, the 
media was removed and 1 mL of DPBS was added to each well to wash the remnant media. DPBS 
was then removed and 1 mL of 0.25% (w/v) trypsin in Hank’s balanced salt solution (HBSS) and 
2.21 mM EDTA (catalogue no. 25-053-CI; Mediatech) was dispensed in each well. The culture 
plates were placed at 37° C for ~3 min, 1 mL of undiluted FBS was added to each well to terminate 
the digestion, and the suspended cells were centrifuged at 500× g at 16° C for 5 min. The 
supernatant was removed, and the resultant cell pellet was resuspended in DMEM. Freshly isolated 
and cultured cells were each mixed with 1:1 ratio of trypan blue (100 µL of 0.4% in saline; 





hemocytometer chamber. The number of live and dead cells were counted under a light microscope 
(Nikon, Eclipse E100). Percentage of cell viability and cell yield were calculated based on an 
average of two counts for each replicate or culture well. Also, gonocytes were visualized using a 
gonocyte-specific marker and their percentage was calculated on freshly isolated and cultured cell 
smears (Awang-Junaidi and Honaramooz 2018). 
4.3.4. Cell Culture 
Prepared cell suspensions for each treatment were seeded at a density of 3.0 × 105 cell/well in 6-
well plates (catalogue no. 353046; Corning). The seeded cells were then provided with 
DMEM+15% FBS or DMEM+15% KSR, containing 1% w/v antibiotics along with individual 
and/or combined concentrations of bFGF, GDNF, and/or LIF (treatments). The optimal bFGF 
concentration which led to the maximum number of gonocytes in Experiment 4.1 was used in 
Experiment 4.2 in combination with different concentrations of GDNF and LIF. For control 
groups, cells were cultured in DMEM+15% FBS or DMEM+5% FBS+10% KSR without growth 
factor supplementation. More specifically, when comparing the number of EBLCs, DMEM+5% 
FBS+10% KSR was used as a control since we previously showed that this treatment leads to the 
greatest EBLC numbers in cultures without additional growth factor supplementation. The 
treatment groups (n = 3 replicates per treatment) were as follows: 
– Experiment 4.1 (an individual concentration of each growth factor): 
● DMEM+15% FBS supplemented with 0.1, 1, or 10 ng/mL bFGF (i.e., 3 groups) 
● DMEM+15% KSR supplemented with 0.1, 1, or 10 ng/mL bFGF (i.e., 3 groups) 
● DMEM+15% FBS supplemented with 10, 50, or 100 ng/mL GDNF (i.e., 3 groups) 
● DMEM+15% KSR supplemented with 10, 50, or 100 ng/mL GDNF (i.e., 3 groups) 
● DMEM+15% FBS supplemented with 1000, 1200, or 1500 U/mL LIF (i.e., 3 groups) 
● DMEM+15% KSR supplemented with 1000, 1200, or 1500 U/mL LIF (i.e., 3 groups) 
● DMEM+15% FBS without growth factor supplementation 
● DMEM+5% FBS+10% KSR without growth factor supplementation 
– Experiment 4.2 (combined concentrations of growth factors): 
● (First step) DMEM+15% FBS supplemented with the selected bFGF concentration and 





● (Second step) DMEM+15% FBS supplemented with the selected bFGF+GDNF 
concentration and 1000, 1200, or 1500 U/mL LIF as well as four different control groups 
(i.e., 7 groups) 
Each replicate for each treatment group was cultured in two separate wells of a 6-well plate using 
our overall optimized culture conditions (Awang-Junaidi and Honaramooz 2018). The cells were 
incubated at 37° C with 5% CO2 and 95% humidity and monitored twice daily using an inverted 
phase contrast microscope (Nikon, Eclipse TS100). The media was replenished every 7 days using 
the same components described above, and the cells were maintained for 28 days. 
4.3.5. Imaging and Assessment of Cultured Cells 
For each experiment, using an inverted phase contrast microscope equipped with a camera (Sony 
α5000, Sony Corporation, Tokyo, Japan), photomicrographs were captured from both wells of 
each replicate of all treatment groups. On Days 7, 14, 21, and 28 of culture, images were captured 
from randomly selected fields of view from each well at 40× and 200× magnifications (n = 10 
images per magnification). On Day 28, the visual quantification and morphometrical evaluation of 
gonocytes and/or EBLCs (if present) were conducted using 40× magnification images using 
ImageJ software (ImageJ, U.S. National Institutes of Health, Bethesda, MD, USA). On Day 28, 
the average diameter of EBLCs in X and Y axes was also calculated using 200× magnification 
images. When cultured, gonocytes typically form clusters and colonies and as such, multiple 
gonocytes in close contact with an identifiable interface were counted as separate cells (Awang-
Junaidi and Honaramooz 2018). 
4.3.6. Immunocytochemistry 
Cell samples from both the freshly isolated and cultured cells of different treatment groups, with 
the maximum number of gonocytes, were examined further for the expression of gonocyte-specific 
and pluripotency-determining markers. To obtain samples, the cells were cultured on 22 × 22 mm 
coverslips (catalogue no. 12-540B; Thermo Fisher Scientific), coated with 0.01% w/v poly-L-
lysine solution. Preparation of coverslips was performed as described previously with minor 
modifications (Awang-Junaidi and Honaramooz 2018). Briefly, coverslips were placed in sterile 
metal racks (catalogue no. 114; Thermo Fisher Scientific) and immersed in 1% HCL in 70% 





cabinet under sterile conditions to air-dry for 20 min. A diluted solution of poly-L-lysine 0.01% 
w/v was prepared from 0.1% w/v stock solution (catalogue no. P8920; Sigma-Aldrich), in which 
the metal rack containing the coverslips was immersed for 20 min. The coverslips were air-dried 
overnight in the biosafety cabinet and were placed in each well using sterile conditions. 
Gonocytes and EBLCs were identified using (FITC)-labeled Dolichos biflorus agglutinin (DBA-
FITC; catalogue no. FL1031; Vector Labs, Burlington, ON, Canada) (Awang-Junaidi and 
Honaramooz 2018; Goel et al. 2007). POU5F1 (OCT4) (Choi et al. 2019; Shi and Jin 2010), 
homeobox NANOG (Choi et al. 2019; Yang et al. 2015), and epithelial-cadherin (E-cadherin) 
(Chen et al. 2010; Wolf et al. 2011) were used as pluripotency-determining factors, and stage-
specific embryonic antigen-1 (SSEA-1) (Choi et al. 2019) was used as a dual germ-cell- and 
pluripotency-determining marker. Cell smears of the freshly isolated testis cells and coverslips 
with cultured cells obtained on Day 28 were washed 3 times with PBS containing 0.1% Tween-20 
(PBST; catalogue no. J60304; Alfa Aesar, Tewksbury, MA, USA), followed by fixation with a 4% 
paraformaldehyde solution for 6 min. The samples were washed again with PBST 3 times, 3 min 
each, and incubated at room temperature with a blocking solution of 5% BSA for 30 min in a 
humidified chamber. After removal of BSA, each sample was covered with 1:100 concentration 
of both DBA-FITC and one of the primary antibodies at 4° C overnight. Primary antibodies for 
pluripotency-determining factors were anti-POU5F1 antibody (rabbit polyclonal to POU5F1; 
catalogue no. AB18976; Abcam, Toronto, ON, Canada), anti-SSEA-1 antibody (mouse 
monoclonal to SSEA-1; catalogue no. sc-21702; Santa Cruz Biotechnology; Santa Cruz, CA, 
USA), anti- NANOG antibody (mouse monoclonal to NANOG; catalogue no. N3038; Sigma-
Aldrich), and anti-E-cadherin antibody (rabbit polyclonal to E-cadherin; catalogue no. 15148; 
Abcam). Next, the samples were washed 3 times, 3 min each, with PBST and covered with diluted 
(1:200 concentration) Alexa Fluor 594-conjugated goat anti-rabbit IgG (catalogue no. AB150088; 
Abcam) or Alexa Fluor 594-conjugated goat anti-mouse IgG (catalogue no. 150116; Abcam) at 
room temperature for 1 h. The samples were washed with phosphate buffered saline (PBS; 
catalogue no. 21-040-CV; Corning) 3 times, 3 min each, and placed on glass slides (catalogue no. 
22-0370246; Thermo Fisher Scientific) using a mounting medium with 4′, 6-diamidino-2-





Photomicrography from the samples was performed at 40× using a DAPI filter set (catalogue no. 
49000; Chroma, Bellows Falls, VT, USA; excitation 350 nm/50 nm and emission 460 nm/50 nm), 
a FITC filter set (catalogue no. 49008; Chroma; excitation 470 nm/40 nm and emission 525 nm/50 
nm), and a Texas Red filter set (catalogue no. 49008; Chroma; excitation 560 nm/40 nm and 
emission 630 nm/75 nm) to observe DAPI, FITC, and Alexa Fluor 594, respectively. 
4.3.7. Extraction of RNA and RT-PCR 
To determine the expression of pluripotency markers by developed gonocytes and/or EBLCs on 
Days 7, 14, 21, and 28, selected treatments were used for reverse-transcriptase polymerase chain 
reaction (RT-PCR) analysis. Cultured cells in randomly selected wells were suspended at each 
sampling time-point using trypsin-EDTA as described above, and the resultant suspension was 
centrifuged at 500× g at 16° C for 5 min. The cell pellet was washed with DPBS and centrifuged 
using the same settings. RNA extraction from the freshly isolated and cultured cells was then 
performed using Invitrogen RNAqueous Micro Total Isolation Kit (catalogue no. AM1931; 
Thermo Fisher Scientific), according to the manufacturer’s instructions and as described in 
Chapter 3. Details of the primers used for RT-PCR analysis were as described in Chapter 3.  
4.3.8. Statistical Analyses 
The presented data are mean ± standard error of mean (SEM) and P < 0.05 was considered as 
significant. For all comparisons, one-way analysis of variance (ANOVA) and repeated measures 
ANOVA were used with Tukey’s HSD as the post hoc test. All analyses were performed using the 
Statistical Package for Social Sciences (IBM SPSS Statistics for Macintosh, Version 26.00; IBM 
Corporation, Armonk, NY, USA). 
4.4. Results 
4.4.1. Testis Cell Count and Viability Assessment 
Using the trypan blue exclusion technique, the viability of both freshly isolated and dissociated 
cultured testis cells from Day 28 was greater than 95% in all treatment groups. Also, using 
immunocytochemistry against DBA, the population of gonocytes in smears prepared from the 
freshly isolated testis cells was ~40%. The number of gonocytes in groups treated only with 10 





groups treated with combined concentrations of 10 ng/mL bFGF+100 ng/mL GDNF and 10 ng/mL 
bFGF+100 ng/mL GDNF+1500 U/mL LIF. 
4.4.2. Cell Development and Morphology 
4.4.2.1. Experiment 4.1: Effects of Individual Growth Factors 
The cell suspension at the time of seeding contained ~40% gonocytes. During the first 24 hr of 
culture, when observed using a conventional phase-contrast microscope, the cells in all treatment 
groups remained floating in the media and appeared heterogenous in shape. After 24 h, increasing 
numbers of somatic cells settled and adhered to the culture, forming sparse and irregular-shaped 
flattened cytoplasmic extensions, while most of the original cell mixture continued floating in the 
media. This pattern continued and after 7 days these somatic cells completely covered the culture 
well, forming a wave-shape monolayer with >90% confluency in all treatment groups (Fig. 4.2A). 
Round gonocytes appeared as single cells, pairs, or clusters of multiple cells sitting on top of the 
somatic cell monolayer (Fig. 4.2A and 4.2B). Gradually, the somatic cells extended their 
cytoplasmic projections further and in sparse locations formed ‘circular growth arrangements’, in 
which a disproportionate number of gonocytes aggregated and formed clusters. By Day 14, the 
gonocyte clusters converged to form large 3-D colonies with multiple nuclei. These colonies, 
known as EBLCs, appeared in miscellaneous shapes, and gradually enlarged via coalescence of 
surrounding individual gonocytes in all treatment groups. From Day 14 to 28, the gonocyte clusters 
and EBLCs became more prevalent and appeared in larger dimensions (Fig. 4.2C and 4.2D).  
In all KSR-supplemented groups, regardless of the growth factor used, cell confluency did not 
improve beyond ~20% and somatic cells appeared sparse on the culture well (Fig. 4.2E). In all 
cultures with KSR, gonocytes aggregated and formed small clusters which, by Day 14, converged, 
formed small 3-D colonies (Fig. 4.2F) and gradually enlarged further (Fig. 4.2G and 4.2H). As a 
result of the underdeveloped somatic cell monolayer, low confluency, and small numbers of 
gonocytes, the KSR-treated groups were excluded from further analyses.  
On Days 7, 14, 21, and 28, the greatest number of gonocytes was found in cultures supplemented 
with 10 ng/mL bFGF (P < 0.001; Fig. 4.3A). On Day 28, the number of gonocytes was ~44% 
greater in the group supplemented with 10 ng/mL bFGF compared with the control (P < 0.001; 





in cultures containing 10 ng/mL bFGF was ~13% or ~75% greater than those containing the 
highest concentrations of GDNF or LIF, respectively (P < 0.001; Fig. 4.3A). From Day 7 to 28, 
the gonocyte numbers increased by ~2-fold in the 10 ng/mL bFGF treatment group (Fig. 4.3B). 
However, since KSR supplementation alone did not result in satisfactory cell growth, at this time, 
we also tested the effects of combining FBS and KSR in the same media (DMEM+5% FBS+10% 
KSR) in additional cultures and compared the resultant EBLC numbers with other groups. 
Although the DMEM+15% FBS+10 ng/mL bFGF group had the greatest gonocyte numbers, 
cultures with 5% FBS+10% KSR developed the greatest number of EBLCs on Day 28 of culture 
(P < 0.001; Fig. 4.3C). Overall, the EBLC number in 5% FBS+10% KSR cultures was not different 
from that of groups treated with individual concentrations of LIF (Fig. 4.3C).  
Largest EBLC diameters were found in groups treated with 10 ng/mL bFGF, 1500 U/mL LIF, or 
a combination of 5% FBS+10% KSR and without growth factor supplementation (P < 0.001, Table 
4.1). Numerically, the largest average diameter of EBLCs was still found in the 5% FBS+10% 
KSR group. Other than the latter differences, the groups did not differ in any of the morphometric 
measurements including formation of the somatic cell monolayer, settlement of gonocytes on top 
of the monolayer, formation of gonocyte clusters and colonies, or development of EBLCs. 
4.4.2.2. Experiment 4.2: Effects of Combined Concentrations of Growth Factors 
Morphometric changes of cultured cells in groups treated with combined concentrations of growth 
factors followed the same pattern and timing as those described above. Since in Experiment 4.1 
the greatest number of gonocytes was found in cultures with DMEM+15% FBS supplemented 
with 10 ng/mL bFGF, in the first step of Experiment 4.2 we tested the effects of combining 10 
ng/mL bFGF and each of the three concentrations of GDNF on the number of gonocytes using the 
same basic media (DMEM+15% FBS). On Day 7 of culture, the group treated with an individual 
concentration of 10 ng/mL bFGF (DMEM+15% FBS+10 ng/mL bFGF) contained the greatest 
number of gonocytes compared to all other groups (P < 0.001). On Day 14, 21, and 28, cultures 
supplemented with an individual concentration of 10 ng/mL bFGF (DMEM+15% FBS+10 ng/mL 
bFGF) or a combination of 10 ng/mL bFGF+100 ng/mL GDNF contained the greatest numbers of 
gonocytes (P < 0.001; Fig. 4.4A). On Day 28, the number of gonocytes in cultures supplemented 
with 10 ng/mL bFGF-only and 10 ng/mL bFGF+100 ng/mL GDNF was ~44% and ~50% greater 





the number of gonocytes in cultures with 10 ng/mL bFGF+100 ng/mL GDNF increased by 3.3-
fold from Day 7 to Day 28. Although the greatest gonocyte numbers were found in the growth 
factor-supplemented media, the number of EBLCs was still the greatest in cultures with 5% 
FBS+10% KSR without growth factors (P < 0.001).  
Given the promoting effects of 10 ng/mL bFGF+100 ng/mL GDNF on gonocyte proliferation, in 
the second step of Experiment 4.2, this combination was mixed with each of the three 
concentrations of LIF (1000, 1200, or 1500 U/mL). On Day 7, cultures treated with basic media 
supplemented with 10 ng/mL bFGF contained the greatest number of gonocytes (P < 0.001), while 
on Day 14, 21, and 28, cultures supplemented with 10 ng/mL bFGF, 10 ng/mL bFGF+100 ng/mL 
GDNF, or 10 ng/mL bFGF+100 ng/mL GDNF+1500 U/mL LIF developed the greatest numbers 
of gonocytes (P = 0.005; Fig. 4.4B). Also, a ~2.8-fold increase in the gonocyte number was 
observed from Day 7 to 28 in cultures treated with the highest concentration of bFGF, GDNF, and 
LIF (10 ng/mL bFGF+100 ng/mL GDNF+1500 U/mL LIF, P < 0.001; Fig. 4.4C).  
Additionally, the number of EBLCs was quantified and their diameters measured via 
photomicrographs on Day 28 in cultures supplemented with all three growth factors. The greatest 
number of EBLCs was found in cultures containing 5% FBS+10% KSR without growth factor 
supplementation (P = 0.009; Fig. 4.4D). However, among the groups with combined 
concentrations of growth factors, the largest EBLCs were developed in cultures supplemented with 
a cocktail of 10 ng/mL bFGF, 100 ng/mL GDNF, and 1500 U/mL LIF (P < 0.001, Table 4.2). 
4.4.3. Double Immunocytochemistry against Pluripotency-determining and Gonocyte-specific 
Markers 
Freshly isolated gonocytes were positive for DBA and SSEA-1 but were negative for POU5F1, 
NANOG, and E-cadherin. After 28 days of culture, both EBLCs and individual gonocytes were 
positive for DBA and POU5F1, SSEA-1, NANOG, and E-cadherin. DBA signals were found on 
the surface of gonocytes and EBLCs, while the expression of the other four markers was identified 
within the cytoplasm and nucleus of gonocytes (Fig. 4.5). 
4.4.4. Gene Expression of Pluripotency-determining Factors 
Samples from cultured neonatal porcine testis cells on Days 7, 14, 21, and 28 were positive for 





marker was also positive in freshly isolated testis cells, which conformed with the 



























Table 4.1. X- and Y-axis average diameter (mean ± SEM) of EBLCs on Day 28 in culture wells 
treated with basic media (DMEM+15% FBS) supplemented with individual concentrations of 
bFGF, GDNF, or LIF and without growth factor supplementation (DMEM+15% FBS or 
DMEM+5% FBS+10% KSR) 
Growth factor Concentration Average diameter ± SEM (µm) Range of diameter (µm) 
bFGF 
0.1 ng/mL 144.24 A ± 16.47 102.96 – 209.98 
1 ng/mL 146.04 A ± 10.72 121.14 – 184.92 
10 ng/mL 194.71 B ± 11.25 167.4 – 243.15 
GDNF 
10 ng/mL 145.40 A ± 14.15 109.73 – 199.82 
50 ng/mL 147.77 A ± 15.48 107.54 – 209.20 
100 ng/mL 148.13 A ± 14.61 103.95 – 197.11 
LIF 
1000 U/mL 150.36 AC ± 13.03 122.14 – 202.57 
1200 U/mL 151.86 AC ± 8.93 123.20 – 175.43 
1500 U/mL 188.01 BC ± 8.73 148.3 – 203.20 
5% FBS+10% KSR - 209.05 B ± 9.69 118.60 – 348.72 
15% FBS - 161.13 AC ± 12.14 49.81 – 264.67 
A,B,C Diameters with different superscripts are significantly different (P < 0.05). 
 
Table 4.2. X- and Y- axis average diameter (mean ± SEM) of EBLCs on Day 28 in culture wells 
treated with basic media (DMEM+15% FBS) supplemented with 10 ng/mL bFGF, combined 
concentrations of bFGF, GDNF and LIF or without growth factor supplementation (DMEM+15% 
FBS or DMEM+5% FBS+10% KSR) 
Growth factor combination LIF Concentration 




10 ng/mL bFGF - 194.71 ± 11.25 AC 167.4 – 243.15 
10 ng/mL bFGF+100 ng/mL GDNF - 206.45 ± 12.50 A 163.51 – 262.99 
10 ng /mL bFGF+100 ng/mL 
GDNF+LIF 
1000 U/mL 220.70 ± 7.35 A 196.33 – 245.02 
1200 U/mL 223.06 ± 8.88 A 204.23 – 259.17 
1500 U/mL  265.29 ± 9.71 B 226.82 – 307.33 
5% FBS+10% KSR - 209.05 ± 9.69 A 118.60 – 348.72 
15% FBS - 161.13 ± 12.14 C 49.81 – 264.67 






Fig. 4.1. Schematic overview of the experimental design. In Experiment 4.1, isolated testis cells 
were cultured in a basic medium with FBS (DMEM+15% FBS) or with KSR (DMEM+15% KSR), 
supplemented with individual concentrations of bFGF (0.1, 1, or 10 ng/mL), GDNF (10, 50, or 
100 ng/mL), or LIF (1000, 1200, or 1500 U/mL). The culture condition most supportive of 
gonocytes proliferation was selected to be used in Experiment 4.2. In Experiment 4.2, the optimal 
growth factor concentration (10 ng/mL bFGF) was combined with each of the three concentrations 
of GDNF (10, 50, or 100 ng/mL) to be tested on their effects on proliferation of gonocytes. The 
optimal combined bFGF and GDNF concentration was then mixed with each of the three 
concentrations of LIF (1000, 1200, or 1500 U/mL) in the next step to be tested for their effects on 
gonocyte proliferation and colony-formation. Among all treatments, the selected culture condition 
resulting in the highest number of gonocytes was selected to determine the expression of germ 













Fig. 4.2. Representative photomicrographs of cultured cells in groups treated with 10 ng/mL bFGF. 
Gradual morphometrical changes of the cultured testis cells were similar among treatment groups, 
where FBS or KSR was added to the media. (A-D) Addition of FBS to the cultures led to greater 
somatic cell confluency. (A) Somatic cells adhered to the bottom of the culture well by Day 7 and 
appeared as spindle-shape formations (white arrows). Single (black arrowheads), paired (white 
arrowhead), and clustered (black arrows) gonocytes appeared on top of the somatic cell monolayer 
with loose attachments. (B) By Day 14, gonocytes formed larger clusters (black arrow) and showed 
greater tendency to aggregate in circular arrangements. (C) By Day 21, clustered gonocytes 
converged to form large 3-D colonies, namely embryoid body-like colonies (EBLCs) (dotted 
circle). (D) Coalesce of individual gonocytes surrounding multi-nucleated EBLCs resulted in their 
gradual enlargement by Day 28 (black arrows). (E and F) When KSR was used as an alternative 
to FBS, somatic cell confluency did not increase beyond 20% (white arrow) after 7 days of culture 
and gonocytes formed small 3-D colonies by Day 14 (asterisk). (G and H) These colonies seemed 
to slightly increase in size by Day 28 of culture (asterisks). Although growth factors were 
supplemented, the underdevelopment of somatic cell monolayer (white arrows) may have resulted 
in decreased gonocyte proliferation (black arrowhead) and as such cultures with KSR 







Fig. 4.3. Number of gonocytes (mean ± SEM) in different treatment groups on (A) Day 28 and (B) 
over time changes in the number of gonocytes in cultures supplemented with 10 ng/mL bFGF. 
Visual quantification of gonocytes was performed every 7 days. (A) When three tested growth 
factors were added individually to the culture media, the highest number of gonocytes was found 
in groups supplemented with 10 ng/mL bFGF in all the time points including Day 28 of culture (P 





supplemented with 10 ng/mL bFGF (P < 0.001). Exogenous bFGF supplementation along with 
production of endogenous bFGF by the somatic cells in culture is speculated to provide greater 
support for Sertoli cell survival, which in turn may have resulted in improved gonocyte 
proliferation. When comparing the number of developed EBLCs, LIF and combined 
concentrations of 10% KSR+5% FBS seemed to have promoting effects on aggregation and 
colonization of gonocytes (P < 0.001). Different letters denote significant differences and P < 0.05 


























Fig. 4.4. Number of gonocytes (mean ± SEM) in cultures supplemented with combined 
concentrations of growth factors. (A) Since 10 ng/mL bFGF led to increased gonocyte numbers in 
Experiment 4.1, combined bFGF and GDNF concentrations were added to the basic media. In 
long-term culture, highest number of gonocytes was found in groups supplemented with 10 ng/mL 
bFGF or 10 ng/mL bFGF+100 ng/mL GDNF (P < 0.001). (B) In the second step, a cocktail of 
growth factors, consisting of 10 ng/mL bFGF+100 ng/mL GDNF with each of the three 
concentrations of LIF was supplemented. Greatest number of gonocytes was obtained in groups 
treated with maximum concentrations of all three growth factors, 10 ng/mL bFGF-only, and 10 
ng/mL bFGF+100 ng/mL GDNF (P = 0.005). (C) The number of gonocytes increased by ~2.8-
fold from Day 7 to Day 28 in cultures supplemented with maximum concentrations of all three 
growth factors. Nevertheless, the same enhancing effect was found on the gonocyte numbers when 
10 ng/mL bFGF alone was added to the media, which may indicate that bFGF can sufficiently 
support somatic cell proliferation and survival. Survival of somatic cells may have provided an 
increased support for gonocyte proliferation in culture conditions. Mixture of media with 5% 
FBS+10% KSR without added growth factors seemed to have an enhancing effect on gonocyte 
colonization and subsequent EBLC development, as the greatest number of EBLCs was found 
when FBS and KSR were both present in the culture media (P = 0.009). Different letters denote 















Fig. 4.5. Double-immunostaining of the freshly isolated and cultured testis cells against gonocyte- 
and pluripotency-specific markers. Freshly isolated testis cells appeared positive for fluorescein 
isothiocyanate (FITC)-labeled Dolichos biflorus agglutinin (DBA-FITC) as a gonocyte-specific 
marker and SSEA-1 as a spermatogonia and pluripotent stem cells marker. However, gonocytes in 
the fresh samples were negative for POU5F1, NANOG, and E-cadherin. When cultured, gonocytes 
which were DBA-positive also expressed pluripotency-determining factors. DBA appeared on the 





cytoplasm and nuclei. Co-localization of DBA and pluripotency-determining factors in cultured 
gonocytes is suggestive of induced reprogramming of germ cells to obtain stem cell characteristics 

























Fig. 4.6. RT-PCR analysis for detection of pluripotency-determining gene transcripts in fresh testis 
cell isolate and 28-day cultured testis cells. Positive expression of FUT4 known as a marker for 
both pluripotent embryonic stem cells and spermatogonia was found in freshly isolated testis cells. 
On Day 28, cultured testis cells expressed POU5F1, FUT4, NANOG, and E-cadherin, known as 
pluripotent embryonic stem cell markers. N, no template control; M, 50 bp DNA ladder; Lines 1-
5, amplified cDNA synthesized from samples of freshly isolated testis cells, and cultured testis 












To harness the potential of MGSCs for various downstream applications, the optimal culture 
conditions conducive to their in vitro proliferation and colony-formation must be decided. Towards 
this goal, the present study was designed to systematically study the effects of select key growth 
factors on the in vitro proliferation and behaviour of porcine gonocytes. In a previous study, we 
optimized other fundamental culture variables including cell density, gonocyte proportions, 
incubation temperatures, sampling, and media changing regimens (Awang-Junaidi and 
Honaramooz 2018). Recently, we also examined the effects of media choices (DMEM, 
DMEM/F12, GMEM, MEM, StemPro, and RPMI), each supplemented with 5, 10, or 15% FBS 
and/or KSR. In the later study, we observed that DMEM+15% FBS provided an optimal condition 
to support gonocyte proliferation, while DMEM+5% FBS+10% KSR promoted gonocyte 
colonization. Furthermore, increasing FBS concentration from 10% to 15% in long-term cultures 
led to an increase in gonocyte numbers by ~35%. Given a lack of background information 
regarding the optimal growth factors, in the present study we chose to investigate the effects of 
bFGF, GDNF, and LIF, three growth factors known to play important roles in germ cell 
proliferation and/or differentiation (Kubota et al. 2004; Kubota et al. 2004; Mirzapour et al. 2012; 
Phillips et al. 2010; Piquet-Pellorce et al. 2000).  
Here, we developed a simplified culture system composed of a basic media (DMEM+15% FBS), 
supplemented with 10 ng/mL bFGF without passaging or adding multiple exogenous factors. This 
led to an increase in gonocyte proliferation by ~44%. We found that combined concentrations of 
10 ng/mL bFGF+100 ng/mL GDNF, or 10 ng/mL bFGF+100 ng/mL GDNF+1500 U/mL LIF 
similarly promote the proliferation of porcine gonocytes. Additionally, we showed that 
supplementation with LIF or a combination of FBS and KSR is equally capable of maximizing 
EBLC formation. Importantly, the gonocytes developed in our optimized culture system co-
expressed gonocyte- and pluripotency-determining factors, indicative of their spontaneous 
dedifferentiation to obtain the characteristics of pluripotent stem cells. Our findings especially 
benefit applications where large numbers of gonocytes are required as a source of potential 
pluripotent stem cells or for the ultrastructural study of EBLCs. 
Given the non-adherent nature of gonocytes in culture, they typically require co-culturing with a 





In the present study, the somatic cells among the initial population of primary testis cells acted as 
the feeder layer and sufficiently supported the in vitro propagation of gonocytes. As such, our 
three-step isolation protocol (Yang and Honaramooz, 2011) resulted in a relatively high ratio of 
gonocytes (~40%) and sufficient numbers of somatic cells, eliminating the need for additional 
steps to enrich gonocyte or to use exogenous feeder cells. This may in turn have provided a 
balanced proportion of germ-to-somatic cells and influenced cell proliferation or differentiation. 
While low numbers of initial gonocytes lead to inferior culture results, additional steps taken prior 
to culturing to highly enrich gonocytes (to 80% or more) does not necessarily result in improved 
cell survival and propagation. We previously observed that enriching gonocytes to 86% in fact can 
lead to their apoptosis once cultured (Awang-Junaidi and Honaramooz 2018). Survival and 
propagation of isolated cells in the present study further support the notion that gonocytes require 
a proportional ratio of somatic cells to proliferate and form colonies in culture.  
We recently observed that FBS sufficiently supports the growth of testicular somatic cells in 
culture; thereby, FBS must directly or indirectly promote the survival of germ cells which rely on 
the somatic cell monolayer. However, using different suppliers of the serum, batch-to-batch 
variations, or supplementation of serum with undefined components can affect the outcome of 
testis cell cultures reported by various studies. To reduce such a potential effect, we used aliquots 
of the same serum source/batch over the course of the present study. In Experiment 4.1, we also 
included groups with KSR instead of FBS for comparison, as well as to eliminate the potential 
confounding effects of undefined endogenous components of FBS on gonocyte proliferation and 
colony-formation. However, regardless of the growth factor used, the survival and propagation of 
somatic and germ cells were reduced in all KSR-containing cultures. Somatic cells are deemed 
essential for in vitro survival of germ cells as they support gonocytes functionality and provide 
them with the necessary survival components, such as cytokines and nutritional factors (van 
Dissel-Emiliani et al. 1993). As such, only FBS-supplemented media were considered in 
Experiment 4.2 to further improve the culture conditions.  
Overall, the majority of previous studies have suggested positive effects of growth factors on 
proliferation and/or survival of germ cells co-cultured with various feeder layers (De Felici et al. 
2004). Given the complexity of testing multiple growth factors with different concentrations, we 





with other growth factors, increased gonocyte proliferation in our primary culture conditions. For 
its effects, bFGF may have directly increased the mitotic activity of germ cells or increased somatic 
cell growth, which indirectly provided a greater support for germ cells. Previously, it was shown 
that neutralizing antibodies against bFGF can significantly reduce rat gonocyte numbers in culture. 
This can be indicative of a direct or indirect involvement of bFGF on the mitogenic and 
proliferative activity of germ cells (van Dissel-Emiliani et al. 1996). Similar to our findings, 
supplements of bFGF increased mouse and human germ cells, as well as neonatal rat gonocyte 
numbers following 6 days of culture (Jiang et al. 2013; Kanatsu-Shinohara et al. 2003; Mirzapour 
et al. 2012; Takashima et al. 2015; van Dissel-Emiliani et al. 1996). Also, the addition of bFGF to 
media has been reported to increase the formation and diameter of human SSC clusters (Mirzapour 
et al. 2012). In contrast, a negative effect of bFGF (at 10 ng/mL) on proliferation of mouse SSCs 
has been observed after culturing in minimum essential medium (MEM) using STO feeders 
(Kubota et al. 2004). Yet, a separate study suggested that a much lower concentration of bFGF (1 
ng/mL) has the optimal supportive effects on expansion of cultured mouse germ cells, compared 
with higher bFGF concentrations (Matsui et al. 1992). Nevertheless, the use of different culture 
conditions, media, and feeder cells may partly explain the seemingly contradictory outcomes of 
foregoing studies. Here, our use of the same basic media and endogenous somatic cells as the 
feeder layer eliminated such potential confounding effects when testing different concentrations 
of different growth factors. 
Growth factor bFGF belongs to a larger fibroblast growth factor family and is involved in the 
proliferation and differentiation of various cell types with mesodermal and neuroectodermal origin 
(Li 2016). It plays a key role in paracrine regulation of germ cell growth (Jiang et al. 2013; Li 
2016; van Dissel-Emiliani et al. 1996) and is a potent mitogenic factor for rat Sertoli cells (van 
Dissel-Emiliani et al. 1996). Additionally, bFGF is also involved in angiogenesis surrounding the 
seminiferous tubules, Sertoli cell proliferation, and controlling Sertoli-germinal cell interactions 
(Mullaney and Skinner 1992). Interestingly, using an in vivo testis cell aggregate implantation 
model, our lab previously demonstrated that brief pre-implantation exposure of the donor cells to 
bFGF can result in enhanced implant weight as well as increased cross-sectional implant and 
seminiferous cord areas (Awang‐Junaidi 2019). Other studies have also shown a supportive role 
of bFGF for porcine Sertoli cell growth and proliferation (Jaillard et al. 1987; van Dissel-Emiliani 





which in turn may have led to an improved re-formation of seminiferous cords in vivo or indirectly 
enhanced gonocyte proliferation in vitro. 
We also studied the effects of GDNF, a neurotrophic factor secreted by glial cells in the central 
nervous system. Within the testes, GDNF is also expressed by Sertoli cells (Hofmann 2008). Given 
the importance of GDNF in determining germ cell fate, we tested its effects on the number of 
cultured gonocytes, both individually and combined with other growth factors. We showed that in 
all examination time points, increasing concentrations of GDNF can increase gonocyte 
proliferation, possibly due to the activation of various signaling cascades that trigger mitosis 
divisions in gonocytes (Hofmann 2008). Increased germ cell numbers in response to higher GDNF 
concentrations have also been observed in previous reports. For instance, mouse germ cells 
increased ~1.5-fold following the addition of GDNF to the culture media (Kubota et al. 2004). The 
enhancing effect of GDNF on germ cell proliferation was also shown using long- and short-term 
cultures of different MGSCs (Hofmann et al. 2005; Kanatsu-Shinohara et al. 2003; Kanatsu-
Shinohara et al. 2003; Nagano et al. 2003). Additionally, GDNF-expressing STO feeder cells were 
reported to support the long-term proliferation of cultured mouse spermatogonia without a need 
for refreshment of the growth factor (Wei et al. 2016). This can be indicative of the crucial role of 
GDNF on in vitro germ cell survival. Nevertheless, a study using porcine gonocytes reported non-
significant mitogenic effects of the recombinant GDNF and weak expression of GFRA1 when 
cultured in a serum-free medium (Kakiuchi et al. 2018). They concluded that although in rodents 
a peak expression of GDNF and GFRA1 is observed in the first week after birth, such an increase 
may not be present in cultured porcine testis cells (Kakiuchi et al. 2018). It can be postulated that 
different culture conditions including varying media or feeder layers in foregoing studies partly 
account for the discrepancies (Hofmann et al. 2005; Kanatsu-Shinohara et al. 2003; Kanatsu-
Shinohara et al. 2003; Kuijk et al. 2009; Mirzapour et al. 2012; Nagano et al. 2003). GDNF has 
been shown to up-regulate the expression of bFGF receptors on gonocytes. Thus, GDNF can 
potentially render a population of MGSCs more responsive to bFGF, wherein the synergistic 
effects of both growth factors combined affect germ cell proliferation (Hofmann et al. 2005). The 
release of GDNF by Sertoli cells has also been shown to be regulated by follicle stimulating 
hormone (FSH) (Kanatsu-Shinohara 2005; Kuijk et al. 2009). Subsequently, a signaling cascade 
is induced by GDNF, leading to the expression of Ets variant gene 5 (Etv5) which is an important 





tubules in GDNF-knockout mice showed an absence of spermatogonia, whereas its overexpression 
resulted in accumulation of undifferentiated spermatogonia (Kanatsu-Shinohara et al. 2003; 
Kanatsu-Shinohara et al. 2014). GDNF is known to be involved in the regulation of Sertoli- and 
germ cell communications, formation of actin cytoskeleton, and movement of germ cells towards 
the stem cell niche (Dovere et al. 2013). Due to its supportive effects on in vitro survival and 
colony-formation of mouse germ cells, GDNF has been commonly used for the establishment of 
long-term SSC cultures and is considered an important component for such cultures (Kanatsu-
Shinohara et al. 2003; Kanatsu-Shinohara et al. 2004a; Kubota et al. 2004). Furthermore, it has 
been shown that disruption of GDNF signaling pathways can supress self-renewal of germ cells 
and as such, lead to formation of seminiferous tubules devoid of germ cells (Kanatsu-Shinohara et 
al. 2012; Kanatsu-Shinohara and Shinohara 2013). Overall, our findings are indicative of the 
stimulatory effects of GDNF on porcine gonocyte proliferation, which agrees with previous 
studies. 
Additionally, LIF is an important pleiotropic growth factor from the interleukin-6 family and is 
involved in stem cell regulation (Curley et al. 2018). By attaching to its heterodimeric receptor, 
LIF initiates phosphorylation of several tyrosine residues and activates a signaling cascade 
involved in the maintenance or self-renewal of stem cells in many tissues (Kanatsu-Shinohara et 
al. 2007). In the present study, LIF supplementation did not significantly increase gonocyte 
numbers compared with the control group. It is possible that increasing LIF concentrations much 
beyond our highest dose (1500 U/mL) might have led to an observable effect on porcine germ cell 
proliferation. In the absence of previous studies using LIF on neonatal porcine testis cells, we 
chose the range of growth factor concentrations based on our best estimates from various other 
culture systems (Kanatsu-Shinohara et al. 2007; Kubota et al. 2004a; Matsui et al. 1992; Pesce et 
al. 1993). Here, we also observed that individual concentrations of LIF can result in the same 
number of EBLCs as groups exposed to mixed concentrations of FBS and KSR, a mixture we 
recently found to be the optimal condition for EBLC development. Moreover, when the highest 
concentrations of bFGF, GDNF, and LIF were supplemented in combination, the average diameter 
of EBLCs was ~1.3-fold greater than those developed in FBS+KSR without growth factor 
supplementation. In contrast to our results, porcine gonocytes cultured in GMEM and StemPro 
media developed relatively smaller colonies when supplemented with bFGF, GDNF and EGF 





culture conditions, such as the growth factor combination and media, on the behavior and colony-
formation of porcine gonocytes. Our results indicate that LIF promotes germ cell aggregation and 
colonization, and, when combined with bFGF and GDNF, larger EBLC diameters may be 
expected. In a previous report, LIF was deemed essential for increasing the colony numbers of 
human SSCs co-cultured with Sertoli cells (Mirzapour et al. 2012); when LIF and bFGF were 
combined, both the number and diameter of said colonies increased. This agrees with our findings. 
LIF has also been found to increase colony-formation of neonatal mouse germ cells in culture 
(Kanatsu-Shinohara et al. 2007). Once released, LIF attaches to its receptor complex consisting of 
LIF receptor and gp130 receptor. Upregulation of gp130 expression has been detected on the 
surface of clustered rat germ cells and may hence be associated with enhanced colony-formation 
of germ cells. This may partly explain the underlying reason for the increased in vitro colonization 
of germ cells following LIF supplementation (Mirzapour et al. 2012; Ryu et al. 2004).  
In the present study, after 28 days of culture, the number of gonocytes was not different between 
groups treated with 10 ng/mL bFGF alone and those with combined concentrations of 10 ng/mL 
bFGF+100 ng/mL GDNF, or with 10 ng/mL bFGF+100 ng/mL GDNF+1500 U/mL LIF. Similar 
to our findings, combined concentrations of seven growth factors (stem cell factor, LIF, bFGF, 
insulin-like growth factor, platelet-derived growth factor, murine oncostatin M, and interlukin-11) 
has been shown to support murine SSC culture over a 3-month period (Jeong et al. 2003). Our 
results hence indicate that the support conferred by bFGF is sufficient for long-term culture of 
porcine gonocytes. Therefore, in germ cell cultures, both species differences and specific culture 
conditions have an important influence on the survival, behavior, and differentiation fate of the 
cultured cells.  
In addition, we observed that, starting from Day 7, gonocytes and EBLCs originating from both 
freshly isolated and cultured testis cells displayed co-expression of germ- and pluripotency-
markers. This observation may point to the dedifferentiation potential of germ cells in our media, 
consisting of basic components and supplemented with bFGF. We also found that neonatal germ 
cells were negative for POU5F1 at the time of isolation and become positive only when cultured. 
POU5F1 is known as a marker for ES cells and plays a central role in pluripotency and self-renewal 
of stem cells during embryonic development (Nichols et al. 1998). Therefore, the expression of 





Previous studies have also shown porcine gonocytes becoming positive for POU5F1 and SSEA-1 
in culture conditions (Awang‐Junaidi et al. 2020; Goel et al. 2008). Another study showed 
successful colonization of cultured porcine gonocytes positive for POU5F1, NANOG, and PLZF 
following cross-species germ cell transplantation which further supports their germline stem cell 
potential while expressing pluripotency markers (Lee et al. 2013). POU5F1 expression has been 
shown previously to become downregulated in germ cells during embryonic development which 
demonstrates their differentiation to more specialized germ cells (Rajpert‐De Meyts et al. 2004).  
Here, we observed the expression of SSEA-1 by freshly isolated and cultured gonocytes. SSEA-1 
is known as both a pluripotency and germ cell marker, with diminishing expression in more 
differentiated germ cells (Goel et al. 2007; González and Dobrinski 2015; Kim et al. 2013). Its 
expression has also been demonstrated by mouse blastomeres, cells of the inner cell mass, and 
human germline stem cells (Sivasubramaniyan et al. 2015; Solter and Knowles 1978). We were 
also able to find that gonocytes become positive for NANOG when cultured under our selected 
conditions, which further supports their dedifferentiation potential into more primitive stages. 
NANOG is an important pluripotency-determining factor and an essential regulator of ES cell 
population (Culty 2009; Hoei-Hansen et al. 2005). NANOG expression is necessary for 
maintaining the pluripotent state of mouse and human ES cells and as such has been used as a 
marker of pluripotency. The role of this factor is believed to be conserved among species (Kuijk 
et al. 2010). Similar to our findings, in bovine germ cells, NANOG and POU5F1 expression levels 
were enhanced after being in culture (Fujihara et al. 2011).  
In the present study, we also observed E-cadherin expression in cultured porcine gonocytes, while 
freshly isolated cells appeared negative for this marker. E-cadherin is also expressed in ES cells 
and as such, its positive expression by cultured germ cells can similarly point to their in vitro 
reprogramming into an undifferentiated stage. E-cadherin is a protein component of adherens-type 
junctions and has a crucial role in the formation of cell-to-cell contacts with important functions 
(Redmer et al. 2011), such as maintaining the integrity of blastocysts during embryonic 
development (Larue et al. 1994). E-cadherin is also known as an important regulator of early 
differentiation, with its high rate of expression deemed essential for the maintenance of 





Co-localization of DBA, a gonocyte-specific marker, with the above-mentioned pluripotency-
determining markers in cultured gonocytes and EBLCs by Day 28 was indicative of their potential 
to maintain their germ cell characteristics while undergoing in vitro reprogramming to obtain 
characteristics of pluripotent stem cells. In neonatal testes, gonocytes represent a multipotent 
population of cells, which can undergo mitosis and differentiate into more advanced germ cells. 
However, the behavior of gonocytes seems to be different in vivo, where they do not demonstrate 
the tendency to undergo multi-lineage differentiation within the testis due to their special 
interaction with the surrounding Sertoli cells. This phenomenon is observed in both in situ 
gonocytes and those present in testis tissue grafts or cell implants in recipient mice (Awang‐Junaidi 
et al. 2020; Fayaz et al. 2020a,b; Honaramooz et al. 2007, 2002; Mirzapour et al. 2012). However, 
gonocytes in a two-dimensional culture system may be expected to behave differently, given 
separation from the regulatory controls of Sertoli cells. As such, in 2-D systems, gonocytes display 
a tendency to convert into a more primitive and undifferentiated stage. Positive expression of 
pluripotency-determining markers by in vitro-developed germ cells and EBLCs is especially 
important due to their potential use as an alternative source for pluripotent stem cells in 
downstream applications. Given that general safety and/or ethical concerns limit the use of induced 
pluripotent stem (iPS) cells or ES cells for cell-based therapy, the development of alternative 
sources of pluripotent stem cells for regenerative medicine is a subject of great interest. More 
importantly, our optimized cell isolation method and culture conditions can lead to spontaneous 
increases in germ cell numbers and formation of EBLCs without a need for supplementation of 
the media with multiple factors. The addition of multiple factors, especially those with potential 
carcinogenic properties, can affect the germ cell fate and/or increase the risk of unwanted genetic 
and/or epigenetic aberrations in the resultant pluripotent cells, thus limiting their safety and 
potential use in medicine. 
In conclusion, supplementation of a basic medium consisting of DMEM+15% FBS with only 10 
ng/mL bFGF can effectively maximize in vitro proliferation of porcine gonocytes. Furthermore, 
supplementation of LIF alone to the basic media can enhance porcine gonocyte colony-formation 
while the addition of 10 ng/mL bFGF+100 ng/mL GDNF+1500 U/mL LIF significantly increases 
EBLC diameters. When cultured in these conditions, somatic cells form a monolayer and circular 
arrangements while gonocytes aggregate to produce multinucleated EBLCs. More importantly, 





in our selected conditions. Overall, our optimized basic culture conditions can be used to increase 
germ cell numbers and their colonies. This can be viewed as a successful step forward in using in 
vitro cultured gonocytes as an alternative source of pluripotent stem cells for downstream 


























Given the ability of germline stem cells to express ES markers in culture conditions in Chapters 3 
and 4, these cells may be used as an alternative to current sources of pluripotent stem cells for 
downstream applications in regenerative medicine. However, full potential of germline-derived 
stem cells such as their conversion into somatic cell lineages needs further investigation. 
Therefore, the study in Chapter 5 was designed and conducted to both assess the pluripotency of 
MGSCs using an in vivo implantation assay and evaluation of their tumorigenic potential as well 




























NEONATAL PORCINE GERM CELLS DEDIFFERENTIATE AND DISPLAY 
OSTEOGENIC AND PLURIPOTENCY PROPERTIES IN VITRO 5, 6 
5.1. Abstract 
Gonocytes are progenitors of spermatogonial stem cells in the neonatal testis. We have previously 
shown that upon culturing, neonatal porcine gonocytes and their colonies express germ cell and 
pluripotency markers. The objectives of present study were to investigate in vitro trans-
differentiation potential of porcine gonocytes and their colonies into cells from three germinal 
layers, and to assess pluripotency of cultured gonocytes/colonies in vivo. For osteogenic and tri-
lineage differentiation, cells were incubated in regular culture media for 14 and 28 days, 
respectively. Cells were cultured for an additional 14 days for osteogenic differentiation or 7 days 
for differentiation into derivates of the three germinal layers. Osteogenic differentiation of cells 
and colonies was verified by Alizarin Red S staining and tri-lineage differentiation was confirmed 
using immunofluorescence and gene expression analyses. Furthermore, upon implantation into 
recipient mice, the cultured cells/colonies developed teratomas expressing markers of all three 
germinal layers. Successful osteogenic differentiation from porcine germ cells has important 
implications for bone regeneration and matrix formation studies. Hence, gonocytes emerge as a 
promising source of adult pluripotent stem cells due to the ability to differentiate into all germinal 
layers without typical biosafety risks associated with viral vectors or ethical implications. 
5.2. Introduction 
Gonocytes are a transitory population of male germline stem cells (MGSCs) in the neonatal testis; 
they develop from fetal primordial germ cells (PGCs) and postnatally undergo transition into 
spermatogonial stem cells (SSCs). In mice, gonocytes proliferate within the testicular niche by 
embryonic day (ED) ~12.5, gradually become mitotically inactive by ED ~15.5, and then maintain 
their quiescent state for the remainder of the prenatal period (de Rooij 1998; Phillips et al. 2010). 
 
5 This study has been published. Fayaz MA, Rosa GS, and Honaramooz H (2021) Cells 10:2816. 
6 MAF contributed to the design of the experiments, performed the study, and wrote the first draft of the 
manuscript. GSR assisted in the initial experiments and revised the manuscript. AH contributed to the 





The transition of gonocytes into SSCs occurs at ~6 days after birth in rodents or ~2 months in 
humans (Wu et al. 2009). SSCs, considered adult stem cells, are fundamental for spermatogenesis 
due to their dual potential for self-renewal and differentiation ability for subsequent mitosis and 
meiosis (Roosen‐Runge and Giesel Jr 1950; Ibtisham et al. 2020). Compared to both PGCs and 
SSCs, gonocytes in the neonatal testis are a preferred source of MGSCs, since they offer a 
relatively large population, ease of accessibility, identifiable morphology, and more specific 
molecular markers for their identification and isolation (Lehmann 2012). 
When still situated in the testis niche, MGSCs are programmed to unipotently differentiate into 
more specialized germ cells (Golestaneh et al. 2009; Azizi et al. 2019). However, compiling 
evidence demonstrates the dedifferentiation potential of MGSCs, as well as their ability to derive 
multipotent or even pluripotent stem cells in an ex situ environment (Kanatsu-Shinohara et al. 
2004; Guan et al. 2006; Seandel et al. 2007; Kossack et al. 2009; Awang‐Junaidi et al. 2020; Chen 
et al. 2020). These cells can spontaneously transform into a population of cells that express 
embryonic stem (ES) cell markers, otherwise if genetic manipulations were needed, they would 
have imposed safety concerns regarding their use and expansion (Holstein et al. 1996; Kanatsu-
Shinohara, Inoue et al. 2004; Ko et al. 2009). The ability to dedifferentiate into a pluripotent state 
allows these ES-like cells to convert into other cell types from derivatives of three germinal layers 
(Kanatsu-Shinohara et al. 2004; Guan et al. 2006; Seandel et al. 2007; Chen et al. 2020).  
Although several studies have demonstrated the potential of MGSCs as a source of pluripotent 
stem cells, the extent of their full potential is yet to be known and the complicated derivation 
process remains a major limitation in their application. Further, the conversion of MGSCs into a 
dedifferentiated state in the presence of exogenous factors, such as multiple growth factors and 
embryonic fibroblasts used as the supportive feeder layer, may pose unwanted genetic and 
epigenetic changes to the dedifferentiated cells; this, too, may limit their applications. 
Additionally, passaging of MGSCs for their expansion or induction of reprogramming can disrupt 
their normal cell cycle, growth, and overall physiological response to their microenvironment 
(Kanatsu-Shinohara et al. 2004). Therefore, the use of minimal exogenous factors and 
manipulations for induction of pluripotency in prospective studies is desirable for reducing 
concerns of immunogenicity, tumorigenicity, and/or viral contamination, and provides a more 





Pluripotent stem cells have also been produced by introducing specific sets of pluripotency-
associated genes or ‘reprogramming factors’ to the somatic cells. The resultant cells, known as 
induced pluripotent stem (iPS) cells, were developed via retroviral delivery of various transcription 
factors (e.g., Oct3/4, Sox2, c-Myc, and Klf4) to adult dermal fibroblasts (Takahashi and Yamanaka 
2006; Takahashi et al. 2007; Wernig et al. 2007), hepatocytes, gastric epithelial cells, and even 
neural stem cells (Aoi et al. 2008; Kim et al. 2008). However, the practicality of utilizing different 
stem cells in clinical settings remains limited due to the ethical and safety concerns over their 
source (Yang et al. 2019). In addition, current protocols for inducing differentiation into specific 
cell lineages are inefficient, time-consuming, technically complex, and are not cost effective given 
the requirement for multiple induction materials (Ben-Porath et al. 2008; Volarevic et al. 2018). 
Increased tumorigenicity of iPS cells due to introduced transcription factors, genetic instability, 
and biosafety risks associated with the use of viral vectors in their development further limits their 
applications as therapeutic agents (Chen et al. 2020). As a result, it is imperative to seek alternative 
stem cell sources that lack the biosafety risks associated with viral transduction or tumor formation, 
and the ethical concerns associated with the manipulation of embryos to harvest stem cells.  
Our laboratory has recently shown that porcine gonocytes, co-cultured with testis somatic cells as 
a feeder layer, rapidly expand in our developed culture conditions composed of basic media and 
fetal bovine serum (FBS), with or without basic fibroblast growth factor (bFGF). More 
importantly, in Chapter 3 and 4 we demonstrated that porcine gonocytes are capable of 
spontaneous dedifferentiation into more primitive stages that express ES cell markers such as 
SSEA-1, POU5F1, NANOG, and E-cadherin. This is especially important since in vitro 
dedifferentiation and trans-differentiation of germ cells in previous reports required coculturing 
with somatic cells from other species and/or supplementation of the media with multiple 
exogenous factors (Azizi et al. 2019; Yang et al. 2019; Chen et al. 2020). In the present study, we 
used our recently developed culture conditions to obtain a population of ES-like cells that express 
pluripotency markers from porcine gonocytes, and then further evaluated their teratoma formation 
potential using an in vivo implantation assay. We also investigated the induction of their 
differentiation into derivatives of all three germinal layers by using a simple protocol without the 
addition of multiple exogenous factors. In doing so, the present study provides a much faster and 
safer approach for the acquisition of differentiated germinal cells than that reported in previous 





5.3. Materials and Methods 
5.3.1. General Experimental Design 
Figure 5.1 shows the schematic representation of the experimental design. The present study was 
comprised of four sets of experiments used to investigate the differentiation potential and in vivo 
teratoma formation of cultured neonatal porcine gonocytes. In Experiment 5.1, cultured gonocytes 
were directed to differentiate into an osteogenic pathway, where differentiation was confirmed 
using Alizarin Red S staining. In Experiments 5.2 and 5.3, the cultured cells were directed to 
differentiate into derivatives of the three germinal layers (e.g., ectoderm, mesoderm, and 
endoderm) followed by confirmation using immunocytochemistry and expression analysis for 
lineage-specific markers. In Experiment 5.4, the in vivo teratoma formation of cultured cells was 
tested using an implantation assay as a follow up to our previous report of their expression of 
several pluripotency markers.  
5.3.2. Castration of Donors, Testis Cell Isolation, and Culture in Regular Media 
Procedures for the castration of neonatal piglets (~1-wk old; n = 15 for Experiment 5.1, n = 60 for 
Experiments 5.2 and 5.3, and n = 15 for Experiment 5.4), testis cell isolation, and cell culture were 
conducted as previously described (Yang et al. 2010; Awang-Junaidi and Honaramooz 2018; 
Awang‐Junaidi et al. 2020). Cells were cultured in Dulbecco’s modified Eagle’s media (DMEM; 
catalogue no. 12-604F; Corning, New York, NY, USA) supplemented with 10% fetal bovine 
serum (FBS; catalogue no. A15-701; PAA Laboratories, Etobicoke, ON, Canada) for 14 days in 
Experiment 5.1, 28 days for Experiment 5.4, and in DMEM+15% FBS+10 ng/mL basic fibroblast 
growth factor (bFGF; catalogue no. 233-FB-025; R&D Systems, Minneapolis, MN, USA) for 28 
days in Experiment 5.2. However, in Experiment 5.2, following immunocytochemistry, the cells 
and colonies did not stain positive for the selected differentiation markers. Also, cells showed a 
reduced confluency following visual examination on day 4 of differentiation in Experiment 5.2. 
As such, we designed Experiment 5.3 where cultures were exposed to the various differentiation 
media for a longer period and without frequently changing the media to prevent potential 
interference with cell organization and interactions. In Experiment 5.3, similar seeding density, 





5.3.3. In Vitro Osteogenic Trans-Differentiation of Porcine Germ Cells 
The osteogenic differentiation media was prepared according to the manufacturer’s instructions 
(catalogue no. A1007201; StemPro Osteogenesis Differentiation Kit, Gibco, Grand Island, NY, 
USA). Briefly, the differentiation supplement was mixed with base media at a 1:9 ratio. On day 
14 of culture, regular media was removed, and each well was rinsed with Dulbecco’s phosphate-
buffered saline (DPBS; catalogue no. 20-031-CV; Mediatech, Manassas, VA, USA) and cells were 
exposed to the prepared osteogenesis differentiation media for 14 days. This differentiation media 
was replenished every 3 days and cultures were visually examined using phase-contrast 
microscopy. 
5.3.4. In Vitro Tri-lineage Differentiation of Porcine Germ Cells 
For trans-differentiation of gonocytes and colonies into derivatives of the three germinal layers, 
tri-lineage differentiation kits were used according to the manufacturer’s instructions with 
modifications. On day 28 of Experiment 5.2, regular media in different wells was switched with 
each tri-lineage differentiation media that was developed for differentiation of human pluripotent 
stem cells (catalogue no. SC031B ectoderm kit; catalogue no. SC030B mesoderm kit; and 
catalogue no. SC019B endoderm kit; all from R&D Systems). To prepare the endoderm 
differentiation media-I, bFGF, Activin A, and Wnt-a were diluted 1000-fold in pre-warmed 
differentiation base media. To prepare the endoderm differentiation media-II, only bFGF and 
Activin A were diluted 1000-folds in pre-warmed differentiation base media. Each tri-lineage 
differentiation media was tested in a 6-well plate containing three replicates. For ectoderm and 
mesoderm differentiation, regular media was switched with 2.5 mL of the differentiation media 
and cells were incubated for 24 hr at 37° C and 5% CO2. The media was replenished with fresh 
differentiation media every 24 hr on days 2 and 3. For endoderm differentiation, regular media 
was switched with differentiation media-I and plates were maintained in similar conditions as 
described above. Media-I was then replaced with media-II after 16 hr of incubation. Media-II was 
replenished every 12 hr on days 2 and 3. Alternatively, in Experiment 5.3, cultures were incubated 
with 2.5 mL of the ectoderm or mesoderm differentiation media for 7 days, but without regularly 
replenishing the media. For endoderm differentiation, regular media was replaced with 





cultures were maintained for an additional 7 days without replenishing the media. In each 
differentiation group, cultures were examined daily under a phase-contrast microscope. 
5.3.5. Imaging and Morphometrical Assessment 
Viability of freshly isolated and cultured cells was evaluated using the trypan blue exclusion 
technique (Yang et al. 2010; Awang-Junaidi and Honaramooz 2018; Awang‐Junaidi et al. 2020). 
For quantification and measurements in Experiment 5.1, photomicrographs were captured from 
culture plates in treatment and control groups before and after staining with Alizarin Red S. In 
Experiments 5.2 and 5.3, photomicrographs were obtained before adding the differentiation media 
(day 0), as well as on days 3, 5, and 7 after incubation with differentiation media. Imaging, 
morphometrical assessment, and quantification protocols were carried out as described in Chapters 
3 and 4. 
5.3.6. Staining and Immunocytochemistry for Evaluation of Dedifferentiation and Trans-
Differentiation 
5.3.6.1. Alizarin Red S Staining 
Calcium deposition is a known indicator of successful differentiation of stem cells into osteoblasts, 
and of in vitro bone matrix formation (Virtanen and Isotupa 1980). Therefore, on day 14 of 
differentiation in Experiment 5.1, Alizarin Red S staining solution was used to identify calcium 
deposition as described previously (Silva et al. 2005). Briefly, the media was aspirated, wells were 
rinsed with DPBS, and cells/colonies were fixed using 10% formaldehyde solution (catalogue no. 
HT501128; Sigma-Aldrich) for 30 min. Wells were rinsed and incubated with the staining solution 
at room temperature for 20 min. Wells were rinsed again with distilled water and visualized under 
an inverted light microscope. 
5.3.6.2. Immunofluorescence Assay 
In Experiments 5.2 and 5.3, cells and colonies were grown on poly-L-lysine-coated coverslips. 
The preparation of coverslips followed our previously described protocols (Awang-Junaidi and 
Honaramooz 2018). As shown in Chapter 3 and 4, culture of neonatal porcine MGSCs in regular 
media leads to their dedifferentiation and expression of main ES cell markers. As such, here we 
also evaluated the expression of POU5F1 as a representative ES marker to confirm MGSC 





Zeineddine et al. 2014). The expression of this marker was examined immediately after cell 
isolation and on day 28 of culture in regular media. On day 4 of Experiment 5.2 and day 7 of 
differentiation in Experiment 5.3 the coverslips were removed from culture wells and stained 
against gonocyte- and germinal layer markers, as summarized in Table 5.1. The procedure used 
for immunofluorescence assay has been previously described by our laboratory (Awang-Junaidi 
and Honaramooz 2018; Awang‐Junaidi et al. 2020). To double-label the cells and colonies with a 
gonocyte-specific marker, FITC-labeled Dolichos biflorus agglutinin (DBA-FITC; catalogue no. 
FL1031; Vector Labs, Burlington, ON, Canada) was used (Goel et al. 2007).  
5.3.7. Gene Expression Analyses for Confirmation of Dedifferentiation and Trans-
Differentiation 
In Experiment 5.3, the expression of the pluripotency marker (POU5F1) and 6 germinal layer 
markers was examined using reverse-transcriptase polymerase chain reaction (RT-PCR). To 
confirm dedifferentiation of cultured MGSCs, expression of POU5F1 was examined using 
samples of freshly-isolated testis cells and cultured cells in regular media on days 7, 14, 21, and 
28. Following 7 days of culture in differentiation media, RT-PCR analysis for differentiation 
markers was carried out on cells and colonies from each differentiation group. The procedures for 
RT-PCR analyses were performed as described in Chapters 3 and 4. Selected target genes for 
confirmation of differentiation were as follows: POU5F1, OTX2, GFAP, TBXT (T-box 
transcription factor T; gene for Brachyury), ACTA2 (Actin alpha 2; gene for ASM), SOX17, and 
AFP. The annealing temperatures, names, and primer sequences for each gene are listed in Table 
5.2.  
5.3.8. Subcutaneous Implantation of Cultured Cells and Colonies 
Cultured cells were examined for pluripotency based on their teratogenic potential following 
subcutaneous injection into male hairless immunodeficient mice (n = 2; SHO, Crl: SHO-
PrkdcscidHrhr, strain code 474; Charles River, Montreal, Canada). On the day of implantation all 
media (DMEM+10% FBS) was removed, the wells were rinsed with sterile DPBS, and 
cells/colonies were detached using trypsin-EDTA solution as previously described (Awang-
Junaidi and Honaramooz 2018). To stop the trypsin reaction, FBS was added to each well, then 
contents were pooled and centrifuged at 500× g at 16° C for 5 min. The supernatant was discarded, 





anesthesia of recipient mice were as described previously (Awang-Junaidi et al. 2020; Fayaz et al. 
2020a,b). For implantation procedure, 0.1 mL of the cell aggregates (equals to the content of ~3 
wells) were injected subcutaneously into each of 8 sites per mouse (4 sites on the left and 4 sites 
on the right side of the dorsal midline) as described previously (Awang-Junaidi et al. 2020; Fayaz 
et al. 2020a,b). Each mouse was kept in an individual plexiglass micro-isolator cage under sterile 
conditions and maintained in standard temperature (22 ± 2° C) and controlled lighting photoperiod 
(12 hr light/dark cycles). The mice were kept for 4 wk, evaluated daily for abnormal signs, and 
provided with sterile water and chow ad libitum. 
5.3.9. Retrieval of the Subcutaneous Implants and (Immuno)histochemistry 
Recipient mice were sacrificed after 4 wk. The implants were retrieved, rinsed with DPBS, fixed 
in Bouin’s solution, processed, embedded in paraffin, and sectioned at 5 µm. Among the largest 
sections, randomly selected samples were used for routine histology (hematoxylin and eosin; H&E 
staining) and immunohistochemistry against lineage-specific antibodies (i.e., GFAP, ASM, and 
AFP). The procedure for immunohistochemistry was performed as described previously (Fayaz et 
al. 2020a). 
5.3.10. Statistical Analyses 
All the data are presented as the mean ± standard error of mean (SEM) from at least three 
independent replicates and P < 0.05 was considered as statistically significant. The statistical 
methods used for the analyses include t-test and one-way analysis of variance (ANOVA), and 
Tukey’s HSD was used as the post hoc test, unless stated otherwise. All data analyses were 
performed using the Statistical Package for Social Sciences (IBM SPSS Statistics for Macintosh, 
Version 26.00; IBM Corporation, Armonk, NY, USA). 
5.4. Results 
5.4.1. Viability and Morphometric Assessments 
The viability of the freshly isolated testis cells and cultured cells sampled on day 28 in the 
osteogenic differentiation group, (Experiment 5.1) and day 35 in the tri-lineage differentiation 
groups (Experiment 5.3), was ~90%. In Experiments 5.1, 5.2, and 5.3 and during the culture period 
in regular media, morphological features of the cells and colonies were similar to those reported 





circular arrangements, and 3-D embryoid body-like colonies (EBLCs) after ~14 days (Fig. 5.2A-
D). 
In Experiment 5.1, EBLCs in the control group appeared light in color, while those developed in 
the differentiation induction media had a more compact appearance with a darker center. The 
margins of EBLCs developed in differentiation induction media was relatively translucent 
compared to their opaquer central areas (Fig. 5.2E-J). The number of EBLCs did not differ between 
these groups (P = 0.56), although the average EBLC diameter was ~26% greater in the 
differentiation induction media compared to control groups (P < 0.001; Fig. 5.2K). The average 
EBLC diameter in the differentiation and regular cultures were 197.16 ± 16.66 µm and 156.10 ± 
10 µm, respectively. 
In Experiment 5.2, cell confluency was reduced following incubation with tri-lineage 
differentiation media in all treatment groups. Hence, Experiment 5.2 was removed from further 
analyses. Following this, Experiment 5.3 was designed and conducted, wherein a modified media 
changing regimen was used to reduce cell loss and interference with cell organization and 
arrangement. 
In Experiment 5.3, after 7 days of culture, the overall morphology of cells and colonies cultured 
in differentiation media did not differ from those developed in the regular media. However, after 
7 days of incubation in differentiation media, EBLCs appeared more translucent and lighter 
colored compared to day 0 of differentiation (Fig. 5.3). Further, EBLCs developed in 
differentiation media appeared to have two different, albeit indistinct, areas: a narrow marginal 
region close to their edges and a more central area. Notably, while the number of gonocytes or 
EBLCs in differentiation media were not different from that of control groups (0.59 < P < 0.93), 
the average diameter of EBLCs was smaller than that of the control group and was reduced from 
day 0 to day 7 of differentiation in all tri-lineage differentiation media (0.001 < P ≤ 0.002; Fig. 
5.3). 
5.4.2. Alizarin Red S Staining and Immunofluorescence Assay 
5.4.2.1. Osteogenic Differentiation 
All colonies developed in the differentiation group produced hydroxyapatite deposits, while none 





extent of differentiation were observed between colonies in the differentiation group. In the control 
group, gonocytes appeared translucent without color staining and colonies showed a homogenous 
distribution of dark color. Conversely, all colonies in the differentiation group showed light red 
staining in the narrow marginal areas and dark red staining in more central areas, indicative of 
hydroxyapatite deposition (Fig. 5.2E-J). Gonocytes and somatic cells in the differentiation group 
appeared in light red color following the staining process. The overall distribution pattern of 
gonocytes, EBLCs, and somatic cells was similar to those observed in the control group. 
5.4.2.2. Pluripotency of Germ Cells and their Differentiation into Derivatives of Three 
Germinal Layers 
Freshly-isolated testis cells were negative for POU5F1; however, both gonocytes and EBLCs in 
regular media appeared positive for POU5F1 on day 28 of culture. Co-localization of DBA and 
POU5F1 was observed in all germ cells. DBA+/POU5F1+ cells comprised ~42 ± 4% of total 
number of cells in the regular media. Also, gonocytes and EBLCs in regular media were positive 
for Brachyury but negative for all other markers. In both regular and differentiation media, germ 
cells appeared positive for DBA. In differentiation groups, some cells and colonies showed strong 
expression of DBA but weak expression of designated lineage-specific markers. Conversely, a 
fraction of cells appeared strongly positive for the designated differentiation marker but showed 
weak expression of DBA. A similar expression pattern for each lineage-specific marker was 
observed in the corresponding differentiation media (Fig. 5.4A and 5.5). 
5.4.3. Gene Expression Analyses 
Freshly-isolated testis cells appeared negative for expression of POU5F1. However, in Experiment 
5.3, cultured cells in regular media displayed POU5F1 expression on day 7 to day 28. In 
Experiment 5.3, RT-PCR for cultured cells in ectoderm, mesoderm, and endoderm differentiation 
media were positive for OTX2/GFAP, TBXT/ACTA2, and SOX17/AFP, respectively. Samples of 
freshly isolated testis cells were also positive for SOX17, TBXT, ACTA2, OTX2, and GFAP. Cells 
cultured in regular media (DMEM+15% FBS+10 ng/mL bFGF) were positive for TBXT and 
ACTA2. Also, ACTA2 expression was evident in samples of endoderm and ectoderm 





5.4.4. Characterization of Dedifferentiated Cell Implants 
5.4.4.1. H&E Staining 
Histological examination of the injected cells/colonies (n = 16 injected aggregates) revealed 
gradual formation of cellular structures, which morphologically did not belong to the normal 
adjacent peripheral tissues. These structures were located at the expected implantation sites, 
including immediately ventral to the dermis and dorsal to the hypodermis. The morphologies, 
dimensions and extension of these tumor-like growth formations varied between injection sites 
and animals. These formations appeared as multicellular dense structures, were present in all 
implantation sites, and were encapsulated within a dense connective tissue. In sparse areas within 
the formations, the distribution of cells formed circular and oval patterns. In certain other areas, 
the formations contained distinguishable groups of cells that resembled melanocyte nests. 
Furthermore, increased numbers of melanocytes with melanin deposition were detected in cross-
sections of all implants, representing the formation of melanomas. In addition, the formations 
contained bundles resembling those of peripheral nerves (Fig. 5.7A-D).  
5.4.4.2. Immunohistochemistry 
To confirm the differentiation of implanted cells and colonies we used antibodies associated with 
each germinal layer. Expression of each maker was observed in all samples but were localized to 
specific areas of the formations. Cells in adjacent foci to the adipose tissue appeared positive for 
anti-pig-AFP, which was expressed in both the nucleus and cytoplasm. Cells within and 
surrounding the aforementioned circular/oval patterns expressed ASM. Also, GFAP was expressed 
in small foci, and within the bundles resembling peripheral nerves. GFAP expression also appeared 











Table 5.1. Antibodies used for immunofluorescence and immunocytochemistry 
Antibody Supplier Catalogue no. Dilution 
Rabbit anti-POU5F1 Abcam AB18976 1:200 
Goat anti-OTX2 R&D Systems SC031B 1:200 
Mouse anti-GFAP Novus Biological NBP1-05197SS 1:200 
Goat anti-Brachyury R&D Systems SC030B 1:200 
Mouse anti-ASM Novus Biological NBP1-33006 1:200 
Goat anti-SOX17 R&D Systems SC019B 1:200 
Rabbit anti-AFP Novus Biological NBP1-76275 1:200 
Alexa Fluor 594 goat anti-rabbit Abcam AB150088 1:200 
Alexa Fluor 594 goat anti-mouse Abcam 150116 1:200 
Alexa Fluor 594 rabbit anti-goat Abcam 150148 1:200 
 
Table 5.2. RT-PCR primer sequences for gene expression analyses 
Target name Direction Primer sequence (5′-3′) Annealing Temperature (° C) 
Product 
size (BP) 






































Fig. 5.1. Schematic representation of the experimental design. In Experiment 5.1, differentiation 
of neonatal porcine gonocytes to osteogenic pathway was investigated. Gonocytes were isolated 
from neonatal piglets and cultured in regular media for 2 wk to induce dedifferentiation. Media 
was then changed to osteogenic differentiation media to direct their differentiation into osteogenic 
cells. Cells and colonies were stained with Alizarin Red S for confirmation of osteogenic 
differentiation. In Experiments 5.2 and 5.3, to induce tri-lineage differentiation, porcine gonocytes 
were cultured in regular media for 4 wk to induce dedifferentiation. Cells and colonies were then 
cultured in ectoderm, mesoderm, or endoderm differentiation media to direct their differentiation 
into the respective cell derivates. Tri-lineage differentiation was confirmed by 
immunocytochemistry and RT-PCR analyses against markers associated with formation of 
ectoderm, mesoderm, and endoderm. The pluripotency and tumorigenicity of cultured gonocytes 
and their colonies were also investigated using an implantation assay (Experiment 5.4). Isolated 
testis cells were cultured for 4 wk in DMEM+10% FBS, dislodged from culture wells, and injected 
into the subcutaneous tissue of immunodeficient recipient mice. After 4 wk, recipient mice were 







Fig. 5.2. Representative photomicrographs of culture wells in regular media and osteogenic 
differentiation media, as well as the average diameter of EBLCs in different groups. When cultured 
in regular media, by day 7, somatic cells of the testis formed a complete monolayer attached to the 
culture well (black arrowhead). Gonocytes were located on top of the spindle-shaped somatic cells 
(white arrowhead) (A). By day 14, somatic cells formed circular arrangements (black broken line) 
(B). In circular arrangements, gonocytes were surrounded by cytoplasmic projections of somatic 
cells. Gonocytes gradually increased in number by undergoing proliferation. Also, by day 14, 
convergence of surrounding gonocytes in circular arrangements led to formation of large 





and EBLCs became larger (black asterisk) (C and D). EBLCs in osteogenic differentiation group 
(E, F, H, I, L, and M) possessed a more compact appearance compared to those developed in 
control groups (G, J, N and O). Also, EBLCs in osteogenic differentiation groups developed darker 
central areas and narrower translucent marginal areas. This may be related to their dome-shaped 
structure leading to a thicker central area compared to thinner marginal areas. EBLCs appeared 
positive for Alizarin Red S staining, indicative of their transformation into calcium deposition sites 
(H, I, L, and M), while control groups appeared negative for this staining (J, N, and O). Although 
the number of EBLCs did not differ between osteogenic differentiation and control groups, their 



















Fig. 5.3. Representative photomicrographs obtained from culture wells before (day 0) and 7 days 
after incubation with the tri-lineage differentiation media. The overall morphological features of 
gonocytes (black arrows), embryoid body-like colonies (EBLCs) (dotted circles), and somatic cell 
monolayer (white arrowheads) did not differ between control groups provided with regular media 
(DMEM+15% FBS+10 ng/mL bFGF) and treatment groups incubated with ectoderm, mesoderm, 
or endoderm differentiation media. However, the diameter of EBLCs decreased in the three 
differentiation media compared with those in the control group (0.001 < P ≤ 0.002). Also, the 
EBLCs in differentiation media possessed a narrow marginal area close to the periphery (black 
arrowheads) and more central areas (asterisks). Insets show higher magnification. A and B denote 






Fig. 5.4. Evaluation of POU5F1 expression as a pluripotency marker and DBA as gonocyte-
specific marker by freshly-isolated and cultured porcine testis cells in regular media. Following 
isolation of testis cells, gonocytes were positive for DBA (green arrows) but negative for POU5F1. 
When cultured in regular media, gonocytes (blue arrows) and EBLCs (yellow arrows) were 
positive for both POU5F1 and DBA (A). Also, testis cells appeared negative for POU5F1 
immediately after isolation in RT-PCR analyses, while in samples of day 7, 14, 21, and 28, cultured 
testis cells appeared positive for this marker (B). These findings are indicative of spontaneous 
MGSC reversion into more primitive developmental stages. N, no template control; M, 50 bp DNA 
ladder; F, freshly isolated testis cell sample; Lines 1-4, cultured cells and colonies in regular media 







Fig. 5.5. Expression of a gonocyte-specific marker (DBA) and markers of endoderm (SOX17 and 





and their colonies in regular and differentiation media. Overall, gonocytes and embryoid body-like 
colonies (EBLCs) were positive for DBA. Many gonocytes showed strong expression of DBA 
(green arrows) but weak expression of lineage-specific markers. Other gonocytes showed strong 
expression of the lineage-specific markers (orange arrows) when cultured in corresponding media. 
EBLCs appeared positive for all three lineage differentiation markers. When cultured in regular 
media, gonocytes and EBLCs were positive for DBA and Brachyury, but were negative for OTX2, 
SOX17, AFP, ASM, and GFAP. This may indicate that gonocytes in differentiation media are 
gradually converting into a new population of cells with similar biomolecular properties as cells 




















Fig. 5.6. Gene expression analyses of germinal layer-specific markers using RT-PCR. Expression 
of germinal layer markers was positive in respective differentiation media. Also, freshly isolated 
testis cell samples were positive for the expression of SOX17, TBXT, ACTA2, OTX2, and GFAP. 
Cultured testis cells in regular media (DMEM+15% FBS) were positive for mesoderm markers 
(TBXT and ACTA2). ACTA2 expression was also positive in cultures of endoderm and ectoderm 
differentiation media in addition to cultures treated with mesoderm differentiation media. Mo, 50 
bp DNA ladder; F, freshly isolated testis cell sample; R, cultured cells and colonies in regular 
media; En, cultured cells and colonies in endoderm differentiation media; Me, cultured cells and 
colonies in mesoderm differentiation media; Ec, cultured cells and colonies in ectoderm 
differentiation media; C, positive control (liver sample for SOX17 and AFP; muscle sample for 
TBXT and ACTA2; brain sample for OTX2 and GFAP); L, liver sample; M, muscle sample; B, 









Fig. 5.7. Representative photomicrographs captured from (immuno)histological sections of 
dedifferentiated cell implants. Implants were stained using H&E (A-D) or labelled with lineage-
specific antibodies including AFP (E), ASM (F), or GFAP (G and H). The implants were 
surrounded by a dense fibrous capsule (green arrowhead) (A and B). Implants developed into 
tumour-like growth formations containing circular and/or oval patterns as well as large numbers 
of melanocytes with remarkable accumulation of melanin pigments (orange arrows) (A, B, and C). 
The distribution pattern of the cells resembled nests of melanocytes (red broken lines) (B and C). 





(asterisk) (D). AFP as endoderm marker was expressed in foci of implanted cells/EBLCs (E). Focal 
AFP expression can be attributed to endodermal elements in tumour-like formations. Also, limited 
expression of ASM was observed by the cells inside and surrounding the circular patterns (F), 
which can be deemed as the presence of differentiated myofibroblasts. Small foci within the 
formations and nerve bundle-like structures both appeared positive for GFAP as neuroectodermal 
marker (G and H), which can point at development of ectodermal components within the 
























In previous works as well as the present Chapter, our laboratory has shown that gonocytes from 
neonatal porcine testis can spontaneously dedifferentiate and express pluripotency-associated 
markers when cultured under basic conditions (Awang‐Junaidi et al. 2020). Given the potential of 
these cells in conversion into a pluripotent state, here we first developed a population of 
dedifferentiated gonocytes using our previously established culture conditions, evaluated their 
potential to generate derivatives of three germinal layers in vitro, and assessed their pluripotency 
and plasticity using an in vivo implantation assay. As such, the present study is the first to show 
that, upon providing the appropriate media and supplements, dedifferentiated porcine gonocytes 
and their colonies can undergo osteogenic differentiation in vitro and can convert into cells of the 
three germinal layers (i.e., ectoderm, mesoderm, or endoderm). Additionally, we showed that 
implantation of cultured gonocytes and their colonies into the subcutaneous tissue of recipient 
mice can lead to development of tumor-like growth formations. These formations contain areas 
which morphologically resembled ectoderm, mesoderm, or endoderm-derived tissues and express 
markers that are present in all three germinal layers. This observation further confirms the unique 
potential of gonocytes to spontaneously transform into a pluripotent state under simple in vitro 
conditions. The dedifferentiation and trans-differentiation potential of germ cells is a remarkable 
finding that sheds light on their unique conversion potential and can open new avenues of research 
into their applications in stem cell therapy and regenerative medicine.  
In Experiment 5.1 of the present study, we successfully induced osteogenic differentiation in 
gonocyte colonies. Osteoblasts have mesodermal origin and are specialized mesenchymal cells 
that synthesize bone matrix (Mackie 2003; Franz‐Odendaal et al. 2006). Here, we used simple 
culture conditions to develop pluripotent germline stem cells in a short-term culture (~2 wk) and 
transformed them into osteogenic cell derivatives with bone matrix deposition potential. Following 
differentiation, morphological features of EBLCs stained with Alizarin Red S resembled those of 
in vitro developed osteoblast colonies which typically possess darker color in the central areas and 
lighter color in the marginal areas (Yin et al. 2007; Orriss et al. 2012). This morphological pattern 
of EBLCs features a dome shape appearance and greater calcium deposition in the central areas 
compared to the narrow marginal areas. Previously, embryonic chicken SSCs were shown to 





layer and in media composed of multiple growth factors and/or other supplements (Li et al. 2010). 
Although successful, trans-differentiation rate of chicken SSCs was 75-80%. In contrast, we 
showed that all EBLCs developed from porcine testis cells transformed into calcium phosphate 
deposition sites and appeared positive for Alizarin Red S staining; all in a relatively short period 
of time and without supplementation of multiple exogenous factors. In another study, bovine germ 
cells were co-cultured with Sertoli cells for 21 days in a differentiation induction media to become 
trans-differentiated into osteoblasts followed by confirmation of differentiation using Alizarin Red 
S staining (Qasemi-Panahi et al. 2011). Although multiple studies have already shown 
mesenchymal and ES cell potential to convert into osteogenic cell lineages (Parikka et al. 2005; 
Hanna et al. 2018), successful generation of osteogenic progenitors from porcine germ cells acts 
as an even stronger indication of similar potential in human germ cells, given the anatomical and 
physiological similarities between pigs and humans. As such, our findings introduce a new avenue 
for application of these cells in bone regeneration and matrix formation. Of notable importance, 
using MGSCs for the purpose of bone regeneration in an autologous manner does not carry the 
same ethical concerns associated with the use of ES cells, nor the biosafety risks associated with 
the use of iPS cells.  
In addition to the osteogenic differentiation, we also examined the conversion potential of cultured 
gonocytes into cell derivatives of all three germinal layers. As mentioned above, Experiment 5.2 
was not continued due to limited cell growth and negative expression of lineage-specific markers 
following brief exposure to the differentiation media. Limited cell growth in Experiment 5.2 can 
be attributed to an underdeveloped somatic cell monolayer, which is essential for survival of non-
adherent gonocytes (Awang-Junaidi and Honaramooz 2018; Awang‐Junaidi et al. 2020). We 
suggest that perhaps the frequent replenishment of the differentiation media in Experiment 5.2 led 
to physical detachment of the monolayer and/or removed essential components that were naturally 
produced by cultured cells. However, in the immunofluorescence results of Experiment 5.3 we 
showed decreased intensity of DBA expression and increased intensity of lineage-specific 
markers, including AFP/SOX17 in endoderm differentiation group, ASM in mesoderm 
differentiation group, and GFAP/OTX2 in ectoderm differentiation group, all indicative of gradual 





The expression of transcription factors examined in the present study are critical for normal 
formation and development of germinal layers during embryonic development (Eng 1985; Babai 
et al. 1990; Ang et al. 1994; Abe et al. 1996; de Jong et al. 2008; Bernardo et al. 2011; Mortensen 
et al. 2015). Here, positive expression of SOX17 in freshly isolated testis cells is in agreement 
with previous studies on isolated human PGCs and gonocytes (Irie et al. 2015; Fang et al. 2020). 
Conversely, negative expression of SOX17 in cultures of regular media may be indicative of germ 
cell transformation into more primitive developmental stages. SOX17 is a key transcription factor 
in the development of endoderm as its mutation leads to defective intercellular transport in 
endoderm (Viotti et al. 2012; Fang et al. 2020). Additionally, we used AFP as a secondary 
endoderm marker. Expression of AFP is typically upregulated in nonseminomatous germ cell 
tumors (Bostwick 2006) and expectedly was not expressed in our fresh testis cell samples. Here, 
mesoderm and ectoderm cultures were also negative for AFP, perhaps due to the lack of chemical 
components required for directing cell differentiation towards definitive endodermal lineages. 
Components of endoderm differentiation media such as bFGF, Wnt-a, and Activin A play 
important roles in enhancement of definitive endoderm-associated gene expression and cell 
viability in a dose dependent manner (Yao et al. 2006; Xu et al. 2011; Qu et al. 2017; Diekmann 
et al. 2019). The same interplay can be speculated between these components in our culture system, 
leading to expression of endodermal gene transcripts.  
Here, we also showed mesoderm differentiation cultures became Brachyury+ while endoderm and 
ectoderm differentiation cultures appeared Brachyury–. Brachyury is a factor required for posterior 
mesoderm formation (Barresi et al. 2014). In agreement with our observations, a previous study 
on mouse germ cells showed fresh testis lysates and germ cell enriched cultures were positive for 
Brachyury, which the authors concluded was essential for mouse germ cell self-renewal (Wu et al. 
2011). Interestingly, multipotent germline stem cells developed from murine testis cells were also 
positive for Brachyury (Baba et al. 2007). This further supports our finding regarding Brachyury+ 
cultures in regular media, which were previously demonstrated to express pluripotency-associated 
markers (Awang‐Junaidi et al. 2020). Additionally, ASM as a secondary marker for mesoderm 
differentiation was positive in all samples. This could have occurred due to contaminating 
peritubular myoid cells and/or blood endothelial cells; however, in immunocytochemistry, ASM 
expression was localized to the cells surrounding the EBLCs, which also weakly expressed DBA. 





Identification and positive expression of ASM has been also reported in previous studies on 
primate testis cell culture (Langenstroth et al. 2014; Sharma et al. 2019). ASM is one of the actin 
isoforms responsible for mechanical tension of the cells (Wang et al. 2006).  
Here, like SOX17, the expression of OTX2 and GFAP was downregulated in germ cells during 
culture in regular media. OTX2 is required for neuroectoderm differentiation (Boyl et al. 2001; Li 
and Joyner 2001; Beby and Lamonerie 2013; Yang et al. 2019) and is inherently expressed in 
porcine brain and reproductive tissues (Wang et al. 2016; Dawson et al. 2018). Additionally, 
Leydig cells possess neuroendocrine features and are immunopositive for neuroectodermal and 
astrocyte markers such as GFAP (Apte et al. 1998; Davidoff et al. 2002). Thus, positive GFAP 
expression by freshly isolated cells can be explained by the presence of Leydig cells, which once 
isolated and cultured in regular media, perhaps downregulated its expression.  
In Experiments 5.1 and 5.3, migrating gonocytes formed clusters and colonies which transformed 
into EBLCs. Although smaller in size, the morphology of the EBLCs in Experiment 5.3 was 
comparable to those of Experiment 5.1. The presence of two indistinct peripheral and central areas 
in EBLCs can be explained by their dome-shape appearance, which normally have thinner 
marginal areas and thicker central areas. This can lead to a more translucent edge and opaque 
centre in EBLCs. 
We have previously shown that MGSCs in regular media dedifferentiate and express a number of 
ES cell markers (Awang‐Junaidi et al. 2020). Similarly, to confirm dedifferentiation of cultured 
MGSCs in regular media into primitive developmental stages, here we examined their expression 
of POU5F1 as one of the accepted and important ES markers (Nichols et al. 1998; Pan et al. 2002; 
Zeineddine et al. 2014). As demonstrated previously, unlike freshly-isolated testis cells which are 
negative for this marker, cultured cells showed positive POU5F1 expression (Awang‐Junaidi et al. 
2020). Here we showed that all MGSCs in culture conditions appeared both DBA- and POU5F1- 
positive. This further confirms that MGSCs are able to spontaneously revert to a dedifferentiated 
state and express markers that are mutually present in ES cells. As such, in the present study we 
used an implantation assay to evaluate their tumorigenic potential and examined the expression of 
selected germinal layer biomarkers (i.e., AFP, ASM, and GFAP) in retrieved samples. In all 
injection sites, multicellular tumor-like formations contained foci with positive cells for AFP, 





2012), and its expression may point at development of endodermal component within our observed 
formations (Jacobsen 1983; Lempiäinen et al. 2014; Mosbech et al. 2014). ASM expression was 
similarly observed in sparse locations of our retrieved samples. ASM expression is associated with 
mesodermal differentiation in tumors derived from pluripotent stem cells (Wakao et al. 2012; 
Wagner et al. 2020). Here, we also observed GFAP expression in focal areas within the formations. 
The morphology and pattern of diffuse GFAP-positive areas partly resembled those observed in 
previously reported glial cell neoplastic tissues containing polygonal and spindle shape cells with 
indistinct cellular borders (Akiyama et al. 2014). Additionally, nerve bundle-like structures within 
these formations appeared positive for GFAP, which may suggest the presence of a 
neuroectodermal component. Increased GFAP expression has been attributed to neuroectodermal 
component in teratomas (Sundström et al. 1999; Gu et al. 2011). Importantly, excessive 
accumulation of melanin and development of melanocyte nests further confirms the presence of 
ectodermal tissue in the developed tumor-like formations. Thus, the overall morphological and 
immunohistochemical attributes of the implanted cells and EBLCs point at their potential 
contribution to formation of tumor-like structures which contain endodermal, mesodermal, and 
ectodermal components. The tumorigenic potential is one of the staple characteristics of ES- or 
iPS cells derived from somatic cells (Wakao et al. 2012). Additionally, by definition, pluripotent 
stem cells can give rise to the cells of all three germinal layers, whereas multipotent stem cells can 
differentiate to particular tissue types/cell lineages but not all, which suggests that similar to ES- 
or iPS cells, developed germ cell-derived stem cells in our culture conditions can be classified as 
pluripotent (Singh et al. 2016). As such, gonocytes in our primary culture conditions 
spontaneously underwent reprogramming into a pluripotent state in a relatively shorter time (~4 
wk post-implantation) as confirmed by the implantation assay. Additionally, we successfully 
converted these cells into cell derivatives from all three germinal layers, which has not been 
achieved previously. Harvesting germ cells from primary culture is important since multiple 
passages and removal of the cells from their microenvironment causes unwanted changes to their 
physiological and biochemical properties (Goel et al. 2009). Such changes can generate 
confounding factors for their downstream applications and pose negative effects on their 
proliferation and differentiation potential at genetic or epigenetic levels (Goel et al. 2009).  
In conclusion, neonatal porcine gonocytes represent a promising source of adult stem cells. In our 





stages. When implanted into recipient mice, the cultured gonocytes and their colonies develop 
formations with morphological and biomolecular characteristics of all three germinal layers, which 
further confirms their plasticity. Furthermore, cultured gonocytes and their colonies effectively 
convert into derivatives of ectodermal, mesodermal, and endodermal germinal layers in trans-
differentiation media. In vitro dedifferentiation and subsequent conversion of neonatal gonocytes 
into osteogenic cells and derivatives of three germinal layers are important observations since this 
in vitro system can provide an easily accessible and abundant source of adult stem cells for 
numerous downstream applications in regenerative medicine. More importantly, unique 
conversion potential of neonatal gonocytes into other cell types makes them a potentially attractive 
autologous pluripotent cell source since their use eliminates ethical implications and the biosafety 
risks associated with viral vectors to induce pluripotency, and they can be easily produced in vitro 
without addition of multiple extrinsic factors. The capacity of neonatal germ cells to differentiate 
into cells of all embryonic germinal layers highlights their importance and warrants further 
research including on their putative differentiation triggers. Such studies may put these cells in a 
privileged position to treat tissues of high interest in regenerative medicine, especially those that 
present low regeneration rates such as neural tissue, tendon, or cartilage when compared to other 
better studied multipotent stem cells. More specifically, the testicular biopsies obtained from 
preadolescent boys can potentially serve as a dual source of germ cells for fertility restoration and 
germ cell-derived pluripotent stem cells for development of somatic cells and tissues. As such, 
MGSCs offer an autologous alternative stem cell source to the available adult stem cells such as 
cord blood stem cells with similar potentials. It goes without saying that any in vivo application of 













Beside in vitro models for the study of testis cells and tissues, in vivo models have been developed 
and optimized over time to provide invaluable information about testis development and cell-cell 
interactions. These models include testis tissue xenografting and testis cell aggregate implantation 
which are known as versatile tools to study testis morphogenesis and function especially where in 
situ studies are not possible. These models also allow testing the effects of various factors on testis 
formation and function. To introduce a non-invasive approach for in vivo study of testicular 
morphogenesis and testis tissue development in Chapter 6 we used ultrasound biomicroscopy in a 
validation study. We successfully established a non-invasive and accurate approach for monitoring 
the ectopic testis tissue grafts and cell implants located in the recipient host by using ultrasound 
biomicroscopy. The study presented in Chapter 6 would eliminate the need for multiple surgical 
sampling following grafting/implantation thereby reducing the risk of infection in recipients and 



















VALIDATION OF ULTRASOUND BIOMICROSCOPY FOR THE ASSESSMENT OF 
XENOGENEIC TESTIS TISSUE GRAFTS AND CELL IMPLANTS IN RECIPIENT 
MICE 7, 8 
6.1. Abstract 
Subcutaneous grafting/implantation of neonatal testis tissue/cells from diverse donor species into 
recipient mice can be used as an in vivo model to study testis development, spermatogenesis, and 
steroidogenesis. Ultrasound biomicroscopy (UBM) allows obtaining high definition cross-
sectional images of tissues at microscopic resolutions. The present study was designed to 1) 
validate the use of UBM for non-invasive monitoring of grafts/implants over time, and to 2) 
correlate UBM findings with the morphological attributes of recovered grafts/implants. Testis 
tissue fragments (~14 mm3, each) and cell aggregates (100×106 cells, each) obtained from 1-wk-
old donor piglets (n = 30) were grafted/implanted under the back skin of immunodeficient mice (n 
= 6) in eight analogous sites per mouse. Three-dimensional transcutaneous Doppler UBM was 
performed and a randomly-selected graft and its corresponding implant were recovered at 2, 4, 6, 
and 8 wk. Graft/implant weight (P = 0.04) and physical height (P = 0.03) increased over time. 
The dynamics of physical length and volume increases over time differed between tissue grafts 
and cell implants (P = 0.02 and 0.01 for sample type*time interactions, respectively). UBM-
estimated volume was correlated with the post-recovery weight and volume of the grafts/implants 
(r = 0.98 and r = 0.99, respectively; P < 0.001). Pre- and post-recovery length and height of the 
grafts/implants were positively and strongly correlated (r = 0.50, P = 0.01; r = 0.70, P = 0.001) 
and so were the areas covered by cordal, non-cordal or fluid-filled cavities between UBM and 
histology (r = 0.87, P < 0.001). UBM findings correlated with physical attributes of the 
grafts/implants, validating its use as a non-invasive high-fidelity tool to quantify the developmental 
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changes in ectopic testis tissue grafts and cell implants, potentially leading to a reduction in the 
number of recipient mice needed for similar experiments. 
6.2. Introduction 
(Xeno)grafting of testis tissue fragments and implantation of testis cell aggregates from various 
donor species into phylogenetically-distant recipients are powerful new tools in reproductive 
biology and technology (Honaramooz et al. 2002; Honaramooz et al. 2007). These models can 
provide an easy access within a mouse recipient to study spermatogenesis, steroidogenesis, and 
testis development/function from diverse donor species, where in situ studies are inherently 
difficult (e.g., large animals) or impossible (e.g., humans) (Honaramooz 2014). For instance, 
testing the effects of different drugs or potential environmental toxicants, all without 
experimenting on the target donor species per se can be achieved using these models. Salvaging 
the genetic potential of recently deceased newborn endangered/valuable males or preserving the 
fertility potential of prepubertal boys undergoing gonadotoxic cancer treatments are among some 
other important applications of these models.  
In the first successful report of testis tissue xenografting (TTX), testis fragments from neonatal 
donor mice, pigs, and goats developed under the back skin of recipient mice, formed complete 
spermatogenesis, and eventually produced fertilization-competent sperm (Honaramooz et al. 
2002). This model was then applied using a diverse range of donor species including laboratory, 
domestic, and non-domestic animals, as well as primates (Honaramooz 2014). TTX has been 
successfully used to preserve the genetic potential of immature mammalian species; however, 
development of testis tissue from mature donors has been less successful, possibly due to the 
inability of mature somatic cells to proliferate and support the grafted tissue in the new 
environment (Honaramooz et al. 2002; Schlatt et al. 2006; Arregui et al. 2008). 
Interestingly, ectopic subcutaneous implantation of pig testis cell suspensions, obtained after 
complete enzymatic dissociation of tissue to obtain single cells, into immunodeficient recipient 
mice resulted in post-implantation cellular rearrangements and regeneration of a functional testis 
tissue (Honaramooz et al. 2007). This de novo tissue formation was rather surprising as the newly-
formed tissue was morphologically and functionally identical to the age-matched testis tissue 
(Honaramooz et al. 2007). Re-organization of the implanted cells was evident as early as 4 days 





al. 2007). Using other species such as rodents (Kita et al. 2007) and sheep (Arregui et al. 2008) as 
donors of testis cells, for this in vivo system, has also led to similar results. Although the TTX 
model is easier to perform, implantation of testis cell aggregates provides easier access for 
manipulation of individual cells when the behavior and developmental potential of testis stem cells 
are examined under different conditions (Dobrinski 2007). 
So far, all studies using these two models have employed surgical recovery of the grafts/implants 
as the endpoint for evaluating the development of testis tissue/cells (Honaramooz et al. 2002; 
Honaramooz et al. 2007; Honaramooz 2014). Therefore, examining the developmental events 
within grafts/implants are limited by the number of timepoints that samples can be surgically 
recovered. Moreover, samples recovered from the subcutaneous tissue undergo multiple steps of 
fixation and tissue processing, which in turn, leads to tissue shrinkage and underestimation of their 
actual dimensions. Surgical procedures in general, and especially repeated sample recoveries in 
immunodeficient recipient mice carry complications such as potential for infection. Hence, it is 
desirable to employ novel imaging modalities that allow non-invasive, accurate, and repeated 
evaluation of the growth and structural changes in the grafted/implanted tissues/cells.  
Ultrasound biomicroscopy (UBM) is a fairly new technology used in both diagnostic and research 
fields. First introduced in 1989, this high-resolution non-invasive imaging tool was originally 
designed for examination of the anterior chamber of the eye (Sherar et al. 1989). UBM utilizes a 
high-frequency transducer (20-100 MHz) to capture high-definition cross-sections of living 
objects at microscopic resolutions (Pavlin and Foster 2012). Compared with conventional clinical 
ultrasound systems, the frequencies used in UBM result in higher resolution (up to 25 µm axial 
and 50 µm lateral resolution), but with lower tissue penetration depth (Ishikawa and Schuman 
2004; Kumar et al. 2016). Because of its low cost, high speed, accuracy, and non-invasiveness, 
UBM has been widely used in imaging of laboratory animals, especially to investigate 
pathogenesis of diseases and embryonic development of mice (Turnbull et al. 1995; Foster et al. 
2002; Goertz et al. 2002; Zhou et al. 2003; Cheung et al. 2005). This technology has been 
successfully used in reproductive sciences to visualize the ovarian follicular development and 
cumulus-oocyte-complexes in laboratory animals (Jaiswal et al. 2009; Mircea et al. 2009) as well 
as in farm animals (Pfeifer et al. 2012, 2014) and humans (Baerwald et al. 2009; Pfeifer et al. 





mice where the UBM-measured dimensions were shown to be in excellent agreement with those 
measured using the caliper volume of tumors (Turnbull et al. 1995; Cheung et al. 2005). Although 
UBM has been used in a number of applications including in oncology, embryology, and 
developmental biology (Liu et al. 1998) no study has validated its use for monitoring the 
developmental changes in tissue grafts/cell implants in vivo. 
In this study, we used UBM to examine ectopically grafted/implanted tissues/cells to study their 
volume, dimensions, and composition prior to sample recovery. We captured consecutive 2-D 
UBM images, followed by reconstruction of 3-D views for volumetry. The recovered samples 
underwent morphometric and histologic analyses to compare with the UBM data. Our objectives 
were 1) to validate the use of UBM as a non-invasive and practical tool to monitor the development 
of testis tissue grafts/cell implants, and 2) to correlate the UBM data with the physical and 
histological attributes of recovered samples. 
6.3. Materials and Methods 
6.3.1. Study Design 
Figure 6.1 summarizes the experimental design used in this study. Testis tissue fragments and 
testis cell aggregates were prepared from testes of 1-wk-old piglets. The tissue grafts and cell 
implants were placed within the dorsal subcutaneous tissue of recipient mice (n = 6) on 4 parallel 
sites on each side of the body. The grafting/implantation sites were examined every 2 wk using 
transcutaneous ultrasound (UBM) for 8 wk followed by randomized recovery of corresponding 
grafts and implants. Physical attributes of the recovered samples including their weight, volume, 
and dimensions were measured followed by histological analysis of the samples. All experiments 
involving animals were reviewed and approved by the University of Saskatchewan’s Institutional 
Animal Care and Use Committee (Protocol # 20080042). 
6.3.2. Preparation of Testis Tissue Fragments and Testis Cell Aggregates 
Testis tissue fragments and testis cell aggregates were prepared using aseptic castration of 1-wk-
old donor Yorkshire-cross piglets (n = 30; Camborough-22 line 65; PIC Canada, Winnipeg, MB, 
Canada) at a university-affiliated swine facility. Castration of animals and cell dissociation were 





with 10% FBS and 1% antibiotics to prepare a single-cell suspension and was refrigerated before 
transfer. 
6.3.3. Recipient Mice and Grafting/Implantation Procedures 
Recipient mice were male double-homozygous severe combined hairless immunodeficient outbred 
(SHO, Crl: SHO-PrkdcscidHrhr, strain code 474; Charles River, Montreal, Canada, n = 6) at 7 wk 
of age at the time of grafting/implantation. The mice were kept individually in plexiglass micro-
insulator cages under sterile conditions, standard temperature (22 ± 2° C), and controlled lighting 
photoperiod (12 hr light/dark cycles). Sterile water and mouse chow were provided ad libitum. 
The mice were acclimatized for 1 wk prior to the study and were handled aseptically. For the 
induction and maintenance of anesthesia, isoflurane at 5% and 2% in oxygen were used, 
respectively, and the mice were placed on a heat pad on sternal recumbency. After the surgical 
preparation of the skin, each mouse received 4 longitudinal linear incisions through the dorsal skin, 
each ~0.5 cm, on the right side of the midline. Using blunt dissection, small subcutaneous pouches 
were formed through each incision, in which testis tissue grafts were embedded. The incision sites 
were closed using metal wound clips (Michel Clips 7.5 mm, Miltex, York, PA, USA). 
Testis cells were prepared as described above and kept at 4° C overnight. On the day of 
implantation (same day as grafting), the cells were prepared for injection by centrifugation at 500× 
g for 5 min at 16° C leading to aggregation of highly concentrated cellular sediments containing 
100×107 cells per mL. Using a 1-mL syringe attached to a 22-gauge needle, 0.1 mL of the cell 
aggregates were injected subcutaneously in each of the 4 contralateral sites on the left side of the 
midline. The tissue grafts and cell implants were assigned a letter (L or R = left or right) and a 
number (1 to 4, in order of cranial to caudal position) to track samples (Fig. 6.1).  
6.3.4. UBM Examination 
3-D transcutaneous Doppler UBM (VisualSonics Vevo3100, 32-55 MHz MX550D transducer, 
VisualSonics, Toronto, ON, Canada) was performed on all surgical/injection sites prior to 
graft/implant recovery. The mice underwent UBM examination every 2 wk for 8 wk. For each 
UBM examination, the animals were anesthetized using isoflurane as described above, placed on 
the heated UBM stage on sternal recumbency, and the skin over the grafted/implanted sites was 





Mississauga, ON, Canada). The B-mode setting was used to perform 3-D measurements of the 
grafts/implants using a 3-D-motor-driven 32-55MHz transducer. Machine settings were as 
follows: MX550D transducer with the central frequency of 32-55, 100% power, radio frequency 
of 2 kHz, master gain of 35 decibel and, 0.1 mm delay, field of view of 15×14.08 mm, 19 frames 
per second, and a dynamic range of 70 decibel.   
The transducer was placed on the ultrasound gel and its position was maintained steady as soon as 
the target tissue was completely within the borders of the image. The focal points and 3-D range 
were then adjusted based on the lateromedial dimension of the graft. The transducer notch was 
located cranially and by slight movements of the 3-D motor, consecutive images (X and Y 
dimensions = 15 mm, axial and lateral pixel sizes = 12.0 × 55.2 µm) were captured every 0.038 
mm (Z dimension) starting from the point where the graft/implant was observed from lateral to 
medial for the tissue grafts and medial to lateral for the cell implants. Once the imaging of a 
graft/implant was completed, the transducer, mounted on a stand, was moved using levers to be 
adjusted for the next imaging site until all remaining grafts/implants were examined. 
The ultrasound findings were used in a correlation analysis with the physical and histological 
attributes of the samples recovered immediately following the imaging process. The specifications 
evaluated in the 2-D UBM images included volume, length (craniocaudal axis), width 
(lateromedial axis), and height (dorsoventral axis) of all samples. Given the noticeable heterogenic 
echogenicity of cell implants, we also quantified the relative hyperechoic, hypoechoic, and 
anechoic areas by manually outlining their boundaries on UBM images, and by quantifying the 
pixel intensity and pixel heterogeneity of each area. The relative surface areas occupied by the 
differing echogenicities were then used in correlation analyses with the putative corresponding 
areas on histological cross-sections of the same cell implants. The length, height, and relative 
areas, as well as the pixel intensity and heterogeneity of samples were measured in the largest 2-
D UBM planes. Length and height were measured using the designated software (Vevo Lab, 
Version 3, Fujifilm VisualSonics Inc, Toronto, ON, Canada) and the pixel intensity and 
heterogeneity as well as the relative areas were measured using ImageJ (ImageJ, U.S. National 
Institutes of Health, Bethesda, MD, USA). Width measurements were made by multiplying the 
step size (0.038 mm) by the recorded number of images from one side to the other. UBM volume 





calculations (segmentation volume measurement) (Elliot et al. 1996; Cheung et al. 2005). For this 
purpose, using the same software, 3-D images were segmented into 1-mm slices, each consisting 
of 26 two-dimensional images (1 mm slice ÷ 0.038 mm step size), followed by calculation of the 
area of each graft/implant by manually outlining their boundaries in a randomly-selected 2-D 
image within the first 1-mm slice, skipping 26 images, and repeating the same measurement for 
each of the following slices. Each delineated area (in mm2) was then multiplied by the inter-slice 
interval (0.038 mm step size × 26 = 1 mm) to obtain the volume of a section (in mm3), followed 
by adding all the section volumes to calculate the total volume of an individual mass (Fig. 6.2). 
6.3.5. Graft and Implant Sample Recovery, and Physical Evaluation  
Three of the 6 recipient mice were randomly selected to undergo UBM scanning and sample 
recovery at 2 and 6 wk post-procedure, and the remaining three mice at 4 and 8 wk. After scanning 
all grafts/implants in each mouse, one tissue graft and its corresponding cell implant were 
surgically recovered. For the recovery from each mouse, a site was randomly chosen to avoid the 
potential confounding effects of graft/implant site. The physical volume, weight, and dimensions 
of the recovered grafts/implants were also measured for comparison with the UBM data. For gross 
measurement of sample dimensions, immediately after recovery, each sample was placed on a 
stage with backlight for added clarity, and close-up photomacrographs were captured dorsally with 
a camera (Sony α5000, Sony Corporation, Tokyo, Japan) mounted on a stabilized macro stand to 
document the length and width, followed by repositioning the sample laterally for documenting its 
height. The macrographs were used to calculate the gross dimensions of the grafts/implants using 
ImageJ. Volume of the recovered samples was calculated using a water displacement method. 
Briefly, the water level within a graduated 1-mL pipette (polystyrene serological pipette, 
Fisherbrand Scientific Company, Toronto, ON, Canada) was recorded before and after submerging 
the recovered samples. The difference was recorded as the physical volume of the graft/implant 
and was used to compare with the UBM measurements of volume. 
6.3.6. Histological Analyses 
Using Bouin’s solution, the recovered grafts/implants were fixed overnight, followed by rinsing 3 
times with and maintaining in 70% ethanol until the processing time with an automated tissue 
processor (Leica ASP300 S tissue processor, Leica Biosystems Corporation, ON, Canada). 





observed within the blocks. Every 5 sections were placed on a single slide, followed by skipping 
15 sections before another slide was prepared. Starting from the first slide, every 5th slide (~375 
µm interval) was stained with hematoxylin and eosin (H&E). 
Histological analyses were performed using a calibrated binocular microscope equipped with 
digital photomicrography (Northern Eclipse Image Analysis software version 7.0, Empix Imaging, 
Mississauga, ON, Canada). Descriptive side-by-side comparisons of histological cross-sections 
with their corresponding 2-D UBM images were performed using the largest diameter of the 
samples. In the same sections, the areas of seminiferous cords (cordal), connective tissue (non-
cordal), and fluid-filled cavities were also measured using ImageJ. 
6.3.7. Statistical Analyses 
The data presented are mean ± standard error of mean (SEM) and P < 0.05 was considered as 
significant. All the data were analyzed using t-test, one- or two-way analysis of variance 
(ANOVA), or Pearson correlation coefficient analysis, unless stated otherwise. Bland-Altman 
plotting (Giavarina 2015) was utilized to examine the differences between the two methods of 
volume measurements. Simple linear regressions were used to show relationships between UBM 
and physical as well as between UBM and histological measurements. Statistical Package for 
Social Sciences was used for all data analysis (IBM SPSS Statistics for Macintosh, Version 23.00; 
IBM Corporation, Armonk, NY, USA). 
6.4. Results 
6.4.1. UBM Assessment 
Detection of the tissue grafts and cell implants was performed using UBM at 2, 4, 6, and 8 wk 
post-procedure. As shown in Figure 6.3, testis grafts (n = 12) and implants (n = 12) were detectable 
under the skin as non-uniform masses that appeared ellipsoid, sphere, hemisphere, or irregular in 
shape. The 2-D ultrasound images contained sufficient contrast to allow differentiation of different 
areas or layers within the grafts and implants, suggestive of being made of different structural 
compositions. As early as 2 wk post-procedure, encapsulation of the grafts and implants within the 
subcutaneous tissue was evident using UBM (Fig. 6.3A). The mouse skin appeared as a thick 
hyperechoic structure covering the dorsal border of the grafts and implants (Fig. 6.3A). The skin 





The capsule on the ventral aspect was only partially observed and appeared as a hyperechoic line 
(Fig. 6.3A).  
While the tissue grafts appeared as homogenous structures (Fig. 6.3D), cell implants consisted of 
multiple layers with differing echogenicity (Fig. 6.3B). In two of the three cell implants collected 
at earlier stages (2 and 4 wk), a centrally-located anechoic region was detected, indicating a fluid-
filled cavity (Fig. 6.3C). These cavities decreased in size by 4 wk (3.41 ± 2.3 mm at 2 wk and 0.17 
± 1 mm at 4 wk) and were absent in 6- and 8 wk implants. 
The diameters (length, width, and height) measured at the largest cross-sectional UBM images of 
samples at each time point are displayed in Figure 6.4, where only the length of samples increased 
over time (P = 0.02; Fig. 6.4A). For the UBM-measured volume (using 3-D segmentation), an 
interaction was found between the sample type and time (P = 0.01), where the UBM volume 
increased over time for tissue grafts but not for cell implants (Fig. 6.4G and 6.5).  
6.4.2. Physical and Morphometric Assessment 
As shown in Figure 6.6, the recovered samples had various shapes including lenticular, spherical, 
ellipsoid, and in some cases irregular. There were no discernible differences in shape or texture 
between the recovered tissue grafts and cell implants at any time point; both types of samples had 
connective tissue capsules and a few visible blood vessels.  
Physical measurements showed an increase in the height (P = 0.03) of recovered samples over 
time (Fig. 6.4F). For the physical length, there was an interaction (P= 0.02) between the time and 
sample type, where the length of cell implants decreased at 4 wk and the length of tissue grafts 
increased at 8 wk. The length of cell implants was also greater than that of tissue grafts at 2 wk (P 
= 0.03; Fig. 6.4B). The overall weight of the samples increased (P = 0.04) over time from 36.9±5 
mg at 4 wk to 83.3±20 mg at 8 wk for grafts, and from 23.8±5 mg to 69±22 mg for implants at the 
same period of time (Fig. 6.6). For the physical-measured volume of recovered samples (using 
water displacement), there was an interaction between the sample type and time, where the 





6.4.3. Histological Assessment 
In histological examinations, all grafts (n = 12) and implants (n = 12) were surrounded by a fibrous 
capsule; in tissue grafts branching of the connective tissue from the capsule divided the tissue into 
groups of seminiferous cords.  
The histology of tissue grafts resembled that of a normal neonatal/immature testis tissue, 
comprising of seminiferous cords with gonocytes and Sertoli cells, surrounded by peritubular 
myoid cells, and the interstitial tissue housing Leydig cells and fibroblasts. Gonocytes within the 
cords were located centrally, next to the basement membrane of the cords, or in between.  
Cellular organization and/or cord formation were observed in all histological cross-sections of cell 
implants. While at 2 wk these cellular arrangements were observed immediately interior to the 
capsule of the implants, by 4 wk, convoluted cords were completely formed and distributed further 
into the implants. The central areas were occupied by connective tissue and/or fluid-filled cavities 
to various degrees. Cross-sections of the newly formed cords contained the expected cellular 
components; multiple Sertoli cells and a few gonocytes, which were mostly located away from the 
basement membrane. Although sections of tissue grafts at 2 wk also contained large areas of 
interstitial and connective tissue lacking cords, the fluid-filled cavities were only observed in some 
cell implants; two out of the three recovered cell implants at 2 wk and one out of the three implants 
at 4 wk. Therefore, cross-sectional histology of implants could be divided into capsular, cordal 
formation layer, and central areas/cavities; the cavities were replaced by connective tissue in more 
developed implants.  
6.4.4. Comparative Analysis 
Side-by-side comparison of the UBM and histological images of implants at 2 wk revealed that 
the peripherally-located hypoechoic areas on UBM images coincided with the presence of newly-
formed seminiferous cords in histological sections. Conversely, centrally-located hyperechoic 
areas of the implants corresponded to the non-cordal regions in histological sections, while as 
expected the anechoic regions corresponded with fluid-filled cavities (Fig. 6.3A-C, 6.7, and 6.8). 
This described pattern for the distribution of cords in cell implants was observed for 
UBM/histology images of the majority but not all implants; in some samples the distribution 





morphological changes between 2 wk cell implants (some containing fluid-filled cavities) and later 
stages (Fig. 6.7), we used cell implants from 2 and 6 wk to represent early and late developmental 
stages for further comparisons between UBM and histological attributes. An interaction was found 
between the area type (cordal, non-cordal, and fluid-filled cavity) and time of sampling on the 
relative areas (%) in the largest histological sections (P = 0.03; Fig. 6.8A-C). The percentage of 
non-cordal areas increased by ~88% from 2 wk to 6 wk, whereas the percentage of cordal areas 
did not change (Fig. 6.8C). The overall percentage of cordal areas was ~95% higher than that of 
non-cordal areas in 2-D UBM images (P = 0.004; Fig. 6.8D-F). The pixel intensity of UBM images 
did not differ between the cordal and non-cordal areas or over time. However, the pixel 
heterogeneity showed a tendency to decrease from 2 to 6 wk (P = 0.07; Fig. 6.8G and 6.8H). 
The Pearson correlation coefficient analyses showed a strong positive correlation between the 
percentage of measured areas between UBM images and histological cross-sections (r = 0.87, n 
=15, P < 0.001; Fig. 6.8I). The physical and UBM measurements of length and height of the grafts 
and implants were also strongly and positively correlated (r = 0.50, n = 24, P = 0.01; and r = 0.70, 
n = 24, P = 0.001, respectively; Fig. 6.9A and 6.9B). Similarly, sample volumes measured using 
UBM were strongly and positively correlated with both sample volumes measured using water-
displacement method (r = 0.99, n = 24, P < 0.001; Fig. 6.9C) and sample weights (r = 0.98, n = 
24, P < 0.001). Bland-Altman analysis showed an equal frequency of data points above and below 
the mean percentage differences of volume between the two approaches of volume measurement, 
indicating an agreement between the two methods (Fig. 6.9D). Moreover, the difference between 
the two methods of volume measurement decreased over time (P = 0.001; Table 6.1). Using simple 
linear regression, the following equations were calculated to quantify the relationships between 
UBM, physical, and histological measurements:  
Physical volume = –3.78 + (0.95 × UBM volume) 
Physical length = 1.76 + (0.61 × UBM length) 
Physical height = 1.29 + (0.91 × UBM height) 






Table 6.1. Percentage difference (% of increases/decreases, mean ± SEM) in biomicroscopy 
(UBM) and physical measurements of the length, width, height, and volume of grafts and implants 
Parameters Sample 2 wk 4 wk 6 wk 8 wk 
Length 
Implant –7 ± 7 25 ± 16 7 ± 3 17 ± 9 
Graft 21 ± 7 13 ± 2 16 ± 13 –2 ± 14 
Width 
Implant 51 ± 2 67 ± 7 64 ± 6 61 ± 4 
Graft 57 ± 1 61 ± 9 68 ± 5 60 ± 8 
Height 
Implant –29 ± 33 –29 ± 12 –38 ± 11 –34 ± 10 
Graft –32 ± 12 –35 ± 22 –50 ± 19 –75 ± 15 
Volume 
Implant 22 ± 1a 17 ± 4ab 11 ± 2b 9 ± 4b 
Graft 19 ± 1a 16 ± 1ab 11 ± 1b 6 ± 2b 
Note: Percentage increases/decreases in values between the UBM and physical measurements 
were calculated using ("#$	&'()*	–	,-./01'(	&'()*)
"#$	&'()*
	× 	100 
Positive numbers indicate that UBM values were greater than physical values by the given 
percentage. 
Negative numbers indicate that UBM values were smaller than the physical values by the given 
percentage. 













Fig. 6.1. Schematic representation of the experimental design. Neonatal testes (n = 30) were 
obtained after aseptic castration of 1-wk-old piglets. The testis parenchyma was either cut into 
small fragments for grafting or underwent tissue digestion for cell-aggregate implantation. Testis 
tissue grafts were placed subcutaneously in 4 sites on the right (R) side, and cell implants were 
injected subcutaneously into 4 contralateral sites on the left (L) side. The grafting and implantation 
sites were examined using ultrasound biomicroscopy (UBM) at 2, 4, 6, and 8 wk post-
grafting/implantation. After each UBM examination, one randomly-selected tissue graft and its 






Fig. 6.2. Representative ultrasound biomicroscopy (UBM) images used for segmentation volume 
measurement of testis cell implants. Cube views (A and C) and cross views (B and D) of the cell 
implants at 2 and 8 wk, respectively. (A and C) The target implant is shown within a cube with six 
rectangular faces which can be moved in different axes, making it possible to observe the cross-
sectional views from different aspects. In cross views, three movable planes are shown, which can 
also be displaced along different axes. All samples (grafts and implants) were segmented into 










Fig. 6.3. Representative two-dimensional (2-D) ultrasound biomicroscopic (UBM) images of cell 
implants at 2 wk (A and C) and 4 wk (B) post-implantation, or tissue graft at 2 wk (D). (A) A 2-
wk cell implant with a hyperechoic line (yellow arrows) representing the dorsal skin and a thin 
layer representing the ventral capsule (black arrows). (B) A 4-wk cell implant with hypoechoic 
areas (green arrows) with newly formed parenchymal testis tissue seen mostly in the peripheral 
regions, in contrast to the central hyperechoic area (black arrow), corresponding to more compact 
cellular areas. (C) In a few cell implants, including in this 2-wk sample, fluid-filled cavities (white 
arrows) were detected, which had disappeared by 6 wk. (D) Uniform appearance of a 2-wk testis 










Fig. 6.4. Ultrasound biomicroscopic (UBM) and physical measurements (mean±SEM) of tissue 
grafts and cell implants. “Sx” denotes tissue grafts or cell implants. “X, X′, Y, and Y′ ”, denote 
statistically significant differences over time. “a” and “b” denote statistically significant 









Fig. 6.5. Representative three-dimensional (3-D) reconstructed images from ultrasound 
biomicroscopy (UBM) of testis tissue grafts and cell implants. 3-D volumetric mesh and 
reconstructed 3-D image of a cell implant examined at 2 wk (A-C) or 8 wk (D-F). In order to 
measure the volume of each sample, 3-D images were segmented into parallel slices (Vevo LAB, 
Version 3, Fujifilm VisualSonics Inc, Toronto, ON, Canada). Within every two-dimensional (2-
D) cross-sectional slice, the area occupied by the sample was measured followed by multiplication 
of the inter-slice interval by the measured area. Sample boundaries were outlined manually on 
each of the cross-sectional views, followed by combining the obtained 2-D images. The resulting 










Fig. 6.6. Representative macrophotographs of testis tissue grafts and cell implants recovered after 
2 or 8 wk post-grafting/implantation. Recovered samples appeared in various shapes, but all were 
covered by connective tissue and blood vessels. “R” and “L” letters denote tissue grafts or cell 
implants that were recovered from the right or left sides of the back skin of recipient mice, 














Fig. 6.7. Representative images of testis cell implants obtained using ultrasound biomicroscopy 
(UBM) and histology at different time points. Cell organization and seminiferous cord formation 





cavities seen in a few cell implants at earlier time points were disappeared and replaced with 
cellular structures and connective tissue by 6 wk. The areas occupied by seminiferous cords 
appeared hypoechoic (darker) when compared to the areas occupied by dense cellular formations. 
Compared to the newly formed cords at 2 wk (M and Q), more developed cords appeared at 8 wk 






















Fig. 6.8. The percentage (mean±SEM) of cordal, non-cordal and fluid-filled cavity areas 
delineated on histological cross-sections and 2-D UBM images of implants (A-F and I), as well as 
the UBM pixel intensity and pixel heterogeneity (mean±SEM) (G and H) in recovered implants at 
2 and 6 wk. Replacement of the fluid-filled cavities with connective tissue, may have resulted in 
an increase in the percentage of non-cordal areas from 2 to 6 wk, whereas the percentage of cordal 
areas did not change on histological cross-sections. The overall percentage of cordal areas was 
significantly greater than that of non-cordal areas at both time points in UBM images (A-F). The 
percentage of corresponding areas were strongly and positively correlated between UBM images 
and histological cross-sections (r = 0.87, n = 15, P < 0.001), indicating the reliability of UBM in 
differentiating structural differences between the cordal, non-cordal and fluid-filled cavity areas 
(I). The differences in echotexture between the cordal and non-cordal areas allowed distinguishing 
the two areas on UBM images; however, the pixel intensity values did not differ between the two 
areas. The pixel heterogeneity tended to decrease from 2 to 6 wk, indicating that the cordal and 
non-cordal areas had become more homogenous over time (G and H). Area type denotes 
cordal/non-cordal areas and areas of fluid-filled cavities. X and Y denote statistically significant 






Fig. 6.9. Comparison between physical and UBM attributes of the grafts and implants. Correlations 
between the UBM vs. physical measurements of length (A), height (B), and volume (C) of the 
grafts and implants. (D) Bland-Altman analysis of volume measurements using percentage 
differences between UBM and physical volume of the grafts and implants 
(("#$	&'()*	–	,-./01'(	&'()*)
"#$	&'()*
	× 	100). Positive correlations were found between the physical and 
UBM measurements of length (r = 0.50, n = 24, P = 0.01), height (r = 0.70, n = 24, P = 0.001), 
and volume (r = 0.99, n = 24, P < 0.001) of the grafts and implants (A-C). (D) The same number 
of data points were found above and below the mean difference of two methods of volume 







The objective of the present study was to validate the use of UBM for non-invasive assessment of 
testis tissue grafts and cell implants in an immunodeficient mouse model. Here, we found positive 
correlations between the pre-recovery UBM and post-recovery morphometrical measurements for 
both testis tissue grafts and cell implants. We also found positive correlations between the UBM 
and histological attributes of cell implants. Using these correlations, we were able to define 
equations to allow future experiments to use UBM estimates to calculate the expected physical 
dimensions and volumes of grafts and implants, as well as the relative histological areas within 
implants. We also found strong agreements between UBM images and histological micrographs, 
which would allow distinguishing cellular layers and other histological attributes of the samples 
by using UBM imaging. We therefore validated the use of UBM as a non-invasive, accurate, and 
repeatable monitoring method for the assessment of testis tissue grafts and cell implants in 
prospective studies. As such, our results have important implications including a potential 
reduction of the required number of recipient animals in various studies using subcutaneous 
grafting or implantation.  
An indispensable component of studies using testis tissue xenografting and testis cell implantation 
models is the evaluation of graft or implant development, which thus far has only been achieved 
after physical removal of grafts or implants for (immuno)histochemical analyses (Honaramooz et 
al. 2002; Honaramooz et al. 2007; Arregui and Dobrinski 2014). UBM has facilitated several fields 
of basic research and clinical applications, including developmental biology (Hibino et al. 2011) 
female reproductive biology,(Baerwald et al. 2009; Jaiswal et al. 2009; Mircea et al. 2009; Pfeifer 
et al. 2012, 2014), cardiology (Spurney et al. 2006; Buckley and Stokes 2011; Jaffré et al. 2012), 
neurology (Stokvis et al. 2009), oncology (Turnbull et al. 1995; Cheung et al. 2005; Nuccitelli et 
al. 2006; Snyder et al. 2009), embryology (Foster et al. 2002), and ophthalmology (Pavlin et al. 
1992; He et al. 2007; Pavlin and Foster 2012). In a recent feasibility study, we showed that UBM 
has the potential to be used as a predictive tool for the development of testis tissue grafts and cell 
implants (Awang-Junaidi et al. 2019). However, the present study is the first to validate the use of 






A previous study using neoplastic xenografts showed high accuracy of UBM in 3-D segmentation 
volume estimation (Cheung et al. 2005). Hence, we applied the same principles for the precise 
volume measurements of testis tissue grafts and cell implants. We also used echogenicity and 3-D 
rendering of UBM images for the qualitative and quantitative evaluation of grafts and implants. 
These approaches have been shown to be effective in estimating the thickness of follicular walls, 
granulosa- and theca-cell layers, as well in describing follicular dynamics using UBM in mouse 
and bovine models (Baerwald et al. 2009; Mircea et al. 2009; Pfeifer et al. 2012). 
In the present study, in histological cross-sections of cell implants there was an 88% increase in 
the percentage of non-cordal areas from 2 to 6 wk, whereas the percentage of cordal areas over the 
same period remined unchanged (Fig. 6.8C). This may be explained by the replacement of fluid-
filled cavities at 2 wk with connective tissue at later time points. More importantly, the established 
positive correlations between the UBM and histological measurements of cordal/non-cordal areas 
and fluid-filled cavity were indicative of the UBM potential in detecting various textures and 
structural components to predict the histological attributes of cell implants. Although the 
differences in echotexture were sufficient to visually differentiate between the putative cordal and 
non-cordal areas, the pixel intensity values did not differ between these two areas to quantify the 
differences (Fig. 6.8G). However, there was a tendency for pixel heterogeneity to decrease over 
time (Fig. 6.8H), indicating that the tissues were becoming more homogeneous from 2 to 6 wk. 
These differences need to be tested in a larger study.  
In the present study, the overall developmental patterns observed in the histological cross-sections 
of grafts and implants conformed to those shown in relevant previous studies in which neonatal 
pig testis cells and tissues were also implanted or grafted into host mice (Honaramooz et al. 2002; 
Honaramooz et al. 2007). These patterns for cell implants included extensive cellular re-
arrangement and re-organization, leading to the formation of seminiferous cords by 2 wk and 
tubular lumen and complete tissue formation by 4 wk (Dobrinski 2007; Honaramooz et al. 2007). 
The developmental patterns of piglet testis tissue xenografts resembled those of the in situ testis 
tissue, where seminiferous cords gradually developed and transformed into fully functional 
seminiferous tubules over time (Honaramooz et al. 2002). 
Furthermore, the observed strong and positive correlations between pre- and post-recovery 





growth and physical development of testis tissue grafts and cell implants. Bland-Altman analysis 
of the two volume estimation approaches (3-D segmentation and water displacement) showed the 
reliability of our estimated values and agreements between pre- and post-recovery volume 
measurements. 
Although UBM and physical measurements of length were positively correlated for all samples, 
when considered as a whole, mean UBM values of width and length were numerically greater than 
those of physical measurements. Lack of a correlation between the UBM and physical 
measurements of sample widths, as well as smaller physical width and length measurements may 
have resulted from the rounding of grafts and implants upon recovery, likely due to removal of the 
surrounding physical restrictions such as attachments to adjacent tissues. The physical heights of 
samples were greater than those of UBM, again supporting the speculation about rounding of 
samples after recovery. Alternatively, sample heights recorded by UBM may represent potentially 
underestimated values, given the undetectability of the ventral capsular border of most samples. 
Therefore, it is recommended that our proposed coefficients be used in future experiments to 
predict the post-recovery physical attributes of samples more accurately from UBM estimates.  
Although positively correlated, the physical measurements of volume were lower than those 
estimated from UBM. This difference may be due to tissue shrinkage and/or fluid loss from the 
fluid-filled cavities as a result of physical manipulation of cell implants during sample recovery. 
Nevertheless, the UBM estimated length, height, and volume of the samples corresponded to those 
of physical evaluations, validating the use of UBM for axial and volumetric estimation of testis 
grafts and implants. The average UBM volume of tissue grafts and cell implants changed from 
13.49±0.94 mm3 and 100 mm3 at the time of grafting or implantation to 22.23±2.29 mm3 and 
71.12±19.56 mm3 at 2 wk, respectively. The volume decreases observed for cell implants may be 
as a result of resorption of the remnant media, which was mixed in with the donor cells during 
implantation. 
Retrospective comparison of images from 2 wk implants revealed that relatively less echogenic 
(darker) areas near the margins of cell implants in UBM images coincided with the presence of 
newly-formed testis tissue containing seminiferous cords in histological cross-sections. 
Conversely, relatively hyperechoic areas of the implants in UBM images corresponded with the 





The observed preferential pattern of cordal distribution around the periphery may indicate that 
these areas benefited from accessibility to diffusion from the host and earlier development of new 
blood supply (Schlatt et al. 2006). Using testis tissue xenografting models, it has been proposed 
that limited central vascularization combined with high oxygen and metabolic demands of the 
implanted cells during re-organization may lead to better development of testicular cords in the 
peripheral regions of the grafts (Schlatt et al. 2006; Ntemou et al. 2019). In our study, only cell 
implants showed the differential pattern of cordal development whereas all grafts displayed a 
uniform distribution of cords. However, in a study using young chicks, auto-transplanted testis 
tissue grafts maintained tubular structures in peripheral areas and their central areas undergoing 
necrosis (Cheng et al. 2017). Similarly, earlier reports of testis tissue xenografting from neonatal 
piglets into recipient mice also showed more advanced development in the periphery of some 
grafts (Honaramooz et al. 2002). These observations are consistent with our observation of 
preferential cordal distribution pattern within the cell implants. 
The interaction between the sample type and time for sample volumes in both UBM and 
histological measurements (P = 0.01 for both) indicated that the volume of tissue grafts increased 
towards wk 8 by ~290%, measured using UBM, and by ~360%, measured using the displacement 
method (Fig. 6.4G and 6.4H). While for cell implants the volume change over time was not 
significant, their initial reduction in volume may be explained by resorption of fluids from 2 to 4 
wk, followed by limited growth from 4 to 8 wk mainly in their periphery. 
Taken together, the present study supports the use of UBM data for examining and predicting the 
ex situ development of testis tissue grafts and cell implants. These results may also indicate the 
potential use of UBM for other organ systems or neoplasia where detection of superficial structures 
or masses and their changes over time are being investigated. The accuracy and non-invasiveness 
of UBM are also important advantages in its use as an in vivo evaluation technique.  
The present study was designed to compare the UBM data of recovered testis tissue grafts and cell 
implants with their physical and histological attributes in order to validate the use of UBM for 
monitoring the development of grafts and implants. The correlations found between the approaches 
showed that UBM can be used as a consistent, accurate, and non-invasive alternative to surgical 
recovery of multiple samples over time for monitoring the development of such grafts and 





assessment of physical growth and structural changes of grafts and implants. The potential 
replacement of repeated surgical sample recoveries with UBM can reduce fatality rates among the 
immunodeficient host mice which, in turn, can result in a reduced number of animals required for 


























In Chapter 6, by using side-by-side comparison of UBM images and histological cross-sections of 
obtained samples in a short-term study (2 mo) we validated the use of UBM as a non-invasive and 
accurate approach to monitor the development of ectopic testis tissue grafts and cells implants. 
Therefore, we designed and conducted a long-term study in Chapter 7 to repeatedly use UBM for 
over time evaluations of the samples and to demonstrate the gradual changes in grafts and implants 




















LONG-TERM MONITORING OF DONOR XENOGENEIC TESTIS TISSUE GRAFTS 
AND CELL IMPLANTS IN RECIPIENT MICE USING ULTRASOUND 
BIOMICROSCOPY 9, 10 
7.1. Abstract 
Testis tissue xenografting (TTX) and testis cell aggregate implantation (TCAI) from various donor 
species into recipient mice are novel models for the study and manipulation of testis formation and 
function in target species. Thus far, the analysis of such studies has been limited to surgical or 
post-mortem retrieval of samples. Here, we used ultrasound biomicroscopy (UBM) to monitor the 
development of neonatal porcine testis grafts/implants in host mice for 24 wk, and to correlate 
UBM and (immuno)histological changes. This led to 1) long-term visualization of gradual changes 
in volume, dimension, and structure of grafts and implants, 2) detection of a 4-wk developmental 
gap between grafts and implants, and 3) revealing differences in implant development depending 
on the craniocaudal site of implantation on the back of host mice. Our data support the reliability 
and precision of UBM for longitudinal study of transplants, which eliminates the need for frequent 
surgical sampling. 
7.2. Introduction 
In situ study of testis development and function is challenging; this is especially the case for non-
rodent animals, endangered species, and humans. The advent of innovative in vivo and in vitro 
testis culture systems has made it feasible to overcome the conventional limited access to the male 
gonads in various target species. Testis tissue xenografting (TTX) and testis cell aggregate 
implantation (TCAI) were among the first in vivo models to offer alternative strategies for the 
study of male gonadal development, spermatogenesis, and steroidogenesis of various donor 
species within a host mouse. These models have ever since led to more in-depth understanding of 
 
9 This study has been published. Fayaz MA, Awang-Junaidi AH, Singh J, and Honaramooz A (2020) 
Ultrasound in Medicine & Biology 46:3088–3103. 
10 MAF contributed to the experimental design, performed the study, analyzed the data, and wrote the first 
draft of the manuscript. AHAJ contributed to performing the study and analyses. JS contributed to the 
experimental design and revised the manuscript. AH supervised the study, contributed to the experimental 





the pathobiology of the testis in a wide range of species than comparable animal models 
(Honaramooz 2014; Ibtisham et al. 2020). 
TTX leads to physical growth and maturational development of the grafted tissue, induction of 
complete spermatogenesis, and even production of fertilization-competent sperm (Honaramooz et 
al. 2002). Similarly, de novo morphogenesis of functional testis tissue makes TCAI a unique model 
for the developmental studies (Honaramooz et al. 2007). By now, a range of species have been 
used as donors in TTX and TCAI studies, and as such these two models have provided an 
invaluable opportunity to investigate testis development and function, conservation of fertility 
potential of endangered mammalian species, and prepubertal boys undergoing gonadotoxic cancer 
treatments (Gassei et al. 2006; Honaramooz et al. 2007; Kita et al. 2007; Arregui et al. 2008; 
Aeckerle et al. 2013; Honaramooz 2014; Sharma et al. 2018; Ibtisham and Honaramooz 2020). 
When neonatal/immature testis is used as donor tissue, testicular development and xenogeneic 
spermatogenesis can be expected in TTX, perhaps with a notable exception of human testis tissue 
as donor (Schlatt et al. 2006; Arregui et al. 2008b; Honaramooz 2014; Tharmalingam et al. 2018; 
Ibtisham et al. 2020). Previous studies showed that especially male SCID mice (irrespective of 
gonadal status) provide a more suitable recipient model (Abbasi and Honaramooz 2010) and 
grafting 8 or 16 fragments per recipient mouse leads to better overall development in TTX studies 
(Abbasi and Honaramooz 2011b). Recently, we optimized TCAI by showing the feasibility of a 
less invasive approach involving a bolus injection of very large numbers of concentrated cells (i.e., 
100 × 106 per implant) containing high percentage of gonocytes (i.e., ~40%) (Awang-Junaidi et 
al. 2020) rather than depositing unknown numbers of cells through surgically created wounds as a 
conventional method (Honaramooz et al. 2007). 
Initially, evaluations of grafts from TTX and TCAI experiments were primarily restricted to 
terminal collection of all samples from groups of mice undergoing euthanasia (Honaramooz et al. 
2002, 2007). We later showed that surgical removal of a few randomly-selected samples at each 
of several time points can provide sufficient indications about the developmental status of grafts 
or implants over time (Abbasi and Honaramooz 2011a, 2011c, 2012; Fayaz et al. 2020b). 
However, surgical retrieval of sample grafts and implants is still invasive, and the retrieved 
samples need to be processed for histological assessments. Thus, although informative, this 





surgeries, and can also lead to inaccurate volume measurements of grafts/implants due to fixation 
and histological processing leading to tissue shrinkage. More importantly, histological assessment 
of samples can only provide retrospective information about the tissue status at the time of 
retrieval, and since the number of grafts/implants per mouse are limited, only a few observational 
time points can be included in a longitudinal TTX or TCAI study (Honaramooz 2014). Therefore, 
non-invasive real-time monitoring modalities that can be repeated over time will provide 
invaluable information and are advantageous from several perspectives. 
Ultrasound biomicroscopy (UBM) is well-suited to provide the repeatability and precision required 
for non-invasive acquisition of data in various clinical and research settings, including female 
reproductive tissue and organs (Baerwald et al. 2009; Jaiswal et al. 2009; Mircea et al. 2009; 
Pfeifer et al. 2012; Pfeifer et al. 2014). In short-term feasibility and validation studies (Awang-
Junaidi et al. 2020; Fayaz et al. 2020b), conducted up to 2 or 8 wk, respectively, we showed that 
UBM is an accurate tool for evaluation of testis tissue xenografts and cell implants in host mice. 
However, foregoing short-term studies may not reflect the complete developmental changes in 
samples, and the post-retrieval evaluations of samples were mainly focused on macroscopic 
aspects. Also, a study with focus on UBM practicality in screening the over time changes in sample 
structure and effects of grafting/implantation location based on the echotexture is deemed 
essential. Therefore, the present study was designed to (1) repeatedly apply UBM for the non-
invasive and long-term (24 wk) monitoring of orthogonal dimension and volume changes in 
samples to encompass the putative length of the pre-pubertal process of donor pigs (~6 mo) and 
through spermatogenesis and to (2) use histology and UBM to evaluate the long-term structural 
and developmental changes in testis tissue xenografts and cell implants from neonatal donor pigs 
in recipient mice. We hypothesised that UBM can be used accurately and independently to 
determine long-term orthogonal dimensions, volumes, and compositional changes in samples. We 
also hypothesised that longitudinal UBM and histological attributes of retrieved samples will be 
positively correlated. 
7.3. Materials and Methods 
7.3.1. Preparation of Testis Tissue Fragments and Cells 
A schematic representation of the study design is provided in Figure 7.1. Small fragments of testis 





as described previously and in Chapter 6 (Yang et al. 2010; Yang and Honaramooz 2011; Fayaz 
et al. 2020b) using the obtained testes from 1-wk-old Yorkshire-cross piglets (n = 30). Prepared 
fragments were kept on ice-cold medium mixed with antibiotics (10,000 I.U. penicillin and 10,000 
µg streptomycin; catalogue no. 30-002-CI; Mediatech) until TTX into immunodeficient recipient 
mice and the resultant cell pellets were prepared and refrigerated for TCAI procedure, as 
previously described (Awang-Junaidi et al. 2020; Fayaz et al. 2020b). All experiments involving 
animals were reviewed and approved by the University of Saskatchewan’s Institutional Animal 
Care and Use Committee (Protocol # 20080042). 
7.3.2. Procedures for TTX and TCAI 
The recipient mice were ~7-wk-old male severe combined hairless immunodeficient (SHO, Crl: 
SHO-PrkdcscidHrhr, strain code 474; Charles River, Montreal, Canada, n = 6). The acclimatization, 
care, handling, anesthesia, and surgical procedures of mice were as described in Chapter 6. TTX 
and TCAI were performed on the same day as was described in detail in our previous studies 
(Awang-Junaidi et al. 2020; Fayaz et al. 2020b). Grafts were designated a letter (R for right) and 
a number (1-4, corresponding to their cranial through caudal position), and implants were similarly 
designated L1-L4 (Fig. 7.1). 
7.3.3. UBM of the Grafts and Implants 
Using 3-D transcutaneous colour Doppler UBM (VisualSonics Vevo3100, 32-55 MHz MX550D 
transducer, VisualSonics, Toronto, ON, Canada), all grafts and implants were examined weekly 
for the first 8 wk, followed by once every 4 wk for up to 24 wk. The examination process was 
performed as previously described in more details (Awang-Junaidi et al. 2020; Fayaz et al. 2020b). 
In addition to B-mode for determination of size, volume, and pixel intensity/heterogeneity, colour 
Doppler mode was used to detect the flow-dependent signals.  
Measurements and quantifications on UBM images were performed for all examination time 
points, and the UBM measurements were correlated with corresponding histological 
measurements. As described previously (Fayaz et al. 2020b), tissue grafts demonstrated a more 
homogenic structure, whereas cell implants consisted of areas with varying echogenicities, 
corresponding with areas with cord formation (cordal areas), areas with connective tissue (non-





images, volume measurement, orthogonal dimension measurement, and hyperechoic and 
hypoechoic area measurements were performed as described previously (Robb 1995; Fenster and 
Downey 2000; Cheung et al. 2005; Fayaz et al. 2020b). For 3-D reconstruction, the most caudal 
graft and its corresponding cell implant were used (i.e., R4 and L4); these were not included in 
samplings and hence were present in all recordings of all recipient animals over time. The same 
graft and implant were used for 3-D reconstruction at each time point (Fig. 7.2). Sample volumes 
were also measured using the Cavaleri principle of stereological approach and on 2-D images 
recorded through the B-mode (Elliot et al. 1996; Cheung et al. 2005; Fayaz et al. 2020b). Length, 
height, and width were also measured as described previously (Fayaz et al. 2020b) and cordal 
volume was quantified using multiplication of the obtained UBM volume by the percentage of 
cordal areas, measured on 2-D UBM images for each implant. Using the colour Doppler mode, 
flow-dependent signals appearing within the boundaries of each sample in three consecutive 
images were considered as an individual blood vessel in Vevo LAB software. Two or more signals 
within 0.25 mm distance were considered as the same individual vessel.  
7.3.4. Sample Retrieval and Histological Evaluations 
Recipient mice were randomly assigned a number (# 1-6). At 2, 6, and 16 wk, mice # 1, 2, and 3 
underwent sampling, while the remaining three recipients (# 4, 5, and 6) were used for sampling 
at 4 and 8 wk. At each sampling time point, after UBM examination of all grafts and implants out 
of R1-3 grafts and L1-3 implants, one of each sample was randomly selected for retrieval. 
Therefore, at each sampling time point a total of 3 grafts and 3 implants was obtained for further 
evaluations. The most caudal grafts and implants (i.e., R4 and L4) were not included in random 
sampling and remained intact in all recipients, to be used as a time-course control within each 
animal and for 3-D re-construction of grafts and implants over time. The remaining grafts and 
implants were all retrieved at the time of euthanasia at 24 wk. The procedure for sample retrieval 
was as described previously (Fayaz et al. 2020b).  
Physical dimensions of the obtained samples were documented using photomacrographs and the 
samples were then fixed and processed for histology as previously described (Fayaz et al. 2020b). 
2-D UBM images and histological attributes of each sample were compared at the largest diameter. 
The two slides immediately following the H&E-stained slide were used for immunohistochemistry 





(Fayaz et al. 2020b) for dimension estimation of grafts and implants in this study, we randomly 
selected grafts and their corresponding implants at 16 and 24 wk, and used their measured physical 
volume, length, and height in correlation analyses to be compared with the expected dimensions 
calculated based on our established equations. 
7.3.5. Immunohistochemistry and Trichrome Staining 
To identify germ cells in sample cross-sections, expression of the ubiquitin C-terminal hydrolase-
1 (UCH-L1, also known as PGP9.5) was evaluated. Briefly, among five sections on an individual 
slide, one was randomly selected, deparaffinized in xylene, and dehydrated through descending 
grades of alcohol. Antigen retrieval was performed at 98° C in citrate buffer (catalogue no. H3300; 
Vector Laboratories, Burlingame, CA, USA) and Tris (hydroxymethyl) aminomethane-
Ethylenediaminetetraacetic acid (Tris-EDTA) (Tris; catalogue no. T87602; Sigma-Aldrich; 
EDTA; catalogue no. E9884; Sigma-Aldrich) for 30 min, each. The slides were washed with 0.1 
M phosphate buffered saline (PBS; catalogue no. BP243820; Fisher scientific, Toronto, ON, 
Canada) three times, followed by incubation with 0.3% w/v hydrogen peroxide in distilled water 
(H2O2; catalogue no. 7722841; RW consumer products, Winnipeg, MB, Canada) for 30 min to 
block endogenous peroxidase activity. Sections were covered with 2.5% horse serum (catalogue 
no. S-2012; Vector Laboratories), for 30 min in a moist chamber at room temperature to block 
non-specific proteins. The blocking solution was then removed and the primary antibody (1:200 
mouse monoclonal to UCH-L1; catalogue no. ab8189; Abcam, Toronto, ON, Canada) was used to 
cover the sections at 4° C overnight. Subsequently, slides were washed three times with 0.1 M 
PBS and incubated for 1 hr with the secondary universal antibody (horse anti-mouse/rabbit IgG; 
catalogue no. BP-1400; Vector Laboratories) at room temperature in a moist chamber. Sections 
were again washed three times with PBS and covered with 3,3'-Diaminobenzidine (DAB) 
chromogen (catalogue no. SK-4105; Vector Laboratories) for 3 min, immersed in distilled water 
for 5 min, and counter-stained with hematoxylin for 5 min (catalogue no. H-3401; Vector 
Laboratories). Sections were dehydrated with alcohol, cleared with xylene and mounted using a 
mounting medium (Fisher Chemical Permount mounting medium, catalogue no. SP15-100; Fisher 
scientific). 
Trichrome staining was performed using a trichrome staining kit (catalogue no. ab150686; Abcam) 





above, hydrated in distilled water, and placed in Bouin’s solution in a 56° C water bath for 1 hr, 
followed by 10 min of cooling at room temperature. The sections were then rinsed with tap and 
distilled water, respectively, followed by immersion in a working solution of Weigert’s 
hematoxylin for 5 min and under running tap water for 2 min. The Biebrich scarlet/acid fuchsin 
solution was used for 15 min, followed by rinsing the slides in distilled water. In the next step, the 
sections were covered with phosphomolybdic/phosphotungstic acid for 10 min. Aniline blue 
solution was then applied for 5 min, and the slides were rinsed with distilled water and covered 
with 1% acetic acid solution for 3 min. The sections were dehydrated using 95% and 100% alcohol, 
respectively, cleared using xylene, and mounted with the mounting medium. 
7.3.6. Histomorphometric Analyses 
Photomicrographs were obtained using a calibrated binocular microscope equipped with digital 
photomicrography (Northern Eclipse Image Analysis software version 7.0, Empix Imaging, 
Mississauga, ON, Canada) and measurements on obtained images were performed using ImageJ 
(ImageJ, US national Institutes of Health, Bethesda, Maryland, USA). One photomicrograph was 
captured at 40 × magnification and 10 photomicrographs were captured from randomly selected 
fields of view at 200 × magnification from each of the three stained slides. 
As was described previously, using low magnifications on H&E-stained slides, cordal and non-
cordal areas as well as areas of the total section and fluid-filled cavities were measured by outlining 
their boundaries (Fayaz et al. 2020b). Measured areas were then used in correlation analyses with 
similar measurements performed on the largest 2-D UBM images. Diameter and density of cords 
were measured using images obtained at higher magnifications. To compare the grafts and 
implants at a more comparable developmental stage, the diameter and density of cords in implants 
were also compared with those of grafts of one and two earlier time points. 
Slides stained against UCH-L1 were used to quantify the percentage of seminiferous cords or 
tubules with the most advanced germ cells to assess their development at each sampling time point. 
Cords or tubules were categorized based on the presence of 1) Sertoli cell-only, 2) 
gonocyte/spermatogonia, 3) spermatocytes, 4) round spermatids, and 5) elongated spermatids as 
the most advanced stages. Using trichrome-stained slides and ImageJ, the total area of blood 





sections, the number of blood vessels was counted and used in correlation analyses with the 
number of flow-dependent signals, detected in colour Doppler mode.  
7.3.7. Statistical Analyses 
The data presented are mean ± standard error of mean (SEM) and P < 0.05 was considered 
statistically significant. All the analyses were performed using t-test, one- or two-way analysis of 
variance (ANOVA), one- or two-way repeated measures ANOVA, or Pearson correlation 
coefficient analysis, unless stated otherwise. Simple linear regression was used to find the 
relationship between UBM and histological measurements. Statistical Package for Social Sciences 
(IBM SPSS Statistics for Macintosh, Version 23.00; IBM Corporation, Armonk, NY, USA) was 
used for statistical data analyses. 
7.4. Results 
7.4.1. UBM Evaluations 
As early as 1 wk and throughout the examination time points, all samples were detectable by UBM 
under the skin and appeared in various shapes, ranging from sphere, hemisphere, and ellipsoid to 
irregular (Fig. 7.2). The dorsal skin of mice covering grafts and implants appeared as a hyperechoic 
(white) band. Located immediately under the skin, grafts (n = 24) and implants (n = 24) were 
surrounded by a fibrous capsule which appeared as a hyperechoic line, notably at the ventral 
boundary of the samples (Fig. 7.3). 
Overall, unlike tissue grafts which displayed a relatively homogenous echogenicity, cell implants 
were composed of varying echogenicities indicative of multiple zones (Fig. 7.4). These zones 
included hypoechoic areas adjacent to the boundaries, hyperechoic areas near the center, and 
anechoic areas (dark) also located in the center of the cell implants. Hypoechoic, hyperechoic, and 
anechoic areas on 2-D UBM images corresponded with the cordal areas, non-cordal areas, and 
fluid-filled cavities on histological cross-sections, respectively (Fig. 7.3 and 7.4). At wk 1, the 
cavities were present in ~92% of cell implants, while this number decreased to ~8% by wk 5, and 
to 0% by wk 6 (Fig. 7.3J, 7.3K, and 7.3L). 
Changes in the average UBM volume (through 3-D segmentation), cordal volume, and orthogonal 
diameters (length, width, and height) at the largest 2-D UBM images of samples are shown in 





UBM volume and diameters of implants initially decreased to wk 3 but was followed thereafter by 
a progressive increase over time, while the volume and diameter of grafts gradually increased from 
the first UBM examination to wk 24. The UBM implant volume decreased by ~37% from wk 1 to 
3, while the graft volume increased by ~235% within the same period (P = 0.001; Fig. 7.5A). 
Similarly, from wk 1 to 4, the UBM length of implants decreased by ~8%, while for the grafts this 
measurement was up by 12% (P = 0.004; Fig. 7.5B). Also, the UBM width of implants deceased 
by ~17% from wk 1 to 3, when grafts width increased by ~6% in the same period (P < 0.001; Fig. 
7.5C). Likewise, from wk 1 to 4, the implants height decreased by ~35%, while grafts height 
increased by ~22% (P < 0.001; Fig. 7.5D). The overall UBM-estimated cordal volume increased 
by ~245% from wk 2 to 24 in all implants (P < 0.001), but this was also influenced by the location 
of implants; the cordal volume of cranial and mid-cranial implants was ~50% greater than that of 
mid-caudal and caudal implants (P = 0.02; Fig. 7.5E). For pixel intensity in 2-D UBM images of 
implants, an interaction was found between the area type (cordal vs. non-cordal areas) and time of 
UBM examination (P < 0.001), where cordal pixel intensity decreased by ~30% from wk 3 to 24, 
while non-cordal pixel intensity remained unchanged (Fig. 7.5F). Over time, pixel heterogeneity 
showed a tendency to decrease for both area types (P = 0.08). At wk 1, 20, and 24, pixel 
heterogeneity of cordal areas was ~8%, ~9%, and 3% greater than that of non-cordal areas, 
respectively (P < 0.001; Fig. 7.5G). The overall number of flow-dependent signals (vessels) in the 
colour Doppler mode increased over time (P < 0.001). Also, at 2- and 24-wk grafts contained 
~40% and ~28% greater number of signals compared with implants, respectively (P = 0.01; Fig. 
7.5H). 
7.4.2. (Immuno)histological Evaluations 
All samples were visible at every retrieval point to be surgically removed from the subcutaneous 
tissue. In the largest histological sections, a dense connective tissue surrounded both grafts (n = 
24) and implants (n = 24). For grafts, the interstitial tissue seemed to be interconnected with the 
fibrous capsule via branches (Fig. 7.3 and 7.4). Also, the distribution pattern of cords and 
interstitial tissue appeared random throughout the histological cross-sections of the grafts. For 
implants, the initial cellular organization and cord formation were first observed at wk 2 near the 
fibrous capsule, further cellular alignments formed morphologically normal seminiferous cords by 





fluid-filled cavities and/or connective tissue (Fig. 7.3P, 7.3Q, and 7.3R). The same cordal 
distribution pattern was observed in all implants collected at all sampling time points. The fluid-
filled cavities were observed in histological sections of two implants at 2 wk, one implant at 4 wk, 
whereas no cavity was present at 6 wk or later. The histological appearance of tissue grafts at 2 
wk was similar to that of age-matched testis tissue, composed of clusters of seminiferous cords 
surrounded by interstitial tissue (Fig. 7.3G, 7.3H, and 7.3I). Within each cord, Sertoli cells with 
detectable nuclei surrounded germ cells and cords gradually underwent developmental changes 
and luminal formation by wk 4. Expectedly, in 2-wk implants, cellular alignments and initial cords 
were observed which further developed into tubules at later time points. 
Previously, based on a short validation study, we established equations to calculate the expected 
physical measurements based on UBM measurements (Fayaz et al. 2020b). Here we utilized the 
equations to test their accuracy by calculating the expected attributes of samples obtained at much 
later time points (wk 16 and 24) and comparing them with actual measured values. The expected 
measurements of volume, length, and height calculated using our previously established equations 
(Fayaz et al. 2020b) were strongly and positively correlated with the actual physical measurements 
of representative samples at wk 16 and 24 (volume: r = 0.99, n = 12, P < 0.001; length: r = 0.95, 
n = 12, P < 0.001; height: r = 0.97, n = 12, P < 0.001). 
The overall diameter and density of cords increased over time (P < 0.001 for both; Fig. 7.6A and 
7.6B). Also, diameter of cords in grafts was greater than that of implants at all sampling time points 
except for wk 2 (P < 0.001). The density of cords was also greater in grafts at wk 2, 6, 8, 16, and 
24 (P < 0.001). When comparing implants at a given time point with grafts of two time points 
earlier, to correct for the perceived delayed development of implants, the diameter of cords was 
~22% greater only in 24-wk implants compared to 8-wk grafts (P < 0.001). Similar to the diameter, 
the density of cords was not different at earlier time points with 4 wk developmental interval 
between grafts and implants but at later time points with 10 and 16 wk intervals, density of cords 
was greater in grafts (P < 0.001). 
In sections stained against UCH-L1, the percentage of Sertoli cell-only cords or tubules decreased 
by ~48% from wk 4 to 24 in both grafts and implants (P < 0.001) and overall ~15% more 
cords/tubules in grafts displayed this morphology than implants (P = 0.001; Table 7.1). From wk 





types (Fig. 7.7). However, from wk 2 to 8, the percentage of cords/tubules with 
gonocytes/spermatogonia as the most advanced germ cells increased by ~28% in both sample 
types, followed by ~64% decrease from wk 8 to 24 (P < 0.001). Overall, the number of 
gonocyte/spermatogonia-containing cords/tubules were ~10% greater in implants than grafts (P = 
0.005; Table 7.1). Spermatocytes were first observed in grafts and implants at wk 16. In grafts, the 
percentage of cords/tubules containing round and elongated spermatids were 10.97 ± 1.35 and 7.00 
± 1.52, respectively, while no spermatids were detected in the corresponding implants.  
Masson’s trichrome staining allowed visualization of collagen and muscle fibers located at the 
basement membrane of vascular walls, and thereby allowed identification of blood vessels in 
histological sections (Fig. 7.8). In both grafts and implants, the number of detected vessels 
decreased over time (P < 0.001; Fig. 7.6C), whereas their total measured area increased (P = 0.006; 
Fig. 7.6D).  
7.4.3. UBM vs. Histological Findings 
Comparison between 2-D UBM images and their corresponding histological sections revealed that 
the observed ventral hyperechoic line in 2-D UBM images corresponded to a dense fibrous capsule 
in histological sections. This capsule was not limited to the ventral boundary in histological 
sections and surrounded both sample types. Only the ventral part of the capsule was discernible in 
2-D UBM images. Also, in histomorphometric evaluations, the capsule showed thinner 
interconnecting branches with interstitial connective tissue within the tissue grafts, which was not 
identifiable by UBM (Fig. 7.3). 
Cordal, non-cordal, and fluid-filled cavity areas on histological sections corresponded to the hypo- 
(dark), hyper- (white), and anechoic (black) areas on 2-D UBM images, respectively (Fig. 7.3J-3R 
and Fig. 7.4). These areas on the largest 2-D UBM images were strongly and positively correlated 
with their corresponding areas on histological cross-sections (r = 0.81, n = 25, P < 0.001; Fig. 
7.9A). In implants, the distribution of cords appeared to be random but was near the fibrous 
capsule, while the cavities and non-cordal areas were located centrally at all examinations and 
sampling time points (Fig. 7.4). Although cords developed towards the central areas, still the 
density of cords was lower in the central vs. peripheral areas of implants at wk 24. Also, the total 
pixel intensity of implants on the largest 2-D UBM images was positively correlated with the 





0.001; Fig. 7.9B). In grafts, uniform echogenicity and distribution of cords was found in 2-D UBM 
images and histological sections, respectively. In 2-D UBM images anechoic areas of fluid-filled 
cavities were identified in 6 and 2 cell implants at wk 2 and 4, respectively, whereas in histological 
sections, these cavities appeared in 2 and 1 implants at wk 2 and 4, respectively. Cavities and 
movements of their contents were detectable as early as 1 wk by UBM and medial to lateral 
changes to their 2-D shape could be visualized by movements of the probe. In histological sections, 
the architecture of these cavities as well as their surrounding cellular and non-cellular zones were 
visualized with more accuracy. Additionally, the number of flow-dependent signals, recorded in 
colour Doppler mode, was negatively correlated with the number of vessels on histological 




















Table 7.1. Histomorphometric analysis of cell implants and tissue grafts at different retrieval time 
points showing the percentage (mean ± SEM) of cords/tubules with the most advanced germ cells.  
     week 
Parameter  Sx type 2  4  6  8  16  24  
Sertoli cell-only 
cords/tubules  
Implant 46.21 ± 0.72A 44.55 ± 0.95A 33.39 ± 0.1B 31.64 ± 3.83B 30.60 ± 3.56B 23.41 ± 1.51C 
Graft 52.70 ± 2.58A 48.49 ± 1.91A 39.51 ± 0.67B 39.16 ± 2.20B 33.77 ± 2.73B 25.029 ± 1.30C 
Gonocyte/ 
spermatogonia  
Implant 53.78 ± 0.72A 55.44 ± 0.96AB 66.60 ± 0.06BC 68. 35 ± 3.83C 36.08 ± 0.60D 25.36 ± 5.88D 
Graft 47.29 ± 2.60A 51.51 ± 1.92AB 60.49 ± 0.68BC 60.83 ± 2.20C 27.25 ± 3.38D 21.47 ± 6.78D 
Spermatocyte 
Implant - - - - 33.31 ± 3.90 51.22 ± 6.93 
Graft - - - - 38.96 ± 4.27 35.52 ± 3.59 
Round spermatid 
Implant - - - - - - 
Graft - - - - - 10.97 ± 1.35 
Elongated 
spermatid 
Implant - - - - - - 
Graft - - - - - 7 ± 1.52 














Fig. 7.1. Experimental design of the present study. Teste (n = 30) were collected by aseptic 
castration of 1-wk-old piglets and the parenchyma was used to prepare small fragments (~14 mm3). 
Using the same source, testis cell aggregates, comprised of ~40% gonocytes, were isolated (100 × 
107 cells/mL) by enzymatic digestion. Dorsal skin of immunodeficient recipient mice (n = 6) was 
prepared, testis tissue grafts embedded in small subcutaneous pouches on 4 grafting sites on the 
right side and cell implants injected into 4 contralateral sites on the left side (0.1 mL/injection site). 
Starting from wk 1 post-grafting/implantation, each site was examined using ultrasound 
biomicroscopy (UBM) every wk for the first 8 wk and then every 4 wk until 24 wk. Following 
UBM examination, randomly-selected grafts and corresponding cell implants were surgically 
removed for (immuno)histochemical evaluation at 2, 4, 6, 8, and 16 wk. Grafts and implants, 
included in the retrieval were defined as R1-R3/L1-L3. Nevertheless, the most caudal samples 










Fig. 7.2. Three-dimensional (3-D) reconstruction of a representative subcutaneous tissue graft and 
its contralateral cell implant from wk 1 to 24. Using a built-in feature of the Vevo Lab software 
(Vevo LAB, Version 3, Fujifilm VisualSonics Inc, Toronto, ON, Canada), the borders of each 
sample were delineated every 0.5 mm on 2-D UBM images in three axes in order to construct 
polyhedral 3-D representation of each sample. Reconstructed images could be moved in different 
orientations for a better visualization of their 3-D growth estimation analysis and shape changes. 



















Fig. 7.3. Representative 2-D UBM images and largest histological sections of grafts (A-I) and 
implants (J-R). Both sample types were covered by dorsal skin on the top (yellow triangles; A-C 
and J-L) and fibrous capsule, which could only be detected in the lower boundary of grafts and 
implants (blue arrows; A-C, G-I, J-L, and P-R). The tissue grafts were composed of seminiferous 
cords/tubules in histological sections, representing a homogenous structure in 2-D UBM images. 
However, cell implants consisted of different echogenic areas. By comparing UBM with the largest 
histological sections, these areas could be defined as cordal areas (blue triangles; P-R), appeared 
as hypoechoic (grey; J-L), non-cordal areas (white asterisks; P-R), appeared as hyperechoic (white 
asterisks; J-L), and fluid-filled cavity areas (green arrows; P), appeared as anechoic (dark; J). The 






Fig. 7.4. Histological sections and their corresponding 2-D UBM images of representative cell 
implants at the largest section and at different time points. The fluid-filled cavities with 
eosinophilic content in histological sections appeared as anechoic areas in 2-D UBM images. In 
UBM examination, these cavities were present in 6 implants at wk 2 and were disappeared and 
replaced by connective tissue by wk 6. By wk 24, implants size and density of cords increased. 






Fig. 7.5. UBM measurements (mean ± SEM) of tissue grafts and cell implants. “Sx” denotes tissue 
grafts or cell implants. “Location” denotes cranial, mid-cranial, mid-caudal and caudal 
grafting/implantation sites on the dorsal skin of recipients. “Area type” denotes cordal, non-cordal, 
and fluid-filled cavity area. The first and second numbers on the horizontal axis refers to 
examination wk of the grafts and implants, respectively (H). “A, B, and C” denote statistically 
significant differences between locations (E) or over time (F and H). “X and Y” denote statistically 
significant differences between cordal/non-cordal area (G) or tissue grafts/cell implants (H) and P 






Fig. 7.6. Histological measurements (mean ± SEM) of retrieved samples. (A and B) Diameter and 
density of cords increased over time (P < 0.001 for both). Also, the diameter and density of cords 
in grafts were greater compared to those in implants retrieved at a later time point (P < 0.001). (C 
and D) Although in histological sections, number of blood vessels gradually decreased (P < 0.001), 
their area increased (P = 0.006). This may indicate over time formation of vascular anastomoses 
and integration of small capillaries to form larger vessels. “A and B” denote over time statistically 
significant differences. “X and Y” denote statistically significant differences between tissue grafts 














Fig. 7.7. Immunolocalization of UCH-L1 (PGP9.5) in germ cells of cell implants (A and B) and 
tissue grafts (C, D, E, and F). Gonocytes/spermatogonia were the most advanced germ cells in 2-
wk implants (A) and grafts (C). Elongated and round spermatids were first identified in tissue 
grafts at wk 24 (D), while spermatocytes were the most advanced germ cells in implants at wk 24 















Fig. 7.8. Representative photomicrographs of grafts (A and B) and implants (C and D) at wk 2 (A 
and C) and 24 (B and D) as well as representative 2-D UBM images of implants at the largest 
section in colour Doppler mode at wk 2 (E) and 24 (F). Masson’s Trichrome staining (A-D) was 
used to visualize the vascular wall in grafts and implants and to quantify the blood vessel 





respectively (A-D). The number of blood vessels in histological sections decreased over time, 
while their area increased, possibly due to convergence of small capillaries to form large vessels. 
However, flow-dependent signals increased in colour Doppler mode, indicative of greater 
detectability of larger vessels by UBM. Inset or green arrow shows a representative blood vessel 





















Fig. 7.9. Correlation analysis between UBM and histological attributes of retrieved samples. A 
positive correlation between percentage of areas in UBM and histological sections (r = 0.81, n = 
25, P < 0.001) was indicative of UBM accuracy in predicting area of cordal, non-cordal and fluid-
filled cavities (A). Similarly, positive correlation between total pixel intensity on 2-D UBM images 
and non-cordal area of implants (r = 0.87, n = 25, P < 0.001) points at UBM ability in 


















Longitudinal changes in ectopic testis tissue grafts and cell implants were evaluated using UBM 
and (immuno)histology of samples retrieved over a 24-wk period. Previously, we demonstrated 
the feasibility of UBM and validated this approach for examination of grafts and implants in two 
separate studies (Awang-Junaidi et al. 2020; Fayaz et al. 2020b). Here, for the first time, we 
applied this repeatable monitoring approach to visualize changes in volume, dimensions, and 
structures of grafts and implants in a long-term study and used (immuno)histochemical analyses 
to support the accuracy of UBM measurements. More importantly, to demonstrate the 
developmental gap between the grafts and implants, we used a novel approach in our analyses, 
where, for the first time, we showed a developmental gap of ~4 wk between grafts and implants 
by comparing two sample types at various time points. Additionally, using UBM, we also revealed 
differences in developmental potential for de novo formation of seminiferous cords depending on 
the craniocaudal site of implantation. To our knowledge, the present study is the first to describe 
side-by-side and gradual histological and UBM changes in tissue grafts and cell implants over a 
6-month period by obtaining samples at various time points.  
As a novel imaging multimodality, UBM has been successfully used in a range of studies to 
visualize different structures in vivo and in vitro (Baerwald et al. 2009; Mircea et al. 2009; Greco 
et al. 2012; Pfeifer et al. 2012; Awang-Junaidi et al. 2020; Fayaz et al. 2020b). In female 
reproductive biology, due to its high accuracy, UBM has been used to study the ovarian dynamics 
and details in various species (Baerwald et al. 2009; Jaiswal et al. 2009; Mircea et al. 2009; Pfeifer 
et al. 2012, 2014). Similarly, TTX and TCAI studies require a reliable and consistent assessment 
methodology; however, until recently there was no standardized method for evaluation of 
xenogeneic testis tissue grafts and cell implants, other than their surgical retrieval and/or post-
mortem histopathological analyses of samples (Honaramooz et al. 2002, 2007). To address this 
limitation, we recently performed proof-of-concept and validation studies on the use of UBM for 
non-invasive monitoring of grafts and implants in short-term experiments (Awang-Junaidi et al. 
2020; Fayaz et al. 2020b). In the latter studies we showed the UBM reliability and accuracy for in 
vivo examination of grafts and implants. 
Here, the initial decrease in dimensions and volume of implants may be explained by gradual 





volume of the corresponding grafts increased from wk 1 to 24. Following the initial decrease, the 
constant increase in implants volume/orthogonal dimensions up to wk 24 may be due to both cavity 
replacement with connective tissue and gradual development of cordal areas. In implants, the 
percentage of cordal areas on histological sections was previously shown to remain unchanged 
between wk 2 and 6 (Fayaz et al. 2020b). However, UBM cordal volume increased over time in 
all implantation locations. Being consistent with previous findings (Awang-Junaidi et al. 2020), 
we speculate that the greater cordal volume in more cranial implants, compared with more caudal 
implants, is the result of vicinity to blood supply from larger arteries such as branches of the 
subclavian artery and/or less cutaneous tension providing more favorable conditions for implant 
development. The increase in cordal volume from wk 2 to 24 is likely because of expansion of the 
cordal areas toward the center of implants over time (Fig. 7.5E). Additionally, positive correlations 
between the percentage of areas on 2-D UBM images and histological sections further supported 
the accuracy and reliability of UBM in predicting the cordal/non cordal areas or volumes in 
implants, indicating that such UBM estimations can reliably represent actual morphological 
changes (Fig. 7.9A). Similarly, given the hyperechoic appearance of non-cordal areas (Fayaz et al. 
2020b), the total pixel intensity on 2-D UBM images and non-cordal areas on histological sections 
were positively correlated and thereby, corresponding areas can be reliably measured on 2-D UBM 
images (Fig. 7.9B). 
The combined effects of gradual cordal development, lumen formation, and increased diameter 
and density of cords, may have led to the observed decreased cordal echogenicity and as such, 
reduced the cordal pixel intensity over time. Conversely, unchanged non-cordal pixel intensity 
may point to the echogenic nature of connective tissue with limited structural changes over time 
due to their relatively constant cellular and extra cellular matrix contents (Fig. 7.5F, 7.6A, and 
7.6B). The observed changing patterns of cordal/non-cordal pixel intensities can also highlight the 
ability of UBM in detecting gradual cordal development and differentiating components within a 
mass. This finding is in agreement with previous studies where UBM was reported to be an 
effective tool in visualizing detailed structures such as small antral follicles, luteal tissue, and 
stroma of mouse and human ovaries (Baerwald et al. 2009; Mircea et al. 2009). Higher pixel 
heterogeneity in cordal areas compared with non-cordal areas could be possibly due to cellular 
organization and cordal formation leading to varying echogenic spots, all within the cordal areas. 





contained dense connective tissue and as such, appeared as hyperechoic spots; in contrast, cordal 
formation spots were less echogenic, which, taken together, led to greater pixel heterogeneity in 
cordal areas (Fig. 7.3J-R and 7.5G). 
As previously described in our preliminary study, color Doppler UBM can be effectively used to 
detect flow-dependent signals (Awang-Junaidi et al. 2020). Flow-dependent signals and blood 
vessels were detected as early as wk 1 in UBM images and wk 2 in histological sections, 
respectively, in interstitial and peripheral connective tissues. Prevalence of cellular arrangements 
and small capillaries near the implant boundaries, as observed during our colour Doppler 
examinations, may suggest that testis cells initially become attracted to areas with better access to 
blood vessels. Over time, the vessels further penetrated toward the center of implants. The 
observed pattern of vessel development from periphery to the center was also supported by 
histological observations.  
We also found that the number of flow-dependent signals increased by 68% in grafts and 83% in 
implants from wk 1 to 24. Expectedly, the additional time required for cellular reorganization in 
implants leads to a developmental delay compared with age-matched grafts (Honaramooz et al. 
2007; Fayaz et al. 2020b). To compensate for this developmental delay, we compared the implants 
of a given time point with grafts of an earlier time point. However, despite shifting the relative 
developmental stage of implants back by 2 wk, a greater number of flow-dependent signals was 
detected in 4-wk grafts compared with 6-wk implants. This might indicate that similar to initiation 
of spermatogenesis that was reported to occur at least 3 wk later in implants compared with grafts 
(Honaramooz et al. 2007), different stages of vascular development may also be delayed by 3 wk 
or more. 
UBM did not detect the same extent of vessels as that observed in histological sections of the same 
samples. This is perhaps not surprising given the vast difference between the two approaches and 
may be partly due to the low sensitivity of colour Doppler mode in detection of weak flow-
dependent signals. In histological examinations, the number of vessels decreased by 67% in grafts 
and 47% in implants from wk 1 to 24, which was also revealed by a negative correlation between 
the number of flow-dependent signals in UBM and the number of vessels in histological sections 





sections increased by 20% in grafts and 123% in implants (Fig. 7.6D), indicating that small vessels 
converge to form large blood vessels that can be detected by UBM (Fig. 7.8). 
Furthermore, the estimated physical measurements, obtained from our previously-introduced 
equations (Fayaz et al. 2020b) were all positively and strongly correlated with the actual measured 
values, suggesting that these equations can be used reliably in future experiments to predict the 
size and volume of grafts and implants. 
As was described previously, cordal development commences earlier within tissue grafts, while 
cell implants need to undergo cellular reorganization and cord formation in the first ~2 wk 
following implantation (Fayaz et al. 2020b). Here, since diameter and density of cords in grafts 
were greater than those of implants at multiple time points, the developmental delay was then 
adjusted in analyses by comparing implants with grafts of two earlier time points. Using these 
comparisons, we showed that the initial developmental status of implants was not different from 
that of grafts obtained 4 wk earlier, indicative of ~4 wk of developmental delay for cell implants. 
At later time points, when the developmental gap was larger, expectedly, the diameter of cords 
was greater in implants; however, density of cords was still greater in grafts. This may indicate 
that the density of cords in grafts undergoes an exponential increase over time. Overall, grafts 
seemed to adapt to the new in vivo environment sooner and show a greater diameter and density 
of cords especially at later stages of the study. This phenomenon may be suggestive of an amplified 
developmental gap between grafts and implants at later time points and warrant further 
investigation. 
In the present study, we observed a decrease of ~48% in the overall number of Sertoli cell-only 
cords and tubules, alongside an increased number of germ cell-containing cords/tubules for both 
grafts and implants, which point to the gradual proliferation and differentiation of germ cells. 
Compared with implants, grafts possessed a higher percentage of Sertoli cell-only cords/tubules. 
This may be indicative of greater germ cell loss in the grafts or an abundance of germ cells within 
the newly formed cords of implants. This was rather surprising and is likely as a result of using 
testis cells with a high proportion of gonocytes (~40%) for implants. The increase in gonocyte 
proportion was a strategy we have started to implement (Awang-Junaidi et al. 2020; Fayaz et al. 
2020b) to overcome an earlier reported problem where the newly-formed cords/tubules in implants 





However, even though a lower number of cords/tubules contained germ cells in grafts, they were 
more efficient at later stages in giving rise to more developed germ cells such as round and 
elongated spermatids. The percentage of spermatogonia-containing cords/tubules gradually 
decreased in both sample types, which was expected as gonocytes differentiated, leading to 
appearance of cords/tubules with more advanced germ cells. 
We first identified spermatocytes at 16 wk in both sample types and spermatids at 24 wk in grafts 
but not in their corresponding implants. The absence of spermatids in cell implants by 24 wk can 
further highlight our proposed increase in the developmental gap between grafts and implants over 
time. Here, although germ cell differentiation up to the elongated spermatid stage was evident in 
tissue grafts by 24 wk, no sperm was found, suggesting that complete development of the grafts 
and implants would have required more time. This finding is in line with previous TTX studies, 
where fully formed sperm appeared at later time points (by ~27 wk in grafts and ~30 wk in cell 
implants) (Honaramooz et al. 2002, 2007; Abbasi and Honaramooz 2010) (Table 7.1). 
Overall, UBM and histomorphometric findings in the present study suggest that UBM can be used 
to accurately document the long-term development of xenogeneic testis tissue grafts and cell 
implants. In agreement with previous reports (Dada et al. 2011; Schöne et al. 2016; Awang-Junaidi 
et al. 2020; Fayaz et al. 2020b), the present results are indicative of high potential of UBM in 
predicting the changes in sample size and structural composition. Therefore, UBM can be used 
independently to evaluate testis grafts and implants at various time points, which eliminates the 
need for frequent sample retrieval for (histo)morphometrical evaluations and, as such, reduces the 
number of animals required in future experiments. This is an important consideration in time-
course experiments, especially where recipient animals such as immunodeficient models are being 
used. Also, UBM is unique in that it can provide non-invasive repeated measurements of the same 
samples to improve the analysis power while reducing the overall number of samples needed. 
Furthermore, evaluation using UBM can lead to more consistent results, which circumvents some 
of the potential bias caused by incomplete sample retrieval and/or distortion due to fixation 
process, commonly observed in histological evaluations. 
In conclusion, the present study is first to reveal different developmental levels between 
grafting/implantation locations in recipient mice by using long-term side-by-side UBM and 





demonstrated accurate estimation of developmental gap between the xenogeneic tissue grafts and 
cell implants. The strong correlations and agreements between histology and UBM findings in the 
present study showed that UBM can be used independently for visualization of changes in 
orthogonal dimensions, volume, and structural composition of grafts/implants in both short- and 
long-term studies. Therefore, given the non-invasiveness and repeatability of UBM, it can be 
introduced as an excellent tool for longitudinal studies of testis grafts and implants with high 
consistency. Although this study was conducted using superficial testis grafts and implants, the 




















GENERAL DISCUSSION AND FUTURE DIRECTIONS 
8.1. General Discussion 
Testis is a multifunctional organ and the prominent source for production of spermatozoa and 
androgens throughout the reproductive life of an individual. The dual function of spermatogenesis 
and steroidogenesis by the testes requires a complex structural foundation to allow signaling 
cascades, cell-cell interactions, and paracrine regulation within and among different testicular 
compartments. Despite multiple studies and tremendous progress on understanding the 
pathophysiology of the male reproductive system, and particularly the gonads, our knowledge of 
testis development and function is limited due to its structural, functional, and developmental 
complexities. Alternative strategies such as in vitro and in vivo culture systems have contributed 
significantly to exploration of unknown and complex aspects of testis formation and function. 
Therefore, we used these approaches to study some of the underlying factors which can possibly 
affect regulation of testicular cell and/or tissue development using porcine testis as donor tissue. 
The following paragraphs contain a brief description of general discussion of our findings in each 
study, as well as a general conclusion based on our overall findings. 
8.1.1. In Vitro Effects of Different Media and Serum Types on Porcine Germ Cell Proliferation, 
Colony-Formation, Ultrastructure, and Potency 
Germline stem cells are a promising source of adult stem cells with dual potential of proliferation 
and differentiation towards production of spermatozoa. These cells possess a range of potential 
applications from GCT and fertility preservation to tissue regeneration and stem cell therapy (Jiang 
and Short 1998a; Bai et al. 2018; Chen et al. 2020). Therefore, as demonstrated in Chapter 3, using 
stepwise experiments, we tested the effects of 6 different culture media (i.e., DMEM, DMEM/F12, 
GMEM, α-MEM, RPMI and StemPro SFM) each supplemented with 3 different concentrations of 
FBS and/or KSR on porcine germ cell proliferation, colony-formation, ultrastructure, and 
expression of pluripotency markers in a long-term co-culture of germ-Somatic cells. We showed 
that DMEM+15% FBS could effectively increase the number of germ cells, while culture in 
combination of DMEM+5% FBS+10% KSR resulted in greater tendency of gonocytes to form 





survival largely depends on their communication to and attachments with somatic cell monolayer. 
We also found that most populations of germ cells in culture developed pseudopodia, enabling 
them to freely migrate on top of the monolayer and towards each other, thereby initially forming 
colonies and EBLCs at later developmental stages. Using TEM and immunofluorescence assay, 
we found the EBLCs to be multi-nucleated large structures surrounded by individual gonocytes. 
One of the exciting findings in our study was that gonocytes cultured in DMEM+15% FBS, 
without addition of growth factors or other supplements, spontaneously reprogrammed into 
primitive stages and expressed markers that are normally present in ES cells such as POU5F1, 
SSEA-1, NANOG, and E-cadherin. This is especially important since generation of ES cell-like 
cells from MGSCs typically require addition of different factors (e.g., growth factors or cytokines), 
multiple passages, or exposure of the cells to gene transcripts to induce pluripotency (Jiang and 
Short 1998a; Seandel et al. 2007; Zhang et al. 2013; Bai et al. 2018; Chen et al. 2020). Thus, our 
findings offered a facile approach to increase the number of MGSCs and were indicative of great 
potential of neonatal germ cells to be used as a source of adult stem cells for applications in 
regenerative medicine, restoration of fertility, or transgenesis. 
8.1.2. Effects of Individual and Combined Growth Factor Concentrations on Porcine Germ 
Cell Proliferation, Colony-Formation, and Potency 
As discussed earlier, numerous applications of MGSCs, including gonocytes, make them an 
attractive source for in vitro studies. Gonocytes are considered a superior source of MGSCs due 
to their identifiable morphology, feasibility of using cell-specific markers for their identification 
and isolation, and relatively greater population in the neonatal testes. Hence, in Chapter 4, using 
the selected base media composition in Chapter 3 we designed stepwise experiments to explore 
the effects of individual or combined supplementation of staple growth factors including bFGF, 
GDNF, and LIF on propagation, colony-formation, and expression of pluripotency markers by 
gonocytes. The greatest number of gonocytes were found in culture when media was supplemented 
with 10 ng/mL bFGF and they formed the largest colonies when media was supplemented with 
bFGF+100 ng/mL GDNF+1500 U/mL LIF. Also, following growth factor supplementation, 
resultant gonocytes and colonies expressed both germ cell- and pluripotency-specific markers (i.e., 
POU5F1, SSEA-1, NANOG, E-cadherin). It can be speculated that increased bFGF concentration 





better support for germ cell survival and expansion. Similar to our findings, it has been shown that 
supplementation of media with combined growth factors including SCF, LIF, bFGF, IGF enhances 
colony formation of murine germ cells in both cell and tissue culture systems (Jeong et al. 2003; 
Kanatsu-Shinohara et al. 2007). Overall, the results of our study in Chapter 4 clarified unknown 
effects of crucial growth factors that are normally involved in in situ paracrine signaling on porcine 
gonocyte survival and proliferation. In addition, our developed culture composition could be 
applied for in vitro expansion of pluripotent germ cells and their subsequent downstream 
applications in cell-based therapy, transgenesis, and/or conservation of fertility potential. Given 
the structural and physiological similarities between human and porcine testis tissue, in particular, 
our results provided a strong proof-of-concept for the same potential in human germline stem cells. 
8.1.3. Dedifferentiation and Trans-Differentiation Potential of Porcine Germ Cells 
When located in the testis, MGSCs such as gonocytes are unipotently restricted to undergo 
proliferation to maintain their population or differentiation to develop more specialized germ cells. 
Commitment of gonocytes to establish the SSC pool and ultimately initiation of spermatogenesis 
is regulated by their surrounding niche and particularly their engulfing Sertoli cells. As has been 
shown in Chapters 3 and 4 porcine gonocytes have the remarkable feature of expressing 
pluripotency-determining factors when cultured in vitro. This unique characteristic of gonocytes 
is thought to be the result of their release from in situ restrictions, which spontaneously induce 
them to return to primitive stages. In Chapter 5, we investigated in vitro trans-differentiation of 
these cells into somatic cells derivatives of three germinal layers (i.e., endoderm, mesoderm, and 
ectoderm) and also assessed the pluripotency of dedifferentiated gonocytes using an in vivo 
implantation assay. Using differentiation media, specifically designed to direct the differentiation 
of stem cells into osteogenic pathway, we showed that EBLCs formed after ~14 days of culture 
transformed into hydroxyapatite deposition sites, confirmed by Alizarin Red S staining. We also 
showed that gonocytes and EBLCs exposed to tri-lineage differentiation media gradually lost 
expression of gonocyte-specific marker (DBA), while a fraction of germ cells displayed stronger 
expression of lineage-specific markers (i.e., SOX17 and AFP for endoderm, Brachyury and ASM 
for mesoderm, and OTX2 and GFAP for ectoderm) both at gene and protein expression levels. 
Expression of these markers has been previously shown to be crucial for normal development of 





1996; de Jong et al. 2008; Bernardo et al. 2011; Mortensen et al. 2015). This was indicative of 
gradual gonocyte conversion into new population of cells with biomolecular properties of three 
germinal layers. A remarkable finding in this study was development of tumour-like formations 
following implantation of dedifferentiated gonocytes and colonies. These formations showed 
circular/oval patterns and melanin pigmentation. The observed patterns represented similar 
appearance as nests of melanocytes. Additionally, bundles resembling peripheral nerves were also 
observed within these formations. Furthermore, the formations appeared positive for expression 
of lineage-specific markers including AFP, ASM, and GFAP at localized foci, which might be 
indicative of their differentiation into cell derivatives from three germinal layers. Our observations 
in this study confirmed the potential of gonocytes to convert into a pluripotent state previously 
shown in Chapters 3 and 4. Importantly, the study in this chapter has been the first to induce tri-
lineage differentiation in dedifferentiated porcine MGSCs in a shorter period of time, using 
primary cultures and without passaging the cells, which otherwise would have posed unwanted 
changes to their in vitro niche and biochemical properties. These changes would have possibly 
generated confounding factors and negative effects on their self-renewal or differentiation 
properties (Goel et al. 2009). Possible application of germ cell derived-pluripotent stem cells 
eliminates the ethical concerns associated with ES cells and biosafety risks of iPS cells where viral 
vectors are required for their derivation (Chen et al. 2020). Dedifferentiation and trans-
differentiation potential of porcine gonocytes are outstanding findings in that they open windows 
of opportunity for further research on their applicability in clinical settings.  
8.1.4. Validation of UBM for In Vivo Examination of Testis Tissue Grafts and Cell Implants 
Beside in vitro culture systems, in vivo testis tissue and cell culture, known as TTX and TCAI, 
respectively, are invaluable models which provide an easy access in a mouse model to study 
various aspects of spermatogenesis, steroidogenesis, and testis development. Testis tissue and 
isolated testis cells retain their developmental potential even after being separated from the 
parenchyma and are able to ultimately generate spermatozoa when grafted/implanted into the 
subcutaneous tissue of immunodeficient recipient mice (Honaramooz et al. 2002; Honaramooz et 
al. 2007; Honaramooz 2014). Studies using TTX and TCAI models has so far applied surgical 
recovery of the grafts/implants as the endpoint for examination of the developmental status of the 





development depends on the number of grafts/implants. Additionally, post-retrieval fixation and 
processing pose unwanted changes to the samples such as tissue shrinkage, and in turn will lead to 
underestimation of actual dimension measurements. Not to mention, multiple surgical procedures 
on immunodeficient mice increases the risk of infection or post-surgical complications. UBM has 
been applied in different research studies and clinical fields, which overall point at its accuracy 
and reliability in real-time displaying detailed tissue structures including reproductive tissues 
(Pavlin et al. 1992; Turnbull et al. 1995; Foster et al. 2002; Cheung et al. 2005; Nuccitelli et al. 
2006; Spurney et al. 2006; He et al. 2007; Baerwald et al. 2009; Snyder et al. 2009; Stokvis et al. 
2009; Jaiswal et al. 2009; Mircea et al. 2009; Buckley and Stokes 2011; Hibino et al. 2011; Pavlin 
and Foster 2012; Pfeifer et al. 2012; Jaffré et al. 2012; Cervantes et al. 2013). Therefore, in an 
attempt to develop an alternative non-invasive and repeatable approach for assessment of 
grafts/implants in Chapter 5, we compared and correlated a number of UBM attributes obtained 
from UBM examination of the samples prior to their retrieval with their histomorphometric 
measurements obtained post-retrieval. We showed strong positive correlations between UBM and 
histological attributes of the samples such as dimensions and volume and revealed UBM accuracy 
in showing detailed structural changes in the samples through different echotextures within the 
samples. The correlations between pre- and post-retrieval measurements showed that UBM was a 
consistent, accurate, and non-invasive alternative to surgical retrieval of tissue grafts and cell 
implants to monitor their development over time. Application of UBM could reduce the fatality 
among the recipient mice, which in turn would reduce the number of animals required for studies 
with similar applications. 
8.1.5. Long-term Examination of Tissue Grafts and Cell Implants Using UBM 
UBM has shown great promise as a non-invasive examination tool in different fields including 
male reproductive biology (Huang et al. 2021). Also, given the accuracy of UBM in showing 
detailed structural and 3-D changes in both testis tissue grafts and cell implants in Chapter 5, we 
designed and conducted a longitudinal study (Chapter 6) to repeatedly apply this non-invasive 
monitoring tool for evaluation of grafts and implants in immunodeficient recipient mice. In this 
study, we maintained the grafts and implants in recipients for 24 weeks, during which each sample 
was examined every week for the first 2 months followed by monthly examinations up to the end 





changes in graft/implant volume, dimension, and structure, a 4-week developmental gap between 
two sample types, and greater support of the cranial grafting/implantation sites for tissue 
development. The developmental gap between grafts and implants was expectedly the result of the 
time required for re-organization of the testis cells in implants. Since tissue grafts normally 
undergo luminal formation, germ cell differentiation, and spermatogenesis immediately following 
grafting, they possessed a relatively more developed structure compared to their implant 
counterparts. Cells within implants, on the other hand, undergo extensive re-arrangements to first 
re-organise themselves, leading to initial formation of testicular cords, which expectedly set their 
developmental status behind the grafts. Based on the presence of different germ cell types, cordal 
development, and (immuno)histochemical properties of grafts/implants, here we reported a 4-week 
developmental gap between two sample types. Another remarkable finding in the present study 
was varying developmental potential between the graft/implants based on their craniocaudal 
location. Samples located cranially showed relatively greater development, which was possibly 
due to the superior blood supply (i.e., branches of subclavian artery) or less cutaneous tension in 
cranial compared to more caudal locations. We showed that UBM could be used independently 
for examination of changes in orthogonal dimensions, volume, and structure of samples in short- 
and long-term studies, which is also in agreement with previous reports (Dada et al. 2011; Schöne 
et al. 2016; Awang-Junaidi et al. 2020). Taken together, this study has been the first to utilize 
UBM for longitudinal evaluation of grafts/implants showing possible applicability to examine and 
monitor diverse range of superficial structures including neoplastic masses. 
8.2. Future Directions 
8.2.1. Manipulation of Culture Conditions to Enhance Proliferation of Gonocytes  
The developed culture conditions in this thesis (Chapters 3 and 4) can be further manipulated by 
supplementation of different growth factors or various combinations of serum/serum replacements 
to further enhance the proliferation of germ cells or possibly monitor alteration in their in vitro 
behavior. These changes could include supplementation of the cultures with different 
concentrations of FBS and KSR at different time points (e.g., week 1, 2, 3) and/or supplementation 
of media with additional growth factors which was not investigated in this thesis (e.g., IGF, SCF, 
RA, FGF-9, EGF) followed by daily or weekly examination to investigate any possible change in 





be monitored using live-cell imaging and ultrastructural analysis by TEM to detect possible 
alterations in development of cytoplasmic extensions by gonocytes, their migratory behavior, or 
gonocyte/colony structure. In addition to foregoing sera sources and cytokines, culture media 
could be supplemented with hormones (e.g., LH, FSH, testosterone, DHT, or progesterone) or 
additives (e.g., proteins, amino acids, or vitamins) to possibly enhance gonocyte survival and 
proliferation. Since germ cells have been occasionally reported to become overwhelmed by 
excessive proliferation of somatic cells, they could be co-cultured with mitotically inactivated cells 
as a substitute for endogenous testis somatic cells (Nagano et al. 1998; Wei et al. 2016). 
8.2.2. Assessment of Pluripotency State of Cultured Germ Cells Following Injection into 
Immunodeficient Recipients using UBM 
As we showed in Chapter 5, once cultured, neonatal porcine gonocytes convert into a population 
of cells with similar biomolecular properties as ES cells and following implantation into the 
subcutaneous tissue of immunodeficient mice, the cells and colonies generate tumour-like 
formations. UBM could be applied for examination of orthogonal dimensions and structural 
composition of the formations in future studies. Notably, UBM (i.e., Colour Doppler mode) could 
be advantageous in identification of neovessel formation within these neoplastic masses since their 
formation and development expectedly require a high blood supply. Given the accuracy of UBM 
in providing detailed structure of testis grafts and implants, this monitoring method could be used 
at different examination time points (weekly or monthly) following implantation while the 
recipients are maintained for a longer period of time (>2 months) to allow the implants to undergo 
further development. 
8.2.3. Non-invasive Examination of Gonad and Accessory Sex Gland Development in Mice 
using UBM 
Application of UBM in reproductive research has been limited to visualization of female gonads 
or ovarian follicular dynamics in laboratory animals (Jaiswal et al. 2009; Mircea et al. 2009; 
Pfeifer et al. 2012, 2014; Cervantes et al. 2013) and assessment of spermatogenic function in male 
mice following busulfan treatment (Huang et al. 2021). However, no study has utilized this 
monitoring approach for examination of male gonadal development and accessory sex glands from 
prenatal to maturity. Given the accuracy of this technique in displaying slight structural differences 
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A PRELIMINARY STUDY FOR THE DEVELOPMENT OF A GONADOTROPIN- AND 
IMMUNODEFICIENT MOUSE MODEL FOR SUBSEQUENT STUDY OF TESTIS 
TISSUE XENOGRAFTING AND DE NOVO TESTIS TISSUE FORMATION 
Background and rationale: 
Performing hypophysectomy on most mouse strains is challenging and is further complicated in 
immunodeficient mice, which is why the mouse suppliers do not offer this procedure for such 
strains. Development of a hypophysectomized immunocompromised mouse model would provide 
a new window of opportunity for various prospective studies on these animals without the 
interference of endogenous gonadotropins. This model would have applications in various research 
areas including endocrinology, developmental biology, and stem cell biology as well as 
reproduction physiology.  
Objectives and hypotheses: 
The ultimate objective of this study was to develop a gonadotropin- and immunodeficient mouse 
model for the subsequent endocrinology studies. 
Our specific objectives included: 1) to compare the feasibility of trans-auricular and para-
pharyngeal approaches to hypophysectomy using mouse cadavers; and 2) to develop and validate 
the surgical competency to perform survival hypophysectomy to create a gonadotropin-deficient 
immunodeficient mouse model. 
Our specific hypotheses included: 1) the trans-auricular approach to hypophysectomy would be a 
more feasible approach (less invasive and time consuming) than the para-pharyngeal approach; 2) 
the hypophysectomized mice would be able to survive for at least one month post-operation; and 
3) compared to the sham-operated mice, hypophysectomized mice will have significantly reduced 
testis size, vesicular glands, body weight, and germ cell layers in their seminiferous tubules. 
Results: 
Feasibility of the two approaches of hypophysectomy (trans-auricular and para-pharyngeal) were 





method due to better visualization of the gland and hence reducing the risk of damage to the 
surrounding tissues. This approach was adopted for use on live mice; however, it has not yet 
provided satisfactory results because the animals only survived until the completion of the 
operation. Therefore, the para-pharyngeal method of pituitary removal appeared to be more 
achievable and reliable, which does not support our first hypothesis. Our second and third 


























Ventral and dorsal approaches to removing the pituitary gland in mouse cadavers aimed at locating 
this gland in mice. (A) In the ventral approach, using a freshly euthanized mouse, the structures 
covering the base of the skull were completely removed. The occipital bone located between the 
two tympanic bullae (one tympanic bulla is shown with a green asterisk) was cut out (yellow 
arrows) to access the cranium structures, including the pituitary gland, through the window created 
in the cranial floor (blue asterisk). (B) Using a dorsal approach and after removing the brain, the 
pituitary gland (green arrows) is readily visible located between the two trigeminal nerves (blue 
asterisks). The sample was fixed in Bouin’s solution prior to dissection to maintain the structures 

















Histological appearance of the collected pituitary gland in mice. (A) Low magnification of the 
complete pituitary gland stained with H&E. Two purple structures (yellow asterisks) surrounding 
the middle lightly stained structure are pars distalis region of the adenohypophysis (anterior 
pituitary gland). (B) Higher magnification of the pituitary gland reveals the typical histological 
attributes including the presence of both acidophil cells (pink in color) and basophil cells (purple) 
on the upper parts of the image indicating the adenohypophysis, presence of the Rathke’s pouch 
as a gap in the middle of the image, presence of basophil cells indicating the pars intermedia 
(intermediate lobe), and the nervous tissue of the pars nervosa (posterior pituitary or 










Investigating the feasibility of two standard approaches of hypophysectomy on euthanized mice. 
Position of the inserted needle tip shown after necropsy of a mouse undergoing trans-auricular 
approach to hypophysectomy (A) and the location of the pituitary gland in a fixed sample for 
comparison (B). Even after the needle was successfully passed through the external and internal 
auditory canals, the sharp needle tip and lack of visual control pose too great a risk to the animal 
for the approach to be practical because the pituitary gland is in close proximity to the trigeminal 
nerves and other nervous structures including the hypothalamus. In the left panel (A), the 
proximity of the trigeminal nerves (green arrows), to the pituitary gland (blue arrow) is shown 
along with the position of the inserted needle tip (yellow arrow). The yellow asterisk indicates the 
rolled over brain. In the right panel (B), the pituitary gland (green asterisk) is shown in between 
the two trigeminal nerves (blue asterisks); the red asterisk indicates the displaced brain. (Scale bars 









The para-pharyngeal approach to hypophysectomy in mouse cadavers. (A) The skin is incised, the 
soft tissues including the salivary glands (blue asterisks), trachea and muscles are retracted using 
a paper clip as a retractor. The pharyngeal mucosa is removed to make the base of the cranium 
visible (blue arrow). (B) The sagittal crest along with the blue line representing the spheno-

















Pituitary removal in euthanized mice. (A) After performing para-pharyngeal hypophysectomy in 
mouse cadavers, the cranium was opened to observe the location of the hole. In this case, the point 
of the burr was placed caudal to the synchondrosis making a perforation behind the pituitary gland 
(blue arrow). The pituitary (yellow asterisk), the optic chiasma (green arrow) and trigeminal nerves 
(green asterisks) can be identified in this image. (B) The brain case is removed to investigate the 
extent of damage and the exact location of the perforation. Yellow asterisk in this figure shows the 
















Practicing removal of the pituitary gland from anesthetized survival mice. (A) Soft tissues are 
retracted and the muscles are dissected to provide visualization of the spheno-occipital 
synchondrosis (green arrow). (B) The synchondrosis is known as the hallmark of location of the 
pituitary gland located directly dorsal to the suture between the occipital and sphenoid bones. 
Using a fine burr attached to a rotor and utilizing the lowest rotation speed, the base of the skull 
(green asterisk) is perforated to gain access to the pituitary gland (blue arrow). The white color 
structure located dorsal to the bone represents the gland (yellow arrow). Using a blunt 16G needle 
attached to a suction pump set to 15 in-Hg (inch mercury) pressure, the gland was removed from 
its place and the soft tissues were returned to their original location. The skin was closed using 
wound clips and the mouse was monitored for any abnormal signs. (Scale bars = 1 mm) 
 
